cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
108031,Trichloro(chloromethyl)silane,216-316-9,1558-25-4,Skin Corr. 1B;Acute Tox. 1,Notified C&L,70,H314:70;H330:64;H335:5;H318:1
108032,(±)-2-(tert-butylamino)-3'-chloropropiophenone hydrochloride,250-759-9,31677-93-7,Not Classified,Notified C&L,106,Not classified:52;H302:54;H410:3;H319:6;H400:4;H332:1;H312:1;H370:1;H372:1;H411:1
108036,Phenoxyacetyl chloride,211-862-4,701-99-5,Skin Corr. 1B;STOT SE 3,Notified C&L,48,H314:48;H335:42;H318:2;H290:1
108037,"Phenol, tetrapropylene-, sulfurized, calcium salts",602-701-2,122384-85-4,Aquatic Chronic 4,Notified C&L,29,H413:28;Not classified:1
108038,"9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-(hydrogen phosphonate)",206-636-7,360-63-4,Repr. 1B;STOT RE 1;Aquatic Chronic 1,Notified C&L,1,H372:1;H360:1;H410:1
108040,"Bicyclo[2.2.2]oct-7-ene-2,3:5,6-tetracarboxylic dianhydride",217-009-2,1719-83-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:42;H315:44
108042,"Trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]cobaltate(3-)",282-438-4,84204-70-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,8,H412:5;H317:8;H319:8
108046,"Epoxides, C>8-alkyl",270-215-4,68413-40-1,Not Classified,REACH registration C&L,25,Not classified:3;H315:22
108047,"Trisodium 5-[[4-[[4-[[4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulphonato-1-anthryl)amino]-2-sulphonatophenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]phenyl]azo]salicylate",229-309-0,6471-09-6,Not Classified,REACH registration C&L,10,Not classified:10
108048,6-deoxy-L-mannose,222-793-4,3615-41-6,Not Classified,REACH registration C&L,130,Not classified:130
108050,"Oleic acid, compound with diethylamine (1:1)",241-242-9,17200-00-9,Not Classified,Notified C&L,6,Not classified:5;H226:1
108052,3-anilinopropanesulphonic acid,277-117-0,72943-20-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
108053,Ethyl 4-[[(methylphenylamino)methylene]amino]benzoate,260-976-0,57834-33-0,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,271,H373:33;H411:34;H302:218;Not classified:19;H317:17;H315:1
108059,Iridium trinitrate,242-382-3,18496-38-3,Not Classified,Notified C&L,1,Not classified:1
108060,"4-Chloro-1-(2-mehtylpropyl-1H-imidazo[4,5-c]quinoline",619-386-2,99010-64-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H302:2;H319:2;H335:2;H315:2
108063,"Fatty acids, tall oil, reaction products with glycidyl neodecanoate",617-001-2,80207-00-7,Muta. 2;Aquatic Chronic 2,REACH registration C&L,72,H341:1;H411:1;Not classified:71
108067,Prolactin,618-335-1,9002-62-4,Repr. 1B,Notified C&L,38,H360:38
108068,Hydroxyectoine,605-411-4,165542-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
108073,"9-Octadecenoic acid (Z)-, ester with 1,2,3-propanetriol",253-407-2,37220-82-9,Not Classified,Notified C&L,168,Not classified:153;H303:15;H333:15
108076,"[5-(2,4-dihalophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methanol",604-005-4,137186-20-0,Not Classified,Notified C&L,1,Not classified:1
108077,"Octane, 1,2-dibromo-",613-071-3,6269-92-7,,Notified C&L,1,H332:1;H302:1;H312:1
108080,Alcohol alkoxylate,603-496-2,131594-92-8,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,33,H411:31;H400:32;H315:33;H319:1
108081,"reaction product of diphenylamine, phenothiazine, and alkenes, branched (C",439-540-0,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0;H315:0
108083,Pentadecafluorotriethylamine,206-632-5,359-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;H314:1
108093,p-menthane-3-carboxylic acid,254-582-8,39668-86-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
108103,"2,2',3,3,3',3'-hexahydroxy-2,2'-bisindan-1,1'-dione",227-713-1,5950-69-6,Eye Dam. 1,Notified C&L,1,H318:1
108105,"pirimiphos-methyl (ISO);pirimiphos-methyl (ISO); O-[2-(diethylamino)-6-methylpyrimidin-4-yl] O,O-dimethyl phosphorothioate;O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate",249-528-5,29232-93-7,Acute Tox. 4;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H372:0;H410:0;H400:0
108106,"Dodecylphenol, ethoxylated, phosphates",500-106-1,39464-67-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H318:2;H411:1;H315:2
108111,"9-Octadecenoic acid (Z)-, reaction products with N-(3-aminopropyl)-1,3-propanediamine",282-510-5,84238-54-0,Not Classified,Notified C&L,7,Not classified:7
108114,Ethyl chlorophenylacetate,225-315-2,4773-33-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
108116,2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica,419-030-4,125804-20-8,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H336:0;H319:0;H225:0
108119,Bromperidol,233-943-3,10457-90-6,Acute Tox. 4,Notified C&L,46,H302:46;H332:7;H336:7
108120,"3,3-Bis(4-diethylamino-2-ethoxyphenyl)-4-azaphthalide",603-598-7,132467-74-4,STOT RE 2,Notified C&L,1,H373:1
108121,"Glycine, N,N'-ethylenebis[2-(o-hydroxyphenyl)-, tetrasodium salt",608-422-2,29854-01-1,Not Classified,Notified C&L,1,Not classified:1
108122,"Ethanaminium, N-[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, molybdatetungstatephosphate",215-406-5,1325-75-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H319:1;H400:1
108125,"(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide",404-940-6,86608-70-0,Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0;H373:0
108130,"Soybean oil, reaction products with ethaneperoxoic acid",614-947-8,693217-63-9,Skin Mild Irrit. 3;Eye Irrit. 2,REACH registration C&L,6,H320:1;H316:1;H319:5
108132,5-allyl-5-phenylbarbituric acid,204-089-9,115-43-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,39,H301:39;H319:38;H331:38;H315:38
108134,4-phenoxybutyryl chloride,225-903-9,5139-89-9,,Notified C&L,4,H314:4
108137,o-nitroaniline,201-855-4,88-74-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H301:0;H331:0;H311:0;H373:0
108140,DL-glyceraldehyde 3-phosphate,209-721-7,591-59-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
108141,"1-Octadecanol, phosphate, potassium salt",273-489-3,68987-29-1,Eye Irrit. 2,REACH registration C&L,112,H319:38;H318:66;H315:66;Not classified:8
108142,"N,N-dimethyl-1-(trimethylsilyl)amine",242-020-4,18135-05-2,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H311:1;H332:1;H314:1;H225:1;H302:1
108143,"Butyl (E,E)-hexa-2,4-dienoate",230-911-0,7367-78-4,,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
108147,"Cuprate(2-), [4-hydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]-6-[(3-sulfophenyl)amino]-2-naphthalenesulfonato(4-)]-, disodium",608-580-2,31102-54-2,Not Classified,REACH registration C&L,2,Not classified:2
108148,Turpentine,232-688-5,9005-90-7,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,130,H304:69;H315:70;H312:69;H226:85;H332:69;H317:69;H302:70;H319:70;H411:70;Not classified:42;H410:2;H400:2
108149,"3,5-Difluor-4-((S)-(-)-1-methylheptyloxy)-4-(4-pentylbicyclo[2.2.2]octyl)-biphenyl",608-800-7,329187-27-1,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
108156,1-Ethyl-3-methylimidazolium Ethyl Sulfate,608-962-9,342573-75-5,Not Classified,Notified C&L,15,Not classified:10;H319:5;H335:4;H315:5
108161,"2-Aminobenzene-1, 4-diyl)bis(oxyethane-2, 1-diyl)diaceate",601-484-1,117541-83-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H317:1
108163,Methyl 2-methylvalerate,218-543-9,2177-77-7,Not Classified,Notified C&L,156,Not classified:88;H226:68
108165,Achromopeptidase crude,602-919-8,123175-82-6,Resp. Sens. 1,Notified C&L,39,H334:38;Not classified:1
108167,2-cyanoacetanilide,210-666-6,621-03-4,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H312:1;H332:1;H319:1
108171,"11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-valerate",276-312-8,72064-79-0,,Notified C&L,3,H332:1;H302:1;H373:1;Not classified:1;H341:1;H361:1
108175,Platinum dinitrate,242-383-9,18496-40-7,Ox. Sol. 2;Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,6,H314:5;H318:5;H290:5;H271:4;H272:2;H334:2;H315:1;H332:1;H317:2;H302:1;H319:1
108176,"1-Propanaminium, N,N,N-trimethyl-3-[(1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 2-propenamide",620-140-1,75150-29-7,Aquatic Chronic 3,Notified C&L,112,H412:46;H411:41;Not classified:25
108178,Indol-3-ylmethyldimethylamine,201-749-8,87-52-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,91,H314:90;H318:90;H319:1;H315:1
108181,Perfluorophenyl acetate,242-891-0,19220-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
108187,"3- [(2S, 4S)-4-MERCAPTOPYRROLIDINE-2-CARBOXAMIDO] BENZOIC ACID HYDROCHLORIDE",606-882-9,219909-83-8,Self-heat. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,3,H412:2;H252:1;H319:3;H317:2;H335:1;H315:1
108188,"Disodium naphthalene-2,6-disulphonate",216-735-7,1655-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
108189,2-octyldodecanoic acid,254-992-7,40596-46-1,Not Classified,Notified C&L,2,Not classified:2
108191,2-(3-amino-4-chlorobenzoyl)benzoic acid,204-230-4,118-04-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,REACH registration C&L,5,H319:5;H335:5;H315:5
108194,Gallamine triethiodide,200-605-1,65-29-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
108197,2-(4-pyridyl)ethanesulphonic acid,258-331-3,53054-76-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H314:5;H318:1
108199,2-chloro-5-(1H-tetrazol-5-yl)sulphanilamide,279-922-2,82212-14-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
108201,"Benzeneacetic acid, 3-ethoxy-4-(ethoxycarbonyl)-, ethyl ester",608-847-3,332347-69-0,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H312:1
108202,Emorfazone,254-220-9,38957-41-4,Acute Tox. 4,Notified C&L,38,H302:38
108205,"reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex",423-940-7,85585-91-7,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
108210,cobalt lithium manganese nickel oxide,620-032-4,346417-97-8,Skin Sens. 1;Carc. 2,Notified C&L,45,H351:45;H317:45
108213,"2,3,4,5-tetrachloroaniline",211-216-1,634-83-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H318:38;H315:38;H335:38;H317:38;H410:38;H302:38;H400:38
108216,Dipyridamole,200-374-7,58-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H319:134;H335:133;H315:134;H370:1;H301:1
108217,1-(2-fluoro-5-hydroxyphenyl)ethan-1-one,604-467-7,145300-04-5,Not Classified,Notified C&L,2,Not classified:1;H302:1;H319:1;H335:1;H315:1
108218,"Protein hydrolyzates, fish",293-481-3,91079-91-3,Not Classified,Notified C&L,43,Not classified:43
108219,Aluminium lithium tri-tert-butoxide hydride,241-490-8,17476-04-9,Flam. Sol. 1;Water-react. 1;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,70,H314:70;H318:2;H260:66;H228:27;H261:4;H225:4
108221,"4,4'-dichlorobiphenyl",218-095-4,2050-68-2,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197,H373:194;H410:194;H400:194;Not classified:3
108226,Bromosuccinic acid,213-087-7,923-06-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H319:42;H315:42;H335:4
108239,Ioxitalamic acid,248-887-5,28179-44-4,Not Classified,REACH registration C&L,2,Not classified:2
108240,"3-mercaptopropane-1,2-diol",202-495-0,96-27-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 3,REACH registration C&L,194,H315:169;H312:60;H331:26;H311:113;H317:7;H302:172;H319:164;H335:102;Not classified:2;H400:2
108243,"5,5-dimethylhexane-2,4-dione",230-760-0,7307-04-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,43,H302:38;H226:42;H319:1;H335:1;H315:1
108246,4-Fluoro-2-methylbenzonitrile,604-600-9,147754-12-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H312:6;H332:6;H302:6;H301:2;H331:2;H311:2
108250,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with formaldehyde-aniline co-oligomer",500-328-9,148894-57-9,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H228:1
108254,"Dipotassium bis(nitrito-N)[sulphato(2-)-O,O']palladate(2-)",267-395-1,67859-45-4,Not Classified,Notified C&L,1,Not classified:1
108255,1-(β-phenethyl)-4-piperidone,254-613-5,39742-60-4,Acute Tox. 4,Notified C&L,51,H302:50;H314:1;Not classified:1;H332:1
108259,[No public or meaningful name is available],457-790-9,,Not Classified,Notified C&L,2,Not classified:2
108260,17β-hydroxyandrost-4-en-3-one hydrogen succinate,208-305-2,521-15-3,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H351:38;H302:38;H312:38
108261,PERFLUORBUTANSULFONYLFLUORIDVINYLETHER,448-130-0,,STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H372:1;H413:1
108264,Decan-1-amide,219-029-7,2319-29-1,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,39,H302:38;H335:38;H315:39;H319:1
108267,Citronellic acid,207-939-7,502-47-6,Acute Tox. 3,Notified C&L,1680,H311:1679;H315:44;H319:5;H335:4;H312:1
108270,"Fatty acids, coco, triesters with trimethylolpropane",287-640-6,85566-29-6,Not Classified,Notified C&L,464,Not classified:464
108275,"Fatty acids, C14-18 and C18-unsatd., branched and linear, isodecyl esters",286-064-2,85186-79-4,Not Classified,Notified C&L,1,Not classified:1
108276,3-bromodihydro-3-methylfuran-2(3H)-one,251-639-9,33693-67-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
108277,ethylene,200-815-3,74-85-1,Press. Gas;Flam. Gas 1;STOT SE 3,Harmonised C&L,0,Not classified:0;H220:0;H336:0
108284,"Phosphoric acid, C8-16-alkyl esters, compds. with triethanolamine",291-893-8,90506-33-5,Not Classified,Notified C&L,1,Not classified:1
108286,Benzarone,216-026-2,1477-19-6,Repr. 2,REACH registration C&L,5,H361:3;H410:1;Not classified:1
108288,Cyclohexanemethylamine,221-741-8,3218-02-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H226:44;H318:1
108293,"Solvate of (17-beta)-17-(phosphonooxy)estra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate with propan-2-ol (1:1)",613-750-4,65175-01-1,Not Classified,Notified C&L,2,Not classified:1;H351:1;H360:1
108294,3-amino-2-chlor-6-methylphenol,283-144-9,84540-50-1,Acute Tox. 4;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,82,H401:8;H302:80;H411:12;H319:55;H315:11;H335:10;H332:8;H317:1;H410:1;H400:1;H312:1
108295,Dodecyl laurate,237-725-9,13945-76-1,Not Classified,REACH registration C&L,30,Not classified:30
108296,"1,2-epoxybutane",203-438-2,106-88-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Harmonised C&L,0,H315:0;H312:0;H335:0;H332:0;H225:0;H351:0;H302:0;H319:0
108299,"1,1-diethoxy-3,5,5-trimethylhexane",289-204-0,86198-35-8,,Notified C&L,2,H317:2;H226:1;H315:1;H410:1;H319:1;H400:1
108315,"3,5-dichloro-4-hydroxybenzenesulphonic acid",246-833-5,25319-98-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
108316,2-aminobenzenesulphonyl fluoride,206-882-5,392-86-9,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H302:1;H314:1;H335:1
108318,3-chlorobenzonitrile,212-172-6,766-84-7,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,41,H412:6;H302:40;H312:36;H319:40;H311:5;H301:1;H331:1
108320,"8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylic acid ethyl ester",616-650-9,78755-81-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,159,H332:158;H302:158;H312:156;Not classified:1
108321,Tetrasodium 8-[[4-[(4-amino-3-sulphonatophenyl)azo]-6-sulphonatonaphthyl]azo]-5-[[6-(benzoylamino)-1-hydroxy-3-sulphonato-2-naphthyl]azo]naphthalene-2-sulphonate,274-427-8,70210-31-0,Not Classified,REACH registration C&L,51,Not classified:42;H412:9
108326,"3'-Adenylic acid, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-P-(2-chlorophenyl)-2'-deoxy-N-(2-methyl-1-oxopropyl)guanylyl-(3'→5')-N-benzoyl-2'-deoxy-, 2-chlorophenyl 2-cyanoethyl ester",278-845-1,78111-53-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H312:38;H335:38;H302:38;H319:38
108328,"Glycerides, mixed 2,3-bis(acetyloxy)butanedioyl and C16-18",307-374-7,97615-87-7,Not Classified,Notified C&L,7,Not classified:7
108329,3-iodoanisole,212-173-1,766-85-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44,H302:39;H319:44;H335:5;H315:6
108330,Tridecyl orthoborate,243-621-4,20236-81-1,Eye Irrit. 2,Notified C&L,38,H319:38
108332,"2,7-Naphthalenedisulfonic acid, 4-hydroxy-5-[[4-(phenylamino)-5-sulfo-1-naphthalenyl]azo]-, compds. with N,N'-di(phenyl, tolyl and xylyl)guanidine (1:3)",276-156-0,71888-82-9,Acute Tox. 4,Notified C&L,1,H302:1
108333,1-(4-methyl-2-thienyl)ethan-1-one,237-180-7,13679-73-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H302:42;H317:38;H319:38
108339,"7H,11H-Benz[de]imidazo[4',5':5,6]benzimidazo[2,1-a]isoquinoline-7,11-dione, 10,12-dihydro-",611-375-0,56279-27-7,,Notified C&L,33,Not classified:33
108345,"(2R-trans)-2,3-dihydro-3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4-benzopyrone",224-486-0,4382-33-6,Acute Tox. 4,Notified C&L,1,H302:1
108349,"4-[3-(5H-dibenz(b,f)azepin-5-yl)propyl]piperazine-1-ethanol dihydrochloride",213-000-2,909-39-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:42;H410:38;H400:38;H411:3
108350,"Carboxylic acids, di-, C4-6, magnesium salts",292-740-8,90989-82-5,Eye Dam. 1,Notified C&L,2,H318:2
108351,3-hydroxy-3-methylbutanoic acid,626-699-8,625-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
108357,reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid,423-750-4,,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
108363,"1H-Pyrazole-3-carboxylic acid, 4-[5-[3-(ethoxycarbonyl)-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2,4-pentadienylidene]-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, 3-ethyl ester, dipotassium salt",611-070-2,53953-04-1,Aquatic Chronic 3,Notified C&L,1,H412:1
108364,"5,6-dihydroxy-2,3-dihydro-1H-indolium bromide",421-170-6,138937-28-7,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
108367,"3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)cyclohexan-1-ol",222-294-1,3407-42-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1366,H319:417;H411:942;H315:1279;H412:165;H400:10
108372,α-(N-ethyl-m-toluidino)-m-toluenesulphonic acid,202-113-2,91-98-5,Not Classified,Notified C&L,9,Not classified:9
108375,Desmopan DP 9985A FR,465-920-0,,,Notified C&L,1,Not classified:1
108376,5-(2-CHLORO-ETHYL)-2H-TETRAZOLE,606-112-1,18755-46-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
108381,"Poly(oxy-1,2-ethanediyl), .alpha.-[2-(dide cylmethylammonio)ethyl]- .omega.- hydroxy-, propanoate (salt) (Bardap 26)",619-057-3,94667-33-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,73,H318:4;H314:73;H410:48;H302:73;H400:73
108385,"Benzoic acid, 3-chloro-5-iodo-, methyl ester",608-288-5,289039-85-6,,Notified C&L,4,H319:4;H335:4;H315:4
108388,Triethoxy(phenyl)silane,212-305-8,780-69-8,Flam. Liq. 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,149,H412:44;H373:86;H226:112;H315:47;H319:21;H225:5;H335:4;Not classified:4
108390,3-Chlorothioanisole,610-431-1,4867-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:40;H335:39;H315:40;H302:4
108397,"(1S,8R,9S,10S,13S,14S,17R)-17-Acetyl-6-chloro-1-(chloromethyl)-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate",605-617-4,17183-98-1,Not Classified,REACH registration C&L,3,Not classified:2;H351:1;H360:1
108400,4-chloro-6-nitro-m-cresol,230-461-5,7147-89-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
108404,"Pelargonium graveolens, ext., sapond.",305-057-8,94333-77-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,123,H317:123;H318:123;H315:123;H411:39
108405,Ethyl L-phenylalaninate hydrochloride,221-673-9,3182-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
108407,"Zinc, bis(2,4-pentanedionato-κO,κO')-, monohydrate, (T-4)-",604-371-5,14363-15-6,,Notified C&L,4,H319:4;H335:4;H315:4
108410,benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate,405-330-2,124088-59-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0;H315:0
108411,bis(hydrogenated tallow C,418-370-0,143925-92-2,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
108414,"3,3'-dimethyl-1,1'-diphenyl-4,4'-bi-5-pyrazolone",231-282-5,7477-67-0,Skin Sens. 1,Notified C&L,43,H317:43
108415,hexasodium (R)-carboxy(phosphono)methanolate (S)-carboxy(phosphono)methanolate,616-639-9,78620-07-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
108416,"Phosphoric acid, magnesium strontium salt, tin-doped",272-235-9,68784-28-1,Not Classified,Notified C&L,1,Not classified:1
108422,Vanadium oxide sulphate,248-652-7,27774-13-6,Met. Corr. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,117,H301:73;H290:47;H315:76;H411:55;H372:38;H319:76;H361:46;H330:4;H302:42;H412:4;H331:4;H335:15;H332:2;Not classified:1
108423,"Fatty acids, coco, potassium salts",263-049-9,61789-30-8,Not Classified,Notified C&L,446,Not classified:219;H319:226;H315:167;H314:1
108424,3-decenoic acid,239-489-2,15469-77-9,Eye Dam. 1,Notified C&L,39,H318:38;H319:1;H315:1
108425,OO-tert-butyl O-(2-ethylhexyl) peroxycarbonate,252-029-5,34443-12-4,Org. Perox. D;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,328,H412:13;H400:63;H242:97;Not classified:177;H312:38;H315:40;H410:1;H319:1
108428,"Sodium 1-amino-9,10-dihydro-4-[[3-[[(2-hydroxyethyl)amino]sulphonyl]-4-methylphenyl]amino]-9,10-dioxoanthracene-2-sulphonate",255-107-7,40847-64-1,Not Classified,Notified C&L,39,Not classified:39
108430,Disodium [4-hydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),271-351-7,68541-71-9,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,132,H317:17;H411:57;H412:40;Not classified:18;H319:20;H400:5
108431,"N,N,N',N',N'',N''-hexamethylmethanetriamine",227-284-0,5762-56-1,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,41,H314:41;H225:41;H318:1
108435,3-oxo-2-pentylcyclopentaneacetic acid,222-687-8,3572-64-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
108440,"Adipic acid, oligomeric reaction products with decanoic acid, isooctadecanoic acid, octanoic acid and pentaerythritol",500-641-0,161308-02-7,Not Classified,Notified C&L,18,Not classified:18
108442,Bromo(phenyl)acetonitrile,227-348-8,5798-79-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H302:39;H319:38;H335:39;H315:39;H318:1;H312:1;H332:1
108443,"O,α-dimethylstyrene",230-996-4,7399-49-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
108444,1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone,426-830-7,78531-59-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
108448,"Soaps, stocks, linseed-oil",271-406-5,68554-72-3,Not Classified,Notified C&L,1,Not classified:1
108449,"1-(3,6-dimethylpyrazinyl)ethan-1-one",259-077-6,54300-09-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
108453,"Fatty acids, tallow, Me esters, sulfonated, sodium salts",270-449-7,68440-31-3,Not Classified,Notified C&L,1,Not classified:1
108455,Tricosanoic acid,219-419-7,2433-96-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
108458,"Disodium 3-[(o-arsonophenyl)azo]-4,5-dihydroxynaphthalene-2,7-disulphonate",222-600-3,3547-38-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H301:39;H331:39;H400:39;H350:1
108462,"Sodium bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",255-527-0,41741-86-0,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2201,H317:91;H411:127;Not classified:2070;H412:4
108463,"Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol and urea",270-170-0,68412-14-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:2;H315:3;H318:1;Not classified:1
108464,"Enzymatic Digest of Gelatin, Pancreatic Digest",919-998-2,,Not Classified,Notified C&L,2,Not classified:2
108467,"Canarium commune, ext.",307-636-0,97675-63-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1423,H304:1419;H315:1421;H226:1419;H317:1422;H410:1419;H400:1382;H411:3;H351:1;H341:1
108470,Cyclohexyl(isopropyl)methylammonium chloride,213-753-7,1007-33-6,Acute Tox. 3;STOT SE 3,Notified C&L,1,H301:1;H319:1;H335:1;H315:1
108472,Succinimido 3-(4-hydroxyphenyl)propionate,251-818-1,34071-95-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
108476,"Hydrocarbon oils, clay-treated spent",293-258-0,91052-94-7,Not Classified,Notified C&L,1,Not classified:1
108477,N-(2-chloroethyl)methanesulphonamide,244-641-6,21896-59-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
108479,"mixed lithium sodium 7-{[2-({5-cyano-4-methyl-2,6-bis[(4-sulfonatophenyl)amino]pyridin-3-yl}diazenyl)-4-(2-naphthyl)-1,3-thiazol-5-yl]diazenyl}naphthalene-1,3,5-trisulfonate",471-980-9,1016986-95-0,Not Classified,Notified C&L,1,Not classified:1
108482,"Amides, castor-oil, N,N-bis(hydroxyethyl)",269-152-5,68188-33-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
108483,"3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, lithium sodium salt , compound with 2,2'-(methylimino)diethanol",280-831-5,83783-95-3,,Notified C&L,33,Not classified:33
108484,chlorotricyclohexylstannane,221-437-5,3091-32-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H332:0;H410:0;H302:0;H400:0
108486,Isoniazid,200-214-6,54-85-3,Acute Tox. 4;Skin Irrit. 2,Notified C&L,368,H302:362;H315:339;H360:6;H300:4;H335:6;H351:5;H319:8;Not classified:2;H373:2;H371:2;H372:1;H301:1;H341:1;H361:1
108487,"(ethylenebis(nitrilomethylidyne)-2,2'-diphenolato)cobalt(II)",238-012-5,14167-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H315:38;H332:4;H302:4;H317:4;H351:1
108489,"N-propylpropane-1,3-diamine",245-869-9,23764-31-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39
108490,Phenethyl benzoate,202-336-5,94-47-3,Aquatic Chronic 2,REACH registration C&L,140,H411:17;Not classified:123
108493,"2-Naphthalenecarboxylic acid, 4-formyl-3-hydroxy-",609-548-0,38399-46-1,Eye Dam. 1,Notified C&L,1,H318:1
108497,Disodium 6-acetamido-4-hydroxy-3-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonate,235-431-5,12225-83-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H317:68;H319:68;H335:67;H315:67;H334:22;Not classified:2
108506,REACTIVE SCARLET 9909,436-910-3,,Not Classified,Notified C&L,1,Not classified:1
108508,"Propanoic acid, 2-methyl-, 2-methylphenyl ester",609-247-4,36438-54-7,Not Classified,Notified C&L,88,Not classified:88
108513,"1,3-dibromopropane",203-690-3,109-64-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,110,H412:4;H402:3;H315:54;H226:56;H302:54;Not classified:52;H411:51;H319:11;H370:1;H341:1;H312:1;H335:1;H332:1;H351:1
108514,"4-amino-3,5,6-trichloropyridine-2-carboxylic acid;N-methylmethanamine",611-327-9,55870-98-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H410:16;H400:16
108515,Antimony tribromide,232-179-8,7789-61-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,44,H332:44;H302:44;H411:44
108518,"Phosphorodithioic acid, mixed O,O-bis(hexyl and iso-Pr) esters",300-330-8,93925-29-2,Not Classified,Notified C&L,441,Not classified:441
108519,"Indeno(4,3 A-B) Furan Decahydro-2,2,7,7,8,9,9-Heptamethyl-",449-360-4,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,38,H413:36;H317:38;H315:36;H410:2;H400:1
108523,"Phenylphosphinic acid, compound with hexane-1,6-diyldiamine (2:1)",225-902-3,5139-88-8,Not Classified,Notified C&L,1,Not classified:1
108526,Diisodecyl phenyl phosphite,247-098-3,25550-98-5,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,385,H412:15;H317:183;H400:249;H410:117;H315:147;Not classified:24;H312:1;H332:1;H302:1;H319:1
108530,"2,5-difluorophenylacetic acid",285-288-8,85068-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
108532,4-methyl-4-(methylthio)pentan-2-one,245-727-6,23550-40-5,Not Classified,Notified C&L,121,Not classified:120;H319:1;H335:1;H315:1
108540,"1-(2,6-bis(4-tolyl)-1,3-dioxano(5,4-d)-1,3-dioxan-4-yl)ethane-1,2-diol",402-950-5,87826-41-3,Not Classified,Notified C&L,89,Not classified:88;H411:1
108542,"Silicic acid, aluminum calcium salt",215-476-7,1327-39-5,Skin Corr. 1B,Notified C&L,22,H314:21;Not classified:1
108544,4-hydroxy-o-toluic acid,209-422-1,578-39-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H302:40;H318:39;H319:1;H315:1
108548,Dibutylbis(stearoyloxy)stannane,227-438-7,5847-55-2,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,348,H360:252;H410:259;H373:183;H341:252;H400:259;H372:76;H301:60;H315:67;H331:60;H335:60;H319:67;Not classified:29;H302:7;H312:7;H314:1;H317:1;H370:1
108549,2-(4-bromophenyl)-2-methylpropionic acid methyl ester,450-630-9,,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:3
108552,"Rosin, fumarated, reaction products with glycerol and pentaerythritol",296-047-1,92202-14-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,85,H317:12;H319:12;H413:6;Not classified:73
108558,"m-xylene-4,α,α'-triol",220-920-8,2937-60-2,Not Classified,Notified C&L,33,Not classified:33
108560,"Fatty acids, tall-oil, 2-(2-hydroxyethoxy)ethyl esters",269-669-6,68309-16-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
108562,"Fatty acids, tallow, Guerbet reaction products",615-918-2,73138-58-6,Not Classified,Notified C&L,31,Not classified:31
108563,"(3S,4R)-3-(1,3-benzodioxol-5-yloxy)methyl-4-(4-fluorophenyl)-piperidine hydrochloride",616-601-1,78246-49-8,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,56,H302:56;H318:53;H411:54;H335:54;H315:2;H312:1;H319:2;H361:2;H373:1;H362:1;H360:1
108564,"Diphenylmethyl (6R,7R)-8-oxo-7-[(phenylacetyl)amino]-3-{[4-(pyridin-4-yl)-1,3-thiazol-2-yl]thio}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",609-782-3,400827-68-1,Not Classified,REACH registration C&L,1,Not classified:1
108565,"Glycerol, ethoxylated",500-075-4,31694-55-0,Not Classified,REACH registration C&L,390,Not classified:333;H317:56;H319:1;H315:1
108567,Octyl 4-hydroxybenzoate,214-943-2,1219-38-1,,Notified C&L,5,H319:5;H335:4;H315:5;H317:1
108571,"trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate",414-130-4,119710-96-2,Acute Tox. 4,Harmonised C&L,0,H302:0
108573,"3,4-dihydro-2,2,4-trimethyl-2H-quinoline-1-ethanol",258-491-4,53350-33-7,Aquatic Chronic 3,REACH registration C&L,2,H412:2
108574,2-methylamino-5-nitrobenzophenone,225-601-7,4958-56-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
108583,2-amino-4-chloro-6-nitrophenol,228-761-6,6358-08-3,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,41,H317:1;H413:1;H319:39;H335:38;H315:39;Not classified:1
108584,"(S)-7-(β-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one",208-464-8,529-55-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:38;H400:38;H302:2
108586,4-bromo-2-chlorophenol,223-572-5,3964-56-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H319:134;H335:133;H315:134;H312:4;H302:4;H314:1
108588,Clorindione,214-553-2,1146-99-2,,Notified C&L,4,H301:4;H319:4;H335:4;H315:4
108589,Allyl vinyl ether,223-482-6,3917-15-5,,Notified C&L,4,H315:4;H335:4;H225:4;H302:4;H319:4
108590,"Acetic acid, sulfo-, 1-C12-14-alkyl esters, sodium salts",288-192-4,85681-55-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,89,H412:89;H302:89;H318:89
108591,O-(triphenylmethyl)hydroxylamine,250-868-1,31938-11-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
108592,Isopentyl nonanoate,231-933-3,7779-70-6,Not Classified,Notified C&L,113,Not classified:113
108593,Ethyl hydrogen 5-nitroisophthalate,245-273-9,22871-55-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
108594,(Trimethoxysilyl)methyl 2-methacrylate,454-220-0,,Not Classified,REACH registration C&L,4,Not classified:4
108596,"metalaxyl (ISO);methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate",260-979-7,57837-19-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H317:0
108597,"4,4'-bis(diethylamino)benzhydryl alcohol",205-162-8,134-91-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
108598,"Reaction product of benzene-1,2:4,5-tetracarboxylic dianhydride, Octadecylamine, (Z)-Octadec-9-enylamine, hexamethylenediamine and 2-Methylpentane-1,5-diamine",919-116-6,,Not Classified,Notified C&L,2,Not classified:2
108600,1-chlorohexadecane,225-461-7,4860-03-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
108602,"Sulfuric acid, polymer with phenol, ammonium salt, compd. with 2-aminoethanol",615-793-4,72727-54-9,Not Classified,Notified C&L,31,Not classified:31
108605,Allyl phenethyl ether,238-212-2,14289-65-7,Not Classified,Notified C&L,89,Not classified:89
108611,4-(2-thioureido)benzoic acid,230-910-5,7366-56-5,Acute Tox. 3;Skin Sens. 1,Notified C&L,43,H317:38;H301:38;H302:4;H319:5;H335:5;H315:5
108613,3-Chlorothiophene,605-636-8,17249-80-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H315:39;H226:45;H335:38;H302:44;H312:6;H332:6;H360:1;H319:1
108615,"Diphosphoric acid, polymers with ethoxylated reduced Me esters of reduced polymd. oxidized tetrafluoroethylene",606-416-4,200013-65-6,Not Classified,Notified C&L,2,Not classified:1;H319:1
108619,4-azaoctamethylenediamine,204-689-0,124-20-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,194,H314:194;H318:181
108623,"3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene] hydrazino}-2'-hydroxy-3-biphenylcarboxylic acid",610-469-9,496775-61-2,Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,4,H302:4;H410:4;H318:4;H373:4
108626,Morpholine phosphate,263-844-0,63079-67-4,Not Classified,Notified C&L,4,Not classified:4
108627,Nifedipine,244-598-3,21829-25-4,Acute Tox. 4,Notified C&L,177,H302:175;H361:31;H411:5;H315:2;H335:2;H319:2;H370:1;H372:1;H317:1;H312:2;H332:2;H301:1;H362:1;H252:1;H228:1
108635,"2-Propenoic acid, 2-methyl-, polymer with diethenylbenzene",610-547-2,50602-21-6,Eye Irrit. 2,Notified C&L,72,H319:39;Not classified:33
108636,"Propylidynetrimethanol, propoxylated, reaction products with ammonia",500-105-6,39423-51-3,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,380,H411:279;H302:323;H312:326;H318:279;H412:57;H314:100;H301:51;H315:43;H311:48;Not classified:5;H304:2;H335:2;H332:1
108639,"6,13-dichloro-3,10-bis[[2-[[4-chloro-6-[(2,4-disulphophenyl)amino]-1,3,5-triazin-2-yl]amino]ethyl]amino]triphenodioxazine-4,11-disulphonic acid",282-902-6,84455-40-3,Not Classified,Notified C&L,1,Not classified:1
108640,"Petrolatum (petroleum), oxidized, ester with sorbitol",271-640-8,68603-13-4,Not Classified,Notified C&L,125,Not classified:125
108642,"1-Propanaminium, 2-hydroxy-N-(2-hydroxypropyl)-N,N-dimethyl-, 3,3'-bis(C10-14-alkyloxy) derivs., chlorides",282-511-0,84238-55-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H318:1;H315:1
108645,((E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide nebo 8-methyl-N-vanillyl-6-nonenamid,617-016-4,8023-77-6,Skin Irrit. 2,Notified C&L,127,H315:121;H302:35;H226:29;H319:31;H318:8;Not classified:5;H332:2;H334:2;H335:2
108646,17β-hydroxyandrost-4-en-3-one undecanoate,227-712-6,5949-44-0,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,Notified C&L,44,H351:43;H302:43;H360:41;H362:24;H312:18;H332:18;H315:2;H335:2;H319:2;H350:1;H361:1
108650,Tosyl azide,213-381-5,941-55-9,Self-react. D;Acute Tox. 2,Notified C&L,39,H300:39;H242:38;H304:1;H315:1;H225:1;H373:1;H336:1;H361:1
108652,Sodium 5-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazinecarboxamidate,283-029-3,84522-34-9,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H314:1;H318:1
108655,Methyl 3-chloro-4-hydroxybenzoate,223-573-0,3964-57-6,,Notified C&L,4,H319:4;H335:4;H315:4
108656,Dipotassium titanate(2-),261-919-2,59766-31-3,Carc. 2,REACH registration C&L,28,H351:27;Not classified:1
108662,Lead dinitrate,233-245-9,10099-74-8,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,191,H318:83;H360:155;H332:155;H317:26;H410:155;H351:26;H302:155;H372:26;H400:154;H272:44;H373:129;Not classified:36
108667,2-bromo-6-chloropyridine,225-904-4,5140-72-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,46,H302:44;H318:39;H315:7;H312:5;H335:6;H332:5;H319:7
108672,"Aluminium, compound with molybdenum (1:3)",234-437-5,12003-72-4,,Notified C&L,4,H228:4
108677,"4,4',4''-trimethyltrityl alcohol",221-822-8,3247-00-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
108678,reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives,421-820-9,192268-65-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
108682,"Equisetum hyemale, ext.",289-822-0,90028-32-3,Not Classified,Notified C&L,36,Not classified:36
108683,p-[[p-(phenylazo)phenyl]azo]phenol,228-370-0,6250-23-3,Not Classified,Notified C&L,1,Not classified:1
108685,"1,2,3,4-tetrahydro-2-methylnaphthalen-1-one",216-461-8,1590-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
108686,"Violanthrene-5,10-dione",204-152-0,116-71-2,Not Classified,REACH registration C&L,24,Not classified:23;H412:1
108688,"3,5-xylyloxyacetic acid",226-462-5,5406-14-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H335:1;H315:1
108691,(trifluoromethoxy)benzene,207-269-5,456-55-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:43;H225:46
108695,"1,3-dihydro-3,3-dimethyl-1-phenylisobenzofuran-1-ol",213-826-3,1023-91-2,Not Classified,REACH registration C&L,4,Not classified:4
108696,Phenyl methacrylate,218-542-3,2177-70-0,Acute Tox. 4;Skin Sens. 1B;STOT SE 3,REACH registration C&L,44,H302:1;H317:1;H335:43;H226:43;H319:43;H315:43;H341:4
108697,"2,6-dichloropyrazine",225-316-8,4774-14-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H335:50;H315:51
108699,Dineodymium dititanium heptaoxide,234-819-1,12035-31-3,Not Classified,Notified C&L,2,Not classified:2
108700,"Polyamides, wastes, pyrolyzed, pyrolysis oils",308-724-1,98219-56-8,Not Classified,Notified C&L,22,Not classified:22
108703,Triethylphosphine,209-068-8,554-70-1,Flam. Liq. 2;Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,80,H314:76;H250:80;H225:65;H318:14;H302:14;H224:14;H332:4;H252:4;Not classified:1
108704,N-(hydroxymethyl)methacrylamide,213-086-1,923-02-4,Acute Tox. 4;Skin Sens. 1B;STOT SE 2;STOT RE 2,REACH registration C&L,181,H302:127;H317:90;H373:90;H371:90;H301:38;H332:37;H312:37;Not classified:16
108706,Indol-3-ylacetic acid,201-748-2,87-51-4,Not Classified,Notified C&L,20,Not classified:5;H319:15;H335:12;H315:15
108710,"S-Benzothiazol-2-yl (Z)-(5-amino-1,2,4-thiadiazol-3-yl)-methoxyiminothioacetate",453-580-6,89604-91-1,Skin Sens. 1;Carc. 2;Aquatic Acute 1,Notified C&L,1,Not classified:1;H317:1;H410:1;H351:1;H400:1
108713,Methyl 4-tert-butylphenylacetate,222-602-4,3549-23-3,Not Classified,Notified C&L,90,Not classified:90
108715,p-menthan-3-one,233-944-9,10458-14-7,Flam. Liq. 3;Aquatic Chronic 3,Notified C&L,1404,H412:1342;H226:1274;H317:66;H315:61;H302:44;H334:38;H319:43
108716,"Paraffin oils (petroleum), solvent-refined dewaxed heavy;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 °C.]",295-810-6,92129-09-4,Carc. 1B,Harmonised C&L,0,H350:0
108719,"Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate",254-993-2,40596-69-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,198,H411:197;H319:198;H335:198;H315:198;H400:1
108721,"1,2-Ethanediamine, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-, reaction products with glycidyl tolyl ether",291-229-7,90366-85-1,Not Classified,Notified C&L,9,Not classified:9
108726,Catechol violet,204-088-3,115-41-3,,Notified C&L,4,H319:4;H335:4;H315:4
108727,4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one,235-920-3,13047-13-7,Acute Tox. 4,REACH registration C&L,55,H302:55;H319:46;H335:43;H315:44;H317:9;H411:7
108728,Sodium naphthalene-2-sulphonate,208-523-8,532-02-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,89,H319:89;H315:52;H335:47
108731,Nicotine sulphate,200-606-7,65-30-5,Acute Tox. 3,REACH registration C&L,45,H301:2;H411:43;H300:43;H330:42;H310:43;H315:1;H319:1;H361:1
108739,4-Sulfamoylphenyl)hydrazine hydrochloride,605-823-4,17852-52-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,52,H317:42;H410:42;H302:42;H319:50;H400:42;H335:8;H315:8;H314:1;Not classified:1
108740,"tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate",418-520-5,183130-96-3,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0
108743,Bis(4-chloro-2-nitrophenyl) disulphide,218-094-9,2050-66-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:38;H319:39;H400:38;H315:1
108745,"2,3,4-trichloroaniline",211-215-6,634-67-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H301:38;H331:38;H311:38;H410:38;H373:38;H400:38;H315:1;H312:1;H332:1;H302:1;H319:1
108747,Desipramine hydrochloride,200-373-1,58-28-6,Acute Tox. 4;STOT SE 3;STOT SE 1,REACH registration C&L,45,H370:3;H302:44;H336:3;H334:41;H315:41;H335:41;H317:41;H319:41;H332:1;H312:1;H410:1;H350:1;H362:1;H400:2
108749,"Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, polymer with N-(1-methylethyl)-2-propanamine and 1H-1,2,4-triazole",922-938-8,,,Notified C&L,25,Not classified:25
108750,"(8α,9R)-1-benzyl-9-hydroxycinchonanium chloride",273-938-3,69257-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
108753,"Bis[(R)-12-hydroxyoleic] acid, diester with glycerol",248-720-6,27902-24-5,Not Classified,Notified C&L,1,Not classified:1
108757,"Cyclopropa[3,4]cyclopenta[1,2-b]furan-2(3H)-one, 4-(5,5-dimethyl-1,3-dioxan-2-yl)hexahydro-, [3aR-(3aα,3bβ,4α,4aβ,5aα)]-",609-715-8,39521-49-8,Not Classified,Notified C&L,1,Not classified:1
108763,"1H-Purine-2,6-dione, 7-[3-[[2-[3,5-bis(acetyloxy)phenyl]-2-oxoethyl](phenylmethyl)amino]propyl]-3,7-dihydro-1,3-dimethyl-, hydrochloride (1:1)",616-014-0,73749-29-8,,Notified C&L,1,Not classified:1
108767,"Tetrasodium 4-amino-6-[[5-[[4-[(3-chlorophenyl)amino]-6-fluoro-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-5-hydroxy-3-[(4-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",274-658-4,70528-89-1,Not Classified,Notified C&L,1,Not classified:1
108768,"N,N'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[3-oxobutyramide]",223-873-1,4104-12-5,Aquatic Acute 1,Notified C&L,38,H400:38
108769,Codeine,200-969-1,76-57-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Lact.,REACH registration C&L,56,H302:52;H317:10;H318:8;H362:9;H301:4;H331:1;H311:1;H332:1;H312:1;H334:2;H361:2;H412:1
108775,"Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 °C to 290 °C (500 °F to 554 °F).]",309-851-5,101316-45-4,Carc. 1B,Harmonised C&L,0,H350:0
108778,Undecylamine,230-761-6,7307-55-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H302:38;H410:38;H314:39;H400:38;H318:1
108786,"1,1,1,5,5,5-hexafluoropentane-2,4-dione",216-191-0,1522-22-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,47,H312:41;H226:47;H332:41;H314:47;H302:42;H301:5;H335:5;H318:4
108791,1-(bromomethyl)-3-chlorobenzene,212-171-0,766-80-3,Skin Corr. 1B,Notified C&L,47,H314:47;H290:2;H318:1
108792,5-chloro-2-methoxybenzenediazonium chloride,202-239-8,93-34-5,Unst. Expl.,REACH registration C&L,1,H200:1
108793,Piperidin-3-ol,229-957-4,6859-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:3;H335:3;H315:3;H314:47;H318:1;H332:1;H302:1;H312:1
108795,Molybdenum dialuminiumsilicide,918-913-6,,Not Classified,Notified C&L,1,Not classified:1
108798,"Cerium trinitrate, hexahydrate",600-370-9,10294-41-4,Ox. Sol. 2;Eye Dam. 1,Notified C&L,64,H272:60;H318:55;H410:14;H400:14;H319:9;H335:5;H315:9;H412:4
108799,"3-bromo-4,5-dihydroxybenzoic acid",262-652-4,61203-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
108800,Ethyl 3-ethoxy-3-iminopropionate hydrochloride,219-028-1,2318-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,77,H319:44;H335:43;H315:43;Not classified:33
108801,Decyl α-D-glucopyranoside,249-846-4,29781-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
108805,Triethyl citrate,201-070-7,77-93-0,Not Classified,REACH registration C&L,1882,Not classified:1812;H332:62;H220:7;H340:7;H350:7;H319:1;H315:1
108806,"Calciate(3-), [N-[2-[bis[(carboxy-κO)methyl]amino-κN]ethyl]-N-[2-[[(carboxy-κO)methyl](carboxymethyl)amino-κN]ethyl]glycinato(5-)-κN]-",602-920-3,12319-23-2,Not Classified,Notified C&L,1,Not classified:1
108809,1-(4-Methylthiazol-2-yl)ethanone,616-211-1,7533-07-5,Acute Tox. 4,Notified C&L,39,H302:39
108810,ethane,200-814-8,74-84-0,Press. Gas;Flam. Gas 1,Harmonised C&L,0,Not classified:0;H220:0
108814,p-phenylbenzaldehyde,221-742-3,3218-36-8,Acute Tox. 4,REACH registration C&L,48,H302:5;H319:44;H335:44;H315:44;H402:1;H361:2;H332:1;H312:1
108816,Basil extract,616-962-5,8015-73-4,Skin Sens. 1;Muta. 2;Carc. 2;STOT SE 2;Aquatic Chronic 3,Notified C&L,223,H412:158;H371:126;H317:159;H351:151;H341:151;H302:64;H319:51;H335:40;H315:82;H251:14;H241:14;H304:11;H373:10;H361:10
108820,"Phosphoric acid, C10-14-alkyl esters, compds. with triethanolamine",291-894-3,90506-34-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
108822,Hexan-6-olide,207-938-1,502-44-3,Eye Irrit. 2,REACH registration C&L,760,H319:399;Not classified:321;H318:40;H335:38;H315:43
108823,"2,4-dimethylcyclohexan-1-ol",274-037-8,69542-91-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
108825,Iproheptine,237-726-4,13946-02-6,Acute Tox. 4,Notified C&L,38,H302:38
108827,sulphamidic acid;sulphamic acid;sulfamic acid,226-218-8,5329-14-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0;H315:0
108832,2-butanone oxime;butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime,202-496-6,96-29-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT SE 3;Carc. 1B;STOT SE 1;STOT RE 2,Harmonised C&L,0,H301:0;H318:0;H315:0;H312:0;H317:0;H350:0;H370:0;H373:0;H336:0
108834,2-cyclohexylacetyl chloride,607-279-3,23860-35-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,39,H302:39;H314:39;H412:1;H227:1;H335:1
108838,"[N,N',N''-tris[3-[(2-ethylhexyl)oxy]propyl]-29H,31H-phthalocyanine-1,16,23-trisulphonamidato(2-)-N29,N30,N31,N32]copper",274-200-3,69898-57-3,Not Classified,REACH registration C&L,8,Not classified:7;H412:1
108839,"Methyl ester of fatty acids, Cx-Cy, Hydroxymethylated",,,Skin Sens. 1,Notified C&L,56,H317:56
108843,"3,3,4,4-tetrachlorotetrahydrothiophene 1,1-dioxide",223-113-9,3737-41-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H301:1;H319:1;H315:1
108855,"Hydrocarbons, C14-C15, n-alkanes, <2% aromatics",928-868-4,,Asp. Tox. 1,REACH registration C&L,6,H304:6
108859,"Germanium magnesium fluoride oxide, manganese-doped",272-222-8,68784-13-4,Not Classified,Notified C&L,1,Not classified:1
108861,1-(5-methyl-2-thienyl)ethan-1-one,237-181-2,13679-74-8,,Notified C&L,9,H302:8;H319:2;H315:2;H332:1;H312:1;H335:1
108865,"BENZOGUANEMINE RPW FORMALDEHYDE, ETHYLATED, METHYLATED",614-216-3,68037-08-1,Aquatic Chronic 2,Notified C&L,269,H411:250;H413:19
108866,5-methoxyindole-2-carboxylic acid,224-487-6,4382-54-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
108868,"Carboxylic acids, di-, C4-6, sodium salts",292-741-3,90989-83-6,Not Classified,Notified C&L,84,Not classified:84
108872,"2-hydroxybenzene-1,3,5-trimethanol",220-921-3,2937-61-3,Not Classified,Notified C&L,33,Not classified:33
108874,"Fatty acids, tallow, Guerbet reaction products, calcium salts",615-919-8,73138-59-7,Not Classified,Notified C&L,31,Not classified:31
108876,"[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonato(3-)]chromium",271-352-2,68541-72-0,Not Classified,Notified C&L,4,Not classified:2;H412:2
108878,"potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate",403-810-6,140876-13-7,Eye Dam. 1,Harmonised C&L,0,H318:0
108884,Pratherm EC 20,603-911-7,135229-48-0,,Notified C&L,33,Not classified:33
108887,"4-(2,4-dichlorophenoxy)phenol",255-106-1,40843-73-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H410:38;H400:38
108891,1-chloropent-2-yne,245-112-2,22592-15-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2,Notified C&L,1,H341:1;H226:1;H319:1;H315:1
108892,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with sodium 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-1-propanesulfonate (1:1)",601-067-4,111286-86-3,Not Classified,Notified C&L,88,Not classified:88
108899,"Barium 2-[(2-hydroxy-3,6-disulphonato-1-naphthyl)azo]benzoate (3:2)",239-880-8,15782-06-6,Not Classified,Notified C&L,11,Not classified:11
108902,"Disodium 4,4'-bis[(4-anilino-6-morpholino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate",240-245-2,16090-02-1,Not Classified,REACH registration C&L,350,Not classified:212;H412:138
108903,"1,2-epoxy-4-epoxyethylcyclohexane;4-vinylcyclohexene diepoxide",203-437-7,106-87-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Harmonised C&L,0,H351:0;H301:0;H331:0;H311:0
108906,"7-amino-1,8-naphthyridin-2(1H)-one",217-688-5,1931-44-8,,Notified C&L,2,H319:2;H335:2;H315:2
108910,"4,5-dimethyl-1H-imidazole",218-954-3,2302-39-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
108911,"Tagetes minuta, ext.",294-862-7,91770-75-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1696,H304:1671;H315:404;H226:380;H317:1671;H411:1487;H400:10
108912,3-dimethylamino-1-(2-thienyl)propan-1-one hydrochloride,611-117-7,5424-47-5,,Notified C&L,6,H319:5;H335:5;H315:5;H332:1;H302:1;H318:1
108914,2-hydroxyethylammonium acetate,259-078-1,54300-24-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,70,H315:60;H312:60;H332:60;H302:60;H319:60;Not classified:10
108916,"Fatty acids, tallow, Me esters, chlorinated",270-448-1,68440-29-9,Not Classified,Notified C&L,80,Not classified:80
108920,methyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate,604-139-3,139481-69-9,Repr. 2,REACH registration C&L,2,H361:2
108922,"1,5-dimethylhexyl acetate",267-911-5,67952-57-2,Not Classified,Notified C&L,88,Not classified:88
108923,"Benzenesulfonamide, N-(2-hydroxyethyl)-",611-870-1,59724-42-4,Not Classified,Notified C&L,1,Not classified:1
108926,5'-O-[bis(4-methoxyphenyl)benzyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)guanosine,272-615-4,68892-41-1,Aquatic Chronic 2,REACH registration C&L,14,H411:2;Not classified:11;H302:1
108927,"Octadecanoic acid, reaction products with triethylenetetramine",270-171-6,68412-15-7,Aquatic Chronic 3,REACH registration C&L,16,H412:14;Not classified:2
108928,N-benzylidenebenzylamine,212-304-2,780-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H319:72;H335:72;H315:72
108931,Aluminium tributanolate,221-394-2,3085-30-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,297,H318:6;H315:49;H226:6;H335:49;H228:83;H302:6;H336:6;H319:290;H225:176
108936,6-methyl-2-pyridylpropan-1-ol,262-944-1,61744-43-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
108937,(2-ethylhexanoato-O)(isooctanoato-O)cobalt,304-162-6,94246-88-5,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H400:1
108941,Isononylamine,248-653-2,27775-00-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:38;H227:1
108945,"4,6-dimethylpyrimidine",216-314-8,1558-17-4,Flam. Liq. 3,Notified C&L,45,H226:44;H319:6;H335:5;H315:6;H228:1
108946,"1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",918-886-0,87239-81-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H317:1;H334:2
108948,"1-Hydroxy-1,2,3-benzotriazole x hydrate",602-929-2,123333-53-9,Expl. 1.3,Notified C&L,49,H203:23;H228:25;H332:2;H302:2;H312:2;H319:4;H412:2;H200:1;H413:1;H351:1;H341:1
108951,"Hydrogen tribromide, compound with pyrrolidin-2-one (1:3)",245-100-7,22580-55-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:38;H335:44;H315:44;H319:6
108952,"N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide",411-840-6,83372-55-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
108954,"2,2'-(m-tolylimino)diethanol",202-114-8,91-99-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT RE 2,REACH registration C&L,155,H302:2;H318:37;H315:3;H317:2;H373:2;H312:88;H301:88;H319:89;Not classified:29
108958,"Trisodium 4-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonate",276-548-1,72259-17-7,Not Classified,Notified C&L,15,Not classified:15
108963,M-XYLYLENEDIAMINE/ACRYLONITRILE ADDUCT,615-900-4,73050-11-0,Not Classified,Notified C&L,160,Not classified:105;H332:55;H302:55;H312:38;H334:38;H412:17;H314:17;H317:17
108964,1-bromo-3-chloropropan-2-ol,224-891-2,4540-44-7,Acute Tox. 4,Notified C&L,38,H302:38
108968,3-Bromothioanisole,608-901-6,33733-73-2,,Notified C&L,8,H319:8;H335:7;H315:8;H336:1
108970,1-bromobutane,203-691-9,109-65-9,Flam. Liq. 2;Skin Irrit. 2;Carc. 2;Repr. 1B;Repr. 1B;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,202,H315:169;H360:9;H335:196;H225:114;H351:9;H373:9;H411:59;H226:88;H319:190;Not classified:2;H341:1
108975,Tris(2-methylphenyl)phosphine,228-193-9,6163-58-2,Aquatic Chronic 4,REACH registration C&L,101,H413:3;H319:97;H335:60;H315:97;H410:14;H400:14;H302:2;H317:2;H373:2;Not classified:2
108983,4-Benzyloxyphenylacetonitrile,617-499-1,838-96-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,44,H318:38;H400:38;H315:39;H302:6;H312:5;H332:1;H319:1
108984,3-ethoxycyclohex-2-ene-1-one,226-190-7,5323-87-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
108987,"Fatty acids, C14-18 and C16-18-unsatd., compds. with 2-amino-2-methyl-1-propanol",305-618-7,94891-19-7,Not Classified,Notified C&L,1,Not classified:1
108990,Sodium 5-(aminosulphonyl)-4-chloro-2-(furan-2-ylmethyl)anthranilate,255-526-5,41733-55-5,Muta. 2;Repr. 2;Lact.;Aquatic Chronic 3,REACH registration C&L,1,H362:1;H412:1;H341:1;H361:1
108995,"6,6'-[[3,3',5,5'-Tetrakis(1,1-dimethylethyl)-[1,1'-biphenyl]-2,2'-diyl] bis(oxy)] bis-dibenzo [d,f] [1,3,2]-dioxaphosphepin",619-697-3,138776-88-2,Aquatic Chronic 4,Notified C&L,138,H413:138;H317:55
108997,"1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]-1H-imidazolium nitrate",246-051-4,24168-96-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,37,H410:34;H400:34;H362:1;H312:1;H335:1;H302:1;H319:1;Not classified:1;H301:1;H361:1
109000,Sodium 5-amino-4-methoxy-2-nitrobenzenesulphonate,261-695-6,59312-73-1,Not Classified,Notified C&L,1,Not classified:1
109001,diquat dichloride,223-714-6,4032-26-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H315:0;H335:0;H317:0;H410:0;H302:0;H372:0;H319:0;H400:0
109003,Discandium dicarbonate,257-117-7,51299-79-7,Not Classified,Notified C&L,1,Not classified:1
109004,N-allylglycine,221-672-3,3182-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
109005,2-(2-aminobenzoyl)benzoic acid,214-554-8,1147-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
109006,"4,4'-(1,3,4-oxadiazole-2,5-diyl)bis[N,N-diethylaniline]",216-851-8,1679-98-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
109008,"(2R)-(+)-3,3,3-Trifluoro-1,2-propenoxide",604-331-7,143142-90-9,Flam. Liq. 1,Notified C&L,42,H224:41;H319:4;H335:4;H315:4;H340:1;H312:2;H332:2;H350:1;H302:2;H225:1
109011,"3,3',4,4',5',7-hexahydro-2-phenyl-4H-chromen-4-one",208-463-2,529-44-2,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
109012,"4-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid",235-432-0,12225-86-4,,Notified C&L,3,H334:3
109016,"Aluminium, 6-hydroxy-5-[(2-methoxy-5-methyl-4-sulfophenyl)azo]-2-naphthalenesulfonic acid complex",271-524-7,68583-95-9,Not Classified,REACH registration C&L,178,Not classified:178
109021,1-benzyl-3-carboxylatopyridinium,240-129-1,15990-43-9,Not Classified,Notified C&L,5,Not classified:5
109023,[(benzyloxy)methyl]benzene,220-899-5,2930-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
109025,"Apple, Malus sylvestris, ext.",286-475-7,85251-63-4,Not Classified,REACH registration C&L,121,Not classified:116;H225:2;H226:2;H371:1;H319:1
109027,1-chloro-6-iodohexane,252-144-0,34683-73-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
109030,"2,6-difluorophenylacetic acid",285-289-3,85068-28-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
109033,1-phenylbutan-2-one,213-752-1,1007-32-5,Acute Tox. 4,Notified C&L,39,H302:39
109034,"Aluminum chloride, basic",215-477-2,1327-41-9,Met. Corr. 1;Eye Dam. 1,REACH registration C&L,518,H318:360;H290:372;Not classified:61;H302:38;H319:40;H315:20;H314:21;H411:13
109036,"Oils, cananga",614-648-2,68606-83-7,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,117,H412:89;H304:91;H317:116;H319:27;H411:27
109037,Tolazoline hydrochloride,200-447-3,59-97-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:45;H319:43;H335:42;H315:43
109040,Potassium salicylate,209-421-6,578-36-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,44,H302:40;H319:2;H318:38;Not classified:4
109043,"Decanoic acid, mixed esters with dipentaerythritol, heptanoic acid, octanoic acid and valeric acid",615-237-0,71010-75-8,Not Classified,Notified C&L,4,Not classified:4
109045,"[μ-[[3,3'-[methylenebis[(4,6-dihydroxy-m-phenylene)azo]]bis[4-hydroxy-5-nitrobenzenesulphonato]](6-)]]diiron dihydrochloride",277-369-1,73297-21-9,Not Classified,Notified C&L,1,Not classified:1
109047,3-cyclohexylaminopropiononitrile,211-864-5,702-03-4,Not Classified,Notified C&L,156,Not classified:83;H335:39;H301:38;H318:38;H315:39;H412:34;H302:34;H314:34;H319:1
109050,Geranyl benzoate,202-337-0,94-48-4,Not Classified,Notified C&L,164,Not classified:163;H319:1;H335:1;H315:1
109053,"Fatty acids, linseed-oil, conjugated",920-247-6,,Not Classified,Notified C&L,6,Not classified:6
109057,"1,1-dimethyl-4-phenylpiperazinium iodide",200-213-0,54-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H301:1;H331:1;H311:1
109063,2-amino-6-chloro-4-nitrophenol,228-762-1,6358-09-4,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,140,H317:74;H319:91;H411:62;H315:85;H335:65;H351:9;H302:10;H412:1;H312:1;H332:1
109064,"9,10-phenanthrenediamine",258-490-9,53348-04-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109066,"Ethanol, 2-[2-(ethenyloxy)ethoxy]-",618-888-9,929-37-3,Not Classified,Notified C&L,88,Not classified:88
109069,Calcium bis[2-[(2-hydroxynaphthyl)azo]naphthalenesulphonate],214-161-1,1103-39-5,Not Classified,REACH registration C&L,156,Not classified:105;H410:51;H400:51
109072,3-nitrophthalic acid,210-030-8,603-11-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,213,H318:203;H335:212;H315:213;H319:10
109073,Streptomycin sulphate,223-286-0,3810-74-0,,Notified C&L,285,H317:167;H335:117;H302:167;H361:63;H360:37;H410:35;H372:35;H319:36;H400:36;H373:10;H311:10;H332:3;Not classified:1;H334:3;H315:1
109074,"Bis(1,5-cyclooctadiene)rhodium (I) tetrafluoroborate",460-220-1,35138-22-8,Flam. Sol. 1,Notified C&L,3,H228:2;H314:2;H318:1
109078,Chlorodimethylvinylsilane,217-007-1,1719-58-0,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,127,H302:30;H314:127;H318:10;H225:127;H290:2
109079,(3-bromophenyl)acetonitrile,250-867-6,31938-07-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:45;H312:41;H335:45;H332:40;H302:41;H319:45;H301:5;H331:5;H311:5
109082,Pentazocine,206-634-6,359-83-1,Acute Tox. 4,Notified C&L,41,H302:41;H315:1;H312:1;H332:1;H319:1
109083,2-((4-methyl-2-nitrophenyl)amino)ethanol,408-090-7,100418-33-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H317:0
109085,(S)-(-)-1-Phenylethyl Alcohol,604-424-2,1445-91-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,47,H302:46;H318:45;H315:47;H335:6;H314:1;H319:2
109088,"UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C",422-720-8,166242-53-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H314:0;H317:0;H410:0;H351:0;H302:0;H400:0
109090,"Hydrogen [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",277-091-0,72928-81-5,Aquatic Chronic 2,REACH registration C&L,2,H411:2
109095,Trimethylbenzene,247-099-9,25551-13-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1355,H315:1283;H312:1173;H226:1298;H302:998;H319:1111;H332:315;H304:112;H411:149;H335:73;H336:43;Not classified:28;H225:22;H372:1;H361:1;H314:1;H410:1;H400:1
109098,"Glycerides, C14-18 and C16-18-unsatd., reaction products with diethanolamine",298-736-2,93821-48-8,Eye Irrit. 2,Notified C&L,3,H319:3
109106,Benzophenone oxime,209-373-6,574-66-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
109109,Diphenylpyraline hydrochloride,205-049-3,132-18-3,Acute Tox. 4,Notified C&L,40,H302:40
109111,3-fluorobenzaldehyde,207-266-9,456-48-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:46;H319:46;H335:45;H315:46;H302:7;H312:2;H332:2
109115,"1,1'-oxybisdodecane",224-895-4,4542-57-8,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,60,H318:38;H413:38;Not classified:22
109117,Chromium hydroxide sulphate,619-674-8,39380-78-4,Skin Corr. 1B,Notified C&L,38,H314:38
109118,Tri(isopropoxy)vinylsilane,241-931-4,18023-33-1,Flam. Liq. 3,REACH registration C&L,88,H226:66;Not classified:22
109119,"Formaldehyde, reaction products with trimethylenediamine",291-332-7,90387-58-9,Ox. Liq. 1,Notified C&L,1,H271:1
109122,Nicotine dihydrogen ditartrate,200-607-2,65-31-6,Acute Tox. 3;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,REACH registration C&L,48,H411:47;H301:5;H319:4;H361:4;H300:43;H330:42;H310:43;H332:1;H318:1
109124,D-phenylalanine,211-603-5,673-06-3,Not Classified,REACH registration C&L,14,Not classified:12;H302:1;H319:1;H335:1;H315:1
109127,Isopropyl isovalerate,251-145-3,32665-23-9,Flam. Liq. 3,Notified C&L,114,H226:114
109128,Methocarbamol,208-524-3,532-03-6,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,105,H302:105;H317:95;H334:95
109130,5-chloro-1H-pyrimidin-2-one,259-106-2,54326-16-8,Acute Tox. 4,Notified C&L,1,H302:1
109132,"4,8-dimethylnon-7-en-2-ol",254-994-8,40596-76-7,Aquatic Acute 1,Notified C&L,42,H400:38;Not classified:4
109134,Benzoxazole-2-thiol,219-191-9,2382-96-9,,Notified C&L,5,H319:4;H335:4;H315:4;H400:1
109136,"3,7-dihydro-1,7-dimethyl-1H-purine-2,6-dione",210-271-9,611-59-6,Acute Tox. 4,Notified C&L,44,H302:41;Not classified:3
109137,"Disodium (5or8)-[[3-[[4-[(3-chloro-2-methyl-5-sulphonatophenyl)azo]-3-methylphenyl]azo]-2,6-dihydroxyphenyl]azo]naphthalene-2-sulphonate",232-324-5,8003-78-9,Not Classified,Notified C&L,37,Not classified:37
109138,Sodium [3-(5-chloro-2-methoxyphenyl)-1-methyl-2-triazeno]acetate,251-364-4,33067-78-6,Not Classified,Notified C&L,9,Not classified:9
109139,"Fatty acids, coco, Bu esters",292-988-7,91031-82-2,Not Classified,Notified C&L,2,Not classified:2
109140,Benzo[f]quinoline,201-582-0,85-02-9,Acute Tox. 3;Eye Dam. 1,Notified C&L,39,H301:38;H318:38;H332:1;H302:1;H312:1;H341:1
109141,"Fatty acids, C14-18 and C16-18-unsatd., Et esters",285-205-5,85049-35-0,Not Classified,Notified C&L,30,Not classified:30
109142,"Dihydrogen hydroxy[3,8,13,17-tetramethyl-7,12-divinyl-21H,23H-porphine-2,18-dipropionato(4-)-N21,N22,N23,N24]ferrate(2-)",239-518-9,15489-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109146,Diisopropyl maleate,233-242-2,10099-70-4,Skin Sens. 1,REACH registration C&L,2,H317:2
109147,2-chloro-N-methylacetamide,202-497-1,96-30-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H301:38;H319:46;H335:44;H315:45;H317:7;H302:7
109149,"Benzenesulfonic acid, C10-60-alkyl derivs., barium salts",296-719-4,93028-28-5,Skin Sens. 1B,REACH registration C&L,25,H317:1;H332:17;H302:17;H319:17;Not classified:7
109151,"2,4,5-trimethyl-4-phenyl-1,3-dioxane",253-717-8,37922-18-2,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,13,H412:13;H302:13
109153,2-methylthiophene,209-063-0,554-14-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1451,H332:1387;H302:1386;H312:1382;H225:163;H319:1;H335:1;H315:1
109156,Rifampicin,236-312-0,13292-46-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H302:57;H319:51;H335:50;H315:51;H351:3;H362:4;H361:4;H312:4;H360:4;H332:4;H300:1;H330:1;H310:1;H411:1
109157,"(Z,E)-tetradeca-9,12-dienyl acetate",250-753-6,31654-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109162,"Hexadecanoic acid, reaction products with acetic acid and triethylenetetramine",296-116-6,92257-27-7,Not Classified,Notified C&L,1,Not classified:1
109163,"2,5-Furandione, polymer with ethene and 1-propene",608-575-5,31069-12-2,Not Classified,Notified C&L,68,Not classified:68
109164,2-methyl-6-nitrobenzothiazole,220-927-6,2941-63-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
109166,Cordierite,235-593-7,12330-40-4,Not Classified,Notified C&L,3,Not classified:3
109169,1-bromopropan-2-ol,243-225-1,19686-73-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H314:43;H226:43;H318:1
109176,2-[(2-methoxy-4-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutyramide,228-768-4,6358-31-2,Not Classified,REACH registration C&L,874,Not classified:787;H319:85;H315:85;H303:1;H362:1
109177,Ethyl 2-cyano-2-phenyl-butanoate,700-275-3,718-71-8,Repr. 2,REACH registration C&L,2,H361:1;H319:1;H315:1
109181,C.I. Direct Red 9,612-315-6,61724-94-5,Not Classified,Notified C&L,7,Not classified:7
109182,"Disodium 3-[(4-aminophenyl)azo]-4,5-dihydroxynaphthalene-2,7-disulphonate",216-859-1,1681-60-3,Aquatic Chronic 3,Notified C&L,12,H412:12
109191,Didodecyl hydrogen citrate,247-146-3,25637-88-1,Not Classified,Notified C&L,8,Not classified:8
109194,Butyl octanoate,209-659-0,589-75-3,Not Classified,Notified C&L,137,Not classified:136;H319:1
109198,1-bromo-3-chloropropane,203-697-1,109-70-6,Acute Tox. 4;Acute Tox. 3;STOT SE 3;Muta. 2;Aquatic Chronic 3,REACH registration C&L,186,H412:128;H331:137;H335:83;H302:186;H341:65;H340:3;H301:3;H360:3;H350:4;H226:54;H332:47;H315:20;H319:21;H312:4;H373:1;H371:3;Not classified:2;H351:1;H336:1;H361:1
109200,2-naphthylacetonitrile,231-352-5,7498-57-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:42;H302:42;H312:38;H301:1;H315:1;H331:1;H311:1;H319:1
109202,Allyl chlorooxoacetate,277-900-7,74503-07-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H302:38;H226:38;H314:38
109205,"5-chloro-7-nitro-2,3-dihydro-1,3-benzoxazol-2-one",617-205-1,811810-67-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
109208,Brucine N-oxide hydrate,241-328-6,17301-81-4,Acute Tox. 1;Acute Tox. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H300:2;H330:2
109209,Methyl DL-tyrosinate hydrochloride,272-084-9,68697-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109210,"2,2,4-trimethylpentane-1,3-diyl dibenzoate",268-316-3,68052-23-3,Not Classified,Notified C&L,15,Not classified:15
109212,"Guanidine, N,N'''-1,3-propanediylbis-, N-coco alkyl derivs., diacetates",288-198-7,85681-60-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,98,H302:98;H400:98;H314:98;H318:39;H226:25
109214,"3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-",615-698-8,71939-50-9,Org. Perox. D;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H242:2
109215,"phosacetim (ISO);O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate",223-874-7,4104-14-7,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H400:0;H410:0;H310:0
109216,"α,α,α,2-tetrafluorotoluene",206-880-4,392-85-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H225:45;H302:1
109218,Sodium dimethyl 5-sulphonatoisophthalate,223-578-8,3965-55-7,Not Classified,REACH registration C&L,166,Not classified:65;H319:101;H315:54;H335:6
109220,"2,4,6-trichloroanisole",201-743-5,87-40-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,42,H302:41;H319:41;H413:38;Not classified:1
109221,"(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide",617-525-1,84057-95-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,13,H412:11;H315:10;H332:9;H302:12;H319:10;H335:1
109222,"/-/-1α-Ethyl-1,2,3,4,6,7,12,12b α-octahydro-indolo[2,3-a]-quinolizine-1β-yl-ethyl-pyruvate oxime",617-734-8,85647-38-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2A;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H402:1;H315:1;H317:1;H373:1;H319:1
109234,Lithium dihydrogen 5-sulphonatoisophthalate,256-275-4,46728-75-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:49;H335:49;H315:52;H318:44
109237,"1,2-bis(ethenyl)benzene;(2-ethenylphenyl)methyl-trimethylazanium;chloride",611-942-2,60177-39-1,Not Classified,Notified C&L,8,Not classified:7;H412:1
109238,Ethyl 2-(methyldithio)propionate,245-862-0,23747-43-5,Not Classified,Notified C&L,233,Not classified:233
109244,Pent-3-yn-1-ol,233-550-7,10229-10-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:47;H319:43;H335:42;H315:43;H312:1;H332:1;H302:1
109245,"Epilobium angustifolium, ext.",289-821-5,90028-31-2,Not Classified,Notified C&L,1,Not classified:1
109247,Chlorodimethylpropylsilane,241-492-9,17477-29-1,,Notified C&L,6,H314:6;H225:5;H226:1;H290:1;H318:1
109249,"1,3-Disiloxanediol, 1,3-bis[3-[(2-aminoethyl)amino]propyl]-1,3-dimethyl-",605-908-6,18077-50-4,Not Classified,Notified C&L,1,Not classified:1
109252,Thiazinamium metilsulfate,200-376-8,58-34-4,Not Classified,Notified C&L,1,Not classified:1
109254,"Sulfuric acid, mono-C10-18-alkyl esters, ammonium salts",306-863-2,97434-85-0,Eye Irrit. 2,Notified C&L,1,H319:1
109255,Methyl(methylthio)pyrazine,267-918-3,67952-65-2,Flam. Liq. 3,Notified C&L,1562,H226:1286;Not classified:235;H319:41;H335:41;H315:41;H302:1
109256,2-bromo-1-(4-fluorophenyl)propan-1-one,609-004-2,345-94-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
109258,"Acetic acid, nitrilotri-, trisodium salt, monohydrate",606-091-9,18662-53-8,Acute Tox. 4;Eye Irrit. 2;Carc. 2,Notified C&L,72,H351:65;H302:67;H319:66;Not classified:5;H315:1
109259,"3,4,5-trichloroaniline",211-218-2,634-91-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H301:43;H331:43;H311:43;H410:43;H373:43;H400:42;H315:1;H312:1;H332:1;H302:1;H319:1
109266,"fenitrothion (ISO);O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate",204-524-2,122-14-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
109271,Hexyl laurate,251-932-1,34316-64-8,Not Classified,REACH registration C&L,134,Not classified:134
109272,trans-4-(4-butylcyclohexyl)benzonitrile,262-655-0,61204-00-0,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H301:1;H315:1;H331:1;H311:1;H319:1
109273,"Oleic acid, monoester with decaglycerol",279-230-0,79665-93-3,Not Classified,Notified C&L,42,Not classified:42
109278,(S)-(-)-2-acetoxypropionylchloride;(1S)-2-chloro-1-methyl-2-oxoethyl acetate,420-610-4,36394-75-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0;H314:0
109286,"Hectorite, 2-amino-2-(hydroxymethyl)-1,3-propanediol-modified",270-946-9,68511-77-3,Eye Irrit. 2,Notified C&L,85,H319:83;Not classified:2
109287,"1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride (1:1)",603-599-2,132467-76-6,Eye Dam. 1,Notified C&L,14,H318:14
109292,"Lithium, sodium 2-(4-chloro-6-cyanoamino-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(2-methoxy-5-(sulfatoethanesulfonyl)phenylazo)naphthalene-1,7-disulfonate",440-050-4,,Not Classified,REACH registration C&L,1,Not classified:1
109300,Zinc p-toluate,245-563-5,23292-93-5,Not Classified,Notified C&L,2,Not classified:2
109307,Hydrofluorocarbon,615-043-6,69991-61-3,Not Classified,Notified C&L,7,Not classified:6;H319:1;H335:1;H315:1
109308,"9,12-Octadecadienoic acid (9Z,12Z)-, dimer",612-147-3,6144-28-1,Not Classified,Notified C&L,21,Not classified:21
109309,(E)-2-methylbut-2-enoic acid,201-295-0,80-59-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1612,H319:1567;H315:1565;H314:47;H335:2;H318:2;H290:1
109310,m-tolylidene diisocyanate;toluene-diisocyanate,247-722-4,26471-62-5,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;Resp. Sens. 1;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H330:0;H334:0;H315:0;H335:0;H317:0;H351:0;H319:0
109315,Methyl hydrogen decylphosphonate,284-771-0,84962-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,21,H319:20;H335:21;H315:20;H302:1;H318:1;H314:1;H373:1
109317,"terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine",251-637-8,33693-04-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
109318,Amylodextrin,232-686-4,9005-84-9,Not Classified,Notified C&L,155,Not classified:155
109319,"(1R,5S)-6,6-Dimethyl-3-oxabicyclo[3.1.0]hexane-2,4-dione",614-164-1,67911-21-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
109321,"oxiran-2-ylmethyl 2,2-dimethylpropanoate",413-660-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1B,REACH registration C&L,1,H315:1;H317:1;H350:1;H341:1;H319:1
109325,"Rosin, maleated, reaction products with p-tert-butylphenol, formaldehyde and pentaerythritol",296-049-2,92202-16-9,Not Classified,Notified C&L,72,Not classified:72
109327,Aluminium lithium dioxide,234-434-9,12003-67-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H319:39;H335:39;H315:39;Not classified:25;H413:2
109329,1-bromo-2-chloro-5-fluoro-4-methylbenzene,606-455-7,201849-17-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
109330,"N2,N6-bis(2,4-dinitrophenyl)-L-lysine",216-737-8,1655-49-8,Flam. Sol. 1,Notified C&L,1,H228:1
109331,"Myo-Inositol, hexakis(dihydrogen phosphate), calcium magnesium salt",222-798-1,3615-82-5,Eye Irrit. 2,Notified C&L,39,H319:38;H412:1
109335,"Endo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate",200-964-4,76-49-3,Not Classified,Notified C&L,299,Not classified:299
109339,"Dipotassium 4,4'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis(toluene-3-sulphonate)",280-170-2,83044-88-6,,Notified C&L,2043,H412:2043
109343,2-(dimethylamino)ethyl methacrylate hydrochloride,219-349-7,2421-44-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H312:1;H317:1;H302:1;H319:1
109346,N-(5-chloro-2-methylphenyl)acetamide,227-592-5,5900-55-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
109348,"(-)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalene-1(2H)-one hydrochloride",248-725-3,27912-14-7,Acute Tox. 4,Notified C&L,47,H302:46;Not classified:1;H332:1;H312:1;H319:1
109353,"5-oxo-L-proline, compound with L-arginine (1:1)",260-081-5,56265-06-6,Not Classified,Notified C&L,3,Not classified:3
109354,Blue MGi 1037,438-610-8,,Eye Dam. 1,Notified C&L,37,H318:37
109355,3-methoxysalicyl alcohol,224-488-1,4383-05-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
109357,Iminodi(acetic acid),205-555-4,142-73-4,Eye Irrit. 2,Notified C&L,187,H319:140;H412:48;H335:81;H315:82;Not classified:2
109360,Trichlorooctylstannane,221-435-4,3091-25-6,Skin Irrit. 2;Eye Dam. 1;Repr. 2;Repr. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,21,H318:18;H315:18;H361:18;H410:18;H373:18;H400:18;Not classified:3
109363,"2-Propanamine, 2-methyl-1-(methylthio)-",468-080-3,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,3,H412:3;H318:1;H226:3;H311:2;H314:3;H317:2;H302:3;H312:1;H335:1;H332:1
109364,(3S)-(-)-3-Aminopyrrolidine,603-267-7,128345-57-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H314:5;H318:1
109365,Dichloro(chloromethyl)methylsilane,216-319-5,1558-33-4,Flam. Liq. 3;Skin Corr. 1A;Acute Tox. 3;STOT SE 3,Notified C&L,46,H314:46;H226:46;H331:39;H335:43;H290:1;H318:3;H260:1;H412:1
109369,"Sodium 3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatetracontyl sulphate",266-192-5,66161-57-7,,Notified C&L,1,H319:1;H315:1
109371,"4-amino-α-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol monohydrochloride",244-643-7,21898-19-1,Acute Tox. 3,Notified C&L,42,H301:42;H372:1;H331:1
109372,"Acorus calamus, ext.",283-869-0,84775-39-3,Acute Tox. 4,Notified C&L,1447,H302:1446;H412:150;H317:12;H332:1
109375,"rhodium (III) nitrate, dihydrate",603-842-2,13465-43-5,Ox. Sol. 2;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H272:1;H318:1;H314:1;H317:1;H410:1;H302:1;H290:1;H400:1
109376,"Propane-1,2-diyl dibenzoate",242-894-7,19224-26-1,Not Classified,REACH registration C&L,109,Not classified:86;H319:21;H315:21;H411:2;H335:1
109377,1-[3-(phenylmethoxy)phenyl]ethan-1-one,251-816-0,34068-01-4,Aquatic Acute 1,Notified C&L,38,H400:38
109378,"12H-Dibenzo(d,g)(1,3,2)dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, lithium salt",617-688-9,85209-93-4,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H332:1;H412:1
109381,resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate,233-940-7,10453-86-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0
109389,1-phenyl-2-(phenylsulphonyl)ethan-1-one,222-292-0,3406-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
109395,Phosphoryl tribromide,232-177-7,7789-59-5,Skin Corr. 1B,REACH registration C&L,68,H314:68;H290:9;H335:9;Not classified:2;H318:2
109400,"2,5,5-trimethyl-2-phenyl-1,3-dioxane",226-466-7,5406-58-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,88,H317:88;H319:88
109402,"1H-Pyrrole-1-undecanoic acid, 2,5-dihydro-2,5-dioxo-",611-462-3,57079-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109406,Isopropamide iodide,200-766-8,71-81-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:49;H335:48;H315:49;H302:1
109409,"(2E,6Z)-nona-2,6-dien-1-ol",248-816-8,28069-72-9,Not Classified,Notified C&L,190,Not classified:148;H315:42
109412,"Diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate",211-188-0,632-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109415,Potassium Titanium Oxide,470-870-8,690271-93-3,Not Classified,REACH registration C&L,2,Not classified:2
109416,"Trisodium 5-[[2-methoxy-5-methyl-4-[(4-sulphonatophenyl)azo]phenyl]-N,N,O-azoxy]-2-[2-(4-nitro-2-sulphonatophenyl)vinyl]benzenesulphonate",304-703-6,94278-15-6,Not Classified,Notified C&L,1,Not classified:1
109417,"1,3-Oxazol-2-amine",610-269-1,4570-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
109419,"Sunflower oil, bisulfited, sodium salt",281-980-9,84082-32-6,Skin Irrit. 2,Notified C&L,34,H315:30;Not classified:4
109421,"Methanone, (2,5-dichlorophenyl)phenyl-",605-427-1,16611-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109424,"1(3H)-Isobenzofuranone, 5-bromo-",613-485-4,64169-34-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
109426,"3-hydroxy-4,5-dimethylfuran-2(5H)-one",249-136-4,28664-35-9,Acute Tox. 4,Notified C&L,1482,H302:1289;Not classified:193
109429,Thiomorpholin-3-one,243-581-8,20196-21-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109430,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and ethyl 2-propenoate",608-576-0,31069-81-5,Not Classified,Notified C&L,5,Not classified:5
109432,Triboron trimethyl hexaoxide,203-016-8,102-24-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Repr. 1B;STOT SE 1,REACH registration C&L,583,H301:2;H318:87;H226:2;H360:86;H311:2;H370:2;H314:492;H225:576;Not classified:5
109437,3-Methoxy-1-propanol,605-167-9,1589-49-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H226:42;H319:41;H315:42
109441,"Diacrylic acid, diester with 3,3'-(isopropylidene)bis(p-phenyleneoxy)]di(propane-1,2-diol)",260-731-8,57417-94-4,Not Classified,Notified C&L,1,Not classified:1
109442,Rimsulfuron (aka renriduron),602-908-8,122931-48-0,Eye Irrit. 2,Notified C&L,68,H319:50;H410:15;H400:14;Not classified:4;H314:1;H315:1
109445,2-[2-[bis[2-(2-hydroxyethoxy)ethyl]amino]ethoxy]ethanol,609-315-3,36936-60-4,Not Classified,Notified C&L,13,Not classified:11;H302:1;H318:1;H315:1;H319:1
109446,2-ethylaniline,209-424-2,578-54-1,Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,91,H302:41;H319:12;H311:70;H373:45;H331:43;Not classified:15;H330:11;H301:11;H332:4;H312:5;H315:4;H371:1;H317:1;H351:1
109448,2-quinolylmethanol,217-225-7,1780-17-2,,Notified C&L,3,H315:3;H312:3;H335:3;H332:3;H302:3;H319:3
109452,N-(2-Benzoyl-4 Chlorophenyl)-2-Bromo-N-(Cyclopropylmethyl)-Acetamide,920-284-8,1184768-58-8,Not Classified,REACH registration C&L,1,Not classified:1
109455,Zinc bis(piperidine-1-carbodithioate),237-643-3,13878-54-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,86,H317:86;H319:86
109458,3'-trifluoromethylisobutyranilide,406-740-4,1939-27-1,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0
109459,aluminium phosphide,244-088-0,20859-73-8,Water-react. 1;Acute Tox. 2;Acute Tox. 3;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H300:0;H330:0;H311:0;H400:0;H260:0
109460,Exo-bornyl isovalerate,231-935-4,7779-73-9,Not Classified,Notified C&L,114,Not classified:114
109465,1-benzyl-2-methyl-1H-imidazole,237-333-8,13750-62-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,105,H302:81;H319:77;H335:89;H315:104;H318:27;H301:16;H351:3
109470,"Linseed oil, sodium salt",271-404-4,68554-56-3,Eye Irrit. 2,Notified C&L,1,H319:1
109471,Xylenesulphonic acid,246-839-8,25321-41-9,Skin Corr. 1A;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H314:60;H319:34;H335:33;H315:34;H318:4;H290:5
109473,1-(thiazol-2-ylazo)-2-naphthol,214-555-3,1147-56-4,,Notified C&L,4,H319:4;H335:4;H315:4
109478,"2-Trimethylsilyloxy-1,3-butadiene",609-512-4,38053-91-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H225:2;H311:1;H301:1;H331:1
109480,"Imidazolium compounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-1-(2-tallow amidoethyl), Me sulfates",268-531-2,68122-86-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,37,H319:33;H411:28;H315:37;H332:5;H410:3;H318:4;H335:1
109481,"Benzene Sulphonic acid, alkyl derivs.",610-046-9,42615-29-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,86,H318:83;H314:84;H410:83;H302:86;H400:83;H332:2;H312:2;H319:2
109482,"Benzeneethanamine, 2-(trifluoromethoxy)-",604-009-6,137218-26-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H334:1;H315:1;H312:1;H335:1;H332:1;H317:1;H302:1;H319:1
109484,"Glycerides, tallow",294-532-2,91723-27-2,Not Classified,Notified C&L,1,Not classified:1
109490,Tris(2-ethylhexyl) orthoborate,219-581-9,2467-13-2,Eye Irrit. 2,REACH registration C&L,28,H319:28;H412:22;H315:2
109492,7-(4-ethyl-1-methyloctyl)quinolin-8-ol,277-531-1,73545-11-6,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,4,H314:1;H317:1;H413:1;Not classified:2;H319:1;H335:1;H315:1
109496,"[5,10,15,20-tetraphenyl-21H,23H-porphinato(2-)-N21,N22,N23,N24]cobalt",238-018-8,14172-90-8,Carc. 2,Notified C&L,1,H351:1
109497,Dipotassium hexadecyl phosphate,242-778-6,19045-75-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
109498,"O,O,O-tris(4-nitrophenyl) thiophosphate",264-697-5,64131-85-7,Not Classified,REACH registration C&L,1,Not classified:1
109500,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]sulfonyl]phenyl]diazenyl]-5-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-, lithium salt (1:?)",600-272-6,102082-94-0,Not Classified,Notified C&L,83,Not classified:83
109503,Heptacosanol,217-906-9,2004-39-9,Not Classified,Notified C&L,1,Not classified:1
109504,"Fatty acids, C8-18 and C18-unsatd., barium salts",272-528-1,68876-83-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H302:2
109509,1-(2-thienyl)propan-1-one,237-182-8,13679-75-9,Acute Tox. 4,Notified C&L,1414,H302:1413;H332:39;H312:39;Not classified:1
109510,"Octadecanamide, N-[2-[(2-hydroxyethyl)amino]ethyl]-, reaction products with urea",270-172-1,68412-16-8,Not Classified,Notified C&L,4,Not classified:4
109511,"Urea, octadecyl-, reaction products with formaldehyde, butylated",292-353-4,90604-59-4,Not Classified,Notified C&L,83,Not classified:83
109513,3-methylthiopropylamine,223-875-2,4104-45-4,Skin Corr. 1B,Notified C&L,136,H314:96;H318:76;H335:39;H315:39;H317:10;Not classified:1;H227:1
109516,"(5α)-6,7-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl acetate hydrochloride",243-623-5,20236-82-2,Acute Tox. 3,Notified C&L,1,H301:1
109517,"(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5S)-5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate",616-337-7,764659-72-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
109520,"Formaldehyde, reaction products with triethylenetetramine",600-750-4,1064697-08-0,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
109521,Methyl 4-Amino-3-methylbenzoate,606-066-2,18595-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:4;H315:5
109523,phenylhydrazinium chloride,200-444-7,59-88-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H301:0;H315:0;H331:0;H311:0;H317:0;H350:0;H372:0;H341:0;H319:0;H400:0
109524,Ethyl 4-aminobenzoate hydrochloride,607-211-2,23239-88-5,Skin Sens. 1,Notified C&L,38,H317:38
109525,"([1,3]dioxolan-2-ylmethoxyimino)-phenyl-acetonitrile",616-136-4,74782-23-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,127,H332:89;H302:89;H411:89;H330:38
109529,"1,2-Ethanediamine, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-, reaction products with epichlorohydrin",291-227-6,90366-83-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H312:1;H314:1;H317:1;H302:1;H411:1
109530,"(1S,2S,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol",606-096-6,18680-27-8,Aquatic Chronic 3,REACH registration C&L,8,H412:4;Not classified:4
109532,Methyl henicosaneate,227-994-0,6064-90-0,Not Classified,Notified C&L,2,Not classified:2
109537,dinitrophenol (reaction mass of isomers),247-096-2,25550-58-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H311:0;H410:0;H373:0;H400:0
109540,2-[(2-hydroxyethyl)(3-methoxypropyl)amino]ethyl methacrylate,300-708-2,93962-70-0,Skin Sens. 1,Notified C&L,1,H317:1
109542,"2-chloro-N,N-dimethylpropionamide",233-860-2,10397-68-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
109545,Benzoyl cyanide,210-359-7,613-90-1,Acute Tox. 2,Notified C&L,39,H300:39;H315:1;H331:1;H311:1;H319:1;H400:1
109547,"2,6-diisopropylphenyl isocyanate",248-885-4,28178-42-9,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 1;Resp. Sens. 1;STOT SE 3,REACH registration C&L,522,H330:81;H334:522;H335:81;H314:37;H302:522;H315:485;H312:441;H317:480;H319:441;H318:77
109548,4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide,608-211-5,284462-37-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H302:1;H411:1
109549,"3-[(2,3-dichlorophenyl)methylene]carbazamidine",301-665-2,94023-67-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
109553,TMOCA,458-210-7,,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,REACH registration C&L,1,H301:1;H226:1;H311:1;H373:1;H400:1
109554,Castor oil,232-293-8,8001-79-4,Not Classified,Notified C&L,2446,Not classified:2445;H319:1
109557,"Propanol, 1(or 2)-(2-hydroxymethylethoxy)-, monobenzoate",603-071-1,125457-59-2,,Notified C&L,44,Not classified:44
109560,"Whey, lactose-low",295-893-9,92129-93-6,Eye Irrit. 2,REACH registration C&L,2,H319:2
109562,"Disodium [[[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-sulphophenyl]amino]sulphonyl]bis(sulphamoyl)-29H,31H-phthalocyaninesulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",278-128-3,75214-59-4,Not Classified,Notified C&L,32,Not classified:32
109571,Ethyl 2-acetyl-3-methylbutyrate,216-192-6,1522-46-9,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
109572,N-ethyl-2-nitroaniline,233-305-4,10112-15-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H335:38;H332:38;H302:38;H319:38
109574,"1,5-bis(cyclohexylamino)anthraquinone",240-093-7,15958-68-6,Not Classified,REACH registration C&L,31,Not classified:29;H315:2;H335:2;H332:2;H302:2;H319:2
109575,"3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol",225-856-4,5117-19-1,Not Classified,Notified C&L,95,Not classified:95
109577,3-fluoro-o-toluidine,207-142-4,443-86-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H312:41;H335:40;H332:46;H302:46;H319:47;H373:6;H311:5;H330:1;H301:1
109581,Iodosylbenzene,208-648-8,536-80-1,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H228:3;H335:1;H271:1
109583,N-(cyclopent-1-ene-1-yl)pyrrolidine,230-463-6,7148-07-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,45,H302:2;H226:41;H314:2;H319:43;H335:38;H315:43
109586,(E)-1-(1-methoxypropoxy)hex-3-ene,306-628-4,97358-54-8,Acute Tox. 4;Skin Irrit. 2,Notified C&L,115,H302:115;H315:115
109592,Octyl palmitate,241-028-5,16958-85-3,Not Classified,Notified C&L,4,Not classified:4
109593,"Fatty acids, C16-18 and C18-unsatd., Et esters",285-206-0,85049-36-1,Not Classified,REACH registration C&L,14,Not classified:14
109598,"Trichloro(N,N-dimethyloctylamine)boron",252-200-4,34762-90-8,Skin Sens. 1B;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,150,H317:28;H410:28;H400:28;H361:28;H319:74;H335:74;H315:74;H302:38;H312:38;H314:38;Not classified:10
109600,chloromethane;methyl chloride,200-817-4,74-87-3,Press. Gas;Flam. Gas 1;Carc. 2;STOT RE 2,Harmonised C&L,0,Not classified:0;H220:0;H373:0;H351:0
109601,5-bromo-2-hydroxybenzyl alcohol,219-026-0,2316-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
109605,"1,2-epoxy-4-vinylcyclohexane",203-436-1,106-86-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,151,H332:86;H226:151;H319:150;H315:86;H351:38;H302:87;H411:22;H350:2;H412:1;H317:1
109606,"Fatty acids, tallow, esters with pentaerythritol",270-447-6,68440-28-8,Not Classified,Notified C&L,1,Not classified:1
109607,"2-(3-chloro-2-oxo-2,3-dihydro-1H-indol-4-yl) ethyl benzoate",470-710-7,139122-17-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H400:1
109609,Dec-1-enylsuccinic acid,278-432-6,76386-11-3,Eye Irrit. 2,Notified C&L,38,H319:38
109611,Bis(4-fluorophenyl)phenylphosphine oxide,259-079-7,54300-32-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H335:38;H332:38;H302:38;H319:38
109614,Cyclomethicone,614-966-1,69430-24-6,Flam. Liq. 3;Aquatic Chronic 3,Notified C&L,344,H412:133;H226:219;Not classified:93;H361:91;H413:105;H304:14;H331:14
109615,3-phenyl-5-pyrazolone,225-463-8,4860-93-9,Acute Tox. 3;Skin Sens. 1,Notified C&L,39,H317:38;H301:38;H302:1;H319:1;H335:1;H315:1
109618,"bromophos-ethyl (ISO);O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate",225-399-0,4824-78-6,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H301:0;H400:0
109621,[carbonato(2-)]hexadecahydroxybis(aluminium)hexamagnesium,234-319-3,11097-59-9,Not Classified,REACH registration C&L,2479,Not classified:2479
109623,{4-[2-(Dimethylamino)ethoxy]phenyl}(phenyl)methanone,610-729-1,51777-15-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
109625,"α,α,α',α'-tetrachloro-p-xylene",230-994-3,7398-82-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
109626,"7-chloro-1,3-dihydro-5-phenyl-2-oxo-2H-1,4-benzodiazepin-3-yl acetate",217-359-6,1824-74-4,Acute Tox. 4,REACH registration C&L,2,H302:2
109627,"1-Propanamine, 3-(C10-16-alkyloxy) derivs.",269-097-7,68187-44-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,22,H302:22;H410:22;H314:22
109629,1-(5-tetrazolyl)-4-guanyl tetrazene hydrate,608-603-6,31330-63-9,Expl. 1.1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H201:2;H315:1;H332:1;H302:1;H319:1
109632,Chloro(chloromethyl)dimethylsilane,217-006-6,1719-57-9,Flam. Liq. 2;Skin Corr. 1A;STOT SE 3,Notified C&L,54,H314:54;H335:46;H225:46;H226:8;H302:7;H411:6;H318:3;H290:1
109634,17β-hydroxyestr-4-en-3-one 17-decanoate,206-639-3,360-70-3,Carc. 2,Notified C&L,85,H351:83;H360:45;H362:24;H301:16;H312:20;H332:20;H302:21;H334:4;H317:4;H372:1
109636,3-morpholinopropiononitrile,224-894-9,4542-47-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:43;H302:43;H312:43;H315:5;H319:5
109637,"Fatty acids, C9-13-neo-, calcium salts",270-296-6,68424-35-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,12,H412:2;H319:2;Not classified:8;H315:2
109638,1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone,430-920-1,73096-98-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
109644,"Octadecanoic acid, reaction products with 2-amino-2-methyl-1-propanol",273-159-9,68951-62-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,449,H410:2;H400:2;Not classified:447
109645,"Bis[N-(2-hydroxyethyl)-N-methylglycinato-N,O,ON]copper",300-491-4,93940-93-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H315:1;H317:1;H410:1;H302:10;H319:1;H400:1
109647,"(2,4-diaminopteridin-6-yl)methanol monohydrochloride",700-274-8,73978-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:44;H335:44;H315:44;H302:2
109648,"Licorice, Glycyrrhiza glabra, ext., hydrolyzed",309-191-8,100085-49-2,Not Classified,Notified C&L,1,Not classified:1
109649,"Fatty acids, C16-18, reaction products with 2-[(2-aminoethyl)amino]ethanol, acetates (salts)",287-641-1,85566-30-9,Not Classified,Notified C&L,6,Not classified:3;H319:2;H315:2;H360:1
109650,4-benzyloxy-3-methoxybenzyl alcohol,251-638-3,33693-48-0,,Notified C&L,4,H319:4;H335:4;H315:4
109652,Endo-3-(diphenylmethoxy)-8-methyl-8-azoniabicyclo[3.2.1]octane methanesulphonate,205-048-8,132-17-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,75,H301:39;H331:39;H311:39;H370:35;H300:35;H373:35;H302:1
109656,"2-hydroxy-N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",601-503-3,118026-14-5,Acute Tox. 4,REACH registration C&L,2,H302:2
109658,"L-(+)-2,5-diaminopentanoic acid",221-678-6,3184-13-2,Not Classified,REACH registration C&L,198,Not classified:156;H319:42
109667,"1,3-di-6-quinolylurea",208-525-9,532-05-8,Aquatic Chronic 4,Notified C&L,38,H413:38
109668,Tridocosyl citrate,304-666-6,94277-82-4,Not Classified,Notified C&L,3,Not classified:3
109669,"14-α-hydroxyandrost-4-ene-3,17-dione",427-340-6,,Not Classified,Notified C&L,1,Not classified:1
109670,"(benzoato-O,O')hydroxy(octadecanoato-O,O')aluminium",259-105-7,54326-11-3,Not Classified,REACH registration C&L,530,Not classified:530
109671,4-methoxysalicylaldehyde,211-604-0,673-22-3,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Repr. 1B,REACH registration C&L,87,H315:50;H360:1;H331:1;H335:49;H319:50;Not classified:37
109672,"Copper bis(O,O-diisopropyl) bis(dithiophosphate)",231-287-2,7481-27-8,Not Classified,Notified C&L,33,Not classified:33
109673,"Dipterocarpus turbinatus, ext.",296-902-9,93165-18-5,Asp. Tox. 1,Notified C&L,2,H304:2
109678,"Fatty acids, coco, 2-(2-butoxyethoxy)ethyl esters",292-989-2,91031-83-3,,Notified C&L,36,H319:36
109681,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt, reaction products with 4-[(4-amino-1-naphthalenyl)azo]benzenesulfonic acid monosodium salt",215-403-9,1325-65-1,Not Classified,REACH registration C&L,62,Not classified:61;H319:1;H315:1
109682,9-methylacridine,210-272-4,611-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H302:1;H373:1
109683,"Octanoic acid, compound with 2-(diethylamino)ethanol (1:1)",268-317-9,68052-35-7,Not Classified,Notified C&L,54,Not classified:54
109684,"[(1,1-dimethylethyl)dioxy]trimethylsilane",223-579-3,3965-63-7,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
109685,Tris[2-(2-methoxyethoxy)ethyl]amine,274-590-5,70384-51-9,Skin Corr. 1B,Notified C&L,43,H314:39;H319:4;H315:4;H318:1
109687,"Formaldehyde, reaction products with sulfonated 1,1'-oxybis[methylbenzene], sodium salts",291-331-1,90387-57-8,Aquatic Chronic 3,Notified C&L,334,H412:301;H413:32;Not classified:1
109691,"reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde",429-860-9,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
109693,"Tetrasodium 2,2'-[1,4-phenylenebis[carbonylimino[2-acetamido-4,1-phenylene]azo]]bis[5-[(4-sulphonatophenyl)azo]benzenesulphonate]",274-426-2,70210-30-9,Not Classified,REACH registration C&L,11,Not classified:11
109696,"Rifamycin, 3-formyl-",236-311-5,13292-22-3,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H318:2;H400:2
109698,Rosaramicin,252-742-1,35834-26-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
109701,"Benzaldehyde, 4-[2-(5-ethyl-2-pyridinyl)ethoxy]-",601-310-4,114393-97-4,Not Classified,REACH registration C&L,1,Not classified:1
109702,"perfluidone (ISO);1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide",253-718-3,37924-13-3,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H302:0;H319:0
109704,Ethyl chlorothiolformate,220-928-1,2941-64-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H312:40;H226:40;H335:40;H314:40;H302:40;H319:2;H330:38
109705,"benzophenone-3,3',4,4'-tetracarboxylic dianhydride;4,4'-carbonyldi(phthalic anhydride)",219-348-1,2421-28-5,Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H335:0
109707,(24R)-ergost-5-en-3β-ol,207-484-4,474-62-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H312:40;H335:40;H332:40;H302:40;H319:40
109708,Trihexylsilane,220-893-2,2929-52-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H312:38;H335:38;H332:38;H302:38;H319:39
109709,Methyl 2-methylisocrotonate,227-718-9,5953-76-4,Flam. Liq. 3,Notified C&L,4,H226:3;H317:1
109711,Chalcone,202-330-2,94-41-7,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:39;H319:40;H335:39;Not classified:5;H315:1
109712,3-hydroxy-D-tyrosine,227-343-0,5796-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109716,(butylamino)ethanethiol,227-431-9,5842-00-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H319:38;H335:38;H315:38
109724,3-fluoroanisole,207-267-4,456-49-5,Flam. Liq. 3,Notified C&L,46,H226:46
109728,Trimethyl-2-thiourea,219-644-0,2489-77-2,Acute Tox. 4,Notified C&L,19,H302:18;Not classified:1
109730,2-Hexyl-2 ‘-hydroxy-5 ‘methyldecananilide,448-250-3,,Aquatic Chronic 4,Notified C&L,1,H413:1
109731,Butyllithium,203-698-7,109-72-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,180,H314:125;H250:125;H260:122;Not classified:55;H318:69;H317:36;H302:36;H304:5;H361:5;H411:5;H373:5;H336:5;H252:3;H332:3;H225:4;H261:2
109733,"5-Brom-2,3-difluor-alpha-[1-(4-pentylcyclohexyl)ethenyl]-benzylalcohol",925-976-3,,Not Classified,Notified C&L,1,Not classified:1
109734,"Phosphoric acid, mono- and bis(C16-20-branched and linear alkyl) esters",306-986-1,97468-33-2,Skin Corr. 1B,Notified C&L,16,H314:13;H319:3;H318:1
109737,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 2-methylcyclohexane-1,3-diamine and 4-methylcyclohexane-1,3-diamine",500-404-1,158885-17-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H314:1
109738,"4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonic acid",229-959-5,6860-97-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,2,H413:1;H319:1;H315:1;Not classified:1
109742,chloroacetic acid,201-178-4,79-11-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H301:0;H331:0;H311:0;H314:0;H400:0
109746,2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane,407-360-1,116230-20-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Harmonised C&L,0,H302:0;H318:0;H315:0;H312:0;H373:0
109749,Docosyltrimethylammonium chloride,241-327-0,17301-53-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,436,H410:364;H319:432;H400:365;H315:433;Not classified:3;H318:1;H312:1;H411:1;H373:1
109750,"Cod-liver oil, sulfated, sodium salt",263-042-0,61789-21-7,Not Classified,Notified C&L,1,Not classified:1
109754,Phenanthrene,201-581-5,85-01-8,Acute Tox. 4,Notified C&L,635,H302:632;H410:95;H400:100;Not classified:3;H315:5;H317:1;H351:1;H335:3;H319:3
109756,"(S)-1-chloro-2,3-epoxypropane",482-080-0,67843-74-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Carc. 1B,Notified C&L,86,H330:85;H301:86;H318:84;H226:86;H311:86;H314:86;H317:86;H350:86;H334:1;H370:1;H372:1;H341:1;H361:1;H331:2;H400:1;H412:1
109761,Tetrabutylurea,224-929-8,4559-86-8,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,102,H411:6;H315:5;H410:96;H400:95
109766,Dodecyl acetoacetate,257-896-3,52406-22-1,Not Classified,Notified C&L,42,Not classified:42
109769,"N,N,N',N'-tetrakis(3-aminopropyl)butane-1,4-diamine",601-687-5,120239-63-6,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,39,H302:1;H314:39;H318:1
109770,2-(4-aminopentyl(ethyl)amino)ethanol,274-039-9,69559-11-1,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,14,H332:8;H412:6;H302:7;H314:13;H319:1;H335:1;H315:1;H413:1
109774,1-(3-methyl-2-furyl)propan-1-one,245-861-5,23747-34-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109778,Zirconium iron pink zircon,270-210-7,68412-79-3,Not Classified,REACH registration C&L,123,Not classified:123
109780,"Hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether",604-699-9,149725-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109781,"methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate",432-350-9,81752-87-6,Skin Irrit. 2,Harmonised C&L,0,H315:0
109782,2-bromobutyric acid,201-294-5,80-58-0,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,50,H302:47;H314:50;H300:1;H330:1;H310:1;H290:1;H318:1;H317:1;H312:1
109783,"1,2,3,5-tetrachlorobenzene",211-217-7,634-90-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H302:42;H410:38;H400:38;Not classified:1
109784,Bis(trichloromethyl) sulphone,221-310-4,3064-70-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,76,H315:38;H335:38;H410:75;H302:76;H319:38;H400:76;H332:38;H314:38
109785,Promethazine hydrochloride,200-375-2,58-33-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,87,H315:58;H335:57;H332:55;H317:83;H302:76;H319:57;H411:83;H318:28;H301:10;H312:5;H362:1;Not classified:1;H361:2
109788,"1,1'-[methylenebis(oxyethane-1,2-diyloxy)]bisbenzene",237-644-9,13879-32-8,Aquatic Chronic 2,Notified C&L,83,H411:83
109789,"reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol",413-530-6,111850-00-1,Aquatic Chronic 2,Harmonised C&L,0,H411:0
109796,"5-[(7-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-8-[[4-(phenylazo)-7-sulpho-1-naphthyl]azo]naphthalene-2-sulphonic acid, sodium salt",286-591-8,85283-63-2,Not Classified,Notified C&L,1,Not classified:1
109797,Isobutyl acetoacetate,231-937-5,7779-75-1,Not Classified,Notified C&L,45,Not classified:43;H319:2;H315:2
109800,Isobutyl 2-butenoate,209-658-5,589-66-2,Flam. Liq. 3,Notified C&L,1438,H226:1413;H315:118;H319:39;H335:38
109803,12-hydroxyoctadecyl docosanoate,253-209-6,36781-83-6,Not Classified,Notified C&L,23,Not classified:23
109805,trans-4-pentyl-trans-4'-vinylbicyclohexyl,429-780-4,,Skin Irrit. 2,REACH registration C&L,1,H315:1
109811,Sodium 2(or 4)-dodecylbenzenesulphonate,302-696-4,94131-36-9,Not Classified,Notified C&L,9,Not classified:5;H302:3;H318:4;H315:4
109813,Geranyl phenylacetate,203-014-7,102-22-7,Not Classified,REACH registration C&L,1597,Not classified:1597
109816,"cis-1,4-dichlorobut-2-ene",216-021-5,1476-11-5,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Carc. 1B;Aquatic Acute 1,Notified C&L,80,H330:77;H301:77;H226:47;H311:77;H314:77;H350:77;H400:77;H410:39;H318:2;H340:1;H370:1;H372:1;H361:1
109818,"(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)",410-960-6,92761-26-7,Eye Dam. 1,Harmonised C&L,0,H318:0
109825,"1-[2-(4-trans-Propyl[1,1-bicyclohexyl]-4-trans-yl)ethyl]-4 -trifluormethoxybenzene",601-760-1,121219-85-0,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
109835,Amylose,232-685-9,9005-82-7,Eye Irrit. 2,Notified C&L,3,H319:2;Not classified:1
109838,N-ethylacetanilide,208-466-9,529-65-7,Flam. Sol. 1;Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38;H228:38
109842,"flufenoxuron (ISO);1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea",417-680-3,101463-69-8,Lact.;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H362:0
109843,Tributyl(lauroyloxy)stannane,221-434-9,3090-36-6,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H315:38;H312:38;H410:38;H372:38;H319:38;H400:38
109846,Sulfadimethoxine,204-523-7,122-11-2,Skin Sens. 1,Notified C&L,111,H317:105;H319:50;H335:49;H315:50;H351:9;H361:9;Not classified:5;H332:3;H302:3
109847,Phenyllithium,209-720-1,591-51-5,Pyr. Liq. 1;Skin Corr. 1B,REACH registration C&L,6,H314:2;H250:6;H312:4;H226:4;H332:4;H302:4;H261:4
109848,"Dihydrogen (ethyl)[4-[p-[ethyl(m-sulphonatobenzyl)amino]-p'-sulphonatobenzhydrylene]cyclohexa-2,5-dien-1-ylidene](m-sulphonatobenzyl)ammonium, disodium salt",225-906-5,5141-20-8,,Notified C&L,7,H351:6;Not classified:1
109849,"4,4'-Isopropylidenedicyclohexanol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-070-7,30583-72-3,Skin Sens. 1B,REACH registration C&L,330,H317:301;H319:150;H411:106;H315:167;H412:99;Not classified:10;H302:1
109851,Methyltrioctylammonium bromide,609-158-0,35675-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
109853,trans-4-(4-propylcyclohexyl)benzonitrile,262-654-5,61203-99-4,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H301:1;H315:1;H331:1;H311:1;H319:1
109861,"4-trans-Butyl-4'-trans-vinyl-[1,1'-bicyclohexyl]",604-905-7,153429-47-1,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
109862,"1,3-dimethylurea",202-498-7,96-31-1,Not Classified,REACH registration C&L,147,Not classified:146;H373:1
109863,Lithium Nickel Cobalt Aluminium Oxide,700-042-6,177997-13-6,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,12,H412:12;H330:12;H318:12;H334:12;H360:12;H314:12;H317:12;H350:12;H372:12
109866,Benzo-18-crown 6-Ether,604-215-6,14098-24-9,,Notified C&L,6,H319:6;H335:5;H315:6
109868,Cesium azide,245-196-0,22750-57-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38;H310:38
109872,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane, reaction products with 5-amino-1,3,3-trimethylcyclohexanemethanamine and 2-methyl-1,5-pentanediamine",600-833-5,1075254-00-0,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,19,H302:19;H317:19;H318:19;H411:19
109874,"N,N,N-trimethyl-1,1-bis(1-methylethoxy)amine",242-386-5,18503-89-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:38;H335:38;H315:38
109880,"Amines, C10-16-alkyldimethyl",266-922-2,67700-98-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,56,H302:36;H400:56;H314:56;H318:36;H301:20
109881,Myrtecaine,231-735-7,7712-50-7,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1;H315:1
109884,"3-isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide, sodium salt",256-735-4,50723-80-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,139,H302:139;H317:139;H412:56;H319:56
109888,"Benzene, C10-18-alkyl derivs.",306-694-4,97375-38-7,Aquatic Chronic 4,Notified C&L,566,H413:566
109889,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-β-D-glucopyranosyl-5,7-dihydroxy-",610-045-3,4261-42-1,Not Classified,Notified C&L,2,Not classified:2
109892,3-hydroxy-4-methoxybenzyl alcohol,224-489-7,4383-06-6,,Notified C&L,5,H319:5;H335:4;H315:5
109893,Tetrahydro-2H-pyran-3-methanol,238-841-2,14774-36-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
109894,"1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazolium nitrate",246-053-5,24169-02-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,51,H302:50;H319:42;H315:41;H410:7;H400:7;H312:1;Not classified:1
109903,Chrysanthemic acid,233-941-2,10453-89-1,Not Classified,Notified C&L,1,Not classified:1
109904,"heptachlor (ISO);1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene",200-962-3,76-44-8,Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H311:0;H410:0;H351:0;H373:0;H400:0
109913,"(5α,6α)-4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl thiocyanate",284-239-8,84824-87-3,Acute Tox. 3,Notified C&L,2,H301:2
109916,"3,3'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[N-cyclohexyl-2,4,6-trimethylbenzenesulphonamide]",245-728-1,23552-74-1,Not Classified,REACH registration C&L,2079,Not classified:2079
109919,"XMC;3,5-xylyl methylcarbamate",607-955-8,2655-14-3,Acute Tox. 4,Harmonised C&L,0,H302:0
109921,3-hydroxyquinoline-4-carboxylic acid,204-236-7,118-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
109926,"Fatty acids, tall-oil, sulfurized",270-446-0,68440-27-7,Not Classified,Notified C&L,5,Not classified:5
109930,C.I. Pigment Red 210,612-766-9,61932-63-6,Not Classified,Notified C&L,33,Not classified:33
109934,Tropic acid,208-465-3,529-64-6,Not Classified,Notified C&L,4,Not classified:2;H319:2;H335:1;H315:2
109945,Levallorphan hydrogen tartrate,200-767-3,71-82-9,Acute Tox. 4,Notified C&L,38,H302:38
109949,"Ashes (residues), vanadium-contg.",282-208-3,84144-87-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H334:2;H332:2;H317:2;H350:2;H302:2;H372:2;H341:2;H319:2;H361:2
109952,"(3α,16α)-eburnamenine-14-carboxylic acid",248-651-1,27773-65-5,Acute Tox. 4,Notified C&L,1,H302:1
109953,"Helichrysum stoechas, ext.",295-193-3,91845-22-6,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1,Notified C&L,273,H304:273;H317:273;H226:273;H411:86;H315:1;H410:1;H400:1
109963,Konjak mannan,253-404-6,37220-17-0,Resp. Sens. 1;STOT SE 3,Notified C&L,26,H334:16;H335:16;Not classified:9;H319:1;H315:1
109964,"2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, lithium sodium salt, compd. with 2,2'-(methylimino)bis[ethanol]",280-832-0,83783-96-4,,Notified C&L,33,Not classified:33
109966,COUMARONE-INDENE RESIN,613-209-2,63393-89-5,Eye Irrit. 2,Notified C&L,57,H319:38;Not classified:19
109968,"bis(2-ethylhexyl) 4,4’-{6-[4-tert-butylcarbamoyl)anilino]-1,3,5-triazine-2,4-diyldiimino}dibenzoate",421-450-8,154702-15-5,Aquatic Chronic 4,Notified C&L,37,H413:33;Not classified:3;H412:1
109972,Isotridecyl mercaptoacetate,260-730-2,57417-85-3,Acute Tox. 4,Notified C&L,1,H302:1
109974,5-methyl-o-nitroaniline,209-423-7,578-46-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,44,H301:44;H331:44;H311:44;H373:44;H411:44;H401:1
109976,(2-hydroxy-3-sulphopropyl)dimethyl[3-[(1-oxododecyl)amino]propyl]ammonium hydroxide,242-893-1,19223-55-3,Eye Dam. 1,REACH registration C&L,26,H318:6;H319:20;H315:20
109979,"Ethanone, 2,2-dichloro-1-(1-oxa-4-azaspiro[4.5]dec-4-yl)-",615-301-8,71526-07-3,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,194,H317:194;H411:194
109981,"1H-1,2,3-triazole",608-262-3,288-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,88,H319:88;H335:85;H315:88;H302:2
109982,"Ilmenite (FeTiO3), conc.",308-551-1,98072-94-7,Not Classified,Notified C&L,2,Not classified:2
109987,"Ethyl 2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate",202-579-7,97-41-6,Not Classified,REACH registration C&L,2,Not classified:2
109988,BENZO[B]THIOPHENE-3-CARBOXALDEHYDE,611-051-9,5381-20-4,Not Classified,Notified C&L,3,Not classified:1;H319:2;H335:2;H315:2
109993,Ethyl 2-ethylhexanoate,221-043-3,2983-37-1,Eye Irrit. 2,REACH registration C&L,1554,H319:12;Not classified:1542
109996,"3-(hexyloxy)propane-1,2-diol",600-386-6,10305-38-1,Eye Irrit. 2,Notified C&L,1,H319:1
109997,3-[[(2-hydroxyethyl)amino]carbonyl]-5-nitrobenzoic acid,245-274-4,22871-56-3,Not Classified,REACH registration C&L,4,Not classified:4
109999,phosphorus tribromide,232-178-2,7789-60-8,Skin Corr. 1B;STOT SE 3,Harmonised C&L,0,H314:0;H335:0
110000,2-(2-Furyl)ethanamine,601-166-2,1121-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
110006,"Glycine, N-(carboxymethyl)-N-[2-[[2-[(carboxymethyl)amino]ethyl]amino]ethyl]-, trisodium salt",616-216-9,75348-61-7,Not Classified,Notified C&L,20,Not classified:20
110008,(tert-Butoxycarbonyl)methyl 2-[1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl]acetate,616-210-6,75302-98-6,Acute Tox. 2;Acute Tox. 3;Aquatic Chronic 4,Notified C&L,1,H300:1;H413:1;H311:1
110009,"N,N'-(2-amino-5-nitrosopyrimidine-4,6-diyl)bisacetamide",221-825-4,3247-56-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H319:38;H335:38;H315:38
110010,2-acetoxyisobutyroyl chloride,255-016-2,40635-66-3,Skin Corr. 1B,Notified C&L,45,H314:45;H335:4;H341:1;H318:2;H290:1
110012,"(4-(4-aminophenyl)(4-iminocyclohexa-2,5-dienylidene)methyl)-2-methylaniline hydrochloride",211-189-6,632-99-5,Not Classified,REACH registration C&L,142,Not classified:5;H351:86;H302:46;H319:47;H411:43;H315:46;H350:10;H335:3;H318:1
110013,"4-amino-1-hydroxybutylidene-1,1-bis-(phosphonic acid)",613-929-7,66376-36-1,Skin Corr. 1A,Notified C&L,6,H314:4;Not classified:1;H290:1;H318:1;H371:1;H315:1;H302:1;H319:1;H361:1
110022,Titanium(4+) 2-(dimethylamino)ethanolate,257-897-9,52406-71-0,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,84,H314:84;H226:84;H318:84
110025,"1,1'-(methylenebis(4,1-phenylene))bis(3-phenylurea)",849-914-9,13140-83-5,Not Classified,Notified C&L,2,Not classified:1;H373:1;H312:1;H332:1;H317:1;H302:1
110026,"dicofol (ISO);2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol",204-082-0,115-32-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H312:0;H317:0;H410:0;H302:0;H400:0
110027,"(Z)-1,1-diethoxyhex-3-ene",277-532-7,73545-18-3,Not Classified,Notified C&L,88,Not classified:88
110031,"(2S,3R)-2-amino-3-(tert-butoxy)butanoic acid",610-143-6,4378-13-6,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
110032,"Cobalt, 5-[bis[mixed 3-butoxy-2-hydroxypropyl and 3-(C8-10-alkyloxy)-2-hydroxypropyl]amino]-2-[[2-methoxy-5-methyl-4-(phenylazo)phenyl]azo]phenol complexes, acetylated, compds. with N-butyl-1-butanamine",294-083-2,91672-74-1,Not Classified,Notified C&L,2,Not classified:2
110034,Trisodium bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(3-),278-127-8,75214-58-3,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,140,H412:17;H318:102;H319:28;Not classified:10;H335:1;H315:2;H317:1
110036,Oryzalin,242-777-0,19044-88-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,183,H317:178;H410:178;H400:178;Not classified:3;H413:1;H411:1
110042,"4,4'-difluorobiphenyl",206-910-6,398-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136,H319:129;H335:128;H315:129;H412:4;Not classified:3
110044,clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one,619-396-7,99129-21-2,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H317:0
110045,Bis(tridecyl) adipate,241-029-0,16958-92-2,Not Classified,REACH registration C&L,566,Not classified:552;H317:14
110046,Dihydro-2-methylthiophen-3(2H)-one,237-183-3,13679-85-1,Acute Tox. 4,Notified C&L,1445,H302:1292;Not classified:89;H319:65;H335:64;H315:65;H227:1
110047,Pentapotassium triphosphate,237-574-9,13845-36-8,Not Classified,REACH registration C&L,253,Not classified:158;H319:57;H315:57;H302:38;H335:6
110049,5-hydroxyiminobarbituric acid,201-741-4,87-39-8,Skin Irrit. 2,REACH registration C&L,40,H315:40;H319:39;H335:38
110050,"N,N,N',N'-tetramethylbut-2-enylenediamine",224-928-2,4559-79-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39;H318:1
110051,"Naphtha (petroleum), light steam-cracked arom., piperylene conc., polymd.",614-529-5,68478-07-9,Not Classified,Notified C&L,32,Not classified:32
110053,(Z)-non-3-ene,243-624-0,20237-46-1,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H304:38;H413:38;H315:38;H335:38;H319:38;H225:4
110054,"1,2,3,4-tetrahydro-2-methylquinoline",217-226-2,1780-19-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
110065,Triethoxyoctadecylsilane,230-995-9,7399-00-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H319:46;H315:46;H335:6
110070,Urea phosphate,225-464-3,4861-19-2,Skin Corr. 1B,REACH registration C&L,193,H314:189;Not classified:2;H319:2;H335:2;H315:2
110074,"3,4-dimethoxycinnamic acid",219-025-5,2316-26-9,,Notified C&L,9,H319:9;H335:8;H315:9
110075,"Nitric acid, rare earth salts",270-173-7,68412-17-9,Not Classified,Notified C&L,1,Not classified:1
110076,Octyl 3-octyloxiran-2-octanoate,203-435-6,106-84-3,Not Classified,Notified C&L,1,Not classified:1
110079,Bone oil,232-294-3,8001-85-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,3,H315:1;H413:1;H335:1;H317:1;H302:1;H319:1;Not classified:1;H312:1
110085,4'-methyl-2-(1-pyrrolidinyl)valerophenone hydrochloride,214-556-9,1147-62-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,38,H302:38;H318:38;H411:38
110086,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C16-18-alkyl ethers, ammonium salts",601-445-9,116726-95-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
110092,Dimethiconol,608-658-6,31692-79-2,Aquatic Chronic 2,Notified C&L,29,H411:28;Not classified:1
110093,"2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-butenal",261-121-4,58102-02-6,Not Classified,Notified C&L,89,Not classified:78;H317:10;H411:10;H412:1
110100,"(11β,17α)-11,17-dihydroxy-3-oxoandrosta-1,4-diene-17-carboxylic acid",253-719-9,37927-29-0,,Notified C&L,1,H360:1
110107,o-chlorobenzenesulphonamide,230-156-7,6961-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,216,H319:197;H335:196;H315:197;H302:19
110108,"chrysoidine acetate;4-(phenylazo)benzene-1,3-diamine acetate",279-116-0,79234-33-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H410:0;H302:0;H341:0;H400:0
110111,"4'-methyl[1,1'-biphenyl]-2-carboxylic acid",230-462-0,7148-03-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
110115,"Disodium 3-[(4-amino-5-methoxy-o-tolyl)azo]naphthalene-1,5-disulphonate",267-546-1,67875-30-3,Not Classified,REACH registration C&L,2,Not classified:2
110118,Levodopa,200-445-2,59-92-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,187,H302:187;H319:100;H335:55;H315:57;H411:56;H361:63;H412:16;H372:11;H371:3;H334:1;H317:1;H362:2;H360:2;H341:1
110119,acetylene;ethyne,200-816-9,74-86-2,Press. Gas;Flam. Gas 1,Harmonised C&L,0,Not classified:0;H220:0
110121,"1-((4R,5S)-5-((2-aminoethyl)amino)-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)-, diacetate (salt);",605-859-0,179463-17-3,Eye Dam. 1;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:35;H400:40;H318:39;H362:37;H334:2;H315:3;H335:2;H317:2;H361:3;H372:1;H319:1
110122,2-Hydroxypropyl menthan-3-yl carbonate,605-053-9,156324-82-2,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,110,H319:110;H411:100
110130,Lithium carbonate,209-062-5,554-13-2,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1167,H302:1165;H319:711;H318:452;H315:455;H360:491;H335:452;H372:479;H412:48;H371:33;Not classified:3;H373:1;H361:1;H332:2
110131,Fosfosal,227-993-5,6064-83-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:43;H319:38;H335:38;H315:38
110133,α-bromo-p-toluonitrile,241-246-0,17201-43-3,Skin Corr. 1B;Eye Dam. 1;Resp. Sens. 1,Notified C&L,144,H314:143;H318:91;H334:135;H312:6;H332:6;H317:6;H302:7;H319:1;H315:1;H290:1
110134,"{(2S,3S)-2-{(2R)-1-[(4-chlorophenyl)thio]-1-oxopropan-2-yl}-3-[(1R)-1-hydroxyethyl]-4-oxoazetidin-1-yl}acetic acid",600-646-9,105318-28-3,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,4,H302:4;H317:4;H334:4
110137,2-mercaptoacetanilide,225-398-5,4822-44-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H302:39;H317:38;H319:39;H315:1;H312:1;H335:1;H332:1
110140,Allyl methyl disulphide,218-549-1,2179-58-0,Flam. Liq. 2,Notified C&L,13,H225:10;H226:3;H315:2;H335:2;H302:2;H319:2
110141,Dichloro(diethyl)silane,217-005-0,1719-53-5,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,45,H314:45;H226:45;H335:38;H302:3;H318:1;H290:1
110144,2-Thiopheneacrylic Acid,605-075-9,15690-25-2,,Notified C&L,5,H319:5;H335:4;H315:5;H312:1;H332:1;H302:1
110148,"2,6-dimethoxypyridin-3-amine monohydrochloride",279-554-2,80789-72-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
110150,"4,4'-bis(phenylsulphonyl) dichloride",222-293-6,3406-84-6,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1;H290:1
110153,"2,4-Dibromo-6-[(cyclohexyl-methyl-amino)-methyl]-phenylamine hydrobromide",617-191-7,81060-07-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
110157,3-fluorosulphonylbenzenesulphonyl chloride,219-643-5,2489-52-3,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H302:1;H314:1;H335:1
110160,Tetrahydro-5-isopropenyl-2-methyl-2-vinylfuran,237-184-9,13679-86-2,Flam. Liq. 3,Notified C&L,1401,H226:1401;H319:2;H315:2
110163,Aluminium trilactate,242-670-9,18917-91-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,176,H412:6;H319:134;H335:128;H315:128;Not classified:42
110164,4-chloromercuriobenzoic acid,200-442-6,59-85-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H330:38;H410:38;H373:38;H400:38;H310:38
110166,5-methylisoxazole,227-289-8,5765-44-6,Flam. Liq. 3,Notified C&L,50,H226:50
110172,Cetalkonium chloride,204-526-3,122-18-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,106,H318:4;H314:101;H410:3;H302:104;H400:102;H312:96;H319:5;H332:1;H315:2;H330:1;H311:1;H335:1;H317:1
110173,"N,N'-diethyl-6-methoxy-1,3,5-triazine-2,4-diamine",211-601-4,673-04-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
110178,"1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium",251-930-0,34316-15-9,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H300:1;H319:1;H335:1;H315:1;H302:1
110179,Methoxy(methyl carbonato-O)magnesium,225-466-4,4861-79-4,Skin Irrit. 2,Notified C&L,38,H315:38
110180,"Decaoleic acid, decaester with decaglycerol",234-316-7,11094-60-3,Not Classified,Notified C&L,16,Not classified:16
110182,"Phosphoric acid, mono- and bis(C16-18-branched and linear alkyl) esters",306-985-6,97468-32-1,Skin Corr. 1B,Notified C&L,3,H314:3
110183,Zinc bis(dipentyldithiocarbamate),239-370-5,15337-18-5,Aquatic Chronic 4,REACH registration C&L,519,H413:463;Not classified:42;H315:14;H335:14;H317:14;H410:14;H319:14;H400:14
110184,Tetramethylammonium hydrogen sulphate,279-490-5,80526-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
110185,1-(BROMOMETHYL)-4-CHLORO-2-IODOBENZENE,608-984-9,343929-11-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
110186,Catechu (resin),232-291-7,8001-76-1,Flam. Liq. 2,Notified C&L,1377,H225:1287;H226:77;Not classified:13
110190,Lutetium trichloride,233-240-1,10099-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:40;H315:40;Not classified:1
110192,"1-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-2,2,2-trichloroethan-1-one",278-550-8,76784-42-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H302:2;H319:2;H335:2;H315:2
110193,"2,4-Bis(tert-butyl)-6-bromophenol",606-649-1,20834-61-1,,Notified C&L,5,H319:5;H335:5;H315:5
110194,"Fatty acids, C16-18 and C18-unsatd., esters with propylene glycol",285-203-4,85049-34-9,Not Classified,Notified C&L,6,Not classified:6
110196,"Tris[5-amino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonato(2-)]dialuminium",270-648-9,68475-50-3,Not Classified,REACH registration C&L,3,Not classified:3
110199,C.I. Acid Red 299,602-057-2,12220-29-0,Not Classified,Notified C&L,2,Not classified:2
110200,"3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-one",267-135-7,67801-15-4,Aquatic Chronic 2,REACH registration C&L,2,H411:2
110201,"2-methylbutane-1,4-diol",220-925-5,2938-98-9,Eye Irrit. 2,Notified C&L,40,H319:40;H302:2;H335:2;H315:2
110204,6-nitro-1H-indole,225-311-0,4769-96-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:42;H319:38;H335:38;H315:38;H332:4;H312:4;H341:2
110206,"Trisodium 1-amino-4-[[4-[[4-chloro-6-[(sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-3-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",249-524-3,29225-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
110207,"Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-",236-938-4,13553-79-2,STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H410:2;H371:3;H400:2;H302:1
110211,"3,3',3'',3'''-(butane-1,4-diyldinitrilo)tetrapropanenitrile",601-685-4,120239-62-5,Not Classified,REACH registration C&L,39,Not classified:1;H319:38
110216,3-methylcyclohexanecarboxylic acid,236-314-1,13293-59-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
110217,"4-amino-5-[(phenylsulphonyl)oxy]naphthalene-2,7-disulphonic acid",201-460-7,83-23-8,Not Classified,REACH registration C&L,2,Not classified:2
110226,Ammonium C6-10-alkyl polyoxyethylene sulfate,614-215-8,68037-05-8,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,530,H412:507;H226:507;H318:530;H315:530
110227,"7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-thione",610-252-9,4547-02-8,Not Classified,REACH registration C&L,4,Not classified:4
110228,"4-aminoazobenzene-3,4'-disulphonic acid",202-947-7,101-50-8,Eye Irrit. 2,REACH registration C&L,52,H319:51;H335:39;H315:39;Not classified:1
110229,Inulin,232-684-3,9005-80-5,Not Classified,Notified C&L,16,Not classified:16
110233,Anthranilamide,201-851-2,88-68-6,Eye Dam. 1,REACH registration C&L,235,H318:101;H302:124;H319:134;H315:47;H335:46;H317:41
110234,γ-oxopyrene-1-butyric acid,231-354-6,7499-60-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H312:39;H335:39;H332:39;H302:39;H319:39
110237,acrylic acid;prop-2-enoic acid,201-177-9,79-10-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H312:0;H226:0;H332:0;H314:0;H302:0;H400:0
110238,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid and resorcinol",275-348-1,71342-90-0,Not Classified,Notified C&L,1,Not classified:1
110239,Methylphenobarbital,204-085-7,115-38-8,Acute Tox. 3,Notified C&L,67,H301:62;H360:24;Not classified:2;H302:3;H361:2
110242,Pent-2-ene,203-695-0,109-68-2,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H304:44;H315:40;H335:38;H225:44;H319:40
110243,Aluminium potassium dioxide,234-432-8,12003-63-3,Met. Corr. 1;Skin Corr. 1A,REACH registration C&L,55,H314:55;H290:2
110244,"2,4-diethyloctane-1,5-diol",304-667-1,94277-83-5,Eye Irrit. 2,Notified C&L,83,H319:83
110246,1-methyladenine,225-907-0,5142-22-3,Acute Tox. 4,Notified C&L,2,H302:2
110248,Butyl glycollate,230-991-7,7397-62-8,Eye Dam. 1;Repr. 2,REACH registration C&L,2699,H318:2693;H361:124;Not classified:6;H336:5
110250,"Morinda citrifolia, ext.",284-551-4,84929-68-0,Not Classified,Notified C&L,3,Not classified:3
110251,3'-methylformanilide,221-398-4,3085-53-8,Acute Tox. 4,Notified C&L,42,H302:42
110253,"methyl 2,6,6-trimethyl-1-cyclohexene-1-carboxylate",610-481-4,49815-58-9,Not Classified,REACH registration C&L,4,Not classified:4
110256,"N-(2,4-dinitrophenyl)-L-alanine",216-739-9,1655-52-3,Flam. Sol. 1,Notified C&L,1,H228:1
110257,"Fatty acids, C14-22",270-298-7,68424-37-3,Not Classified,REACH registration C&L,19,Not classified:19
110258,4-amino-3-nitrobenzophenone,250-631-2,31431-19-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
110259,"Benzoic acid, compound with 2-(diethylamino)ethanol (1:1)",268-318-4,68052-36-8,Not Classified,Notified C&L,54,Not classified:54
110261,Bis(Methoxymethylethyl) Maleate,600-267-9,102054-10-4,Aquatic Chronic 3,Notified C&L,22,H412:22
110262,6-chloropurine,201-745-6,87-42-3,Acute Tox. 4,Notified C&L,139,H302:139;H319:1;H335:1;H315:1;H332:2;H312:1
110264,Isopropylammonium p-toluenesulphonate,282-907-3,84461-21-2,,Notified C&L,1,Not classified:1
110266,"6,7-dihydro-5-methyl-5H-cyclopentapyrazine",245-864-1,23747-48-0,Acute Tox. 4,Notified C&L,1498,H302:1440;H319:48;H335:47;H315:48;Not classified:11
110268,"1,1-dibutoxytrimethylamine",242-387-0,18503-90-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H335:38;H315:39
110271,2-tert-butylaniline,228-634-5,6310-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41;H312:1;H332:1;H302:1
110272,Strontium diniobate,234-816-5,12034-89-8,,Notified C&L,4,H319:4;H335:4;H315:4
110274,3-[(2-hydroxyethyl)amino]propionamide,248-211-9,27076-30-8,Eye Irrit. 2,REACH registration C&L,41,H319:35;Not classified:5;H315:1
110276,"1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-one",256-273-3,46503-52-0,,Notified C&L,1,H301:1;H361:1
110278,3-dibutylaminopropan-1-ol,218-091-2,2050-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
110279,"1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone",436-710-6,756-13-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
110281,Tetrylammonium bromide,200-769-4,71-91-0,Aquatic Chronic 3,REACH registration C&L,230,H412:15;H302:58;H335:199;H319:154;H315:154;Not classified:5;H312:2;H332:2
110288,Tetrabromophthalic anhydride,211-185-4,632-79-1,Skin Sens. 1,REACH registration C&L,528,H317:82;Not classified:441;H319:6;H335:5;H315:6
110296,"4-hydroxy-3,5-dimethoxybenzaldehyde",205-167-5,134-96-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1428,H302:1394;H319:1428;H335:1427;H315:1428;H300:1
110297,Tributyl(oleoyloxy)stannane,221-433-3,3090-35-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H315:38;H312:38;H410:38;H372:38;H319:38;H400:38
110299,"3,7,11-trimethyldodeca-6,10-dien-1-yn-3-ol",259-104-1,54325-12-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:1
110304,"1,2-dibromo-1,1,2-trichloroethane",237-330-1,13749-38-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
110305,Thiomersal,200-210-4,54-64-8,Acute Tox. 3;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,152,H330:152;H301:59;H410:149;H373:116;H400:147;H310:152;H300:93;H360:35;H372:35;H319:4;H362:1;Not classified:1
110306,"2-methyloxirane; 3-(2,2,4,6,6-pentamethyl-3,5-dioxa-2,4,6-trisilaheptan-4-yl)propan-1-ol; oxirane",603-798-4,134180-76-0,Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,592,H332:575;H412:256;H319:422;H312:286;H411:275;H318:86;H315:86;Not classified:16
110314,mecoprop-P [1] and its salts;(R)-2-(4-chloro-2-methylphenoxy)propionic acid,240-539-0,16484-77-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H318:0;H411:0
110317,Hexachlorodisiloxane,239-070-4,14986-21-1,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,62,H314:62;H225:38;H335:2
110321,Methyl bromoacetate,202-499-2,96-32-2,Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1,REACH registration C&L,56,H314:53;H317:7;H301:55;H335:40;H331:6;H311:6;H330:1;Not classified:1;H300:1;H318:1
110327,laccase,420-150-4,80498-15-3,Resp. Sens. 1,Harmonised C&L,0,H334:0
110328,"Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 °C to 280 °C (392 °F to 536 °F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C",302-695-9,94114-59-7,Carc. 2,Harmonised C&L,0,H351:0;H350:0
110329,3-(methylsulphinyl)butan-2-one O-[(methylamino)carbonyl]oxime,252-141-4,34681-24-8,Acute Tox. 2,Notified C&L,38,H300:38
110334,α-methylcyclohexanepropanol,234-091-5,10528-67-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H319:3;H315:3
110337,C.I. Reactive Brown 17,602-397-1,12225-72-8,Not Classified,Notified C&L,1,Not classified:1
110340,Phenylmercury benzoate,202-331-8,94-43-9,Not Classified,Notified C&L,3,Not classified:3
110347,"Sebacic acid, compound with 2,2'-iminodiethanol (1:2)",279-702-6,81189-11-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,1,H373:1;H302:1;H318:1;H315:1
110354,4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde,250-863-4,31906-04-4,Skin Sens. 1A,Harmonised C&L,0,H317:0
110355,"2-[[4-[(2,4-dinitrophenyl)azo]phenyl]ethylamino]ethanol",263-602-4,62570-20-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
110357,"(1-imino-1H-isoindol-3-amine-N2)(methanol)[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",300-494-0,93940-95-5,Not Classified,Notified C&L,1,Not classified:1
110358,2-methylanisole,209-426-3,578-58-5,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,1452,H302:1289;H226:156;Not classified:10
110360,"Fatty acids, C12-18 and C16-18-unsatd., sulfurized, compds. with triethanolamine",292-868-4,91001-94-4,Skin Sens. 1,Notified C&L,25,H317:25
110365,Piroxicam,252-974-3,36322-90-4,Acute Tox. 3,Notified C&L,202,H301:200;H372:122;H360:86;H361:36;H302:2;H319:1;H335:1;H373:2;H362:1;H332:1;H312:1
110366,2-Chloro-1-(4-methoxyphenyl)ethanone,606-867-7,2196-99-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,75,H302:42;H314:42;Not classified:33
110369,"Magnesate(3-), [N,N-bis[2-[[(carboxy-κO)methyl](carboxymethyl)amino-κN]ethyl]glycinato(5-)-κN,κO]-",602-921-9,12319-28-7,Not Classified,Notified C&L,1,Not classified:1
110371,"Oleic acid, compound with (Z)-octadec-9-enylamine (1:1)",248-813-1,28065-97-6,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,28,H411:3;H410:3;H400:28;H315:3;H302:25
110375,"Pentaerythritol, ethoxylated",500-071-2,30599-15-6,Not Classified,REACH registration C&L,58,Not classified:58
110376,"Dioleic acid, diester with glycerol",247-144-2,25637-84-7,Not Classified,Notified C&L,41,Not classified:41
110379,2-Bromo-1-chloro-4-fluorobenzene,606-454-1,201849-15-2,,Notified C&L,8,H319:7;H335:7;H315:8;H227:1
110381,Isobutyl anthranilate,231-938-0,7779-77-3,Not Classified,Notified C&L,89,Not classified:88;H319:1;H335:1;H315:1
110384,Glycidyl Propargyl Ether,629-009-3,18180-30-8,Acute Tox. 4;Resp. Sens. 1;Carc. 1B,Notified C&L,39,H332:38;H350:38;H334:38;H319:1;H315:1
110385,RHODIASOLV IRIS,486-070-7,,Not Classified,Notified C&L,1,Not classified:1
110388,Methandriol,208-301-0,521-10-8,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H351:38;H302:38;H312:38
110391,"6-11-dihydro-11-(1-methylpiperidin-4-yl)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ol",223-576-7,3964-79-2,Not Classified,Notified C&L,7,Not classified:7
110401,"Phosphoric acid, decyl ester, ammonium salt",292-400-9,90605-03-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
110405,"N,N-dimethyltetradecylamine N-oxide",222-059-3,3332-27-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1003,H318:1003;H400:929;H315:961;H302:575;H411:95;H319:35;H410:29;H412:14;H314:6
110406,Endo-bornyl isovalerate,200-966-5,76-50-6,Not Classified,Notified C&L,90,Not classified:90
110407,"Carbonic acid, ammonium zinc salt",245-980-2,24012-08-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H315:1;H317:1;H410:1;H411:1;H319:1;H400:1
110409,4-chloro-1-(dichloromethyl)benzene,237-721-7,13940-94-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,35,H412:35;H315:35;H335:35;H302:35;H319:35;H373:1;H317:1;H350:1
110411,5-[(3-ethylthiazolidin-2-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid,244-247-4,21155-21-5,Not Classified,Notified C&L,1,Not classified:1
110414,"methyl 5-(2,4-dichlorophenoxy)-2-nitrobenzoate; bifenox",255-894-7,42576-02-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,199,H410:196;H400:196;Not classified:3
110418,"N,N'-pentane-1,5-diyldiammonium dichloride",216-022-0,1476-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
110424,"Fatty acids, tall-oil, 2-hydroxypropyl esters",296-690-8,92969-78-3,Not Classified,Notified C&L,3,Not classified:3
110428,"Cholan-24-oic acid, 3,7-dihydroxy-, (3α,5β,7β)-, compd. with N,N-diethylethanamine (2:1)",609-224-9,362628-62-4,Not Classified,Notified C&L,1,Not classified:1
110430,3-β-chlorocholest-5-ene,213-004-4,910-31-6,Not Classified,Notified C&L,1,Not classified:1
110434,"(1H,1H,2H,2H-Perfluorodec-1-yl)tris(ethoxy)silane",600-252-7,101947-16-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:38;H318:38;H319:6;H335:6;H315:6
110436,"8-[(7-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-5-[[4-(phenylazo)-6-sulpho-1-naphthyl]azo]naphthalene-2-sulphonic acid, sodium salt",286-592-3,85283-64-3,Not Classified,Notified C&L,2,Not classified:2
110439,Nonan-4-ol,227-679-8,5932-79-6,Eye Irrit. 2,Notified C&L,1,H319:1
110440,"2,6-bis(4-azidobenzylidene)cyclohexan-1-one",243-625-6,20237-98-3,Flam. Sol. 2,Notified C&L,1,H228:1
110444,Pentasodium triphosphate hexahydrate,604-757-3,15091-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;Not classified:5
110445,aluminium lithium hydride,240-877-9,16853-85-3,Water-react. 1;Skin Corr. 1A,Harmonised C&L,0,H314:0;H260:0
110449,3-[(p-nitrophenyl)hydrazono]butan-2-one oxime,263-551-8,62454-83-5,Skin Sens. 1,Notified C&L,38,H317:38
110450,Bis[(4-hydroxyphenyl)ammonium] sulphate,263-847-7,63084-98-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,75,H315:55;H312:56;H335:55;H332:74;H319:55;H302:19;H341:17;H411:10;H373:7;H317:7;H410:7;H400:1;Not classified:1
110452,(S) 4-hydroxy-3-methyl-2-prop-2-ynylcyclopent-2-en-1-one,462-540-7,77087-34-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H302:1;H317:1;H318:1
110454,"Methyl 2-[(3,7-dimethyl-6-octenylidene)amino]benzoate",267-312-9,67845-42-5,Not Classified,Notified C&L,236,Not classified:236
110456,"3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1)",218-951-7,2300-66-5,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0
110458,2-Bromo-6-chloro-4-fluoroaniline,606-453-6,201849-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H312:4;H332:4;H302:4
110461,trans-4-(4-heptylcyclohexyl)benzonitrile,262-658-7,61204-03-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
110470,"Glycine, N,N'-(iminodi-2,1-ethanediyl)bis[N-(carboxymethyl)-, tetrasodium salt",616-215-3,75348-60-6,Not Classified,Notified C&L,20,Not classified:20
110471,Tetramethylammonium acetate,234-179-3,10581-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H335:50;H315:51;H301:3;H300:1
110472,Boron silicate,603-157-9,12676-29-8,Not Classified,REACH registration C&L,84,Not classified:84
110473,"Reaction mass of copper complex of [(2,6-difluoroheterocycl-4-yl)amino]hydroxy{[2-hydroxy-3-sulfonato-5-(vinylsulfonyl)phenyl]diazenyl}naphthalene sulfonic acid, dialkali salt and copper complex of [(2,6-difluoroheterocycl-4-yl)amino]-hydroxy{[2-hydroxy-3-sulfonato-5-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl]diazenyl}naphthalene sulfonic acid, trialkali salt",479-550-2,,Not Classified,REACH registration C&L,1,Not classified:1
110474,"dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylidene)-dimethylazanium; hexafluorophosphate",436-160-7,,Flam. Sol. 1;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,3,H413:2;H317:2;H228:2;H319:1;H335:1;H315:1
110476,Diamminebis(nitrito-O)palladium,248-814-7,28068-05-5,,Notified C&L,4,H314:4
110477,"4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one",201-292-4,80-57-9,Not Classified,Notified C&L,128,Not classified:89;H302:39;H317:38;H319:1;H335:1;H315:1
110478,"Poly(oxy-1,2-ethanediyl), α-(1-oxononyl)-ω-hydroxy-",608-654-4,31621-91-7,Not Classified,Notified C&L,1,Not classified:1
110479,"Esterification products of 2,2'-(oxydimethanediyl)bis[2-(hydroxymethyl)propane-1,3-diol] and heptanoic acid and pentanoic acid and 3,5,5-trimethylhexanoic acid",700-325-4,1149346-12-2,Not Classified,Notified C&L,1,Not classified:1
110482,"2,6-dibenzylidenecyclohexan-1-one",212-981-4,897-78-9,Aquatic Chronic 2,Notified C&L,1,H411:1
110483,N-cyclohexylbenzothiazole-2-sulphenamide,202-411-2,95-33-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0
110484,potassium N-(4-fluorophenyl)glycinate,415-710-1,184637-63-6,Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H373:0;H317:0;H318:0
110486,[4-hydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-1-sulphonato(3-)]chromium,288-520-6,85737-10-6,Not Classified,REACH registration C&L,2,Not classified:2
110490,"Cuprate(3-), [3-[2-[5-(hydroxy-κO)-4-[2-[1-(hydroxy-κO)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-κN1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, potassium (1:3)",601-559-9,118716-59-9,Not Classified,Notified C&L,1,Not classified:1
110495,"9-Octadecenoic acid (Z)-, 2-ethyl-2-[[(1-oxo-9-octadecenyl)oxy]methyl]-1,3-propanediyl ester, (Z)-, sulfated, sodium salts",272-231-7,68784-23-6,Not Classified,Notified C&L,1,Not classified:1
110499,Polixetonium chloride,608-627-7,31512-74-0,Aquatic Acute 1,Notified C&L,485,H400:442;H332:43;H302:44;H319:42;H315:43;H410:1;H312:1
110500,4'-Bromomethylbiphenyl-2-carbonitrile,425-280-5,114772-54-2,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:2;H410:1;H302:1;H341:1;H319:1;H315:1;H411:1
110508,[No public or meaningful name is available],446-550-9,216970-21-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,24,H410:24;H400:24;H315:24
110510,"5-methyl-5-propyl-1,3-dioxan-2-one",230-465-7,7148-50-7,Skin Sens. 1,REACH registration C&L,41,H317:41
110511,2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-N-phenylpentanamide,603-107-6,125971-96-2,Aquatic Chronic 4,REACH registration C&L,41,H413:41
110512,Methylcyclopentadiene,247-724-5,26472-00-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Muta. 1B;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,50,H304:2;H340:3;H315:2;H226:50;H332:2;H410:41;H350:7;H319:2;H400:41;H351:2
110516,"3,7-dimethylocta-1,3,6-triene",237-641-2,13877-91-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1772,H304:1733;H400:45;H315:47;H226:1772;H411:47;H412:1370;H410:39;H317:3;H302:1
110518,Tetrachloro-μ-hydroxy(μ-methacrylato-O:O')dichromium,239-147-2,15096-41-0,Flam. Liq. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,190,H318:67;H400:2;H317:2;H225:2;H411:2;Not classified:103;H315:83;H319:1;H335:1
110519,"1,4-DIISOPROPYLCYCLOHEXANE",607-181-0,22907-72-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H302:38;H319:42;H315:4;H335:4;H225:4
110520,"N-[2,3,4,5,6-2H5]phenylacetamide",239-928-8,15826-91-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
110525,[4-[[3-chloro-4-[(2-cyanoethyl)amino]phenyl]azo]phenacyl]trimethylammonium chloride,276-475-5,72208-25-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
110527,Reaction product of Polymethylene Polyphenyl Polyisocyanate ( CAS 9016-87-9) and cyclohexylamine (EC 203-629-0) and octadecylamine (EC 204-695-3),924-444-8,,,Notified C&L,3,H413:3
110529,"Fatty acids, tall-oil, reaction products with ethanolamine",270-445-5,68440-25-5,Eye Dam. 1,Notified C&L,128,H318:125;Not classified:2;H315:1;H319:1
110531,"Terpenes and Terpenoids, turpentine-oil, limonene fraction, sulfurized",294-867-4,91770-81-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,15,H319:15;H335:15;H315:13;H411:2
110532,2-phenylnicotinic acid,251-510-7,33421-39-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
110533,"Resin acids and Rosin acids, hydrogenated, calcium salts",271-402-3,68554-12-1,Self-heat. 2,REACH registration C&L,154,H252:2;H317:83;Not classified:69
110534,"1,3,3-trimethyl-2-methyleneindoline",204-235-1,118-12-7,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,142,H302:137;H410:97;H400:127;H315:140;H319:6;H335:5;Not classified:1;H317:1
110536,N-isopropylmethacrylamide,237-331-7,13749-61-6,STOT RE 2,REACH registration C&L,50,H373:4;H319:46;H335:41;H315:41;H302:2
110538,cobalt dimolybdenum nickel octaoxide,268-169-5,68016-03-5,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H372:0;H317:0;H350:0
110539,"Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]-, molybdatesilicate",600-271-0,102082-92-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H410:83;H400:83
110544,Triethylammonium 1-(3-aminophenyl)-1H-tetrazol-5-thiolate,433-000-8,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1
110545,"Oxiranemethanol, homopolymer, 2-hydroxydodecyl ether (9CI)",605-129-1,158112-80-2,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1
110549,Salicylamide,200-609-3,65-45-2,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,818,H302:812;H411:27;H312:441;H319:303;H335:302;H315:287;H412:6;H301:5
110551,Tridecyl 3-mercaptopropionate,256-738-0,50727-77-0,,Notified C&L,2,H302:2;H413:2
110552,"1-amino-9,10-dihydro-4-[[4-[(methylamino)methyl]phenyl]amino]-9,10-dioxoanthracene-2-sulphonic acid",264-699-6,64135-01-9,Not Classified,Notified C&L,9,Not classified:9
110554,"1,3,5-tris[[4-tert-butyl-3-hydroxy-2,6-xylyl]methyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",254-996-9,40601-76-1,Not Classified,REACH registration C&L,364,Not classified:108;H413:216;H319:39;H335:38;H315:39;H411:1
110555,"Oxirane, 2-methyl-, polymer with oxirane, mono[2,4,6-tris(1-phenylethyl)phenyl] ether",615-190-6,70880-56-7,Not Classified,Notified C&L,76,Not classified:76
110556,"(1R)-[7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulphonic acid",252-817-9,35963-20-3,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,61,H314:60;H318:7;Not classified:1;H290:2
110557,1-methyl-1H-pyrrole-2-acetic acid,244-645-8,21898-59-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H302:2;H319:2;H335:2;H315:2
110561,4-allyl-2-methoxyphenyl cinnamate,208-526-4,532-08-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H317:38;H410:38;H400:38
110562,"reaction mass of N,N'-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N'-ethane-1,2-diylbis(12-hydroxyoctadecan amide)",432-430-3,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
110566,Sodium 4-hydroxy-7-(phenylamino)naphthalene-2-sulphonate,269-272-8,68213-89-8,Not Classified,Notified C&L,1,Not classified:1
110572,1-methyl-1-phenylthiourea,223-877-3,4104-75-0,,Notified C&L,4,H301:4
110573,α-chloro-p-fluorotoluene,207-264-8,456-42-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,51,H314:51;H226:50;H290:1;H318:2;Not classified:1;H319:1;H335:2;H412:1;H312:1;H302:1
110576,"Nickel, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, sulfo [[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]sulfonyl derivs.",270-174-2,68412-18-0,Not Classified,Notified C&L,16,Not classified:15;H334:1
110577,"2,3-dibromopropiononitrile",224-925-6,4554-16-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:39;H312:39;H335:39;H332:39;H302:39;H319:39
110580,"(1R,2S)-cyclohexane-1,2-diamine; sulfuric acid",613-794-4,65433-80-9,Not Classified,REACH registration C&L,40,Not classified:2;H302:38;H319:38;H335:38;H315:38
110583,"1,1,1-trifluoro-6-methylheptane-2,4-dione",207-319-6,461-92-7,,Notified C&L,1,H226:1
110584,hexahydromethylphthalic anhydride,247-094-1,25550-51-0,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0
110585,Pent-1-ene,203-694-5,109-67-1,Flam. Liq. 1;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,351,H411:6;H304:107;H224:351;H336:8;H412:272;H319:38;H315:38
110587,Chromium hydroxide sulphate,235-595-8,12336-95-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,151,H317:17;H319:18;H411:15;H315:38;Not classified:61;H332:73;H318:20;H335:21;H412:1
110589,"Phosphoric acid, di-C8-18-alkyl esters",273-250-3,68954-77-8,Skin Corr. 1B,Notified C&L,1,H314:1
110590,"1-[4-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)propan-1-one",243-978-6,20702-77-6,Not Classified,REACH registration C&L,98,Not classified:98
110592,"Dodecylbenzenesulphonic acid, compound with diethylamine (1:1)",304-277-1,94248-06-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,20,H412:20;H318:20;H335:20;H314:20;H302:20
110596,2-iodobenzoic acid,201-850-7,88-67-5,Acute Tox. 4,Notified C&L,118,H302:117;H318:45;H335:51;H315:62;Not classified:8;H331:8;H311:8;H332:8;H400:8;H319:9
110598,Heptylcyclohexane,227-041-9,5617-41-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H302:38;H319:38;H413:38
110599,"Fatty acids, tall-oil, reaction products with linoleic acid dimer and polyalkylenepolyamines, compds. with dodecylbenzenesulfonic acid and linoleic acid dimer",614-771-1,68910-85-0,Not Classified,Notified C&L,2,Not classified:2
110600,"4,6-dimethyl-1H-pyrimidine-2-thione hydrochloride",248-883-3,28176-16-1,Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38
110601,3-methylbenzo[f]quinoline,201-584-1,85-06-3,,Notified C&L,4,H319:4;H335:4;H315:4
110602,"2,6,7-trihydroxy-9-methylxanthen-3-one",226-468-8,5407-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
110603,Hexadecyltrimethylammonium hydroxide,208-022-4,505-86-2,Skin Corr. 1B,Notified C&L,49,H314:48;H370:4;H318:5;H332:5;H302:5;H312:4;H335:1;H400:1;Not classified:1
110607,N-(phenylsulphonyl)sulphanilamide,279-555-8,80789-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
110608,"1-(2,4-dimethoxyphenyl)ethan-1-one",212-587-2,829-20-9,,Notified C&L,1,H319:1;H335:1;H315:1
110610,Diallyl disulphide,218-548-6,2179-57-9,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1600,H301:1594;H315:1599;H226:1559;H317:1555;H319:1599;H335:43;H302:6;H412:1;H304:1
110612,BMMPB,476-480-4,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
110617,Renewable hydrocarbons (diesel type fraction),618-882-6,928771-01-1,Asp. Tox. 1,REACH registration C&L,447,H304:447;H412:1;H226:1
110619,3-fluoro-o-xylene,207-140-3,443-82-3,Flam. Liq. 3,Notified C&L,46,H226:46;H319:1;H335:1;H315:1
110620,"Amides, tall-oil fatty, N,N-di-Me",269-665-4,68308-74-7,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1;H400:1
110622,"Oils, sardine, oleins",297-187-6,93348-44-8,Not Classified,Notified C&L,1,Not classified:1
110625,2-naphthyl acetate,216-194-7,1523-11-1,Eye Dam. 1,Notified C&L,39,H318:39
110629,Dibutylbis(myristoyloxy)stannane,249-134-3,28660-67-5,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,355,H360:288;H410:295;H373:205;H341:288;H400:295;H372:90;H314:52;H301:51;Not classified:22;H317:14;H370:14;H302:7;H315:7;H312:7;H319:7
110631,3-cyclohexylpropionic acid,211-861-9,701-97-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,134,H302:94;H319:134;H315:134;H335:39
110633,Disodium [1-[(5-chloro-2-hydroxyphenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(2-),278-126-2,75214-56-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,100,H412:45;H319:46;Not classified:40;H411:13
110636,Tetraammonium decachloro-μ-oxodiruthenate(4-),286-924-7,85392-65-0,Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H317:1;H318:1;H400:1;Not classified:1
110638,(+)-N-(o-chlorobenzyl)-α-methylphenethylamine hydrochloride,227-434-5,5843-53-8,Acute Tox. 4,Notified C&L,6,H302:6;H319:1;H315:1
110639,"1,1-diethoxydecane",252-202-5,34764-02-8,Not Classified,Notified C&L,88,Not classified:88
110640,methyl iodide;iodomethane,200-819-5,74-88-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Harmonised C&L,0,H301:0;H315:0;H312:0;H331:0;H335:0;H351:0
110641,"2,4-dichloro-5-methylpyrimidine",217-227-8,1780-31-0,Skin Corr. 1B,Notified C&L,51,H314:47;H319:4;H335:4;H315:4;H318:2
110642,Dibarium(2+) ion bis(9-(octadecylcarbamoyl)nonanoate) decanedioate,433-080-4,,Not Classified,REACH registration C&L,10,Not classified:10
110649,"1-aminoimidazolidine-2,4-dione hydrochloride",700-277-4,2827-56-7,Not Classified,REACH registration C&L,6,Not classified:4;H332:1;H302:1;H312:1;H319:1;H315:1
110651,N-(2-methoxy-5-methylphenyl)acetamide,230-157-2,6962-44-3,Not Classified,REACH registration C&L,5,Not classified:5
110653,"Disodium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonate",274-422-0,70210-25-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,90,H412:84;H319:87;Not classified:3
110658,"Ethanimidic acid, 2,2,2-trichloro-, 2-(3,4-dimethoxyphenyl)ethyl ester",617-910-4,867152-08-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,33,H332:33;H302:33;H312:33
110662,4-methoxy-6-methyl-2H-pyran-2-one,211-600-9,672-89-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
110663,(4α)-β-D-glucopyranosyl 13-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]kaur-16-en-18-oate,260-975-5,57817-89-7,Not Classified,Notified C&L,6,Not classified:6
110667,1-methylbutylthiophene,225-465-9,4861-58-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1437,H332:1286;H302:1324;H312:1286;Not classified:77;H413:38;H319:36;H315:36;H335:1
110668,[1-methyl-2-[(1-oxo-9-octadecenyl)amino]ethyl] hydrogen maleate,267-201-5,67815-89-8,Not Classified,Notified C&L,1,Not classified:1
110675,o-(trifluoromethyl)benzamide,206-637-2,360-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H315:42;H302:1;H372:1
110677,"7,8-dihydroxy-6-methoxy-2-benzopyrone",209-376-2,574-84-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H335:38;H332:38;H302:38;H319:38
110679,Dichlorobenzene,246-837-7,25321-22-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H315:33;H335:33;H332:33;H317:33;H410:33;H351:33;H302:33;H319:33;H400:33
110680,[2H10]anthracene,217-004-5,1719-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H315:41;H335:41;H410:41;H319:41;H400:41
110684,Sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate,617-526-7,84057-97-6,Aquatic Chronic 2,Notified C&L,5,H411:4;H332:1;H302:1;H319:1;H315:1
110685,N-benzyloxycarbonyl-L-proline,214-557-4,1148-11-4,Not Classified,Notified C&L,6,Not classified:3;H318:1;H319:1;H335:1;H315:1;H317:1
110691,"Olivine, cobalt silicate blue",269-093-5,68187-40-6,Not Classified,REACH registration C&L,76,Not classified:76
110696,"4,4'-methylenebis[2,6-diethylaniline]",237-185-4,13680-35-8,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,144,H302:141;H411:23;H319:42;H335:40;H315:41;Not classified:2;H410:1
110699,4-(2-aminopropyl)phenol hydrobromide,206-181-4,306-21-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
110700,"tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate",400-690-7,85665-98-1,Aquatic Chronic 2,Harmonised C&L,0,H411:0
110703,"11-piperazin-1-yldibenzo[b,f][1,4]thiazepine dihydrochloride",700-276-9,111974-74-4,Aquatic Chronic 4,REACH registration C&L,7,H413:1;H332:2;H302:4;H312:2;Not classified:2;H320:1;H316:1
110704,"2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one",611-001-6,53454-43-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
110705,Butylferrocene,250-862-9,31904-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,36,H319:36;H335:36;H315:36;H312:14;H332:14;H302:14
110707,"Tetrasodium 2-[[4-chloro-6-[[3-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]azo]-4-sulphonatophenyl]amino]-1,3,5-triazin-2-yl]amino]benzene-1,4-disulphonate",301-738-9,94042-73-6,Not Classified,Notified C&L,1,Not classified:1
110708,"1,3-bis(dibromomethyl)benzene",252-975-9,36323-28-1,Skin Corr. 1B;STOT SE 3,Notified C&L,39,H314:39;H335:38;H318:1;H312:1;H332:1;H302:1
110709,"8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo[3,2-b:3',2'-m]triphenodioxazine",228-767-9,6358-30-1,Not Classified,Notified C&L,825,Not classified:824;H412:1;H302:1
110716,"1-(2,3-Dihydro-1H-inden-2-yl)-2-methylpropan-2-amine hydrochloride",928-267-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
110722,"(S)-1,2-epoxypropane",240-241-0,16088-62-3,Flam. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Muta. 1B;Carc. 1B,REACH registration C&L,139,H340:90;H315:6;H312:46;H335:89;H332:45;H350:139;H302:139;H224:139;H319:89;H331:93;H311:93;H330:1;H318:1;H314:1;H317:1;H361:1
110723,Potassium didodecyl phosphate,242-779-1,19045-76-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,13,H318:13;H315:13
110724,5-[ethyl(2-hydroxyethyl)amino]pentan-2-one,277-901-2,74509-79-8,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,3,H332:2;H412:2;H302:3;H314:3;H226:1;H335:1;H319:1
110729,"Amides, C18-unsatd., trimers, N-[2-(2-oxo-1-imidazolidinyl)ethyl]",600-277-3,1021356-52-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
110734,Lutetium trinitrate,233-241-7,10099-67-9,Ox. Sol. 3;Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H272:4;H318:2;H410:2;H302:2;H400:2;Not classified:1;H319:2;H335:2;H315:2
110735,"2-amino-6,7-dimethylpteridin-4-ol",210-270-3,611-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
110737,"(2H3)methyl (3,3,α,α,α-2H5)methacrylate",252-449-9,35233-69-3,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H371:38;H315:38;H335:38;H317:38;H225:38;H319:38
110738,"Fatty acids, C16-18, sodium salts",270-299-2,68424-38-4,Not Classified,REACH registration C&L,70,Not classified:60;H318:10;H315:10
110740,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, reaction products with 4-[(4-amino-5-methoxy-2-methylphenyl)azo]benzenesulfonic acid monosodium salt",215-401-8,1325-62-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,14,H412:9;H302:11;Not classified:3
110743,"2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, monosodium salt",252-204-6,34769-44-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
110744,"Fatty acids, C8-18 and C18-unsatd., esters with pentaerythritol",285-202-9,85049-33-8,Not Classified,Notified C&L,8,Not classified:8
110754,Dimethyl sulphide--borane,236-313-6,13292-87-0,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,160,H412:88;H301:136;H318:158;H360:84;H225:152;H260:152;H315:70;H311:49;H335:65;H336:4;H302:6;H224:4;H361:4;Not classified:1;H261:1;H226:1;H319:1
110756,Hydrated silica,601-214-2,112926-00-8,Not Classified,Notified C&L,1065,Not classified:1026;H330:21;H372:17;H332:1;H318:1;H335:1
110758,"Quaternary ammonium compounds, ethyldimethylsoya alkyl, Et sulfates",269-663-3,68308-67-8,,Notified C&L,151,H318:145;H315:145;H410:126;H302:145;H290:126;H400:126;Not classified:6
110760,(methylstannylidyne)tris(thioethylene) trioleate,261-610-2,59118-79-5,Aquatic Chronic 4,Notified C&L,56,H413:55;H373:1;H361:1;H317:1;H410:1;H302:1;H400:1
110762,Methyl 4-(1-methylethoxy)benzoate,252-740-0,35826-59-6,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H315:1;H335:1;H302:1;H319:1
110764,1-fluoro-3-(trans-4-propylcyclohexyl)benzene,443-100-3,,Skin Irrit. 2,REACH registration C&L,1,H315:1
110765,Ethyl 3-hydroxy-3-phenylpropionate,227-288-2,5764-85-2,Not Classified,Notified C&L,126,Not classified:88;H302:38
110771,Gramicidin,215-790-4,1405-97-6,Not Classified,Notified C&L,1,Not classified:1
110773,5-[(p-aminophenyl)azo]salicylic acid,202-948-2,101-51-9,Not Classified,REACH registration C&L,2,Not classified:2
110774,Ethyl 2-(hydroxyimino)-3-oxobutanoate,611-092-2,5408-04-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
110777,Glycogen,232-683-8,9005-79-2,Not Classified,Notified C&L,3,Not classified:3
110779,"Di(lactato-O1,O2)magnesium",242-671-4,18917-93-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,18,H302:10;H319:16;H315:6;Not classified:2
110780,3-fluorobenzylic alcohol,207-265-3,456-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H335:2;H315:3;H332:1;H302:1
110781,o-phenylenediacetic acid,231-355-1,7500-53-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
110782,"3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride",424-530-0,93076-03-0,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;STOT SE 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H371:0;H318:0;H317:0;H373:0;H411:0
110784,1-chlorobutane;butyl chloride,203-696-6,109-69-3,Flam. Liq. 2,Harmonised C&L,0,H225:0
110785,Aluminium lanthanum trioxide,234-433-3,12003-65-5,,Notified C&L,6,H319:4;H335:4;H315:4;Not classified:2
110786,propionic acid … %,201-176-3,79-09-4,Skin Corr. 1B,Harmonised C&L,0,H314:0
110791,"(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide",603-449-6,130929-57-6,Not Classified,Notified C&L,4,Not classified:1;H332:1;H413:1;H319:2;H315:2;H335:1;H302:1
110793,2-isopropylphenol,201-852-8,88-69-7,Acute Tox. 4;Skin Corr. 1;Aquatic Chronic 2,REACH registration C&L,1616,H302:1603;H314:1407;H411:52;H312:1362;H318:62;H332:16;Not classified:5;H301:4;H311:4
110796,"1-naphthalenesulfonic acid, 4-amino-, diazotized, coupled with Dyer’s mulberry (Chlorophora tinctoria) extract",275-349-7,71342-91-1,Not Classified,Notified C&L,16,Not classified:16
110801,3-methyl-3H-adenine,225-908-6,5142-23-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H302:1
110804,Phthalide,201-744-0,87-41-2,Not Classified,REACH registration C&L,308,Not classified:153;H319:155
110808,"2-ethyl-2,5-dihydro-4,5-dimethylthiazole",278-551-3,76788-46-0,Acute Tox. 4,Notified C&L,93,H302:93
110823,S-methyl 3-methylbutanethioate,245-863-6,23747-45-7,Flam. Liq. 3,Notified C&L,1376,H226:1376
110825,"2-Naphthalenamine, N-(2-ethylhexyl)-1-[[4-(phenylazo)phenyl]azo]-, ar' and ar''-Me derivs.",296-117-1,92257-28-8,Not Classified,REACH registration C&L,100,Not classified:100
110835,trisodium hexafluoroaluminate (cryolite),239-148-8,15096-52-3,Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H372:0;H411:0
110838,Dihydroergocristine,241-493-4,17479-19-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
110842,Diphenoxarsin-10-yl oxide,200-377-3,58-36-6,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,94,H300:69;H330:69;H311:68;H314:68;H410:93;H372:68;H400:93;H301:20;H331:20;H332:5;H350:5;H302:5;H315:1;H319:1
110845,"2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide",422-680-1,287933-44-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
110849,"Glycerides, castor-oil mono-, hydrogenated, acetates",616-005-1,736150-63-3,Not Classified,Notified C&L,7,Not classified:7
110850,"2,4,6-trichloroaniline",211-219-8,634-93-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,140,H302:3;H317:94;H411:92;H301:47;H331:47;H311:47;H410:47;H373:47;H400:46;H315:2;H319:1
110851,"Fatty acids, C16-18, reaction products with ethanolamine",287-643-2,85566-32-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,449,H318:1;H315:2;Not classified:447;H319:1
110855,Methylamine sulphate (2:1),251-636-2,33689-83-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
110857,L-lysine monoacetate,260-664-4,57282-49-2,Not Classified,Notified C&L,8,Not classified:8
110860,"9β,11β-epoxy-17,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione",246-529-2,24916-90-3,Not Classified,REACH registration C&L,11,Not classified:8;H361:1;H319:2;H335:2;H315:2
110863,LAVONAX,402-310-5,,Not Classified,Notified C&L,88,Not classified:88
110865,hexapentyldistannoxane,247-143-7,25637-27-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H332:0;H410:0;H302:0;H400:0
110866,4-methyl-1-phenylpentan-2-ol,231-939-6,7779-78-4,Not Classified,Notified C&L,159,Not classified:120;H302:38;H319:38;H317:1;H411:1
110867,"(5or8)-[[2,4-diamino-5-[(4-sulphophenyl)azo]phenyl]azo]-(8or5)-(phenylazo)naphthalene-2-sulphonic acid",274-737-3,70660-63-8,Not Classified,Notified C&L,1,Not classified:1
110868,Oxolamine dihydrogen phosphate,217-759-0,1949-19-5,Acute Tox. 4,Notified C&L,2,H302:2
110871,"cis-2-methyl-4-propyl-1,3-oxathiane",261-699-8,59323-76-1,Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1519,H412:137;H336:33;H319:120;Not classified:1320;H226:63;H335:2;H315:2
110873,[{3-[tallow alkyl(methyl)amino]propyl}(dimethyl)ammonio]acetate sodium salt,608-608-3,313688-92-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H318:1;H411:1;H315:1
110877,Sodium butyl 4-hydroxybenzoate,253-049-7,36457-20-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,35,H302:32;H318:32;Not classified:3
110878,"7,7'-[(4,6-dihydroxy-m-phenylene)diazo]bis(naphthalene-1,3-disulphonic) acid, compound with N,N'-di(o-tolyl)guanidine (1:4)",276-477-6,72208-28-7,Acute Tox. 4,Notified C&L,3,H302:3
110879,"Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 225 °C (356 °F to 473 °F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C",302-694-3,94114-58-6,Carc. 2,Harmonised C&L,0,H351:0;H350:0
110884,2-Fluoro-5-methoxybenzonitrile,603-210-6,127667-01-0,,Notified C&L,8,H315:8;H311:7;H332:5;H302:5;H319:8;H301:3;H331:3;H335:3;H312:1
110885,1-tert-butyl-4-chlorocyclohexane,263-392-4,62056-46-6,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
110886,"2,5-Dihydroxy-3,6-dimethyl-3,6-bis(dihydroxyphosphinyl)- 1,4,2,5-dioxadiphosphorinane-2,5-dioxide",921-798-5,,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,0,No data
110891,Butoxycarboxim,252-140-9,34681-23-7,Acute Tox. 4,Notified C&L,38,H302:38
110892,"α,4-dichloroanisole",244-246-9,21151-56-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
110894,"1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan",245-566-1,23305-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38;H335:38;H315:38
110895,"2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt",604-753-1,150849-52-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H312:1;H332:1;H302:1
110897,"Fatty acids, tall-oil, reaction products with diethylenetriamine",263-160-2,61790-69-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,769,H319:96;H315:94;H412:2;H317:586;H314:547;H318:518;H410:110;H400:110;Not classified:43;H302:17;H312:1;H411:2;H413:1
110903,Benzyl nicotinate,202-332-3,94-44-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,135,H319:132;H315:133;H335:7;Not classified:2;H302:1
110904,Tridecyl phosphite,220-895-3,2929-86-4,Not Classified,Notified C&L,2,Not classified:2
110905,Novobiocin sodium,216-023-6,1476-53-5,Skin Sens. 1;Eye Irrit. 2,Notified C&L,207,H317:202;H319:203;H332:4;H302:1
110906,Methyl 4-chloroanthranilate,227-593-0,5900-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H335:45;H315:45
110910,"sodium [2,2'-(ethane-1,2-diylbis{[2-(hydroxy-kO)benzyl]imino-kN})diacetato-kO(4-)]ferrat(1-)",700-327-5,1061328-86-6,Skin Sens. 1,Notified C&L,1,H317:1
110912,2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one,438-340-0,119344-86-4,Repr. 2;Aquatic Chronic 1,REACH registration C&L,114,H410:9;H361:112;H413:15
110913,"2,5,8,11-tetraoxatetradec-13-ene",243-224-6,19685-21-3,Not Classified,REACH registration C&L,9,Not classified:2;H315:7;H312:7;H332:7;H302:7;H319:7
110914,"2,5-dimethylcyclohexan-1-ol",223-281-3,3809-32-3,Flam. Liq. 2,Notified C&L,2,H225:1;H227:1;H319:1;H335:1;H315:1
110915,2-bromoanisole,209-425-8,578-57-4,Aquatic Chronic 2,Notified C&L,29,H411:26;Not classified:2;H319:1;H335:1;H315:1
110918,"5-chloro-2-(4-chlorophenoxy)-N,N-diethyl-4-nitroaniline",302-139-5,94094-38-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H335:38;H410:38;H319:38;H400:38
110919,Diallyl maleate,213-658-0,999-21-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,84,H301:75;H315:84;H312:84;H335:62;H319:84;H302:9;H332:1;H317:1
110921,"(Z)-docos-13-enoic acid, monoester with glycerol",248-812-6,28063-42-5,Not Classified,Notified C&L,1,Not classified:1
110923,"Disodium N,N'-[(2-hydroxy-5-nonylphen-1,3-ylene)bis(methylene)]bis[N-methylaminoacetate]",263-601-9,62568-43-8,Not Classified,Notified C&L,22,Not classified:22
110930,Hemicellulose,618-530-1,9034-32-6,Not Classified,Notified C&L,52,Not classified:52
110931,Bis[3-(trimethoxysilyl)propyl] maleate,221-432-8,3090-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
110932,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with diethylenetriamine",500-072-8,31326-29-1,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,662,H318:13;H314:501;H317:97;H410:11;H302:500;H400:11;H335:499;Not classified:101;H334:46;H315:46;H319:46;H312:36;H411:15;H330:3;H311:3
110933,trans-4-(4-pentylcyclohexyl)benzonitrile,262-656-6,61204-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;Not classified:1;H413:1
110934,"Cyclohexaneacetic acid, α-[[(phenylmethoxy)carbonyl]amino]-, (αS)-",615-025-8,69901-75-3,Not Classified,Notified C&L,5,Not classified:3;H317:2;H411:2
110936,"4H-1-Benzopyran-4-one, 3-(β-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-",610-400-2,480-10-4,Not Classified,Notified C&L,1,Not classified:1
110938,"5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;Dimetan",204-525-8,122-15-6,Acute Tox. 3,Harmonised C&L,0,H301:0
110939,"Phosphoric acid, mono- and bis(C12-18-branched and linear alkyl) esters",306-984-0,97468-31-0,Skin Corr. 1B,Notified C&L,38,H314:37;H319:1;H315:1
110947,"Decyl hydrogen sulphate, compound with 1,1',1''-nitrilotripropan-2-ol",266-195-1,66161-60-2,,Notified C&L,1,H319:1
110949,"2,2'-dihydroxy-4'-sulpho-1,1'-azonaphthalene-3-carboxylic acid",223-117-0,3737-95-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
110950,4-methylnonane,241-329-1,17301-94-9,Flam. Liq. 3,Notified C&L,42,H226:42;H304:1
110957,1-Ethynyl-1-cyclohexene,618-915-4,931-49-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H335:38;H315:39
110958,"Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine",300-298-5,93925-00-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,613,H412:613;H317:613;H318:613;H315:613;H226:1
110960,3-bromopropionyl chloride,239-515-2,15486-96-1,Skin Corr. 1B;STOT SE 3,Notified C&L,45,H314:45;H335:39;H318:1;H290:1
110969,"2,6,6-trimethylcyclohexa-1,3-dienecarbonitrile",917-351-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1;H315:1
110970,Tetrapotassium hexacyanoferrate,237-722-2,13943-58-3,Not Classified,REACH registration C&L,190,Not classified:30;H411:135;H412:21;H332:7;H302:7;H312:7;H319:1;H300:1;H330:1;H410:1;H400:1;H310:1
110980,"Tris(1-methylethyl)-1,1'-biphenyl",249-525-9,29225-91-0,Aquatic Chronic 4,Notified C&L,1,H413:1
110981,"2-(p-methoxystyryl)-4,6-bis(trichloromethyl)-1,3,5-triazine",255-893-1,42573-57-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
110982,"Urea, polymer with 1,2-ethanediol, formaldehyde and 1,3,5-triazine-2,4,6-triamine, methylated, compds. with ethanolamine",600-367-2,102922-99-6,Not Classified,Notified C&L,1,Not classified:1
110984,Dipropyl disulphide,211-079-8,629-19-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1422,H302:1288;H319:1399;H335:30;H315:36;Not classified:14;H336:8;H411:4;H226:1;H225:1
110986,"Phenol, C18-30-alkyl derivs.",272-232-2,68784-24-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,443,H319:441;H315:443;H413:2
110989,2-chloro-5-methyl-pyridine,418-050-0,18368-64-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H312:0;H315:0
110990,"8-[(7-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-5-[[4-(phenylazo)-7-sulpho-1-naphthyl]azo]naphthalene-2-sulphonic acid, sodium salt",286-593-9,85283-65-4,Not Classified,Notified C&L,2,Not classified:2
110993,dithallium sulphate;thallic sulphate,231-201-3,7446-18-6,Acute Tox. 2;Skin Irrit. 2;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H300:0;H372:0;H411:0;H315:0
111003,"Bis[(dimethylamino) thioxomethyl](3-sulfopropyl)-sulfoniumhydroxide, inner salt",609-934-9,41515-04-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
111011,"[S(R*,R*)]-2-amino-1-[p-(methylthio)phenyl]propane-1,3-diol",240-878-4,16854-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H302:1
111012,10-désacétyl Baccatin III,608-810-1,32981-86-5,Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1A;STOT RE 2,Notified C&L,3,H340:1;H315:2;H335:2;H350:1;H373:1;H319:2;H301:1;H331:1;H311:1;H412:1;Not classified:1
111016,"Poly(oxy-1,2-ethanediyl), .alpha.-(nonylphenyl)-.omega.-hydroxy-, phosphate, sodium salt (10EO)",609-411-5,37340-60-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,465,H319:465;H411:442;H315:465
111017,"N,N'-dimethyl-9,9'-bisacridinium nitrate",219-023-4,2315-97-1,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H272:1;H319:1;H315:1;Not classified:1
111019,YELLOW DER 8824,438-010-6,,Eye Dam. 1,Notified C&L,1,H318:1
111021,"Benzene-1,2,4-tricarboxylic acid 1,2-anhydride, oligomeric reaction products with ethane- l,2-diol",500-109-8,43011-20-7,Not Classified,Notified C&L,258,Not classified:200;H317:58;H334:58;H335:58
111024,"Fatty acids, tall-oil, C8-13 alkyl esters, mixed with lard oil, sulfurized",294-783-8,91770-01-3,Not Classified,Notified C&L,3,Not classified:3
111026,"Residues (petroleum), alkylation splitter, C4-rich;Petroleum gas;[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11.7 °C to 27.8 °C (11 °F to 82 °F).]",271-010-2,68513-66-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
111027,Pin-2(3)-ene,201-291-9,80-56-8,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1972,H304:1448;H315:1629;H226:1925;H317:1275;H410:1054;H302:147;H400:1000;H318:472;H319:207;H411:91;Not classified:24;H300:22;H330:22;H335:23;H224:22;H310:22;H320:1;H312:3;H332:5;H412:1
111036,2-(morpholinodithio)benzothiazole,202-410-7,95-32-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,23,H317:21;H319:20;H400:1;Not classified:1
111044,"5,5'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[3-methylsalicylic] acid, lithium sodium salt, compound with 2,2'-(methylimino)diethanol",280-834-1,83783-99-7,,Notified C&L,33,Not classified:33
111045,1-cyclobutylethan-1-one,221-163-6,3019-25-8,Flam. Liq. 3,Notified C&L,199,H226:199
111047,"Vaccinium myrtillus, ext.",281-983-5,84082-34-8,Not Classified,Notified C&L,173,Not classified:142;H226:29;H319:2;H412:1
111048,"2,5-dianilinoterephthalic acid",233-302-8,10109-95-2,Not Classified,REACH registration C&L,34,Not classified:34
111051,"1,3,5-triethylbenzene",203-017-3,102-25-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,43,H413:38;H319:43;H315:43;H335:4;H411:1
111054,"(8α)-12'-Hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione",613-412-6,639-81-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,1,H301:1;H331:1;H361:1;H311:1
111055,3-benzylpyridine,210-661-9,620-95-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H312:1;H332:1;H302:1;H319:1
111056,"Oils, spruce",616-929-5,8008-80-8,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,54,H304:54;H317:54;H411:29;H315:25;H226:25;H410:25;H319:25
111064,"2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bisethyl diacetate",242-895-2,19224-29-4,Not Classified,REACH registration C&L,1,Not classified:1
111066,"Distillates (coal), solvent extn., hydrocracked hydrogenated middle;[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 280°C (356°F to 536°F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C",302-693-8,94114-57-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
111068,"Formic acid, compd. with 2,2'-oxybis[N,N-dimethylethanamine] (1:1)",602-990-5,124347-71-3,Flam. Liq. 3;Skin Corr. 1C;STOT SE 3;STOT SE 3,Notified C&L,26,H314:21;H226:21;H335:21;Not classified:5
111072,"9,10-dimethylanthracene",212-308-4,781-43-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,46,H332:38;H312:38;H317:38;H334:38;H351:5;H341:4;H330:3;H373:3;H311:3
111074,Iodine tribromide,232-176-1,7789-58-4,Skin Corr. 1B,Notified C&L,38,H314:38
111081,"3-amino-methyl-3,5,5-trimethylcyclohexylamine and m-phenylene(bismethylamine), oligomeric reaction products with bisphenol A, o-cresol and 1-chloro-2,3-epoxypropane",926-455-3,,Not Classified,Notified C&L,9,Not classified:9
111082,1-allyl 2-acetylamino methyl pyrrolidine,918-518-9,,Skin Corr. 1B,Notified C&L,1,H314:1
111083,[methylenebis(sulphonyl)]bisbenzene,222-291-5,3406-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
111085,"2,4,6-trinitro-m-xylene",211-187-5,632-92-8,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H302:0;H201:0;H312:0;H332:0;H373:0
111087,"biphenyl-3,3',4,4'-tetrayltetraamine;diaminobenzidine",202-110-6,91-95-2,Muta. 2;Carc. 1B,Harmonised C&L,0,H341:0;H350:0
111089,Bencyclane,218-547-0,2179-37-5,Acute Tox. 4,Notified C&L,38,H302:38
111092,"4,7-dimethyl-1,10-phenanthroline",221-827-5,3248-05-3,Acute Tox. 4,Notified C&L,42,H302:42;H319:4;H335:4;H315:4
111094,Ceramides,309-560-3,100403-19-8,Not Classified,Notified C&L,156,Not classified:123;H319:33
111095,"2,3,6-trimethylnaphthalene",212-588-8,829-26-5,Not Classified,Notified C&L,3,Not classified:3
111096,4-tert-butyl-2-nitroaniline,228-632-4,6310-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H312:1;H332:1;H302:1
111098,"N-dodecyl-β-alanine, compound with 2,2',2''-nitrilotriethanol (1:1)",238-015-1,14171-00-7,Eye Irrit. 2,REACH registration C&L,3,H319:3
111099,Cinoxacin,249-133-8,28657-80-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
111101,"2,2'-ethylidenebis[4,6-di-tert-butylphenol]",252-816-3,35958-30-6,Not Classified,Notified C&L,226,Not classified:188;H319:38;H335:38;H315:38
111102,S-(2-amino-2-carboxyethyl)-DL-cysteine,221-676-5,3183-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111104,"trans-penta-1,3-diene",217-909-5,2004-70-8,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H304:64;H315:64;H335:64;H225:69;H319:64;H332:4
111105,3-(2-Hydroxy-ethyl)-5-methylsulfamoylmethyl-1H-indole-2-carboxylic acid methyl ester,929-941-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H305:1;H312:1;H335:1;H332:1;H302:1;H319:1
111108,Trioctyl borate,219-580-3,2467-12-1,Eye Irrit. 2,Notified C&L,60,H319:59;H412:20;H315:20;H302:1;H361:1;H413:1
111110,Thebaine,204-084-1,115-37-7,Acute Tox. 3,REACH registration C&L,110,H301:67;H300:43;H330:82;H373:43;H311:44;H310:38;H317:4;H331:3;H334:4;H315:1;H361:2;H411:1;H336:1
111117,2-Amino-6-methoxy-3-nitropyridine,616-028-7,73896-36-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H334:38;H315:43;H335:42;H302:43;H319:43;H312:5;H332:5
111118,Propylhydrazinium oxalate,260-419-1,56884-75-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
111122,Tetrachloropyrimidine,217-228-3,1780-40-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:40;H335:39;H315:40;H300:10;H314:10;H330:10;H301:1;H331:1;H311:1
111123,Disodium tetrahydrogen [nitrilotris(methylene)]trisphosphonate,223-878-9,4105-01-5,Not Classified,Notified C&L,1,Not classified:1
111125,1-Methyl-2-oxindole,612-193-4,61-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
111126,"Albumins, beef serum",305-179-1,94349-60-7,,Notified C&L,2,H334:1;Not classified:1
111128,Pyridine-4-thiol,224-926-1,4556-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
111133,"N-(2,4-dichlorophenyl)formamide",245-331-3,22923-00-8,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H302:38;H317:38;H319:38
111135,Zinc pivalate,239-929-3,15827-10-8,Not Classified,Notified C&L,1,Not classified:1
111136,"Neodecanoic acid, rare earth salts",270-175-8,68412-21-5,Skin Irrit. 2,Notified C&L,37,H315:36;Not classified:1
111138,Cinchonine,204-234-6,118-10-5,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,64,H302:64;H317:18;H332:41;H334:1;H312:1
111139,"Carbonic acid, sodium salt",231-420-4,7542-12-3,Not Classified,Notified C&L,54,Not classified:54
111143,Diallyldimethylammonium chloride,230-993-8,7398-69-8,Not Classified,REACH registration C&L,602,Not classified:381;H412:219;H410:1;H400:2
111151,"[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)methanone",616-059-6,74191-85-8,Skin Corr. 1B;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,5,H314:4;H373:4;H411:4;H302:1
111153,dinitrotoluene,246-836-1,25321-14-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H301:0;H331:0;H311:0;H361:0;H410:0;H350:0;H373:0;H341:0;H400:0
111158,"2,6-difluorophenol",248-884-9,28177-48-2,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:42;H315:42;H335:41;H228:45;H314:4;H302:6;H312:6;H332:2
111161,"Benzenesulfonic acid, C10-16-alkyl derivs.",271-528-9,68584-22-5,Eye Irrit. 2,REACH registration C&L,1294,H319:198;H302:1043;H312:493;H318:747;H314:983;H311:158;Not classified:59;H335:76;H371:54;H315:60;H317:54;H410:54;H290:77;H400:54;H412:34;H332:1
111162,3-chloropropyldimethylammonium chloride,226-467-2,5407-04-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,85,H412:36;H302:85;H319:80;H315:79;H335:63;H314:3;H341:1
111166,myo-inositol-hexakisphosphate 3-phosphohydrolase,609-386-0,37288-11-2,Resp. Sens. 1,REACH registration C&L,86,H334:86;H317:83
111167,"Castor oil, hydrogenated",232-292-2,8001-78-3,Not Classified,Notified C&L,811,Not classified:795;H319:16;H335:16;H315:16
111168,2-chloro-6-fluorotoluene,207-141-9,443-83-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H312:39;H302:39;H226:45;H332:39;H319:6;H335:5;H315:6
111171,(3-hydroxyphenyl)urea,211-860-3,701-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
111177,Nitrofural,200-443-1,59-87-0,Not Classified,Notified C&L,101,Not classified:52;H302:44;H317:43;H351:4;H301:5;H341:4;H361:4
111182,Potassium difluorodihydroxyborate(1-),286-925-2,85392-66-1,Acute Tox. 4,Notified C&L,16,H302:16;H361:4;H370:1
111186,"Poly(oxy-1,2-ethanediyl), .alpha.-(octylphenyl)-.omega.-hydroxy- (10EO)",618-604-3,9063-89-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,28,H302:23;H318:23;H411:23;Not classified:5
111188,4-chlorobutyl acetate,230-158-8,6962-92-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H302:45;H319:45;H335:44;H315:45
111190,"Xylenethiol, mixed isomers",247-095-7,25550-52-1,Eye Dam. 1;Aquatic Acute 1,Notified C&L,39,H318:38;H400:38;H319:1;H315:1
111192,"1,2,4-triazine-3,5-diol",207-318-0,461-89-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:42;H335:42;H315:42;H341:4;H301:2;H361:2;H371:1
111210,5-β-cholestan-3-β-ol,206-638-8,360-68-9,Not Classified,Notified C&L,3,Not classified:3
111214,"Disodium 8-[[4'-[(4-ethoxyphenyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-7-hydroxynaphthalene-1,3-disulphonate",228-766-3,6358-29-8,Carc. 1B,Notified C&L,38,H350:38
111215,4-hydroxy-7-trifluoromethylquinoline-3-carboxylic acid,209-377-8,574-92-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
111218,Dipropoxymethane,208-021-9,505-84-0,Flam. Liq. 3,REACH registration C&L,39,H226:1;H302:38
111222,"Phosphorodithioic acid, O,O-di-C1-14-alkyl esters",269-094-0,68187-41-7,,Notified C&L,1,Not classified:1
111232,Tetraethylammonium heptadecafluorooctanesulphonate,260-375-3,56773-42-3,Acute Tox. 3;Acute Tox. 4;Carc. 2;Repr. 1B;Lact.;STOT RE 1,Notified C&L,105,H301:74;H362:74;H360:74;H332:74;H351:74;H372:74;H412:67;H302:31
111234,2-(4-methoxyphenyl)-2-piperidinoacetamide,277-882-0,74467-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111235,"Glycerides, C8-18",287-487-5,85536-06-7,Not Classified,REACH registration C&L,20,Not classified:20
111240,"4,6-dimethylpyrimidin-2-ol",203-617-5,108-79-2,,Notified C&L,6,H319:5;H335:4;H315:5;Not classified:1
111246,"1,4-bis[(4-butylphenyl)amino]-5,8-dihydroxyanthraquinone",248-895-9,28198-05-2,Not Classified,REACH registration C&L,2219,Not classified:2219
111250,"Decanoic acid, mixed diesters with octanoic acid and triethylene glycol",271-517-9,68583-52-8,Not Classified,REACH registration C&L,33,Not classified:33
111253,mecoprop (ISO);2-(4-chloro-o-tolyloxy) propionic acid;(RS)-2-(4-chloro-o-tolyloxy)propionic acid,230-386-8,7085-19-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H410:0;H302:0;H400:0
111257,Cyclohexanecarboxylic acid,202-711-3,98-89-5,Skin Irrit. 2,REACH registration C&L,156,H315:67;H373:12;H319:19;Not classified:89;H318:41;H335:47
111259,"dimoxystrobin (ISO);(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide",604-712-8,149961-52-4,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H332:0;H410:0;H351:0;H400:0
111265,"N,N-dimethylglycinium chloride",219-648-2,2491-06-7,Not Classified,REACH registration C&L,12,Not classified:6;H319:5;H335:5;H315:5;H302:1
111269,Trichlorophenylgermane,214-039-8,1074-29-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,40,H318:40;H312:40;H332:40;H314:40;H302:40;H290:1
111271,4-fluorophenyl isocyanate,214-799-0,1195-45-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,Notified C&L,46,H334:44;H312:40;H226:46;H332:40;H317:40;H302:40;H319:46;H330:4;H301:6;H315:6;H335:6;H331:2
111274,Methyl pentacosanoate,259-617-0,55373-89-2,Not Classified,Notified C&L,1,Not classified:1
111275,N-(4-BROMO-2-ETHYL-PHENYL)-ACETAMIDE,610-716-0,51688-73-4,Acute Tox. 4,Notified C&L,38,H302:38
111277,"4-nitro-1,1':4':1'-terphenyl",233-775-0,10355-53-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
111279,Isonicotinaldehyde O-benzyloxime,229-425-1,6530-36-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
111281,N5-benzyloxycarbonyl-L-ornithine,221-980-8,3304-51-6,Not Classified,Notified C&L,4,Not classified:3;H319:1;H335:1;H315:1
111283,Pentetrazol,200-219-3,54-95-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H301:48;H319:39;H335:39;H315:39
111284,Ethyl 3-hydroxybutyrate,226-456-2,5405-41-4,Flam. Liq. 3,Notified C&L,1634,H226:1560;Not classified:74
111286,Undecane,214-300-6,1120-21-4,Asp. Tox. 1,REACH registration C&L,403,H304:399;H319:6;H335:5;H315:6;Not classified:6;H226:8;H411:4
111287,"2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptan-1-ol",206-406-6,335-99-9,Not Classified,REACH registration C&L,9,Not classified:2;H319:7;H335:7;H315:7
111295,"3-(2-(2,4-di-tert-pentylphenoxy)acetamido)-N-(5-oxo-1-(2,4,6-trichlorophenyl)-2-pyrazolin-3-yl)benzamide",250-507-8,31188-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111299,Hexacarbonyltungsten,237-880-2,14040-11-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,51,H301:48;H331:48;H311:43;H319:5;H335:3;H315:5;H413:2
111300,"Benzene, ethylenated",273-493-5,68987-41-7,Not Classified,Notified C&L,1,Not classified:1
111304,Alginic acid,232-680-1,9005-32-7,Not Classified,Notified C&L,184,Not classified:184
111310,4-iodo-o-toluidine,236-154-2,13194-68-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,57,H315:56;H312:57;H335:55;H332:57;H302:57;H319:56
111314,"Disodium 5-(benzoylamino)-4-hydroxy-3-[[2-(2-methylphenoxy)phenyl]azo]naphthalene-2,7-disulphonate",274-434-6,70210-37-6,Not Classified,REACH registration C&L,135,Not classified:134;H411:1
111315,IN-QCC64 (5B intermediate),473-070-7,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H319:1;H411:1
111316,reaction mass of: hexyldioctylphosphineoxide;dihexyloctylphosphineoxide;trioctylphosphineoxide,403-470-9,,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H410:0;H400:0
111318,Fenofibrate,256-376-3,49562-28-9,STOT RE 2;Aquatic Chronic 4,Notified C&L,218,H373:195;H413:193;Not classified:54;H412:10;H361:4;H332:4;H302:9;H312:1;H351:1
111324,Indium antimonide,215-192-3,1312-41-0,,Notified C&L,95,H332:95;H302:95;H411:43
111331,"Diethyl 3,3'-thiobispropionate",211-612-4,673-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111332,Glutamine,230-006-0,6899-04-3,Not Classified,Notified C&L,3,Not classified:3
111335,Pentamethylenediamine,207-329-0,462-94-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,56,H302:7;H312:11;H318:9;H314:56;H227:2;H335:2;H332:4;H226:4
111338,Sodium cyanamidate,241-322-3,17292-62-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H302:39;H317:39;H314:1;H318:1
111339,"(1R)-3-(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one",257-430-9,51800-99-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
111340,"2-[2-[4-[(2-cyanoethyl)ethylamino]-o-tolyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",276-470-8,72208-20-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,10,H411:2;H302:2;H314:2;H318:9;H412:7;Not classified:1
111346,"(E,Z,Z)-trideca-2,4,7-trienal",236-936-3,13552-96-0,Not Classified,Notified C&L,113,Not classified:113
111349,"5-amino-2,4,6-triiodoisophthalic acid",252-575-4,35453-19-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,72,H332:4;H302:4;H319:5;H315:5;H317:43;H334:43;H318:24
111350,"Butane-1,3-diol",203-529-7,107-88-0,Not Classified,REACH registration C&L,2494,Not classified:1143;H226:1286;H319:62;H335:56;H315:59;H413:4;H304:3;H336:3
111351,7-[[2-acetamido-2-deoxy-β-D-galactopyranosyl]oxy]-4-methyl-2H-1-benzopyran-2-one,253-052-3,36476-29-6,Not Classified,Notified C&L,1,Not classified:1
111352,"3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide",431-130-1,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
111357,Methyl 5-nitro-o-tolyl ether,236-048-6,13120-77-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:38
111359,dipropylamine,205-565-9,142-84-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0;H314:0;H225:0;H302:0
111362,"3,7,11-Trimethyldodec-1-en-3-ol",609-221-2,3625-46-5,Skin Irrit. 2;Eye Irrit. 2A;Aquatic Chronic 4,REACH registration C&L,84,H413:84;H319:84;H315:84
111368,3-chloro-o-toluidinium chloride,228-402-3,6259-40-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
111378,6-methylpurine,217-903-2,2004-03-7,Acute Tox. 4;Acute Tox. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H302:38;H317:38;H318:38;H310:38
111380,Dimethylmaleic anhydride,212-165-8,766-39-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,47,H302:41;H319:46;H335:6;H315:8;H314:1;H311:1
111382,"Cuprate(6-), [7-[[6-[[4-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-2,5-dihydroxy-7-sulfo-1-naphthalenyl]azo]-8-hydroxy-1,3,5-naphthalenetrisulfonato(8-)]-, hexasodium",276-550-2,72264-74-5,Resp. Sens. 1,Notified C&L,9,H334:8;Not classified:1
111383,"(1r,4r)-4-(methoxycarbonyl)cyclohexanecarboxylic acid",927-226-0,15177-67-0,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1
111384,methylenediphenyl diisocyanate,247-714-0,26447-40-5,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Resp. Sens. 1;Carc. 2;STOT RE 2,Harmonised C&L,0,H334:0;H315:0;H335:0;H332:0;H317:0;H351:0;H373:0;H319:0
111387,"Methanesulfonamide, N-phenyl-",601-626-2,1197-22-4,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H315:1
111389,"Glass, nonoxide, chemicals",295-731-7,92128-37-5,Not Classified,Notified C&L,3,Not classified:3
111392,(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid,605-440-2,16642-92-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
111393,5'-chloro-3-hydroxy-2'-methyl-2-naphthanilide,205-207-1,135-63-7,Skin Sens. 1A,REACH registration C&L,74,H317:36;H410:38;H400:38;H319:33
111397,hexasodium tungstate hydrate,412-770-9,12141-67-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
111398,"1,4:3,6-dianhydro-D-glucitol 2-acetate",235-917-7,13042-39-2,Not Classified,Notified C&L,7,Not classified:7
111400,4-methyl-2-phenylpyridine,222-448-8,3475-21-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
111405,"1,2-dibromoethane",203-444-5,106-93-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H315:0;H331:0;H311:0;H335:0;H350:0;H319:0;H411:0
111406,2-bromopropionyl chloride,230-466-2,7148-74-5,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,REACH registration C&L,45,H314:45;H226:45;H335:39;H290:1;H318:2
111408,3-nitrobiphenyl,218-305-4,2113-58-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H332:47;H302:47;H312:47;H341:4
111409,"4-[(6-chloro-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile",928-806-6,,Not Classified,REACH registration C&L,2,Not classified:2
111416,reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane,407-640-3,63767-86-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0;H315:0
111418,N-Methylvinylsulfonamid,608-084-6,27325-97-9,Acute Tox. 2;Skin Corr. 1A;Skin Sens. 1,Notified C&L,2,H300:1;H314:1;H317:1;H319:1;H335:1;H315:1
111419,p-isopropylcinnamic acid,222-138-2,3368-21-6,Acute Tox. 4,Notified C&L,43,H302:38;H319:5;H335:5;H315:5
111422,Phenylsilane,211-772-5,694-53-1,Flam. Liq. 2;Water-react. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,48,H315:48;H335:46;H332:47;H225:48;H302:47;H261:45;H319:48
111423,"α-d-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-d-glucopyranuronosyl-, monopotassium salt",255-754-5,42294-03-1,Not Classified,Notified C&L,1,Not classified:1
111425,Dipotassium bis(3-sulphonatopropyl) methylenesuccinate,298-978-9,93841-09-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
111426,"Potassium 5-methyl-1,3,4-oxadiazole-2-carboxylate",618-215-9,888504-28-7,Repr. 2,REACH registration C&L,3,H361:2;H319:1;H335:1;H315:1
111427,"2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)prop-1-enyl]-1,3,3-trimethyl-3H-indolium acetate",265-479-2,65122-08-9,Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,99,H314:85;H400:85;H301:13;H318:95;H300:84;H312:83;H410:84;H411:12;Not classified:2;H315:1;H319:1
111429,2-piperazinylpyrimidine dihydrochloride,301-415-2,94021-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H302:1
111430,Diammonium tetrachlorozincate(2-),238-687-6,14639-97-5,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,9,H411:9;H302:9;H318:8;H400:9;H314:1
111434,"3-phenyl-1,2,4-oxadiazol-5(4H)-one",215-938-8,1456-22-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
111435,"Artemisia, ext.",305-065-1,94333-86-5,Acute Tox. 3;Asp. Tox. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1313,H304:1286;H301:1311;H317:1311;H373:1286;H411:1286;H412:27;H371:25;H332:25;H302:2
111438,potassium 3-iodo-6-methylbenzenesulfonate,426-300-5,,Eye Dam. 1,Harmonised C&L,0,H318:0
111441,VITAL ET trade mark,447-680-9,,Aquatic Chronic 2,Notified C&L,1,H411:1
111445,Tetrapropylammonium hydroxide,224-800-6,4499-86-9,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,173,H314:140;H318:91;H411:84;Not classified:33
111446,2-[[(phenylamino)carbonyl]oxy]ethyl methacrylate,257-359-3,51727-47-0,Not Classified,Notified C&L,13,Not classified:13
111448,Choline dihydrogen citrate,201-068-6,77-91-8,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,94,H317:1;H315:93;H319:92;H335:92;Not classified:1
111452,Ditungsten zirconium octaoxide,240-876-3,16853-74-0,,Notified C&L,4,H319:4;H335:4;H315:4
111453,"disodium butane-1,4-disulfonate",609-262-6,36589-61-4,Not Classified,Notified C&L,1,Not classified:1
111455,"1-Fluor-4-[2-(4-trans-pentyl-[1,1-bicyclohexyl]-4-trans-yl )-ethyl]-benzene",601-408-7,116020-40-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
111460,methyl-5-nitrophenyl-guanidine,435-500-1,152460-07-6,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H317:0;H319:0
111463,"Horehound, ext.",283-638-4,84696-20-8,Flam. Liq. 3,Notified C&L,87,H226:87
111470,"Pyridinium, 1-(phenylmethyl)-, ethyl methyl derivs., chlorides",272-695-0,68909-18-2,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,97,H318:29;H226:40;H314:38;H410:5;H400:39;Not classified:35;H412:20;H315:24;H332:3;H335:2;H317:1;H319:1
111471,"2-[4-[[1-[[(2-methoxy-5-sulphophenyl)amino]carbonyl]-2-oxopropyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, sodium salt, compound with 2,2',2''-[nitrilotris(ethyleneoxy)]tris[ethanol]",286-628-8,85284-00-0,Not Classified,Notified C&L,10,Not classified:10
111472,"1H-Pyrazol-3-amine,5-(1,1-dimethylethyl)-",617-355-8,82560-12-1,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;STOT SE 1,REACH registration C&L,79,H301:2;H315:8;H331:2;H311:2;H335:8;H225:2;H370:2;H319:8;H302:38;Not classified:33
111473,Heptadecylamine,224-103-7,4200-95-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
111474,4-(Butoxymethyl)-2-methoxy-phenol,617-372-0,82654-98-6,Not Classified,Notified C&L,147,Not classified:80;H412:60;H317:62;H319:32;H315:30
111480,Trisodium dihydrogenorthoperiodate,237-720-1,13940-38-0,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H272:46;H319:44;H335:44;H315:44
111483,Diammonium (Z)-1-(octadec-9-enyl) 2-sulphonatosuccinate,303-771-4,94213-66-8,Not Classified,Notified C&L,1,Not classified:1
111485,"3-(decenyl)dihydrofuran-2,5-dione",246-994-1,25447-83-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
111486,"4-bromo-2,2-diphenylbutyric acid",253-648-3,37742-98-6,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,43,H412:1;H317:1;H318:1;H319:42;H335:38;H315:42
111491,Dibromochloromethane,204-704-0,124-48-1,Acute Tox. 4,Notified C&L,15,H302:14;H341:5;H315:1;H312:1;H335:1;H332:1;H319:1;H336:1;H411:1;Not classified:1
111493,"tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate",430-390-1,,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H332:0;H412:0
111494,"N-(2-ammonioethyl)ethane-1,2-diammonium trifluoride",270-583-6,68444-11-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1;H312:1
111495,"Tri-C18-22 (even numbered)-alkyl 2-hydroxypropane-1,2,3-tricarboxylate",700-316-5,,Not Classified,Notified C&L,1,Not classified:1
111496,"Pregna-1,4-diene-3,20-dione, 11β,16α,17,21-tetrahydroxy-, 16,21-diacetate",619-343-8,98422-55-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1;H361:1
111500,4-(4-tolyloxy)biphenyl,405-730-7,51601-57-1,STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H413:0
111501,"2-Butenedioic acid (2E)-, polymer with 1,1'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-propanol]",608-049-5,27136-00-1,,Notified C&L,1,Not classified:1
111503,"Xylosidase, β-",258-496-1,53362-87-1,Resp. Sens. 1,Notified C&L,5,H334:5
111509,"Sodium [3-[[2,4-dihydroxy-5-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxybenzenesulphonato(3-)]cuprate(1-)",280-486-0,83562-89-4,Not Classified,Notified C&L,2,Not classified:2
111511,N5-[imino(phosphonoamino)methyl]L-ornithine,214-714-7,1189-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111512,"Hamamelis virginiana, ext.",283-637-9,84696-19-5,Not Classified,Notified C&L,100,Not classified:98;H226:2
111513,1-methylpentylamine,226-220-9,5329-79-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H332:1;H314:1;H225:1;H302:1
111515,"Phosphoric acid, C3-9-alkyl esters, sodium salts",271-125-8,68516-00-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
111523,Cyclooctapentylose,241-482-4,17465-86-0,Not Classified,REACH registration C&L,13,Not classified:3;H319:10;H315:10
111528,2-(methylsulphonyl)acetamide,266-519-1,66913-97-1,Acute Tox. 4,Notified C&L,39,H302:39
111531,"N,N'-bis(2-propyl)polyoxypropylenediamine",617-236-0,81455-53-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,31,H412:30;H302:30;H314:30;H312:8;Not classified:1
111532,"2-benzyl-1,3-dioxolane",202-946-1,101-49-5,Not Classified,Notified C&L,128,Not classified:88;H319:40;H335:39;H315:40
111533,(Z)-tetradec-11-enyl acetate,243-982-8,20711-10-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:38;H335:38;H315:38;H317:6
111534,"Sulfuric acid, mono-C9-13-alkyl esters, sodium salts",276-987-9,72906-11-7,Not Classified,Notified C&L,8,Not classified:5;H319:2;H315:3;H302:1;H318:1
111535,Benzyltriphenylphosphonium chloride,214-154-3,1100-88-5,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,264,H300:201;H330:123;H318:112;H335:127;H410:73;H372:103;H400:73;H301:62;H319:113;H331:90;H311:107;H315:58;H412:2;H310:2;Not classified:1;H411:3
111536,"4-Methyl-1,3-thiazole-5-carboxylic acid",606-565-5,20485-41-0,Skin Sens. 1,Notified C&L,46,H317:44;H319:2;H315:2;H335:1
111537,"1,2-diethoxyethane",211-076-1,629-14-1,Flam. Liq. 2;Eye Irrit. 2;Repr. 1A,Harmonised C&L,0,H360:0;H319:0;H225:0
111539,6-Amino-2-methylphenol,605-780-1,17672-22-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
111540,"1,1,1-triethoxy-N,N-diethylsilanamine",700-051-5,35077-00-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 2,REACH registration C&L,7,H302:7;H314:7;H371:4;H318:4
111541,2-chloro-6-fluorobenzylic alcohol,260-192-9,56456-50-9,,Notified C&L,9,H319:9;H335:8;H315:9
111542,C.I. Reactive Orange 131,610-215-7,449181-62-8,Eye Dam. 1,Notified C&L,2,H318:2
111543,"Phenol, 4-[(4-amino-3-methylphenyl)amino]-, reaction products with sodium sulfide (Na2(Sx))",215-483-5,1327-57-7,Not Classified,Notified C&L,7,Not classified:7
111545,"Cherry, sweet, ext.",287-632-2,85566-22-9,Flam. Liq. 3,Notified C&L,1374,H226:1314;Not classified:35;H224:25
111546,trans-4-(4-ethylcyclohexyl)benzonitrile,277-084-2,72928-54-2,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,2,Not classified:1;H302:1;H413:1;H301:1;H315:1;H331:1;H311:1;H319:1
111547,"rel-(2R,6S)-2,6-dimethylpiperazine",606-812-7,21655-48-1,,Notified C&L,3,H319:3;H315:3;H228:3;H335:1
111549,Bis[(trimethylsilyl)methyl]mercury,236-315-7,13294-23-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H330:38;H410:38;H373:38;H400:38;H310:38
111553,"(butan-2-olato)bis(ethyl 3-oxobutyrato-O1',O3)aluminium",299-887-7,93918-06-0,Not Classified,Notified C&L,8,Not classified:8
111554,"3-hydroxyoestra-1,3,5(10),7-tetraen-17-one",207-488-6,474-86-2,Carc. 2;Repr. 2,Notified C&L,81,H351:80;H361:54;H360:27;H362:26;H312:16;H332:16;H302:16;H372:1;H350:1
111556,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[2,5-dimethoxy-4-[(methylamino)sulphonyl]phenyl]azo]naphthalene-2-carboxamide",235-426-8,12225-08-0,Not Classified,REACH registration C&L,46,Not classified:46
111558,2'-nitroacetophenone,209-414-8,577-59-3,Acute Tox. 4,Notified C&L,46,H302:46;H332:1;H312:1;H319:1;H335:1;H315:1
111559,Sodium 2-hydroxypropane-2-sulphonate,208-761-2,540-92-1,,Notified C&L,86,Not classified:86
111560,Formamidinium chloride,228-639-2,6313-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:91;H335:91;H315:91
111561,"Benzene, 4-bromo-1-methoxy-2-(3-methoxypropoxy)-",605-674-5,173336-76-0,Acute Tox. 4,Notified C&L,33,H302:33
111568,Tetraphenylphosphonium phenolate,239-480-3,15464-47-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,26,H302:26;H318:26;H411:26
111569,2-methylacridine-9-carbaldehyde,274-594-7,70401-29-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111570,"3-[[5-methyl-2-(1-methylethyl)cyclohexyl]oxy]propane-1,2-diol",289-296-2,87061-04-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1548,H412:1343;H318:37;H315:1343;H319:1306;Not classified:205
111571,"Oils, lard, Me esters, sulfurized",270-454-4,68440-40-4,Not Classified,Notified C&L,11,Not classified:11
111573,"Tall oil, sulfonated, sodium salt",268-777-0,68140-15-8,Not Classified,Notified C&L,2,Not classified:2
111576,[(tetradecyloxy)methyl]oxirane,254-219-3,38954-75-5,Not Classified,Notified C&L,7,Not classified:7
111578,"Benzenamine, 4-bromo-2-ethyl-, hydrochloride (1:1)",608-452-6,30273-22-4,,Notified C&L,4,H315:4;H312:4;H335:4;H332:4;H302:4;H319:4
111579,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium acetate",261-448-2,58798-47-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,135,H318:99;H315:94;H311:92;H410:101;H302:98;H400:101;H412:33;H312:33;H301:36;H319:35;Not classified:1
111581,1-phenylbutan-2-ol,211-858-2,701-70-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
111582,"7-(ethylamino)-4,6-dimethyl-2-benzopyrone",247-446-4,26078-25-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H312:1;H335:1;H332:1;H302:1
111585,"Heptane-2,4-dione",230-759-5,7307-02-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
111586,"secbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine",247-554-1,26259-45-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H319:0;H400:0
111589,"Comfrey, Symphytum officinale, ext.",283-625-3,84696-05-9,Not Classified,Notified C&L,55,Not classified:55
111590,"1,4-Naphthoquinone, 2-methyl-, sodium bisulfite",611-523-4,57414-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111593,3-aminobenzoic acid hydrochloride,239-212-5,15151-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
111598,"Distillates (petroleum), heavy steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 °C to 400 °C (482 °F to 752 °F).]",309-939-3,101631-14-5,Carc. 1B,Harmonised C&L,0,H350:0
111601,BDS-HEXAFLUOROPHOSPHATE,639-675-7,74227-35-3,Not Classified,Notified C&L,104,Not classified:56;H317:35;H410:34;H319:48;H400:34;H315:28;H370:14;H413:13;H312:1;H302:1
111606,Myrcenyl acetate,214-262-0,1118-39-4,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1546,H317:3;H411:3;H315:3;Not classified:1543
111608,"2,2,4-trimethyl-1-oxa-4-aza-2-silacyclohexane",233-487-5,10196-49-3,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,132,H318:29;H226:72;H335:95;H332:2;H314:50;H302:72;H319:60;H315:82;H312:35;H300:22;H330:22
111616,"Diisooctyl hydrogen phosphate, compound with 2-ethylhexylamine (1:1)",262-645-6,61188-14-5,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,572,H318:572;H411:572
111618,"reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide",428-630-5,,Skin Sens. 1,Harmonised C&L,0,H317:0
111620,Diethyl ether--boron trifluoride,203-689-8,109-63-7,Flam. Liq. 3;Skin Corr. 1B;Acute Tox. 4;STOT RE 1,REACH registration C&L,177,H332:135;H314:175;H372:173;H226:148;H318:85;H302:49;H330:34;H290:10;H331:5;Not classified:2;H412:2;H373:2;H261:2;H260:1;H301:1;H311:1;H312:1
111623,"Sodium 2(or 5)-[[9,10-dihydro-4-[(isopropyl)amino]-9,10-dioxo-1-anthryl]amino]-5(or 2)-methylbenzenesulphonate",257-801-5,52270-63-0,Not Classified,Notified C&L,1,Not classified:1
111626,"11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-butyrate",229-715-8,6677-99-2,,Notified C&L,1,H302:1;H341:1
111628,"Oxirane, 2-methyl-, polymer with oxirane, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1)",611-632-7,58205-99-5,Not Classified,Notified C&L,67,Not classified:67
111634,1-chloro-2-isothiocyanato-4-nitrobenzene,260-586-0,57135-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
111636,"1,1-dimethylguanidinium chloride",245-105-4,22583-29-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
111638,"Amines, C12-14-tert-alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",287-007-4,85408-46-4,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,314,H317:86;H411:314
111639,"Fatty acids, C14-18",266-926-4,67701-02-4,Not Classified,Notified C&L,289,Not classified:289
111641,p-N-(7-amino-1-chloro-2-oxohept-3-yl)toluenesulphonamide,224-199-0,4238-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111642,"N-[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenyl]-2-methyl-prop-2-enamide",611-915-5,59941-98-9,Not Classified,REACH registration C&L,2,Not classified:2
111643,"3-hydroxy-5-hydroxymethyl-2,4-dimethylpyridinium chloride",205-714-8,148-51-6,,Notified C&L,1,H302:1
111644,"1,1'-(3,7-dimethyloct-6-enylidene)bis(1H-indole)",267-136-2,67801-16-5,Not Classified,Notified C&L,88,Not classified:88
111646,4-chlorobiphenyl,218-127-7,2051-62-9,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,48,H373:45;H410:45;H400:45;H332:3;H302:3;H312:3;H315:1;H335:1;H319:1
111647,5'-chloro-2'-methoxyacetoacetanilide,258-189-2,52793-11-0,Aquatic Chronic 3,REACH registration C&L,86,H412:48;H302:38
111648,"Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-nortall-oil alkyl, chlorides",269-674-3,68309-34-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,441,H318:441;H315:441
111650,"Almond, sweet, ext.",291-063-5,90320-37-9,Not Classified,REACH registration C&L,1441,Not classified:1440;H226:1;H319:1
111654,"2,4-diaminopteridine-6-ylmethanol",213-412-2,945-24-4,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
111657,"11β,17-dihydroxypregna-1,4-diene-3,20-dione 21-[(6-carboxycyclohex-3-en-1-yl)formate]",222-058-8,3331-71-3,Not Classified,Notified C&L,1,Not classified:1
111659,Potassium methacrylate,230-007-6,6900-35-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,23,H318:2;H312:2;H335:23;H314:2;H302:2;H319:21;H315:21
111660,"4,4'-Isopropylidenediphenol, ethoxylated and propoxylated",500-112-4,52367-02-9,Aquatic Chronic 3,Notified C&L,1,H412:1
111662,1-(m-methylbenzyl)piperazine dihydrochloride,226-187-0,5321-61-9,,Notified C&L,1,H302:1
111677,Sodium N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]glycinate,266-197-2,66161-62-4,Eye Irrit. 2,Notified C&L,68,H319:66;Not classified:2
111679,Nicotinic acid,200-441-0,59-67-6,Eye Irrit. 2,REACH registration C&L,556,H319:399;H412:157;H335:15;H315:8;H302:1;Not classified:1
111680,Heparin,232-681-7,9005-49-6,Acute Tox. 4,Notified C&L,58,H302:52;H351:9;H319:9;Not classified:6
111685,"L-Ornithine, N5-[imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl]-N2-[(phenylmethoxy)carbonyl]-, compd. with cyclohexanamine (1:1)",617-158-7,80745-09-1,Not Classified,Notified C&L,2,Not classified:2
111687,Sage oil,617-012-2,8022-56-8,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,214,H304:174;H226:213;H317:175;H410:169;H341:169;H400:133;H371:6;H332:1;H302:5;H411:6;H412:1;H315:3;H312:1;H331:1;H318:2
111688,Methyl 4-chloro-3-oxobutyrate,251-230-5,32807-28-6,Acute Tox. 3,Notified C&L,53,H301:53;H314:14;H331:1;H311:1;H318:1
111689,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-, N,N'-bis(4-chloro-2,5-dimethoxyphenyl and 2,4-xylyl) derivs.",290-824-9,90268-24-9,Not Classified,REACH registration C&L,107,Not classified:107
111691,"1,3,6,8-tetranitrocarbazole",224-898-0,4543-33-3,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H302:1;H201:1;H332:1;H228:1
111692,4-methylpent-2-en-1-oic acid,233-706-4,10321-71-8,Skin Corr. 1B,Notified C&L,119,H314:119;H318:37;H290:1
111697,Diisopropylammonium dichloroacetate,211-538-2,660-27-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
111699,4-methoxybenzyl phenylacetate,203-010-5,102-17-0,Not Classified,Notified C&L,89,Not classified:89
111701,Zinc dodecyl hydrogen disulphate,244-955-3,22397-58-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H318:2;H315:2;H302:2;H400:2;H335:1;H332:1;H228:1
111702,"α-Amanitin, 1-l-aspartic acid-",244-244-8,21150-22-1,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38;H310:38
111703,Potassium acrylate,233-473-9,10192-85-5,Not Classified,Notified C&L,30,Not classified:26;H319:4;H335:4;H315:4
111704,"Sulphosuccinic acid, sodium salt",243-860-4,20526-58-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
111710,(p-ammoniophenyl)ethyl(2-hydroxyethyl)ammonium sulphate,224-361-0,4327-84-8,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H301:1;H319:1
111711,Methyl 3-amino-4-methylbenzoate,606-067-8,18595-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H412:1
111712,"2',4'-difluoropropiophenone",285-291-4,85068-30-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
111715,"2,5-dibromo-p-xylene",214-038-2,1074-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,45,H411:38;H319:45;H335:44;H315:45
111718,1-chloro-4-fluorobenzene,206-521-1,352-33-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H226:46;H319:44;H335:44;H315:44;H332:9;H225:3;H302:2;H312:1
111725,"2,2',2''-nitrilotris(acetamide)",225-469-0,4862-18-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,70,H319:70;H315:70
111731,(pyrimidin-2-ylthio)acetic acid,289-445-1,88768-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
111733,"(1,4,5,6-tetrahydro-4,6-dioxopyrimidin-2-yl)cyanamide",259-467-6,55067-10-2,Not Classified,REACH registration C&L,42,Not classified:2;H318:40;H315:40;H312:40;H335:40;H332:40;H302:40
111734,"2-chloro-4,5-xylenol",214-386-5,1124-04-5,,Notified C&L,4,H319:4;H335:4;H315:4
111737,Sodium hydrogensulphide,240-778-0,16721-80-5,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,789,H301:634;H318:616;H314:765;H290:607;H400:639;H226:441;H251:89;H302:46;H411:33;Not classified:46;H311:9;H312:4;H332:4;H228:5;H341:1
111738,"Glycerides, C8-10 mono- and di-",287-488-0,85536-07-8,Not Classified,REACH registration C&L,6,Not classified:6
111739,Hydrazinium(2+) sulphate,233-110-4,10034-93-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,58,H301:57;H331:55;H311:57;H314:40;H317:57;H410:57;H350:57;H400:57;Not classified:2;H330:2
111747,"Bis[9-(o-carboxyphenyl)-3,6-bis(diethylamino)xanthylium] dicopper(1+) hexa(cyano-C)ferrate(4-)",279-229-5,79665-42-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,17,H410:17;H318:17;H400:17
111756,"1H-1,2,4-triazole-3,5-diamine",215-937-2,1455-77-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,273,H315:159;H312:159;H332:159;H302:219;H319:159;Not classified:53
111757,2-(4-methoxyphenyl)-2-pyrrolidin-1-ylacetamide,277-883-6,74467-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111762,Cyanuric acid,203-618-0,108-80-5,Not Classified,REACH registration C&L,178,Not classified:103;H319:75;H335:26;H315:23;H332:2;H302:2
111764,"reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)",406-000-0,173939-66-7,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
111765,4-(3-chloropropyl)morpholine,461-510-0,7357-67-7,Acute Tox. 4;Eye Dam. 1;Muta. 2;STOT RE 2,REACH registration C&L,2,H302:1;H318:1;H341:1;H373:1;H319:1;H315:1
111768,"A mixture of: cis-1,4-Dimethylcyclohexyl dibenzoate and trans-1,4-Dimethylcyclohexyl dibenzoate",609-138-1,35541-81-2,Aquatic Chronic 4,Notified C&L,50,H413:50;H400:1
111771,3-methylheptane,209-660-6,589-81-1,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H315:0;H410:0;H225:0;H336:0;H400:0
111773,"Calcium, C5-23-branched carboxylate naphthenate complexes",280-536-1,83711-40-4,Not Classified,Notified C&L,1,Not classified:1
111776,2-bromo-5-nitrothiophene,236-155-8,13195-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
111778,benzoyl chloride,202-710-8,98-88-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0;H314:0;H317:0;H302:0
111787,"Rape oil, polymd., oxidized",614-600-0,68554-11-0,Not Classified,Notified C&L,33,Not classified:33
111788,"Decanoic acid, mixed diesters with octanoic acid and propylene glycol",271-516-3,68583-51-7,Not Classified,REACH registration C&L,269,Not classified:269
111790,Lead diniobium hexaoxide,234-814-4,12034-88-7,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H360:38;H332:38;H410:38;H302:38;H400:38
111791,"3,5-dimethylcyclohex-3-ene-1-carbonitrile",266-497-3,66848-40-6,Not Classified,Notified C&L,88,Not classified:88
111794,3-Fluorophenyl acetate,615-079-2,701-83-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H315:38;H335:38;H317:38;H302:39;H332:1;H312:1
111797,"1,1'-(2,3-dimethylbutane-2,3-diyl)bis[4-(propan-2-yl)benzene]",449-400-0,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
111798,"1,2-Ethanediamine, N,N'-bis(2-aminoethyl)-, reaction products with glycidyl tolyl ether",291-236-5,90366-91-9,Not Classified,Notified C&L,66,Not classified:55;H318:10;H314:1;H317:2;H411:1;H412:1;H315:1;H312:1;H302:1
111801,Secobarbital sodium,206-218-4,309-43-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,39,H301:39;H331:38;H361:39;H311:38;H332:1;H312:1
111802,"5,8-Methano-4H-1-benzopyran, 7-ethylidene-4a,5,6,7,8,8a-hexahydro-",614-979-2,69486-10-8,Not Classified,Notified C&L,1,Not classified:1
111812,N-(benzyloxycarbonyl)-L-serine,214-546-4,1145-80-8,Not Classified,Notified C&L,2,Not classified:2
111813,"Propane-1,2,3-triyl triundecanoate",236-935-8,13552-80-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111814,reaction mass of: potassium o-toluenephosphonate;potassium m-toluenephosphonate;potassium p-toluenephosphonate,433-860-4,,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H319:0
111817,"2-ethoxyethyl {4-[2,6-dioxo-7-(4-propoxyphenyl)-2,6-dihydrobenzo[1,2-b:4,5-b']difuran-3-yl]phenoxy}acetate",408-230-7,126877-06-3,Skin Sens. 1,REACH registration C&L,2,H317:2
111819,"3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate",425-820-1,88150-42-9,Acute Tox. 3;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H318:0;H410:0;H373:0;H400:0
111822,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, reaction products with 3-[(4-amino-5-methoxy-2-methylphenyl)azo]benzenesulfonic acid monosodium salt",215-400-2,1325-61-7,Not Classified,Notified C&L,2,Not classified:2
111823,Nitroscanate,243-393-6,19881-18-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,42,H319:40;H411:38;H335:2;H315:2;H317:1;H410:1;H400:1;Not classified:1
111825,1-(4-butoxy-1-naphthyl)tetrahydrothiophenium nonafluorobutane-1-sulfonate,468-770-4,,Eye Irrit. 2,Notified C&L,1,H319:1
111827,Bis(D-glycero-D-ido-heptonato)zinc,270-646-8,68475-48-9,Not Classified,Notified C&L,3,Not classified:2;H302:1;H318:1
111828,"3-Heptanol, acetate",611-812-5,5921-83-5,Flam. Liq. 3,Notified C&L,38,H226:38
111830,2-hexyldecyl-p-hydroxybenzoate,415-380-7,148348-12-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
111831,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(cyclohexylamino)propyl]amino]sulfonyl derivs.",309-627-7,100545-46-8,Eye Dam. 1,REACH registration C&L,1,H318:1
111834,2-furfuryleneoctanal,267-137-8,67801-17-6,Not Classified,Notified C&L,88,Not classified:88
111837,p-methoxybenzyl carbazate,242-664-6,18912-37-3,,Notified C&L,4,H319:4;H335:4;H315:4
111840,Sodium 2-bromoethanesulphonate,224-244-4,4263-52-9,Not Classified,REACH registration C&L,50,Not classified:3;H319:47;H335:46;H315:47
111841,"2-[7-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)hepta-1,3,5-trienyl]-1,3,3-trimethyl-3H-indolium perchlorate",240-652-5,16595-48-5,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H272:38;H319:38;H335:38;H315:38
111844,"Glycine, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]-, pentapotassium salt",615-726-9,7216-95-7,Eye Irrit. 2;Acute Tox. 4;Repr. 2,Notified C&L,106,H332:86;H319:106;H361:86;H315:20;H351:1
111851,"2,6-diisopropylnaphthalene",246-045-1,24157-81-1,Aquatic Chronic 1,REACH registration C&L,45,H410:42;H302:38;H400:38;Not classified:3
111853,"Quaternary ammonium compounds, pentamethyltallow alkyltrimethylenedi-, bis(Me sulfates)",269-676-4,68309-56-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31,H302:31;H319:31;H411:31
111857,"Almond, ext.",291-061-4,90320-36-8,Flam. Liq. 3,Notified C&L,26,H226:25;Not classified:1
111858,Hexahydroazocin-2(1H)-one,211-611-9,673-66-5,Acute Tox. 4,Notified C&L,40,H302:40;H319:1;H335:1;H315:1
111859,"2,6-dichloro-3-(trichloromethyl)pyridine",259-616-5,55366-30-8,Not Classified,Notified C&L,55,Not classified:55
111868,"2,7-dinitrofluorene",226-457-8,5405-53-8,Carc. 2,Notified C&L,42,H351:38;H341:4
111874,"2,2-diethoxyacetamide",262-647-7,61189-99-9,,Notified C&L,1,H319:1;H335:1;H315:1
111875,"5,6-dimethylhept-5-en-2-one",211-698-3,687-68-3,Not Classified,Notified C&L,11,Not classified:11
111876,4-ethylstyrene,222-381-4,3454-07-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H304:1;H315:1;H226:1;H335:1;H319:1
111877,"4,4'-cyclohexylidenedi-o-cresol",219-110-7,2362-14-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H400:1;H319:1;H315:1
111880,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with ethylenediamine and oleic acid",500-197-8,68154-56-3,Not Classified,Notified C&L,2,Not classified:2
111881,Cyclohexyl cyanoacetate,258-104-9,52688-11-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
111886,"Dibutyl 1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate",217-192-9,1770-80-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,86,H410:44;H400:83;H319:27;H330:4;H301:3;H315:5;H311:4;H335:5;H224:3;H302:1
111893,"N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate",403-340-1,164578-09-0,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
111894,"cyclohexanaminium (6R,7S)-3-(acetoxymethyl)-7-methoxy-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",616-356-0,765910-82-5,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H317:1;H334:1
111897,"Barley, Hordeum distichon, ext.",305-187-5,94349-67-4,Flam. Liq. 1,Notified C&L,26,H224:25;H319:1;H315:1
111899,3-bromo-4-hydroxybenzonitrile,219-022-9,2315-86-8,Acute Tox. 4,Notified C&L,46,H302:45;H319:5;H335:4;H315:5;H411:1;H301:1;H331:1;H311:1;H332:1;H312:1
111901,"3,4-dichloro-5-hydroxyfuran-2(5H)-one",212-166-3,766-40-5,Acute Tox. 3;Skin Corr. 1B;Muta. 2,Notified C&L,1,H314:1;H301:1;H341:1
111904,"2-[4-(β-D-glucopyranosyloxy)-3-hydroxyphenyl]-3,5,7-trihydroxy-4H-1-benzopyran-4-one",243-614-6,20229-56-5,Acute Tox. 4,Notified C&L,40,H302:40
111907,3-(BROMOACETYL)-5-CHLORO-N-(3-METHOXYPROPYL)THIOPHENE-2-SULFONAMIDE,921-699-7,,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H302:1;H331:1;H311:1
111910,"endrin (ISO);1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene",200-775-7,72-20-8,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H400:0;H311:0
111913,"1-[4-(dimethylamino)-3,5-dinitrophenyl]-1H-pyrrole-2,5-dione",222-449-3,3475-74-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111917,3-hydroxy-2'-methoxy-2-naphthanilide,205-206-6,135-62-6,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,87,H317:44;H411:46;H319:40;H335:40;H315:40;Not classified:1
111920,1-bromopropane;n-propyl bromide,203-445-0,106-94-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;STOT RE 2;Repr. 1B,Harmonised C&L,0,H315:0;H360:0;H335:0;H225:0;H373:0;H336:0;H319:0
111923,Acetone oxime,204-820-1,127-06-0,Flam. Sol. 1;Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Carc. 2,REACH registration C&L,116,H318:111;H312:4;H317:25;H228:32;H351:88;H302:88;H373:2
111925,"(3,3-diethoxy-1-propenyl)benzene",230-467-8,7148-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H317:1
111926,"Oils, mixed lard and vegetable oil deodorizer distillates, sulfated, sodium salts",270-456-5,68440-44-8,,Notified C&L,1,Not classified:1
111927,unknow,605-980-9,182824-33-5,Self-heat. 1;Skin Sens. 1,Notified C&L,3,H251:3;H317:3
111930,"Amines, C12-18-alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]cobaltate(1-)",286-236-7,85203-44-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,268,H317:266;H410:266;H400:266;Not classified:2
111931,Pentan-2-one,203-528-1,107-87-9,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1870,H302:1650;H319:1619;H225:578;H335:1403;H315:123;H336:13;Not classified:8;H331:2;H314:1
111933,"Disodium 7,7'-(carbonyldiimino)bis[4-hydroxy-3-(phenylazo)naphthalene-2-sulphonate]",222-838-8,3626-36-6,Not Classified,REACH registration C&L,20,Not classified:14;H319:5;H315:5;H332:1;H302:1;H312:1
111934,Ethylene dithiocyanate,211-078-2,629-17-4,Acute Tox. 4,Notified C&L,42,H302:38;H300:4;H319:4;H335:4;H315:4
111937,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium sulphate (2:1)",255-198-3,41062-73-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H315:2;H410:2;H302:2;H319:2;H400:2
111938,"Hydrogen [tris[[[3-[(2-ethylhexyl)oxy]propyl]amino]sulphonyl]-29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",304-661-9,94277-77-7,Not Classified,REACH registration C&L,790,Not classified:105;H412:685
111940,2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylthio)-1H-benzo[d]imidazole,601-502-8,117977-21-6,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,41,H302:2;H413:1;H319:39;H335:39;H315:39
111944,Ethoxymethyldiphenylsilane,217-368-5,1825-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
111946,"2-propenoic acid, 2-methyl-, 4-benzoylphenyl ester",611-390-2,56467-43-7,Aquatic Acute 1,REACH registration C&L,17,H400:17;H318:2;H315:2;H335:2;H317:2;H225:2
111951,Propan-2-yl 6-chloropyridine-2-carboxylate,606-934-0,220969-59-5,Aquatic Chronic 2,REACH registration C&L,34,H411:34
111955,Tetrasodium dihydrogen [nitrilotris(methylene)]trisphosphonate,301-416-8,94021-23-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
111957,Triethyltrimethylcyclohex-2-en-1-one,272-461-8,68845-35-2,Skin Irrit. 2,Notified C&L,112,H315:102;Not classified:10
111961,Phospholipase A1,618-552-1,9043-29-2,Resp. Sens. 1,Notified C&L,3,H334:3
111963,"Bis[bis(3,5,5-trimethylhexyl)dithiocarbamate-S,S']zinc",283-381-8,84604-96-6,Not Classified,Notified C&L,27,Not classified:26;H413:1
111964,D-aspartic acid,217-234-6,1783-96-6,Not Classified,Notified C&L,6,Not classified:6
111965,Bis-{[2-(4-Methoxy-phenylazo)-1-hydroxy-naphtalene-6-ylamino]-fluoroheteromonocyclylamino}- methylalkan polysulfonate Na/K-salt,413-970-9,,Not Classified,Notified C&L,1,Not classified:1
111966,Hexadecyl (R)-12-hydroxyoleate,233-864-4,10401-55-5,Not Classified,REACH registration C&L,43,Not classified:43
111970,Tributyl O-acetylcitrate,201-067-0,77-90-7,Not Classified,REACH registration C&L,2065,Not classified:2036;H412:14;H220:7;H340:7;H350:7;H319:7;H315:3;H411:1
111972,"methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate",401-340-6,83055-99-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
111973,"O,O,O-1,3,5-trimethylresorcinol",210-673-4,621-23-8,Acute Tox. 4,Notified C&L,99,H302:99;H319:40
111978,Tetramethylsilane,200-899-1,75-76-3,Flam. Liq. 1;Aquatic Chronic 2,REACH registration C&L,120,H224:119;H411:23;H302:22;H319:1;H335:1;H315:1;Not classified:1;H225:1
111980,(±)-indoline-2-carboxylic acid,240-875-8,16851-56-2,Skin Sens. 1;Repr. 2,Notified C&L,1,H317:1;H361:1
111981,"4,5-dichloro-2-octyl- 2",264-843-8,64359-81-5,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Skin Sens. 1A;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H318:0;H314:0;H317:0;H410:0;H302:0;H400:0
111982,"Valerian, Valeriana officinalis collina, ext.",308-322-6,97927-02-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1404,H317:1404;H411:1402;H304:117;H410:2;H319:3;H400:2;H315:1
111983,"O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine hydrochloride",261-057-7,57981-02-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
111985,"(Z)-1,3-dichloropropene",233-195-8,10061-01-5,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H301:0;H315:0;H226:0;H311:0;H332:0;H335:0;H317:0;H410:0;H319:0;H400:0
111986,"[7-hydroxy-8-[(4-sulpho-1-naphthyl)azo]naphthalene-1,3-disulphonato(3-)]aluminium",240-008-3,15876-47-8,Acute Tox. 4,REACH registration C&L,10,H302:2;Not classified:8
111987,2-isopropoxycyclohexan-1-ol,221-033-9,2979-30-8,Eye Dam. 1,Notified C&L,38,H318:38
111988,2-tert-butoxyethanol,456-140-1,,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1;Acute Tox. 3;STOT RE 2,Notified C&L,2,H318:2;H373:1;H226:2;H331:2;H302:2;H315:1;H372:1;H336:1
111989,(±)-(methoxy)phenylacetic acid,230-300-9,7021-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;Not classified:1
111996,Octafluoroadipic acid,206-407-1,336-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H314:1
111998,Ammonium hexafluorogermanate(4),241-037-4,16962-47-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,50,H315:50;H312:41;H335:50;H332:41;H302:41;H319:50;H330:4;H301:4;H311:4;Not classified:1
112001,"Dihydro-3-octylfuran-2,5-dione",224-102-1,4200-92-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112002,"2,2'-oxydiethanethiol",218-421-5,2150-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
112006,(Z)-pent-2-enenitrile,247-323-5,25899-50-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;STOT RE 1;STOT RE 1,REACH registration C&L,1,H301:1;H226:1;H331:1;H311:1;H317:1;H372:1
112008,Bis(p-tert-butylphenyl) hydrogen phosphate,244-245-3,21150-89-0,Skin Corr. 1B,Notified C&L,76,H314:71;Not classified:5
112009,5-Bromo-2-thiophenesulfonyl Chloride,611-324-2,55854-46-1,Skin Corr. 1B;Skin Sens. 1,Notified C&L,46,H314:46;H317:39;H332:1;H302:1;H312:1;H318:1;H290:1
112011,"3,4-dinitrophenol",209-415-3,577-71-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H331:0;H311:0;H373:0;H411:0
112012,"2-ethyl-3,-dimethylpyrazine",248-182-2,27043-05-6,Acute Tox. 4,Notified C&L,298,H302:298;H319:39;H335:39;H315:39
112017,"Octadecanoic acid, reaction products with diethylenetriamine and triethylenetetramine",273-247-7,68954-57-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112020,4-methyl-4-phenylpentan-2-ol,218-002-7,2035-93-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,39,H412:1;H319:39;H302:38
112025,5-bromopentanenitrile,226-505-8,5414-21-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:45;H312:43;H335:39;H332:43;H302:43;H319:45;H301:2;H331:2;H311:2
112027,"Bis(quinolin-8-olato-N1,O8)magnesium",238-686-0,14639-28-2,Not Classified,Notified C&L,1,Not classified:1
112029,Benzyldimethyloleylammonium chloride,253-363-4,37139-99-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,16,H318:13;H400:13;H315:13;Not classified:3
112031,"Dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan",223-118-6,3738-00-9,Not Classified,Notified C&L,1557,Not classified:1556;H411:1
112033,9-oxo-9H-fluorenecarboxylic acid,216-396-5,1573-92-8,,Notified C&L,4,H319:4;H335:4;H315:4
112036,"Benzeneacetic acid, α-hydroxy-, (αR)-, compd. with rel-(1R,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine (1:1)",607-375-5,244223-89-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,2,H302:2;H319:2;H335:2
112043,"Phosphorodithioic acid, mixed O,O-bis(iso-Bu and pentyl) esters",271-126-3,68516-01-8,Flam. Liq. 3;Skin Corr. 1C;Eye Dam. 1,Notified C&L,441,H314:441;H226:441;H318:441
112050,diethylmethoxyborane,425-380-9,7397-46-8,Pyr. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H250:0;H413:0;H312:0;H332:0;H314:0;H317:0;H302:0
112057,"Sodium 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxopyrimidin-5-yl]azo]phenyl]-6-methylbenzothiazole-7-sulphonate",259-468-1,55067-12-4,Not Classified,Notified C&L,1,Not classified:1
112061,(S)-phenylsuccinic acid,223-719-3,4036-30-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112064,4-(trichlorosilyl)butyronitrile,213-990-6,1071-27-8,Skin Corr. 1B;STOT SE 3,Notified C&L,43,H314:43;H335:38
112069,"Gases (petroleum), reformer effluent high-pressure flash drum off;Refinery gas;[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]",271-003-4,68513-18-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
112070,"Alcohols, lanolin, ethoxylated",612-397-3,61791-20-6,Not Classified,Notified C&L,53,Not classified:53
112071,"1,1-dimethoxy-2-phenylethane",202-945-6,101-48-4,Not Classified,REACH registration C&L,1599,Not classified:4;H319:1595
112073,2-hydroxy-m-anisaldehyde,205-715-3,148-53-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H302:43;H319:43;H335:42;H315:62;H317:19;H318:19;Not classified:3
112075,Ethylene diformate,211-077-7,629-15-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,146,H302:116;H318:72;H319:62;H315:24;Not classified:8;H314:1;H335:1;H332:1
112076,2-bromobut-2-ene,236-316-2,13294-71-8,Flam. Liq. 2,Notified C&L,45,H225:45
112078,"(2S,4S)-2-(dimethylaminocarbonyl)-4-mercapto-1-(p-nitrobenzyloxycarbonyl)-1-pyrrolidine",619-190-7,96034-64-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H302:3;H319:3;H335:3;H315:3
112079,tert-butyl acetate,208-760-7,540-88-5,Flam. Liq. 2,Harmonised C&L,0,H225:0
112080,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide",235-425-2,12225-06-8,Not Classified,REACH registration C&L,80,Not classified:79;H319:1
112082,Fludrocortisone 21-acetate,208-180-4,514-36-3,Acute Tox. 4;Repr. 2,Notified C&L,41,H302:39;H361:39;H372:2;H360:1
112083,Tetraphenyldiphosphine,214-155-9,1101-41-3,Pyr. Sol. 1,Notified C&L,38,H250:38
112087,"(dihydro-3,3-diphenyl-3H-furan-2-ylidene)dimethylammonium bromide",253-649-9,37743-18-3,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,7,H318:3;H317:3;H302:7;H341:4;H411:3;H373:1
112088,"4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol",209-218-2,561-41-1,Acute Tox. 4;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,96,H412:13;H350:21;H302:14;H319:14;H373:4;H413:2;Not classified:69;H341:10;H315:1;H332:1
112093,"Fats and Glyceridic oils, vegetable, polymd., oxidized",614-806-0,68918-91-2,Not Classified,Notified C&L,1,Not classified:1
112094,barium perchlorate,236-710-4,13465-95-7,Ox. Sol. 1;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H271:0
112096,2-oxobornane-3-carboxylic acid,207-489-1,474-98-6,Acute Tox. 4,Notified C&L,38,H302:38
112097,Methylarsonic acid,204-705-6,124-58-3,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H301:38;H331:38;H400:38
112098,2-(ethylphenylamino)ethyl acetate,254-218-8,38954-40-4,Not Classified,Notified C&L,9,Not classified:9
112100,4-aminomethyl-2-methoxyphenol hydrochloride,230-468-3,7149-10-2,Aquatic Chronic 3,REACH registration C&L,47,H412:1;H319:45;H335:45;H315:45;H302:1
112102,"Dill, ext.",289-790-8,90028-03-8,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1606,H304:1554;H315:1557;H226:1489;H317:1581;H410:1553;H302:1338;H400:1515;H411:25;Not classified:24;H303:1;H319:3;H412:1
112103,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",274-593-1,70398-33-3,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H400:2;H301:2;H318:2
112104,"Hexa-2,4-dienal",205-564-3,142-83-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1642,H315:1598;H226:1597;H311:1641;H317:1640;H302:1597;H319:1599;H314:43;H301:45;H335:1;H310:1
112105,3-dimethylaminophenyl dimethylcarbamate,240-240-5,16088-19-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H330:1;H310:1
112106,"Glycerides, lard mono-, di- and tri-, hydrogenated",294-611-1,91744-48-8,Not Classified,Notified C&L,1,Not classified:1
112108,"2,4-difluorobenzyl alcohol",260-191-3,56456-47-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
112111,"9,10-Anthracenedione, 1-hydroxy-4-[(4-methylphenyl)amino]-",601-910-6,12217-81-1,,Notified C&L,2,Not classified:2
112112,VERTOXIME,443-450-7,86460-54-0,Acute Tox. 4;Skin Sens. 1B,Notified C&L,24,H302:24;H317:24
112114,"Tall oil, reaction products with diethylenetriamine",268-776-5,68140-14-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:6;H315:6;Not classified:1;H314:1;H317:1;H410:1;H400:1
112115,4-methyl-2-oxo-2H-1-benzopyran-7-ylphosphonic acid,222-137-7,3368-04-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H315:2
112120,morpholine-4-carbonyl chloride,239-213-0,15159-40-7,Skin Irrit. 2;Eye Irrit. 2;Carc. 2,Harmonised C&L,0,H351:0;H319:0;H315:0
112131,Calcium dodecylphenolate,257-802-0,52274-73-4,,Notified C&L,1,Not classified:1
112132,"Disodium 3,4,5,6-tetrachloro-2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate",211-183-3,632-69-9,Not Classified,Notified C&L,73,Not classified:66;H319:7;H335:5;H315:5
112135,Dipropyl tetrasulphide,258-103-3,52687-98-6,,Notified C&L,1,Not classified:1
112138,"3,4,5-trimethoxy-2-nitrobenzoic acid",266-518-6,66907-52-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
112139,Dodecanedinitrile,224-899-6,4543-66-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112142,"Tallow, oxidized",272-851-8,68918-10-5,,Notified C&L,1,Not classified:1
112143,"1H-Phosphole, dihydro-1-methyl-, 1-oxide",608-638-7,31563-86-7,Not Classified,Notified C&L,63,Not classified:33;H319:30;H315:5
112145,ammoniumpentadeca- fluorooctanoate,223-320-4,3825-26-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Repr. 1B,Harmonised C&L,0,H318:0;H362:0;H360:0;H332:0;H351:0;H302:0;H372:0
112147,phenolic resin,607-846-5,26022-00-4,Skin Sens. 1,Notified C&L,4,H317:4
112150,Isooctylamine,215-318-7,1321-35-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,42,H302:38;H318:38;H314:4
112152,disodium 2-[N-hydroxy-N-(2-sulfonatoethyl)amino]ethane-1-sulfonate,407-370-6,133986-51-3,Eye Irrit. 2,REACH registration C&L,5,H319:2;H412:3
112154,Ethyl 6-decyloxy-7-ethoxy-4-hydroxy-3-quinolinate,242-389-1,18507-89-6,Aquatic Chronic 4,Notified C&L,195,H413:195
112155,"3,5-bis(trifluoromethyl)benzylamine",285-290-9,85068-29-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H314:47;H318:39;H411:1
112156,"Argania spinosa, ext.",607-015-7,223747-87-3,Not Classified,Notified C&L,9,Not classified:9
112158,"Zinc, bromo(2,2-dimethylpropyl)-",614-089-4,676137-12-5,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H314:83;H410:83;H400:83
112159,"Fatty acids, C12-18",266-925-9,67701-01-3,Not Classified,REACH registration C&L,145,Not classified:62;H319:83
112163,Pyrimidin-2-ylaminehydrobromide sesquihydrate,255-101-4,40835-96-9,,Notified C&L,4,H319:4;H335:4;H315:4
112165,4-fluoroiodobenzene,206-522-7,352-34-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
112168,"Reaction products of alcohols C8-22, distn. residues, maleic anhydride and sodium sulfite, sodium salt",927-790-8,,Not Classified,Notified C&L,2,Not classified:2
112169,"[7S-(7α,7bβ,10aβ)]-N-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl)acetamide",230-008-1,6901-13-9,Acute Tox. 4,Notified C&L,1,H302:1
112171,Dihexadecyl ether,223-900-7,4113-12-6,Not Classified,Notified C&L,4,Not classified:3;H319:1;H335:1;H315:1
112175,1-phenethylpiperazine,226-186-5,5321-49-3,Acute Tox. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H301:39;H312:1
112176,"1,1,2-trichloro-1,2,2-trimethyldisilane",236-870-5,13528-88-6,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,23,H314:23;H226:22;H312:1;H318:1
112179,"Palm oil, epoxidized",805-711-7,1006899-79-1,Not Classified,REACH registration C&L,1,Not classified:1
112180,"3-aminonaphthalene-1,5-disulphonic acid, sodium salt",257-651-0,52085-24-2,Not Classified,Notified C&L,2,Not classified:1;H319:1
112183,Sodium aluminium silicate(1:1:1),234-430-7,12003-51-9,Skin Irrit. 2,Notified C&L,15,H315:15
112184,"‘amyl nitrite’, mixed isomers",203-770-8,110-46-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H225:0
112186,S-furfuryl ethanethioate,237-173-9,13678-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1499,H319:1337;H335:1334;H315:1337;Not classified:136;H302:25;H301:1
112192,Lignin,232-682-2,9005-53-2,Not Classified,Notified C&L,131,Not classified:131
112193,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-ethenyl-8-oxo-, (6R,7R)-",616-683-9,79349-82-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
112197,"Hyssop, ext.",283-266-2,84603-66-7,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1639,H304:1638;H226:1638;H410:1341;H317:1639;H400:1341;H411:113;H302:10
112198,"Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C11-15-alkyl ethers, phosphates",614-542-6,68511-36-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112206,Toloxatone,249-522-2,29218-27-7,Acute Tox. 4,Notified C&L,38,H302:38
112210,"Trisiloxane, 1,1,1,3,5,5,5-heptamethyl-3-tetradecyl-",476-490-9,,Not Classified,REACH registration C&L,1,Not classified:1
112211,"1,1'-(1,2-diethyl-1,2-dimethylethylene)bisbenzene",233-474-4,10192-93-5,Skin Irrit. 2,Notified C&L,55,H315:55
112212,2-Amino-4-hydroxybenzothiazole,616-128-0,7471-03-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H312:1;H335:1;H332:1;H302:1;H319:2
112215,Anilinetrifluoroboron,211-539-8,660-53-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1,Notified C&L,22,H301:22;H318:22;H331:22;H311:22;H317:22;H351:22;H372:22;H341:22;H400:22
112218,"octapotassium (2R,3R,4S,5R,6R)-2-{[(2S,3S,4R,5R)-3,4-disulfato-2,5-bis(sulfatomethyl)oxolane-2-yl]oxy}-3,4,5-trisulfato-6-(sulfatomethyl)oxane",615-946-5,73264-44-5,,,0,No data
112219,3-chlorobiphenyl,218-126-1,2051-61-8,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H373:41;H410:41;H400:41
112223,"1-Naphthalenol, polymer with formaldehyde",607-708-4,25359-91-5,,Notified C&L,12,H410:9;H400:9;Not classified:2;H319:1;H315:1
112224,"Cyclohexanemethanol, 4-[(ethenyloxy)methyl]-",601-318-8,114651-37-5,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84,H412:83;H317:83;H318:84
112225,"2-amino-6,7-dimethyl-5,6,7,8-tetrahydropteridin-4-ol hydrochloride",213-413-8,945-43-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
112226,"Polyphosphoric acids, reaction products with 2-oxepanone and polyethylene glycol mono-Me ether",605-298-1,162627-21-6,Eye Dam. 1,Notified C&L,61,H318:61
112227,"Fatty acids, tallow, Guerbet reaction products, sodium salts",615-920-3,73138-60-0,Not Classified,Notified C&L,31,Not classified:31
112229,"trans-cyclohexane-1,2-dicarboxylic anhydride",238-009-9,14166-21-3,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0
112235,α-(4-methoxyphenyl)morpholine-4-acetamide,281-224-8,83898-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
112237,"Disodium hydrogen bis[4-[(5-acetyl-2,4-dihydroxyphenyl)azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(3-)]ferrate(3-)",304-576-7,94276-89-8,Not Classified,Notified C&L,3,Not classified:3
112238,"3-Furancarboxylic acid, 2-methyl-",614-978-7,6947-94-0,Skin Corr. 1B,Notified C&L,42,H314:38;H319:4;H335:4;H315:4
112242,"1,1-dichloro-3,3-dimethylbutane",228-101-7,6130-96-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H335:38;H315:38
112245,Isopropyl phenylacetate,225-468-5,4861-85-2,Not Classified,Notified C&L,1,Not classified:1
112248,1-(6-methylpyridin-2-yl)ethan-1-one,806-088-4,6940-57-4,Acute Tox. 4,Notified C&L,43,H302:40;H319:4;H335:3;H315:4
112250,"2,6-dimethylheptan-4-ol",203-619-6,108-82-7,Not Classified,Notified C&L,1821,Not classified:1535;H412:274;H336:266;H319:267;H335:183;H315:1;H332:1;H411:1
112252,Acetazolamide,200-440-5,59-66-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,122,H319:107;H315:107;H361:13;H360:4;H335:2;H302:1;H362:3;Not classified:1
112255,"2,5-Furandione, polymer with 1-butene and ethene",613-292-5,63625-36-5,,Notified C&L,33,Not classified:33
112256,"1,2,3-Propanetricarboxylic acid, 2-(1-oxobutoxy)-, 1,2,3-trihexyl ester",413-890-4,,Not Classified,Notified C&L,38,Not classified:36;H411:2;H400:2
112257,"2,6-Pipecolinoxylidide hydrochloride",613-841-9,65797-42-4,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,41,H412:2;H302:3;H301:38
112260,Bis(2-chloroethyl)amine hydrochloride,212-479-5,821-48-7,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Muta. 1B;Carc. 1B,REACH registration C&L,64,H340:13;H331:18;H314:22;H350:12;H302:20;H290:10;H319:41;H335:41;H315:42;H317:6;H341:9;H312:1;H301:3;H311:3;H330:1;H318:1;H362:1;H360:1;H372:1;H351:1
112265,Melamine,203-615-4,108-78-1,Repr. 2,REACH registration C&L,825,H361:136;Not classified:657;H373:11;H351:6;H314:4;H410:4;H400:4;H302:4;H319:7;H335:4;H315:4;H332:3;H317:3;H312:3
112268,"2,2,5,5-tetramethylthiazolidine-4-carboxylic acid hydrochloride",251-369-1,33078-43-2,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Carc. 2,Notified C&L,38,H351:38;H302:38;H317:38;H334:38
112269,Bis(D-glycero-D-ido-heptonato)manganese,270-645-2,68475-47-8,Not Classified,Notified C&L,2,Not classified:2
112270,"4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bisphthalic acid",221-154-7,3016-76-0,Not Classified,Notified C&L,14,Not classified:14
112272,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyl acid, 7-methoxy-7-((2-tienilacetil) amino), benzathine salt",616-357-6,765910-83-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
112274,"3,4,5-trichloropyridazine",238-006-2,14161-11-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H317:39;H301:41;H319:42;H315:42;H335:3;H302:1
112275,Heptan-3-ol,209-661-1,589-82-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1670,H302:1670;H226:1669;H319:83;H315:83
112276,6-chloro-9-β-D-ribofuranosyl-9H-purin-2-amine,217-905-3,2004-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112277,"N-benzyl-1,1,1-trifluoromethanesulphonamide",253-050-2,36457-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
112278,"1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose",230-220-4,6974-32-9,Not Classified,Notified C&L,3,Not classified:3
112279,"tetraconazole (ISO);(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether",407-760-6,112281-77-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H302:0;H411:0
112282,N'-(N-methyl-4-piperidyl)acetohydrazide,220-537-6,2799-92-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H319:38;H335:38;H315:38
112283,2-ethyl-6-isopropylaniline,258-554-6,53443-93-9,Acute Tox. 4,Notified C&L,38,H302:38
112285,Sucrose heptalaurate,266-496-8,66844-30-2,Not Classified,Notified C&L,1,Not classified:1
112286,Niobium diselenide,234-811-8,12034-77-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H301:42;H331:42;H410:42;H373:42;H400:42
112297,"Almond, bitter, ext.",291-060-9,90320-35-7,Acute Tox. 4,Notified C&L,1419,H302:1409;Not classified:10;H373:2;H335:2;H332:2;H319:2;H312:1;H304:1;H411:1;H315:1
112298,"Poly(oxy-1,2-ethanediyl), .alpha.-[2-[(1-oxooctadecyl)amino]ethyl]-.omega.-hydroxy-",620-277-7,31886-11-0,Eye Dam. 1,Notified C&L,22,H318:22;H315:4
112301,"Aromatic hydrocarbons, C",295-281-1,91995-20-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
112302,4-iodobiphenyl,216-469-1,1591-31-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H302:39;H410:44;H318:39;H400:44
112304,3-fluorotoluene,206-524-8,352-70-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,79,H319:41;H315:41;H335:44;H225:46;Not classified:33
112305,3-hydroxy-2'-methyl-2-naphthanilide,205-205-0,135-61-5,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,313,H317:238;H411:238;H410:39;H400:39;Not classified:34;H319:2;H335:1;H315:1
112307,4-Hydroxycyclohexanone,620-210-1,13482-22-9,Not Classified,REACH registration C&L,39,Not classified:34;H319:4;H335:4;H315:4;H226:1
112318,creatine alpha-ketoglutarate (2:1) dihydrate,921-258-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112319,"1,4,5,8-tetrakis(4-butylphenylamino)anthracene-9,10-dione",445-710-5,,Not Classified,REACH registration C&L,139,Not classified:139
112320,3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid ethyl ester,610-491-9,500011-92-7,Not Classified,REACH registration C&L,2,Not classified:2
112323,alpha-Tropenolhydrochlorid,613-852-9,65907-08-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H301:1;H331:1;H311:1
112324,Ethylidenebis(oxy)dihexane,226-458-3,5405-58-3,Not Classified,Notified C&L,140,Not classified:136;H319:4;H335:4;H315:4
112327,(Diethoxyphosphoryl)methyl 4-methylphenylsulfonate,608-653-9,31618-90-3,Flam. Liq. 3;Aquatic Chronic 3,Notified C&L,5,H412:1;H226:1;H332:2;H302:2;H312:1;H319:2;H335:2;H315:2;H411:1
112331,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate",265-477-1,65122-06-7,Eye Dam. 1,Notified C&L,94,H318:85;Not classified:3;H412:3;H319:6;H315:3;H411:3;H302:1
112336,Tetrahexylammonium bromide,224-363-1,4328-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:42;H315:44;H312:1;H332:1;H302:1
112337,Disodium hydroxyimidodisulphate,250-505-7,31186-36-4,Acute Tox. 4,REACH registration C&L,2,H302:2
112344,nickel bis(tetrafluoroborate),238-753-4,14708-14-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H360:0;H317:0;H410:0;H350:0;H372:0;H341:0;H400:0
112350,Nonane-1-thiol,215-936-7,1455-21-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:38;H315:42;Not classified:1
112355,"[(3-methoxypropyl)imino]di-2,1-ethanediyl bismethacrylate",300-709-8,93962-71-1,Skin Sens. 1,Notified C&L,1,H317:1
112356,Diindium tritelluride,215-194-4,1312-45-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H335:38;H332:38;H302:38;H319:38
112358,Trifluoroiodoethylene,206-629-9,359-37-5,,Notified C&L,4,H319:4;H335:4;H315:4
112359,4-chloro-2-iodoaniline,263-839-3,63069-48-7,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H335:45;H301:41;H318:40;H315:46;H312:4;H332:4;H302:4;H319:6;H371:1;H373:1;H411:1;H331:1;H311:1;H410:1
112364,Diethyl (4-Cyanobenzyl)phosphonate,605-002-0,1552-41-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H301:2;H319:2;H315:2;H331:1;H311:1;H335:1
112367,Vinyl acrylate,218-538-1,2177-18-6,Flam. Liq. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3,Notified C&L,39,H300:38;H318:38;H315:39;H331:39;H225:38;H335:1;H319:1;H411:1
112371,Triethyl O-acetylcitrate,201-066-5,77-89-4,Not Classified,REACH registration C&L,1600,Not classified:205;H317:1334;H304:59;H340:59;H350:59;H319:2
112372,Diisopropyl malonate,236-156-3,13195-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:39;H315:41
112376,Non-1-ene,204-681-7,124-11-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H304:67;H315:67;H226:67;H335:66;H319:67;H411:4;Not classified:3
112377,"[3,5-bis(trifluoromethyl)phenyl]acetonitrile",285-294-0,85068-32-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:40;H312:43;H335:39;H332:43;H302:43;H319:40;H330:1;H301:2;H311:2;H331:1
112387,"Dialuminium tris[2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate]",240-005-7,15876-39-8,Eye Irrit. 2,REACH registration C&L,12,H319:6;Not classified:6
112396,Cobalt zinc silicate blue phenacite,270-208-6,68412-74-8,Skin Sens. 1,REACH registration C&L,33,H317:2;H332:21;H301:21;Not classified:10
112400,Methoxytrimethylsilane,217-369-0,1825-61-2,Not Classified,Notified C&L,122,Not classified:55;H319:44;H225:67;H315:6;H335:5
112405,"Phosphoric acid, monoammonium monosodium salt, tetrahydrate",616-513-3,7783-13-3,,Notified C&L,4,H319:4;H335:4;H315:4
112409,"Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;Petroleum gas;[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]",271-001-3,68513-16-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
112413,1-benzyl-2-phenyl-1H-imidazole,253-646-2,37734-89-7,Not Classified,Notified C&L,26,Not classified:26
112416,N-[3-acetyl-4-(oxiranylmethoxy)phenyl]butyramide,248-893-8,28197-66-2,Not Classified,REACH registration C&L,7,Not classified:4;H312:2;H319:2;H302:1
112417,5-amino-1H-imidazole-4-carboxamide monohydrochloride,200-778-3,72-40-2,Not Classified,Notified C&L,4,Not classified:3;H319:1;H335:1;H315:1
112418,"Prunus virginiana, ext.",290-214-2,90105-95-6,Not Classified,Notified C&L,1,Not classified:1
112423,"Alkenes, C16 .alpha.-, isomerized",824-283-2,148617-57-6,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,1,H304:1;H413:1
112424,"1,3-di-o-tolylguanidine",202-577-6,97-39-2,Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,2152,H412:52;H301:2106;H319:2049;H302:41;Not classified:5;H315:4;H335:4;H317:5;H411:3;H361:2;H331:1;H314:1;H400:1;H350:1;H370:1;H373:1
112428,2-chloroanisole,212-167-9,766-51-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,5,H332:4;H302:4;H312:4;Not classified:1;H227:1;H315:1;H335:1;H319:1
112431,"allyl glycidyl ether;allyl 2,3-epoxypropyl ether;prop-2-en-1-yl 2,3-epoxypropyl ether",203-442-4,106-92-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H412:0;H318:0;H315:0;H226:0;H335:0;H332:0;H317:0;H351:0;H302:0;H341:0;H361:0
112433,2-iodobiphenyl,218-303-3,2113-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
112434,2-sec-butylcyclohexan-1-one,238-830-2,14765-30-1,Skin Irrit. 2,REACH registration C&L,1589,H315:35;Not classified:1554;H412:13
112447,"1,3-Dihydroxyacetone Dimer",612-947-2,62147-49-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64,H319:53;H335:52;H315:53;Not classified:11
112451,"prosulfocarb(ISO);S-benzyl N,N-dipropylthiocarbamate",401-730-6,52888-80-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H317:0;H411:0
112456,Hydrogen peroxide--urea,204-701-4,124-43-6,Ox. Sol. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,53,H272:50;H318:6;H315:5;H314:48;H302:3;H335:3
112457,Phalloidin,241-484-5,17466-45-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,40,H300:40;H330:40;H310:40
112458,"1,2-dichloro-3,3,4,4,5,5,6,6-octafluorocyclohexene",206-408-7,336-19-6,,Notified C&L,4,H330:4
112465,Diethyldimethylcyclohex-2-en-1-one,272-462-3,68845-36-3,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1580,H412:1324;H315:1324;Not classified:256
112469,2-{ethyl[4-(2-phenyldiazen-1-yl)phenyl]amino}ethan-1-ol,608-442-1,3009-45-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H302:1;H413:1
112470,1-[(2-chloroethyl)thio]-4-nitrobenzene,226-892-3,5535-73-9,Acute Tox. 3,Notified C&L,38,H301:38
112473,Dicobalt diphosphate,238-689-7,14640-56-3,Skin Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5,H360:5;H317:5;H410:5;H350:5;H341:5;H400:5
112481,3-amino-1H-pyrazole-4-carboxylic acid,255-493-7,41680-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44;H302:1
112482,"Fatty acids, C14-18, C14-18-alkyl esters",287-634-3,85566-24-1,Not Classified,Notified C&L,40,Not classified:40
112485,"cis-tetrahydropentalene-2,5(1H,3H)-dione",257-357-2,51716-63-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
112488,"7-chloro-5-cyclohexyl-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one",217-237-2,1784-78-7,,Notified C&L,1,H302:1;H361:1
112492,Potassium hydrogen 2-(phosphonatooxy)acrylate,224-247-0,4265-07-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112494,"Fatty acids, C18-unsatd., dimers, compds. with 2-(dimethylamino)ethanol",603-781-1,133934-18-6,Not Classified,Notified C&L,71,Not classified:71
112497,"1H-Imidazole-1-ethanamine, 4,5-dihydro-, 2-nortall-oil alkyl derivs., acetates",268-774-4,68140-11-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,14,H412:4;H318:8;H315:10;Not classified:4;H302:3;H319:2;H410:1;H317:1;H400:1
112499,2-ethoxycyclohexan-1-ol,221-032-3,2979-26-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112500,"Gadolinium yttrium oxide, europium-doped",271-830-0,68609-45-0,,Notified C&L,1,Not classified:1
112501,"Aromatic hydrocarbons, C",297-401-8,93571-75-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
112502,"4-(aminomethyl)octane-1,8-diamine",216-392-3,1572-55-0,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H330:1;H318:1;H311:1;H314:1;H302:1
112506,3-(isodecyloxy)propiononitrile,264-840-1,64354-92-3,Aquatic Chronic 2,REACH registration C&L,42,H411:42;H350:4
112509,"2,2-dimethylpropane-1,3-diyl dinonanoate",239-938-2,15834-05-6,Not Classified,REACH registration C&L,9,Not classified:8;H304:1
112513,"Sulfuric acid, copper salt, basic",215-708-7,1344-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H315:3;H410:3;H302:3;H319:3;H400:3;Not classified:1
112519,"Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica",272-697-1,68909-20-6,Not Classified,Notified C&L,3387,Not classified:3309;H319:73;H315:73;H332:5;H373:3
112520,3-methyl-2-butenal,203-527-6,107-86-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3,Notified C&L,1675,H318:1490;H226:1675;H331:1674;H314:1670;H317:1674;H302:1675;H315:6;H335:5;H332:1;H312:1;H319:1;H313:1
112521,"2,3-Diphenyl-1,4-diazaspiro[4.5]deca-1,3-diene",611-073-9,5396-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,127,H319:127;H335:127;H315:127
112522,"Amides, tallow, hydrogenated, N-[2-[(2-hydroxyethyl)amino]ethyl]",286-235-1,85203-43-6,Not Classified,Notified C&L,1,Not classified:1
112526,6-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine,230-757-4,7306-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112529,Cycloheptatrienylium tetrafluoroborate(1-),248-214-5,27081-10-3,Skin Corr. 1B,Notified C&L,43,H314:43;H302:1;H318:1
112530,(2H10)benzophenone,245-107-5,22583-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
112534,Methyl undec-9-enoate,227-279-3,5760-50-9,Not Classified,Notified C&L,92,Not classified:88;H319:4;H315:4
112540,Adipic anhydride,218-001-1,2035-75-8,Eye Irrit. 2,Notified C&L,3,H319:3;H335:2;H315:2;H302:1
112545,Disodium (Z)-1-(octadec-9-enyl) 2-sulphonatosuccinate,303-773-5,94213-67-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,11,H302:2;H319:2;H400:2;H315:6;Not classified:3
112548,"Ionone, methyl-",215-635-0,1335-46-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1928,H319:1662;H411:1927;H315:1645;H317:122;H412:1;Not classified:1
112549,"1,1-digeranyloxy-2-phenylethane",230-469-9,7149-23-7,Not Classified,Notified C&L,88,Not classified:88
112556,N-ethyl-2-pyrrolidone;1-ethylpyrrolidin-2-one,220-250-6,2687-91-4,Repr. 1B,Harmonised C&L,0,H360:0
112557,Dipotassium 5-carboxylato-4-hexylcyclohex-2-ene-1-octanoate,266-336-7,66375-37-9,Not Classified,Notified C&L,441,Not classified:441
112560,"Grindelia robusta, ext.",283-635-8,84696-17-3,Not Classified,Notified C&L,1,Not classified:1
112562,"Fatty acids, C18-unsatd., dimers, polymers with 2-ethylhexanol and neopentyl glycol",614-590-8,68552-19-2,Not Classified,REACH registration C&L,3,Not classified:3
112568,2-(4-fluorophenyl)oxirane,606-046-3,18511-62-1,Flam. Liq. 2,Notified C&L,44,H225:40;H332:6;H312:6;H319:6;H351:6
112569,3-ethylcyclopentene,211-770-4,694-35-9,Acute Tox. 4,Notified C&L,38,H302:38
112571,"N,N-diethylpiperidine-3-carboxamide",222-136-1,3367-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
112572,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, brominated chlorinated",270-958-4,68512-13-0,Not Classified,REACH registration C&L,189,Not classified:189
112574,"Dimethyl 3,3'-trithiobispropionate",243-980-7,20707-94-2,,Notified C&L,33,Not classified:33
112576,Tetradecanedioic acid,212-476-9,821-38-5,Eye Dam. 1,REACH registration C&L,78,H318:36;H319:41;H335:39;H315:41;Not classified:1
112577,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, 4-[(5-chloro-2-hydroxyphenyl)azo]-4,5-dihydro-3-methyl-1-phenyl-3H-pyrazol-3-one 4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-1-phenyl-3H-pyrazol-3-one 3-[[1-[[(2-ethylhexyl)amino]carbonyl]-2-oxopropyl]azo]-2-hydroxy-5-nitrobenzoate cobaltate complexes",276-160-2,71888-93-2,Not Classified,REACH registration C&L,2052,Not classified:2052
112583,methyl 2-oxoindoline-6-carboxylate,604-263-8,14192-26-8,Not Classified,REACH registration C&L,44,Not classified:4;H302:40;H317:38;H319:2;H335:2;H315:2
112587,Ceraphyl 55,458-930-1,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H400:1
112588,Non-5-en-2-one,248-181-7,27039-84-5,Not Classified,Notified C&L,88,Not classified:88
112589,Isopentyl phenylacetate,203-012-6,102-19-2,Not Classified,REACH registration C&L,1644,Not classified:1600;H315:42;H411:2;H319:1
112591,3-hydroxyflavone,209-416-9,577-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
112594,diarsenic trioxide,215-481-4,1327-53-3,Acute Tox. 2;Skin Corr. 1B;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H314:0;H410:0;H350:0;H400:0
112597,4-(3-Fluorbenzyloxy)benzaldehyd,613-982-6,66742-57-2,Aquatic Chronic 1,REACH registration C&L,3,H410:3;H400:3
112598,"3,7-bis(diethylamino)phenoxazin-5-ium chloride, compound with zinc chloride",259-070-8,54290-64-1,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H410:2;H400:2;H301:2;H318:2;Not classified:1;H302:1;H319:1
112599,"Trihydrogen [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-), compound with N,N'-di(o-tolyl)guanidine (1:3)",277-086-3,72928-60-0,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,3,H302:3;H318:1
112600,"Hexane-1,6-diol",211-074-0,629-11-8,Not Classified,REACH registration C&L,4568,Not classified:4523;H319:45;H335:7;H315:7
112601,"5'-Xanthylic acid, disodium salt",247-324-0,25899-70-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
112602,"8-Quinolinol, 7-(4-ethyl-1-methyl-1-octen-1-yl)-",613-686-7,64744-01-0,,Notified C&L,1,H319:1;H335:1;H315:1
112603,Hexadecamethylheptasiloxane,208-763-3,541-01-5,Not Classified,Notified C&L,5,Not classified:5
112608,ethyl 8-chlorooctanoate,600-658-4,105484-55-7,Aquatic Chronic 3,Notified C&L,1,H412:1
112609,"2,3-epoxypropyl methacrylate;glycidyl methacrylate",203-441-9,106-91-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Skin Sens. 1;STOT SE 3;Muta. 2;Carc. 1B;STOT RE 1;Repr. 1B,Harmonised C&L,0,H318:0;H360:0;H311:0;H335:0;H314:0;H317:0;H350:0;H302:0;H372:0;H341:0
112610,[(dimethylamino)methylene]malononitrile,240-873-7,16849-88-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
112621,Oxydiethylene bis(2-ethylhexanoate),276-553-9,72269-52-4,Not Classified,Notified C&L,1,Not classified:1
112624,Methoxychlor,200-779-9,72-43-5,Acute Tox. 4;STOT SE 2;Aquatic Acute 1,Notified C&L,114,H302:110;H371:94;H400:111;H373:17;H312:17;H332:17;H410:18;H350:16;H361:17;Not classified:3;H351:1
112625,"Ethanamine, N-ethyl-, reaction products with polyethylene-polypropylene glycol ether with trimethylolpropane (3:1) acrylate (>1 <6.5 mol EO and >1 < 6.5 mol PO)",605-659-3,173046-61-2,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,85,H317:85;H319:85;H411:85
112627,Triphenyl(3-phenylpropyl)phosphonium bromide,231-289-3,7484-37-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
112628,"2',4'-dimethylacetoacetanilide",202-576-0,97-36-9,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,715,H412:127;H302:715;H319:38;H312:11;H400:7
112631,N-HEXYLLITHIUM,680-293-5,21369-64-2,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,137,H314:137;H318:83;H250:137;H260:137;Not classified:1
112632,"Dodecylbenzenesulphonic acid, compound with isopropylamine (1:1)",247-556-2,26264-05-1,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,895,H317:2;H319:735;H315:871;H302:236;H318:149;H412:84;H335:100;H411:17;Not classified:11;H314:1
112637,"Colchicum autumnale, ext.",283-623-2,84696-03-7,Acute Tox. 2;Acute Tox. 2,Notified C&L,10,H300:9;H330:9;H340:1;H226:1
112638,"Gases (petroleum), light straight-run naphtha stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]",271-002-9,68513-17-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
112639,2-ethyl-5-phenylisoxazolium-3'-sulphonate,223-988-7,4156-16-5,Acute Tox. 4,Notified C&L,38,H302:38
112647,"2-[2-oxopropyl]tetrahydro-2H-pyran-3,4,5-triol",610-159-3,439685-73-1,Not Classified,REACH registration C&L,4,Not classified:4
112648,"Amides, tall-oil fatty, N,N-bis(hydroxyethyl)",268-949-5,68155-20-4,Eye Irrit. 2,Notified C&L,545,H319:459;H318:53;H315:63;Not classified:33;H411:11;H412:1
112649,"2-methylpenta-1,3-diene",214-264-1,1118-58-7,Flam. Liq. 2,Notified C&L,3,H225:3
112660,Mequitazine,249-521-7,29216-28-2,Acute Tox. 3,Notified C&L,5,H301:3;H315:1;H318:1;H312:1;H332:1;H317:1;H302:1;H411:1
112661,"Amides, rape-oil, N-[3-(dimethylamino)propyl], hydrochlorides",287-005-3,85408-44-2,Not Classified,Notified C&L,1,Not classified:1
112663,5-chloropentan-1-ol,226-067-8,5259-98-3,,Notified C&L,7,H302:7;H319:7;H335:6;H315:7;H312:1;H332:1
112664,"4,5-dihydroxynaphthalene-2,7-disulphonic acid",205-712-7,148-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,72,H319:39;H335:39;H315:39;Not classified:32;H314:1
112666,N-(2-fluorophenyl)acetamide,206-916-9,399-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
112669,2-(1-hydroxy-1-phenylethyl)pyridinium chloride,700-318-6,879671-67-7,Not Classified,REACH registration C&L,3,Not classified:2;H302:1
112670,"Propylidynetrimethanol, ethoxylated",500-110-3,50586-59-9,Not Classified,REACH registration C&L,318,Not classified:318
112674,"Dipteryx odorata, ext.",289-793-4,90028-06-1,Acute Tox. 4;Skin Sens. 1;STOT RE 2,Notified C&L,1439,H302:1434;H317:1368;H373:1365;H312:143;H226:32;H225:1
112680,"Methyl (E)-3,7-dimethylocta-2,6-dienoate",214-712-6,1189-09-9,Not Classified,Notified C&L,120,Not classified:120
112681,Methyl myristate,204-680-1,124-10-7,Not Classified,REACH registration C&L,1648,Not classified:1646;H315:2;H319:1
112682,2-chlorobiphenyl,218-125-6,2051-60-7,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:41;H410:41;H400:41;H319:1;H335:1;H315:1
112683,"Fatty acids, tallow, hydrogenated, sodium salts",269-672-2,68309-30-8,Not Classified,Notified C&L,1,Not classified:1
112684,"chrysoidine sulfate;bis[4-(phenylazo)benzene-1,3-diamine] sulfate",282-432-1,84196-22-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H410:0;H302:0;H341:0;H400:0
112697,"Fatty acids, C9-13-neo-, potassium salts",295-362-1,92044-83-2,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,8,H318:2;H315:2;Not classified:6
112701,"(4-(5-Oxo-4,5-dihydro-1,2,4-oxadiazole-3-yl)phenylamino)acetic acid",460-450-2,872728-82-0,Aquatic Chronic 3,REACH registration C&L,4,H412:4
112703,"3-[(9,10-dihydro-9,10-dioxoanthryl)amino]anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione, monochloro derivative",288-273-4,85702-82-5,Not Classified,Notified C&L,5,Not classified:5
112704,"11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-octanoate",229-717-9,6678-14-4,Repr. 1A;STOT RE 2,Notified C&L,24,H373:24;H360:24
112712,"2,2,2-tribromoethyl morpholinochlorophosphonate",260-819-6,57575-15-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,38,H318:38;H312:38;H332:38;H314:38;H302:38
112718,3-iodothiophene,234-009-8,10486-61-0,,Notified C&L,7,H319:7;H315:7;H302:1;H335:2
112725,Octane-1-thiol,203-918-1,111-88-6,Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,176,H317:100;H410:62;Not classified:74;H319:40;H335:39;H315:40;H400:38;H302:5;H371:1
112727,Diboron trizinc hexaoxide,233-471-8,10192-46-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,7,H302:7;H317:7
112728,"(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3'R)-2-oxo-[1,3'-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trifluoroacetate (salt)",600-396-0,1031275-04-3,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H302:1;H317:1;H334:1
112735,"Propane, 1-chloro-2-(difluoromethoxy)-1,1,2,3,3,3-hexafluoro-",612-002-4,60632-00-0,Not Classified,Notified C&L,1,Not classified:1
112736,Dimethylhydroquinone,215-317-1,1321-28-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H301:1;H319:1;H335:1;H315:1
112737,Dimethyl methoxymethylenemalonate,244-957-4,22398-14-7,,Notified C&L,6,H334:4;H315:6;H335:4;H317:4;H302:6;H319:6
112738,"2,6-diamino-5-bromo-1H-pyrimidin-4-one",228-637-1,6312-72-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H302:39;H317:38;H319:38;H332:1;H312:1
112740,"2,6-dimethylbenzene-1,4-diamine dihydrochloride",260-223-6,56496-89-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
112741,"Ergosta-5,22(E)-dien-3β-ol",207-486-5,474-67-9,,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
112744,Amiloride,220-024-7,2609-46-3,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,40,H412:40;H300:5;H319:5;H315:4;H302:35;H318:35;H362:1;H373:1
112746,"Aluminium, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-1H-pyrazole-3-carboxylic acid complex",235-428-9,12225-21-7,Not Classified,REACH registration C&L,481,Not classified:481
112755,"1,12-dodecanediyl bismethacrylate",276-900-4,72829-09-5,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H317:2;H410:2;H400:2;H319:43;H335:41;H315:43;Not classified:1
112756,"p,α,α,α-tetrafluoroanisole",206-523-2,352-67-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43;H225:43
112757,"1,2,3,4-tetrahydro-2-naphthoic acid",258-553-0,53440-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
112760,"Fatty acids, C14-18 and C16-22-unsatd., reaction products with diethylenetriamine",308-265-7,97926-47-1,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H314:3;H317:3;H410:3
112767,"Shea tree, ext.",293-515-7,91080-23-8,Not Classified,Notified C&L,241,Not classified:241
112768,"4-[(2-bromo-4,6-dinitrophenyl)azo]-N-(3-methoxypropyl)naphthalen-1-amine",274-733-1,70660-55-8,Aquatic Chronic 3,Notified C&L,9,H412:7;Not classified:2
112770,"Disodium (3-oxo-6-oxido-2,4,5,7-tetraiodo-3H-xanthen-9-yl)-3,4,5,6-tetrachlorobenzoate",211-182-8,632-68-8,Not Classified,Notified C&L,5,Not classified:5
112773,"Alcohols, C12-14, ethoxylated, phosphate",614-543-1,68511-37-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,108,H318:49;H315:73;H314:34;H400:29;H412:4
112774,N-[2-[(2-bromo-6-cyano-p-tolyl)azo]-5-(dipropylamino)phenyl]methanesulphonamide,280-324-9,83249-54-1,,Notified C&L,33,Not classified:33
112776,propyl chloroformate;chloroformic acid propylester;n-propyl chloroformate,203-687-7,109-61-5,Flam. Liq. 2;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0,H314:0;H331:0;H225:0
112778,Plant oils / Spear mint oil,616-927-4,8008-79-5,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,439,H304:392;H315:429;H317:391;H302:219;H411:391;H319:40;H335:39;Not classified:8;H412:1;H226:1
112781,Pipemidic acid,257-530-2,51940-44-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H317:39;H334:39;H302:1
112782,Nonan-5-ol,210-820-2,623-93-8,Eye Irrit. 2,Notified C&L,2,H319:2;H315:1
112785,1-bromo-4-iodobenzene,209-662-7,589-87-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,50,H413:40;H319:49;H335:48;H315:49;H332:1;H302:1;H312:1
112788,Vidarabine,226-893-9,5536-17-4,Repr. 2,Notified C&L,40,H361:40;H319:1;H335:1;H315:1;H332:1;H302:1;H312:1
112790,"Fatty acids, C16-18, stearyl esters",287-484-9,85536-04-5,Not Classified,REACH registration C&L,2,Not classified:2
112791,PRO-JET 830 NP,416-170-8,,Not Classified,Notified C&L,1,Not classified:1
112796,2-butylthiophene,215-935-1,1455-20-5,Flam. Liq. 3;Acute Tox. 4,Notified C&L,133,H302:127;H226:95
112798,"Benzene-1,2,4-tricarboxylic acid 1,2-anhydride, oligomeric reaction products with ethane-1,2-diol and glycerol",500-199-9,68183-39-1,Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,REACH registration C&L,3,H317:3;H318:3;H334:3;H335:3
112800,"2,7-Octadien-4-ol, 2-methyl-6-methylene-, (4S)-",609-154-9,35628-00-3,Not Classified,Notified C&L,121,Not classified:83;H400:38
112801,Niobium disilicide,234-812-3,12034-80-9,,Notified C&L,4,H319:4;H335:4
112802,"tert-Dodecanethiol, sulfurized",271-518-4,68583-56-2,Aquatic Chronic 4,Notified C&L,10,H413:10
112808,Diisodecyl adipate,248-299-9,27178-16-1,Not Classified,REACH registration C&L,211,Not classified:207;H319:3;H315:3;H360:1
112809,"2-O-β-glucopyranosyl-(3β,12β)-20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl-β-D-glucopyranoside",255-532-8,41753-43-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:40;H302:44;H312:40
112813,Isopropylnaphthalenesulphonic acid,250-462-4,31093-48-8,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,2,H314:2;H318:2;H290:2
112817,Nimesulide,257-431-4,51803-78-2,Acute Tox. 3,Notified C&L,56,H301:47;H302:7;Not classified:2;H315:2;H335:2;H332:3;H319:2;H361:2;H340:2;H360:2;H373:1
112818,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",276-471-3,72208-21-0,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,7,H302:4;H411:4;Not classified:3
112822,Isosorbide dinitrate,201-740-9,87-33-2,Unst. Expl.;Acute Tox. 4,REACH registration C&L,44,H302:44;H200:2;H201:2;H319:3;H332:2;H312:2;H228:1
112827,"2,2,2-trifluoroethyl methacrylate",206-525-3,352-87-4,Flam. Liq. 2;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,95,H412:7;H301:49;H331:7;H317:7;H225:90;H315:88;H335:87;H319:88;H226:5
112828,Laminaran,232-712-4,9008-22-4,Not Classified,Notified C&L,1,Not classified:1
112830,"ALPHA,ALPHA-DIPHENYL-2-PYRIDINEETHANOL",605-740-3,1748-99-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
112831,4-Bromo-2-methyl-6-nitroaniline,616-508-6,77811-44-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:39;H312:44;H335:38;H332:44;H319:39;H302:6
112832,Sodium propanethiolate,230-005-5,6898-84-6,Skin Corr. 1B,Notified C&L,41,H314:41;H318:2
112833,"8-[[5-anilinosulphonyl-2-methylphenyl]azo]-7-hydroxynaphthalene-1,3-disulphonic acid",287-121-4,85409-52-5,Not Classified,Notified C&L,1,Not classified:1
112834,4-Methoxycyclohexanon,619-588-0,13482-23-0,Eye Irrit. 2,Notified C&L,34,H319:34;H302:1;H335:1;H315:1
112835,"(8S,9S,10R,11R,13S,14S)-13-ethyl-11-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione",610-952-4,53067-82-6,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 4,Notified C&L,2,H362:2;H413:2;H360:2;H351:2;H302:2
112836,"[ethane-1,2-diylbis[[(phosphonomethyl)imino]ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid",253-051-8,36475-52-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,6,H314:6;H318:6
112837,"Formaldehyde, polymer with 2,2'-oxybis[ethanol] and 1,3,5-triazine-2,4,6-triamine, methylated",615-884-9,73018-48-1,Skin Sens. 1,Notified C&L,1,H317:1
112845,Bis(D-glycero-D-ido-heptonato)copper,270-644-7,68475-46-7,Not Classified,Notified C&L,2,Not classified:2
112847,"Tris(hydroxyacetato-O1,O2)aluminium",243-391-5,19878-87-6,Not Classified,Notified C&L,1,Not classified:1
112848,"2,5-bis(2,2,2-trifluoroethoxy)benzoic acid",609-132-9,35480-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:41;H335:40;H315:41;H302:2
112849,4-methoxychalcone,213-499-7,959-33-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
112850,2-phenylpentane,220-324-8,2719-52-0,Aquatic Chronic 4,Notified C&L,38,H413:38
112852,"(E,E)-2,6-dimethylocta-2,4,6-triene",221-153-1,3016-19-1,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,258,H304:258;H302:258;H319:258;H315:258
112856,"1,1,2,2-tetrafluoroethane",206-628-3,359-35-3,Skin Irrit. 2,Notified C&L,1,H315:1
112859,Diindium trioxide,215-193-9,1312-43-2,STOT RE 1;Aquatic Chronic 3,REACH registration C&L,274,H412:3;H372:6;Not classified:223;H319:41;H335:45;H315:45;H320:4
112862,Methyl α-cyclohexylmandelate,233-862-3,10399-13-0,Not Classified,REACH registration C&L,4,Not classified:3;H302:1
112866,"Morpholinomethylenebisphosphonic acid, sodium salt",303-539-2,94200-61-0,Not Classified,Notified C&L,3,Not classified:3
112867,chloro-1-ethylcyclohexyl carbonate,444-950-8,99464-83-2,Skin Sens. 1;Muta. 2,Harmonised C&L,0,H317:0;H341:0
112869,"Fatty acids, tall-oil, esters with propylene glycol",293-124-1,91051-70-6,Not Classified,Notified C&L,5,Not classified:3;H413:2
112871,Bromophenol red,220-538-1,2800-80-8,Not Classified,Notified C&L,2,Not classified:2
112872,Dicyclohexyl maleate,210-671-3,621-13-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H302:14;H319:14;H315:20;H317:6
112878,"[1,1'-biphenyl]-4,4'-dicarbonitrile",216-468-6,1591-30-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:43;H302:43;H312:39;H315:1;H319:1
112879,Octanenitrile,204-682-2,124-12-9,Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,141,H400:36;H315:36;Not classified:61;H332:39;H302:44;H312:39
112884,"bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane",412-060-9,136210-32-7,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
112887,"Lecithins, bisulfited",309-190-2,100085-48-1,Not Classified,Notified C&L,1,Not classified:1
112889,diethyl[(p-ethoxyanilino)methylene]malonate,431-430-0,103976-28-9,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
112891,"Hydrogen [4-[4-(diethylamino)-2',4'-disulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, aluminium salt",240-006-2,15876-40-1,Acute Tox. 4,REACH registration C&L,3,H302:3
112893,N2-acetyl-L-glutamine,219-647-7,2490-97-3,Not Classified,Notified C&L,1,Not classified:1
112899,3-thienylacetic acid,230-166-1,6964-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:38;H335:38;H315:38;H314:6;H318:1;H290:1
112902,"2',6'-difluoropropiophenone",285-293-5,85068-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112906,"Benzonitrile, 2-[2-[4-[bis[2-(acetyloxy)ethyl]amino]phenyl]diazenyl]-5-nitro-",602-318-0,12223-42-6,Skin Sens. 1,Notified C&L,9,H317:9
112907,"Benzene, ethylenated, residues",273-494-0,68987-42-8,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,271,H304:159;H317:24;H410:72;H315:199;H301:12;H334:8;H400:143;H331:12;H311:12;H335:36;H350:108;H225:12;H372:12;H411:60;H336:32;H341:8;H319:60;H361:72;H373:155;H340:100;H226:48;H302:48;H332:32;H314:4;H312:4;H351:8;Not classified:4
112908,Gold tert-dodecanethiolate,247-670-2,26403-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
112911,"1,2-Ethanediamine, N-(2-aminoethyl)-, polymer with oxirane",608-163-5,28063-82-3,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,550,H314:496;H317:496;H334:496;H335:496;H318:35;Not classified:19
112913,Dinonylnaphthalenedisulphonic acid,262-110-7,60223-95-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,328,H412:19;H318:234;H315:73;H410:73;H400:73;H319:16;Not classified:5
112914,3-(1-(Dimethylamino)ethyl)phenol hydrochloride,611-140-2,5441-61-2,Aquatic Chronic 4,Notified C&L,1,H413:1
112915,barium polysulphides,256-814-3,50864-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H400:0;H319:0;H335:0;H315:0
112916,Triammonium pentachlorozincate(3-),238-688-1,14639-98-6,Acute Tox. 4;Skin Corr. 1B;STOT SE 3;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,6,H335:5;H314:5;H410:5;H302:5;H400:5;Not classified:1
112917,cyhexatin (ISO);hydroxytricyclohexylstannane;tri(cyclohexyl)tin hydroxide,236-049-1,13121-70-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H332:0;H410:0;H302:0;H400:0
112918,Indole-2-carboxylic acid,216-030-4,1477-50-5,,Notified C&L,6,H315:6;H312:5;H335:6;H302:5;H319:6
112919,1-cyano-2-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]isothiourea,257-889-5,52378-40-2,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,3,H334:2;H312:2;H332:2;H317:2;H302:2;H361:1
112921,"3,7-dimethylocten-2-ol",255-492-1,41678-36-8,Not Classified,Notified C&L,264,Not classified:264
112924,"Gases (petroleum), full-range straight-run naphtha dehexanizer off;petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]",271-000-8,68513-15-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
112933,"2-Butanone, 3-(acetyloxy)-",610-442-1,4906-24-5,Not Classified,Notified C&L,157,Not classified:128;H315:29;H319:4
112935,Propyl benzoate,219-020-8,2315-68-6,Not Classified,Notified C&L,93,Not classified:93
112937,Hexaamminecobalt(III) nitrate,622-895-2,10534-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H335:38;H315:38;H351:4;H272:4;H317:4
112938,2-chlorocycloheptan-1-one,212-168-4,766-66-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
112939,sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;acifluorfen-sodium,263-560-7,62476-59-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H315:0;H410:0;H302:0;H400:0
112940,Mestranol,200-777-8,72-33-3,Skin Irrit. 2;Eye Irrit. 2;Carc. 2,Notified C&L,83,H351:83;H319:38;H315:38;H360:40;H362:24;H312:16;H332:16;H302:16;H341:3
112942,1-(p-nitrophenylazo)-2-naphthol,229-093-8,6410-10-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:44;H335:43;H315:44;Not classified:5
112944,1-[4-(trifluoromethyl)phenyl]piperazine,250-210-3,30459-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
112952,Hex-2-enedinitrile,235-914-0,13042-02-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
112957,1-(4-chlorophenyl)-3-hydroxyurea,250-037-3,30085-34-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
112958,"N,N-dimethylheptylamine",226-100-6,5277-11-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
112959,"5,5-Dimethyl-perhydro-pyrimidin-2-one alpha-(4-trifluoromethylstyryl)-alpha-(4-trifluoromethyl)cinnamylidenehydrazone",614-073-7,67485-29-4,Acute Tox. 4;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H410:194;H302:194;H372:194;H319:194;H400:194
112962,Dihydroergocornine,246-992-0,25447-65-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1,H332:1;H302:1;H312:1;H361:1
112966,calcium polysulphides,215-709-2,1344-81-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H400:0;H319:0;H335:0;H315:0
112967,"2-aminooctadecane-1,3-diol",236-933-7,13552-09-5,Eye Irrit. 2,REACH registration C&L,3,H319:3
112968,Cyclohexyl phenylacetate,255-751-9,42288-75-5,Not Classified,Notified C&L,89,Not classified:89
112969,Isopentylamine,203-526-0,107-85-7,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1446,H315:1286;H335:1352;H314:1445;H302:1381;H319:1286;H225:160;H332:66;H318:52;H312:26
112971,"3-phenyl-1,2,4-thiadiazol-5-ylamine",241-485-0,17467-15-1,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,11,H412:9;H301:9;H319:2;H335:2;H315:2;H312:1;H332:1;H302:1
112983,6-chloro-9-ribofuranosyl-9H-purine,217-904-8,2004-06-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:1;H312:1;H319:1;H335:1;H315:1
112987,"Fatty acids, C12-18, potassium salts",293-008-0,91032-02-9,,Notified C&L,63,H319:62;Not classified:1
112991,"4,4-dimethyloxazolidinium toluenesulphonate",266-335-1,66375-36-8,,Notified C&L,1,Not classified:1
112992,5-chloro-o-toluidinium chloride,228-403-9,6259-42-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
112995,Troxerutin,230-389-4,7085-55-4,Not Classified,Notified C&L,88,Not classified:62;H302:26
113000,"2-Naphthalenesulfonic acid, 6-[(2,4-diamino-5-sulfophenyl)azo]-4-hydroxy-3-[[4-[[4-[[1-hydroxy-7-[[4-hydroxy-2-[(2-methylphenyl)amino]phenyl]azo]-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-, tetrasodium salt",298-038-8,93777-10-7,Not Classified,Notified C&L,3,Not classified:3
113003,Disodium 4-nitrophenyl phosphate,224-246-5,4264-83-9,Acute Tox. 4,REACH registration C&L,5,H302:2;Not classified:2;H373:1;H318:1;H290:1;H315:1
113009,2-methoxycyclohexan-1-ol,221-031-8,2979-24-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
113011,"N,N-diethyl-N'-(6-methoxy-4-methyl-8-quinolyl)hexane-1,6-diamine dihydrochloride",226-224-0,5330-29-0,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H317:1;H301:1;H318:1
113017,3-bromobiphenyl,218-304-9,2113-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
113018,Ethyl 2-cyanopropionate,216-393-9,1572-99-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H301:3;H319:3;H315:3
113021,Hydantoic acid,207-328-5,462-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
113022,"2,2-bis[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate",239-937-7,15834-04-5,Not Classified,REACH registration C&L,25,Not classified:25
113024,"Chromium, 2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)benzoate 2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoate lithium sodium complexes",617-764-1,85828-89-3,Not Classified,Notified C&L,38,Not classified:38
113026,"Piperazine-1,4-diethylamine",229-428-8,6531-38-0,,Notified C&L,36,Not classified:34;H314:2
113027,Colforsin,266-410-9,66575-29-9,Acute Tox. 4,Notified C&L,45,H312:43;Not classified:1;H302:1
113028,"Addition reaction of 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, 2-hydroxyethyl methacrylate, 2-(2-butoxyethoxy)ethanol and 2-dimethylaminoethanol",928-540-0,,Not Classified,Notified C&L,71,Not classified:71
113030,"Oils, Fucus vesiculosus",614-799-4,68917-51-1,Not Classified,Notified C&L,79,Not classified:79
113031,2-Amino-5-chlorobenzothiazole,606-533-0,20358-00-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H335:1
113032,Zinc(II) acetate dihydrate,611-865-4,5970-45-6,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1,Notified C&L,245,H302:221;H400:116;H315:74;H319:102;H410:86;H318:25;H411:24;Not classified:20;H301:4
113039,"2,3-diphenylpropylamine",226-508-4,5415-80-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
113042,p-(2-acetamidoethyl)benzenesulphonyl chloride,252-574-9,35450-53-4,Not Classified,REACH registration C&L,2,Not classified:2
113045,Phenethyl phenylacetate,203-013-1,102-20-5,Aquatic Chronic 2,REACH registration C&L,1873,H411:1807;Not classified:19;H319:39;H315:39;H412:9
113046,"4-(1,1-dimethylethyl)cyclohexyl methacrylate",256-277-5,46729-07-1,Acute Tox. 5;Skin Sens. 1,REACH registration C&L,144,H303:1;H317:1;H319:142;H335:142;H315:142;H400:2;Not classified:1
113048,(hexahydro-2H-azepin-2-ylidene)bis(phosphonic) acid,260-083-6,56269-44-4,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,15,H412:14;H315:14;Not classified:1
113049,4-benzoyl-3-hydroxyphenyl methacrylate,218-000-6,2035-72-5,,Notified C&L,7,H319:7;H335:7;H315:7
113050,"Phenol, 2-methyl-, methylstyrenated styrenated",273-249-8,68954-72-3,Not Classified,Notified C&L,2,Not classified:2
113051,"6-amino-5-bromopyrimidine-2,4(1H,3H)-dione",228-638-7,6312-73-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H315:3;H312:3;H335:3;H332:3;H302:3;H319:3
113052,Ar-isopropylphenylacetaldehyde,215-634-5,1335-44-0,Skin Irrit. 2,Notified C&L,88,H315:88
113055,3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole,428-910-7,107786-36-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
113056,Dioctyl sebacate,219-411-3,2432-87-3,Not Classified,REACH registration C&L,5,Not classified:5
113059,Glycerol dihydrogen phosphate,248-215-0,27082-31-1,Not Classified,Notified C&L,48,Not classified:46;H314:2
113061,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with octahydro-4,7-methano-lH-indene-1(2),5(6)-di(methylamine)",500-649-4,161308-10-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H302:1;H317:1;H312:1;H314:1
113062,p-cyanophenyl trans-p-(4-pentylcyclohexyl)benzoate,277-085-8,72928-55-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
113063,"Amines, di-C14-18-alkylmethyl",266-923-8,67700-99-6,Skin Irrit. 2;Aquatic Acute 1,Notified C&L,57,H400:57;H315:56;H319:20;H410:1
113068,1-chloro-3-(4-chlorophenoxy) benzene,614-477-3,6842-62-2,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 1,REACH registration C&L,34,H302:34;H410:34;H315:34;H400:33
113069,"Benzenemethanimine, .alpha.-phenyl-",440-870-2,1013-88-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,89,H412:3;H319:89;H315:89;H335:3
113077,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate",605-995-0,183388-64-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
113078,Lithium ricinoleate,239-481-9,15467-06-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,27,H302:20;H314:2;H319:20;H318:2;H315:18;Not classified:7
113079,[No public or meaningful name is available],638-881-4,16493-96-2,Skin Sens. 1,Notified C&L,25,H317:25
113081,o-[(4-hydroxyphenyl)methyl]phenol,219-579-8,2467-03-0,Skin Sens. 1;Eye Dam. 1;STOT SE 3;Repr. 2,Notified C&L,46,H317:38;H318:38;H361:38;H335:38;H412:6;H319:1;H315:1;Not classified:1
113084,acetalization product between glucose and C14 alcohol,923-418-3,,Not Classified,Notified C&L,1,Not classified:1
113085,"Calcium, carbonate tall-oil fatty acids complexes",270-957-9,68512-12-9,Not Classified,Notified C&L,60,Not classified:36;H315:24
113094,"1-Propanamine, 3-(triethoxysilyl)-, hydrolysis products with silica",276-161-8,71888-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
113097,(3Z)-hex-3-en-1-yl cyclopropanecarboxylate,425-200-9,,Not Classified,Notified C&L,2,Not classified:2
113101,6-dimethylamino-4-hydroxynaphthalene-2-sulphonic acid,228-404-4,6259-50-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
113103,Cyclohexyl methacrylate,202-943-5,101-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,249,H319:220;H335:231;H315:220;H317:200;Not classified:3;H310:1
113106,"Morpholine, 4-coco alkyl derivs.",276-986-3,72906-09-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,23,H319:22;H315:22;H302:1;H314:1
113108,Ethyl hydrogen malonate,213-992-7,1071-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:47;H335:46;H315:47
113110,"oxycarboxin (ISO);2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide",226-066-2,5259-88-1,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
113112,4-isopropylcyclohexan-1-one,226-592-2,5432-85-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,90,H302:90;H226:90
113115,Urea nitrate,204-703-5,124-47-0,Flam. Sol. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1
113118,1-Butyl-3-methylimidazolium Methyl Sulfate,609-790-7,401788-98-5,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1;H290:1
113119,"4'-trans-ethyl-[1,1'-bicyclohexyl]-4-one",485-460-4,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1;H315:1
113120,2-diethoxymethyl-1-phenylhept-1-ene,262-413-4,60763-41-9,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,287,H317:1;H410:1;H319:1;H400:1;Not classified:286
113121,"2-bromo-12'-hydroxy-5'α-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate",244-881-1,22260-51-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H410:8;H400:5;H332:4;H302:5;H361:5;H362:2;H360:1
113123,Pentyl isothiocyanate,211-075-6,629-12-9,,Notified C&L,5,H332:4;H302:4;H312:4;H314:5
113127,Dodecamethylcyclohexasiloxane,208-762-8,540-97-6,Not Classified,REACH registration C&L,377,Not classified:299;H413:55;H319:21;H304:1;H226:1;H331:1
113132,2-bromo-4-nitroaniline,236-318-3,13296-94-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,42,H302:41;H317:38;H315:4;H335:3;H332:3;H319:4;H312:2
113134,Diphenyl sulphoxide,213-415-9,945-51-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
113135,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium thiocyanate",282-433-7,84196-23-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2,H302:2;H319:2
113137,1-(allyl)pyrrolidin-2-one,220-251-1,2687-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113142,1-bromoheptadecafluorooctane,207-028-4,423-55-2,Aquatic Chronic 4,REACH registration C&L,54,H413:5;H319:49;H335:48;H315:49
113148,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8), Hexamethylenediamine (124-09-4) and Cyclohexylamine (108-91-8)",923-615-4,,Flam. Sol. 1;Eye Dam. 1;Flam. Sol. 1;Eye Dam. 1,REACH registration C&L,2,H318:2;H228:2
113152,"tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate",405-950-3,131013-83-7,Acute Tox. 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H301:0
113154,"hexasodium 2,2'-ethene-1,2-diylbis[5-({4,6-bis[(2-sulfonatoethyl)amino]-1,3,5-triazin-2-yl}amino)benzenesulfonate]",416-010-7,,Skin Sens. 1,Notified C&L,1,H317:1
113156,"2-Octyldodecan-1-ol, ethoxylated",500-080-1,32128-65-7,Not Classified,Notified C&L,2,Not classified:1;H302:1;H318:1
113158,"3-amino-N,N-diethyl-4-methoxybenzenesulphonamide",202-575-5,97-35-8,Not Classified,REACH registration C&L,5,Not classified:4;H332:1;H302:1;H312:1;H371:1
113160,"1,2-Difluor-3-[4-(trans-4-propylcyclohexyl)-1-(cyclohexen-1-yl)]-benzene",922-613-0,,Not Classified,Notified C&L,1,Not classified:1
113162,"Hydroquinine 2,5-diphenyl-4,6-pyrimidinediyl diether",604-704-4,149820-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
113164,2-chloro-5-nitropyrimidine,233-703-8,10320-42-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:40;H315:41;H335:40;H317:40;H302:40;H319:1
113165,Hex-5-en-1-ol,212-477-4,821-41-0,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,218,H314:123;H226:75;H318:65;Not classified:55
113167,N-butyltin trichloride,214-263-6,1118-46-3,Skin Corr. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,116,H318:21;H335:57;H314:64;H410:107;H400:105;H315:46;H360:46;H302:47;H372:50;H341:46;H319:46;H332:40;Not classified:6;H312:6;H412:1;H290:1;H411:1
113169,Chlorocyclooctane,216-309-0,1556-08-7,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H227:1;H319:1;H335:1;H315:1
113171,Diantimony tritelluride,215-480-9,1327-50-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,213,H332:213;H302:213;H411:213
113172,N-{3-[dimethoxy(methyl)silyl]propyl}butan-1-amine,601-747-0,120939-52-8,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,4,H318:4;H315:4
113173,Trimethyloleylammonium chloride,233-938-6,10450-69-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,67,H302:47;H410:46;H314:67;H400:47
113174,trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-),402-870-0,93952-24-0,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
113178,2-(2-ethoxyethoxy)ethanol,203-919-7,111-90-0,Not Classified,REACH registration C&L,4804,Not classified:4284;H319:463;H302:57;H331:55;H300:9;H226:2;H315:3;H335:1;H373:1;H361:2;H360:1;H370:1;H372:1;H336:1
113179,3-methoxyphenylglycolic acid,244-243-2,21150-12-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113181,chloroxylenol,215-316-6,1321-23-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0;H319:0;H315:0
113186,"3-(4-hydroxy-3,5-diiodophenyl)-2-phenylpropionic acid",209-417-4,577-91-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H335:38;H410:38;H302:38;H319:38;H400:38
113188,"2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid",605-820-8,178306-51-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H301:1;H315:1;H312:1;H335:1;H319:1
113191,C.I. Acid Green 81,602-532-4,12234-89-8,Not Classified,Notified C&L,38,Not classified:38
113198,Aryl substituted aryl substituted aryl triazin,607-654-1,252285-60-2,Not Classified,REACH registration C&L,1,Not classified:1
113200,flurenol (ISO);9-hydroxy-9H-fluorene-9-carboxylic acid,207-397-1,467-69-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
113201,"Pentaerythritol, ethoxylated, esters with acrylic acid",500-111-9,51728-26-8,Skin Irrit. 2;Eye Irrit. 2A;Aquatic Chronic 2,REACH registration C&L,494,H319:339;H411:177;H315:292;Not classified:100;H318:55
113202,(3S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)-1-propanamine hydrochloride (1:1),603-962-5,136434-34-9,Acute Tox. 4,Notified C&L,65,H302:53;H410:12;H318:22;H400:11;H301:10;H336:2;H361:3;H312:3;H332:2;H319:1;H315:1;H362:1;H373:1;H413:1
113205,"D-Glucose, 2-deoxy-2-(sulfoamino)-, monosodium salt",609-596-2,38899-05-7,Not Classified,Notified C&L,4,Not classified:4
113208,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and 1,3-cyclohexanedimethanamine",500-401-5,158885-14-4,Not Classified,Notified C&L,64,Not classified:57;H312:5;H332:4;H314:7;H302:7;H411:3;H317:2;H412:2;H318:1
113214,"Rhodium(3+) 2,6,6-trimethylbicyclo[3.1.1]heptane-2-thiolate",309-624-0,100432-50-6,Flam. Sol. 2,Notified C&L,1,H228:1
113216,"2,5-dichloro-p-xylene",214-387-0,1124-05-6,,Notified C&L,6,H319:6;H335:4;H315:6
113217,AMIDES ISOSTEARIC N-(HYDROXYETHYL)PROPOXYLATED,452-140-0,,Skin Irrit. 2;Eye Irrit. 2A;Aquatic Chronic 1,Notified C&L,1,H410:1;H319:1;H315:1
113222,1-(3-methylbenzyl)piperazine,226-184-4,5321-48-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:39;H319:39;H335:40;H315:40;H318:1
113227,o-fluoro-β-nitrostyrene,206-915-3,399-25-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
113237,"3-(3,5-dichlorophenyl)-1,5-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione",251-233-1,32809-16-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,104,H332:89;H413:89;Not classified:14;H370:1;H373:1;H360:1;H411:1
113238,"Juniper, Juniperus communis, ext.",283-268-3,84603-69-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1696,H304:1683;H315:1576;H226:1684;H317:1685;H319:45;H411:20;H410:1481;H400:1440;Not classified:10;H312:1;H332:1;H302:1
113239,"reaction product of 2,2',2''-nitrilotriethanol and 6-[[(4-methylphenyl)sulphonyl]amino]hexanoic acid",928-487-3,,Not Classified,Notified C&L,1,Not classified:1
113242,"Sodium p-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzenesulphonate",223-989-2,4156-21-2,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,48,H317:48;H318:33;H334:15
113246,"Nonane-1,3-diyl diacetate",264-060-1,63270-14-4,Not Classified,REACH registration C&L,80,Not classified:80
113250,"4,4'-isopropylidenediphenyl diacetate",233-472-3,10192-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
113251,Octahydro-2-nitrosocyclopenta[c]pyrrole,259-348-9,54786-86-6,,Notified C&L,1,H302:1;H341:1
113253,"9-β,10-α-ergosta-5,7,22-trien-3-β-ol",207-487-0,474-69-1,Aquatic Chronic 4,Notified C&L,1,H413:1
113262,4-propylpiperidine,244-956-9,22398-09-0,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:38;H315:38;H335:38;H225:38;H314:6;H226:6
113263,"N-(4-chloro-2,5-dimethoxyphenyl)-2-[[2,5-dimethoxy-4-[(phenylamino)sulphonyl]phenyl]azo]-3-oxobutyramide",235-427-3,12225-18-2,Not Classified,REACH registration C&L,118,Not classified:118
113267,Germanium(4+) ethanolate,238-007-8,14165-55-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H226:42;H319:42;H335:38;H315:42
113268,iprobenfos (ISO);S-benzyl diisopropyl phosphorothioate,247-449-0,26087-47-8,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
113271,"Glycerides, tall-oil",269-673-8,68309-32-0,Not Classified,Notified C&L,73,Not classified:71;H413:2
113272,"(3S,3aS,5aS,9bS)-2,3,3a,4,5,5a,8,9b-octahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8-dione",207-560-7,481-06-1,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,128,H330:127;H315:127;H335:127;H302:128;H319:127;H310:127
113273,Methyl 5-methyl-4-sulfamoylthiophene-3-carboxylate,480-430-7,,Aquatic Chronic 2,REACH registration C&L,3,H411:3
113275,2-piperidin-1-yl-benzonitrile,427-330-1,72752-52-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
113276,aldrin (ISO),206-215-8,309-00-2,Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H311:0;H410:0;H351:0;H372:0;H400:0
113279,1-methyltrimethylene dimethacrylate,214-711-0,1189-08-8,Skin Sens. 1B,REACH registration C&L,191,H317:27;H319:162;H315:162;H335:38;Not classified:2;H302:1
113281,Trisodium 6-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-3-[[4-[[4-amino-6(or 7)-sulphonatonaphthyl]azo]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate,232-322-4,8003-69-8,,Notified C&L,161,Not classified:127;H318:33;H319:1;H315:1
113289,"rel-(1E)-1-[(1R,6R)-2,2,6-trimethylcyclohexyl]hex-1-en-3-one",619-053-1,94608-85-2,Not Classified,REACH registration C&L,4,Not classified:4
113293,"methyl (3E)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexenoate",607-380-2,244626-75-3,Not Classified,REACH registration C&L,4,Not classified:4
113294,"N-[4-[(4-hydroxy[1,1'-biphenyl]-3-yl)azo]phenyl]acetamide",274-732-6,70660-54-7,Not Classified,Notified C&L,10,Not classified:8;H412:2
113300,Tetrachlorophthalic acid,211-181-2,632-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
113301,propyl acetate,203-686-1,109-60-4,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H336:0;H319:0;H225:0
113303,Ammonium sulphite,233-484-9,10196-04-0,Not Classified,REACH registration C&L,54,Not classified:7;H314:25;H319:22;H335:15;H315:21;H031:3
113306,"2',4',5'-trimethoxycinnamic acid",246-047-2,24160-53-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
113307,"Fatty acids, C9-13-neo-, barium salts",295-361-6,92044-82-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,7,H332:6;H302:6;H318:4;H315:4;Not classified:1
113314,Streptavidin,618-481-6,9013-20-1,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
113315,"Alcohols, C16-20, branched, ethoxylated",500-568-4,161133-70-6,Eye Dam. 1,Notified C&L,6,H318:6
113317,2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethanol,221-668-1,3180-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H319:49;H335:48;H315:49;Not classified:10
113321,3-nitro-o-cresol,226-739-0,5460-31-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:45;H312:39;H335:44;H332:43;H302:43;H319:45;H311:7;H301:3;H331:3
113326,"Alkenes, C18 .alpha.-, isomerized",824-284-8,148617-59-8,Asp. Tox. 1,Notified C&L,1,H304:1
113330,"6-N-Phthalimidomethyl-6,11-dihydro-5H-dibenz[b,e]azepine",420-030-1,,Aquatic Chronic 4,Notified C&L,1,H413:1
113335,"2-(6-methoxybenzoxazol-2-yl)-1,3-dimethyl-1H-benzimidazolium methyl sulphate",266-334-6,66371-08-2,Eye Dam. 1,Notified C&L,31,H318:31
113336,"1,4-dimethylcyclohexane",209-663-2,589-90-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H304:0;H315:0;H225:0;H336:0;H411:0
113337,"Disodium 4,4'-bis(4-phenyl-2H-1,2,3-triazol-2-yl)stilbene-2,2'-disulphonate",245-857-3,23743-28-4,Not Classified,Notified C&L,36,Not classified:35;H412:1
113338,"Benzenesulfonic acid, 3-[[ethyl[4-[2-[4-[2-(3-sulfophenyl)diazenyl]-1-naphthalenyl]diazenyl]phenyl]amino]methyl]-, sodium salt (1:2)",602-049-9,12220-20-1,Not Classified,Notified C&L,4,Not classified:4
113339,"(R)-6-(p-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate",275-471-0,71461-24-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:38;H312:38;H319:1;H335:1;H315:1
113340,"2,4,6-trimethylpyridine",203-613-3,108-75-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,203,H315:201;H226:202;H311:55;H332:124;H335:138;H302:201;H319:201;H412:1;H318:1;H312:84;H314:1;H331:10;Not classified:1
113341,"5,9-dimethyl-8-decen-3-ol",243-155-1,19550-54-0,Not Classified,Notified C&L,88,Not classified:88
113343,"Tetrasodium 2-[[8-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]benzoyl]amino]-1-hydroxy-3,6-disulphonato-2-naphthyl]azo]naphthalene-1,5-disulphonate",269-412-8,68238-92-6,Skin Sens. 1B,REACH registration C&L,41,H317:4;Not classified:37
113348,"(4S,4aS,5aR,12aR)-11a-halo-4-(dialkylamino)-3,10,12a-trihydroxy-1,11,12-trioxo-1,4,4a,5,5a,6,11,11a,12,12a-carbopolycyclyl-2-carboxamide hydrohalide",917-355-0,,Lact.,Notified C&L,1,H362:1
113351,Sodium nicotinate,200-215-1,54-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
113353,C.I. Acid Blue 204,612-224-1,61724-00-3,Aquatic Chronic 3,Notified C&L,1,H412:1
113360,fluorosilicic acid ... %,241-034-8,16961-83-4,Skin Corr. 1B,Harmonised C&L,0,H314:0
113363,Methyl icosanoate,214-304-8,1120-28-1,Not Classified,Notified C&L,38,Not classified:38
113371,3-hexylheptamethyltrisiloxane,428-700-5,1873-90-1,Acute Tox. 4;Aquatic Chronic 4,Harmonised C&L,0,H332:0;H413:0
113374,"4,4'-bis[(4-ethoxyphenyl)azo]stilbene-2,2'-disulphonic acid",233-779-2,10359-84-9,,Notified C&L,1,Not classified:1
113375,Methyl 4-(methylthio)butyrate,258-328-7,53053-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:90;H335:90;H315:90;Not classified:1
113381,"Silica, vitreous",262-373-8,60676-86-0,Not Classified,Notified C&L,1687,Not classified:1595;H373:77;H319:85;H335:54;H315:32;H370:2;H372:3;H350:3
113383,"Cuprate(4-), [μ-[[3,3'-[azoxybis[(2-hydroxy-4,1-phenylene)azo]]bis[4-hydroxy-6-[(3-sulfophenyl)amino]-2-naphthalenesulfonato]](8-)]]di-, ammonium sodium",276-983-7,72905-99-8,Not Classified,Notified C&L,9,Not classified:9
113388,"1,4-dichlorobut-2-yne",212-474-8,821-10-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:42;H315:44;H301:5;H331:4;H311:4;H351:2;Not classified:1
113390,Magnesium disalicylate,242-669-3,18917-89-0,Not Classified,Notified C&L,3,Not classified:3
113391,Aluminum cobalt oxide,235-762-5,12672-27-4,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B,REACH registration C&L,8,H334:3;H360:3;H317:7;H350:3;H341:7;H319:3;Not classified:1
113394,2-methylbenzofuran,224-249-1,4265-25-2,Not Classified,Notified C&L,6,Not classified:3;H227:2;H319:3;H335:2;H315:3
113395,Halothane,205-796-5,151-67-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Repr. 1B,Notified C&L,47,H318:44;H360:39;H335:39;H315:39;H341:5;Not classified:3
113397,(R)-Methyl-2-fluoropropanoate,478-990-2,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H315:3;H226:3;H335:3;H302:4;H319:3;H402:1;Not classified:1;H225:1
113407,"6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole",617-540-3,84163-77-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H301:38;H319:40;H335:39;H315:40
113408,"Tetrasodium 5-[[2,4-dihydroxy-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]phenyl]azo]-4-hydroxy-3-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]naphthalene-2,7-disulphonate",274-430-4,70210-34-3,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,45,H412:15;H319:15;Not classified:30
113415,"(6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propanoate",617-082-4,80474-14-2,Repr. 1B;STOT RE 2,Notified C&L,15,H373:9;H360:6;H361:7;Not classified:1;H334:2;H312:1;H332:1;H317:2;H302:3;H315:1;H410:3;H413:1
113416,Potassium 3-sulphonatopropyl acrylate,250-465-0,31098-20-1,Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,112,H412:59;H317:59;H319:53;H335:53;H315:53
113417,"Fatty acids, C8-10, Me esters",287-636-4,85566-26-3,Not Classified,REACH registration C&L,187,Not classified:187
113418,Pyritinol,214-150-1,1098-97-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
113424,"[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium",422-060-0,137390-08-0,Acute Tox. 2,Harmonised C&L,0,H300:0
113429,[(trimethylsilyl)methyl]urea,227-117-1,5663-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
113431,"Fatty acids, C14-18, potassium salts",293-009-6,91032-03-0,Not Classified,Notified C&L,10,Not classified:10
113437,Samarium,231-128-7,7440-19-9,Flam. Sol. 2;Water-react. 3,REACH registration C&L,245,H261:231;H228:228;Not classified:6;H260:6;H413:1
113443,"(S)-1,5-dimethylhexylamine",274-598-9,70419-10-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H226:38;H335:38;H302:38;H319:38
113445,4-(N-Boc-amino)piperidine,616-026-6,73874-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:51;H335:50;H315:51;H314:2;H318:1
113446,3-phenylbut-3-enyl acetate,230-755-3,7306-12-9,Not Classified,Notified C&L,233,Not classified:233
113447,4-[2-(Cyclopropylmethoxy)ethyl]phenol,440-910-9,,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,4,H332:4;H302:4;H312:4;H319:4
113449,1-chloro-3-methylbutane,203-525-5,107-84-6,,Notified C&L,5,H319:4;H315:4;H335:4;H225:5
113453,"bis(2,2,6,6-tetramethyl-4-piperidyl) succinate",402-940-0,62782-03-0,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0
113454,"(4S-trans)-N-(5,6-diidro-6-metil-7,7-diossido-4Htieno[2,3-b]tiopiran-4-il)-acetammide",604-558-1,147086-83-7,Eye Irrit. 2,REACH registration C&L,1,H319:1
113456,"Oxybis(ethane-2,1-diyloxyethane-2,1-diyl) bisheptanoate",274-829-3,70729-68-9,Not Classified,Notified C&L,3,Not classified:3
113457,Sodium 3-amino-2-hydroxy-5-nitrobenzenesulphonate,277-907-5,74525-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
113458,"5-[[4-[(2,4-dinitrophenyl)amino]phenyl]azo][1,1'-biphenyl]-2-ol",235-421-0,12223-91-5,Aquatic Chronic 3,Notified C&L,1,H412:1
113461,"Oils, palm, reaction products with diethylenetriamine, di-Me sulfate-quaternized",308-718-9,98219-51-3,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,7,H411:7;H315:7
113465,4-[(5-{[(benzyloxy)carbonyl]amino}pentyl)(hydroxy)amino]-4-oxobutanoic acid,600-744-1,106410-46-2,Not Classified,REACH registration C&L,3,Not classified:3
113466,4-tert-butyl-2-chlorophenol,202-652-3,98-28-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H302:42;H318:38;H335:42;H315:42;H319:4
113467,Ethyl N-[[5-methyl-2-(isopropyl)cyclohexyl]carbonyl]glycinate,254-573-9,39668-74-1,Not Classified,Notified C&L,6,Not classified:4;H319:2
113468,Hexadecyl D-glucoside,259-220-2,54549-27-8,Not Classified,Notified C&L,42,Not classified:29;H318:13;H315:13
113469,"Amides, from 2-[(2-aminoethyl)amino]ethanol and hydrogenated tallow, acetates (salts)",268-943-2,68155-15-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
113471,Trifluoro(tetrahydrofuran)boron,207-325-9,462-34-0,Skin Corr. 1B;Acute Tox. 4;STOT RE 1,REACH registration C&L,196,H332:154;H314:196;H372:158;H318:95;H412:33;H302:60;H301:4
113473,Dimethyl (3-oxo-2-pentylcyclopentyl)malonate,257-434-0,51806-23-6,Not Classified,Notified C&L,4,Not classified:4
113474,"2-[[4-[[4-[bis(2-hydroxyethyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]azo]-p-cresol",260-088-3,56275-25-3,Not Classified,Notified C&L,3,Not classified:3
113475,2-methoxyphenyl isocyanate,211-853-5,700-87-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H312:40;H335:45;H332:44;H302:44;H319:45;H334:4;H315:6;H301:2;H331:2;H311:1
113476,(±)-2(10)-pinen-3-one,250-211-9,30460-92-5,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Muta. 2,Notified C&L,1,H317:1;H318:1;H341:1;H315:1
113477,"Amides, tallow, N,N-bis(hydroxyethyl)",268-772-3,68140-08-9,Not Classified,Notified C&L,1,Not classified:1
113480,Indan-1-carbonitrile,247-718-2,26452-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113483,4-cyclohexylcyclohexanol,219-418-1,2433-14-9,Eye Irrit. 2,Notified C&L,38,H319:38
113484,Sodium lactate,200-772-0,72-17-3,Eye Irrit. 2,REACH registration C&L,1680,H320:6;H318:1291;H315:1377;Not classified:271;H319:110;H335:85;H413:1
113486,"6,7-dihydroxy-4-methylcoumarin",208-470-0,529-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:43;H315:45
113487,"1-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium chloride",238-382-8,14408-20-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H302:2;H319:2;H411:2
113488,"Amides, from acetic acid, diethylenetriamine and hydrogenated tallow fatty acids, acetates",295-599-0,92112-96-4,Not Classified,Notified C&L,4,Not classified:4
113489,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(hydroxyimino)acetyl]amino]-3-[(E)-[(3'R)-1'-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3'-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, monosodium salt, (6R,7R)-",607-653-6,252188-71-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
113491,"2,2,4(or 2,4,4)-trimethyladipic acid",258-556-7,53445-37-7,Eye Dam. 1,REACH registration C&L,1,H318:1
113492,1-ethylpiperidine,212-161-6,766-09-6,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,187,H301:144;H318:112;H312:145;H331:144;H314:149;H225:187;H315:38;H335:38;H332:39;H302:39;H319:38
113496,2-methyl-6-propoxypyrazine,267-306-6,67845-28-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,158,H319:158;H335:158;H315:158
113497,Rocket Red Dye WT13,609-628-5,39277-28-6,Not Classified,Notified C&L,15,Not classified:14;H330:1;H301:1;H318:1;H311:1;H314:1;H317:1;H350:1;H341:1;H411:1
113500,Silver nitrite,232-041-7,7783-99-5,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,48,H272:47;H315:48;H302:43;H319:48;H400:46;H410:7;H271:1;H335:1
113502,Methyl phenothiazin-2-yl ether,217-195-5,1771-18-2,Not Classified,REACH registration C&L,12,Not classified:9;H302:2;H411:1;H319:1;H335:1;H315:1
113503,"Soaps, stocks, C14-18 and C16-18-unsatd. alkyl",272-857-0,68918-37-6,Not Classified,Notified C&L,1,Not classified:1
113505,"2-Propenenitrile, polymer with 1,3-butadiene, 3-carboxy-1-cyano-1-methylpropyl-terminated, polymers with 2,2'-[1,4-cyclohexanediylbis(methyleneoxymethylene)]bis[oxirane]",605-326-2,163440-98-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,20,H317:20;H319:20;H335:20;H315:20
113509,2-(Dicyclohexylphosphino)biphenyl,607-439-2,247940-06-3,Aquatic Chronic 4,Notified C&L,43,H413:38;H319:5;H335:5;H315:5;H302:1
113510,N-(2-Hydroxyethyl)acrylamide (stabilized with MEHQ),619-814-8,7646-67-5,Eye Dam. 1;STOT RE 2,Notified C&L,46,H373:42;H318:45;H319:1;H315:1
113516,"9-Octadecenoic acid (Z)-, reaction products with diethylenetriamine, cyclized, di-Et sulfate-quaternized",270-952-1,68511-92-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,20,H410:20;H318:20;H400:20;H315:20
113517,"Benzoic acid, 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-4(or 5)-methyl-, methyl ester",617-231-3,81405-85-8,Not Classified,Notified C&L,3,Not classified:3
113520,Diflunisal,245-034-9,22494-42-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,39,H315:38;H335:38;H302:39;H319:38;H361:38
113528,C,414-110-5,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0
113531,1-(2-methylbenzyl)piperazine,226-183-9,5321-47-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H315:38
113534,"Cyclohex-1,2-ylenediamine",211-776-7,694-83-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,468,H318:250;H312:125;H335:124;H332:156;H314:422;H302:124;H317:236;H315:40;H334:19;Not classified:6;H412:1
113537,"2,2'-bithiophene",207-767-2,492-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:3;H335:3;H315:3;H332:1;H302:1;H312:1;Not classified:1
113541,(o-chlorophenyl)acetonitrile,220-669-4,2856-63-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,47,H330:40;H301:43;H315:47;H311:47;H335:46;H319:47;H300:4;H331:6
113542,Allyl carbamate,218-309-6,2114-11-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,39,H302:39;H319:39;H400:38;H410:1
113543,Stilbamidine,204-519-5,122-06-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H302:38;H319:38;H400:38
113546,Dibutoxy(dimethyl)silane,216-467-0,1591-02-2,Not Classified,REACH registration C&L,23,Not classified:23
113556,Ethyl (R)-12-hydroxyoleate,259-462-9,55066-53-0,Not Classified,Notified C&L,90,Not classified:89;H302:1;H373:1
113561,"bis(1-undecyloxy-2,2,6,6-tetramethylpiperidine-4-yl)carbonate",482-440-7,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H413:1
113562,Trometamol,201-064-4,77-86-1,Not Classified,REACH registration C&L,1174,Not classified:207;H319:967;H335:853;H315:966;H312:1;H332:1
113566,"Ethyl-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol",267-922-5,67952-68-5,Not Classified,Notified C&L,88,Not classified:88
113567,"Acetic acid, manganese(2+) salt, tetrahydrate",612-176-1,6156-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:48;H335:48;H315:48;Not classified:4;H361:1;H301:1
113574,Isobutyl 2-methylisocrotonate,231-941-7,7779-81-9,Not Classified,Notified C&L,274,Not classified:234;H226:40
113575,"Lup-20(29)-en-3-ol, (3β)-",208-889-9,545-47-1,Acute Tox. 4,Notified C&L,4,H302:3;Not classified:1
113580,Bis(p-chlorophenyl) diselenide,243-864-6,20541-49-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H331:38;H410:38;H373:38;H400:38
113584,"3',5'-bis(trifluoromethyl)propiophenone",285-296-1,85068-34-4,,Notified C&L,6,H319:6;H315:6;H335:2
113585,Methyl 4-aminobenzoate,210-598-7,619-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
113586,Hexadecyl oleate,244-950-6,22393-86-8,Not Classified,Notified C&L,126,Not classified:126
113589,"Phosphinic acid, bis(perfluoro-C6-12-alkyl) derivs.",270-206-5,68412-69-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
113590,(2S)-2-Chloropropanoic acid,608-381-0,29617-66-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;STOT RE 2,Notified C&L,44,H373:38;H302:44;H312:44;H314:44;H332:1
113594,Octanal,204-683-8,124-13-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1879,H226:1749;H319:1827;H411:1532;H315:1829;H412:294;H317:85;H335:4;Not classified:3;H331:1;H311:1;H302:1;H304:1
113597,"reaction mass of: trans-trans-cyclohexadeca-1,9-diene;cis-trans-cyclohexadeca-1,9-diene",429-620-3,110028-14-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H317:0;H315:0
113602,"Tricyclo[4.2.0.02,4]octan-7-one, 8,8-dichloro-3-(5,5-dimethyl-1,3-dioxan-2-yl)-, (1α,2β,3α,4β,6α)-",609-714-2,39521-37-4,Not Classified,Notified C&L,1,Not classified:1
113606,3-Methyl-6-nitro-1h-indazole,613-731-0,6494-19-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H315:2;H312:2;H332:2;H302:2;H319:2
113607,2-(2-methylprop-2-enoyloxy)ethyl 2-methylprop-2-enoate,607-819-8,25852-47-5,Not Classified,Notified C&L,705,Not classified:254;H412:267;H315:365;H335:319;H317:270;H319:366
113608,5-chlorosalicyl alcohol,226-225-6,5330-38-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:38;H335:44;H315:44;H319:6
113609,tert-butyl 5-oxo-DL-prolinate,285-735-7,85136-12-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113613,"(S)-.alpha.-cyano-3-phenoxybenzyl (Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate",616-373-3,76703-62-3,Acute Tox. 1;Acute Tox. 4;Skin Sens. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H330:90;H301:90;H312:90;H317:90;H410:90;H372:90;H400:90;H300:1
113617,"Deoxyribonucleic acids, fish sperm",309-566-6,100403-24-5,Not Classified,Notified C&L,1,Not classified:1
113620,"L-Glutamic acid, sodium salt, hydrate (1:1:1)",612-072-6,6106-04-3,Not Classified,Notified C&L,143,Not classified:143
113625,Sodium dimethylarsinate,204-708-2,124-65-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,54,H410:51;H301:52;H331:50;H400:47;H373:4;Not classified:2;H330:2;H350:1;H412:2;H413:1;H302:3
113626,"Cyclobutanemethanamine, 1-(4-chlorophenyl)-α-(2-methylpropyl)-, hydrochloride (1:1)",617-574-9,84484-78-6,,Notified C&L,1,H302:1
113627,N-[4-cyano-3-(trifluoromethyl)-pheniy]-2-hydroxi-2-methyl-propánamide,613-077-6,627484-44-0,Acute Tox. 4,Notified C&L,2,H302:2
113628,Isonicotinic anhydride,230-382-6,7082-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
113632,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with o-cresol and trimethylhexane-1,6-diamine",500-644-7,161308-05-0,Not Classified,Notified C&L,22,Not classified:22
113633,"Iron, diazotized coupled 4-aminobenzenesulfonic acid-Dyer’s mulberry (Chlorophora tinctoria) extract complexes",274-989-4,70892-58-9,Not Classified,Notified C&L,1,Not classified:1
113642,2-bromo-1-chloropropane,221-157-3,3017-95-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:43;H312:42;H335:43;H332:42;H302:42;H319:43;H301:1;H226:1
113648,"1,2-bis(2-chlorophenyl)hydrazine",212-314-7,782-74-1,Not Classified,Notified C&L,33,Not classified:33
113652,"Disodium tetraborate, anhydrous",603-411-9,1303-96-4,,Notified C&L,2854,H360:2817;H319:209;H315:25;H412:15;H361:11;H370:1;H335:1;Not classified:1
113655,"3,7-dimethyloct-6-enenitrile",257-288-8,51566-62-2,Not Classified,REACH registration C&L,1789,Not classified:388;H412:1400;H319:1290;H317:1;H411:1;H315:1
113656,3-propylidenephthalide,241-402-8,17369-59-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,1643,H302:1643;H317:1638;H319:5;H315:5
113657,"Formaldehyde, reaction products with 4,4'-sulfonylbis[phenol] disodium salt",296-699-7,92969-86-3,Not Classified,Notified C&L,3,Not classified:3
113659,"Acetic acid, 2,2',2'',2'''-[[5,11,17,23-tetrakis(1,1-dimethylethyl)pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,26,27,28-tetrayl]tetrakis(oxy)]tetrakis-, tetraethyl ester",619-280-6,97600-39-0,Not Classified,Notified C&L,2,Not classified:2
113661,"pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether",605-845-4,179101-81-6,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,158,H373:158;H317:158;H410:158;H400:158
113662,"Resin acids and Rosin acids, manganese salts",232-716-6,9008-34-8,Self-heat. 1,REACH registration C&L,146,H251:1;Not classified:144;H320:1;H316:1;H332:1;H317:1;H228:1
113663,(isodecanoato-O)(isooctanoato-O)nickel,285-909-2,85166-19-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H360:0;H317:0;H410:0;H350:0;H372:0;H341:0;H400:0
113665,Beclamide,207-927-1,501-68-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H335:39;H315:39;H319:1
113667,"2-chloro-3,5-xylenol",226-898-6,5538-41-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H317:1;H410:1;H302:1;H319:1
113669,Disodium hydrogen nitrilotriacetate,239-484-5,15467-20-6,Acute Tox. 4;Carc. 2,Notified C&L,43,H351:40;H302:43
113671,"β-Cyclodextrin, compd. with (S)-3-(1-methyl-2-pyrrolidinyl)pyridine (1:1)",611-765-0,58947-99-2,Not Classified,Notified C&L,1,Not classified:1
113673,methyl 4-amino-5-ethylsulfonyl-2-methoxybenzoate,616-818-1,80036-89-1,Not Classified,REACH registration C&L,4,Not classified:3;H319:1;H335:1;H315:1
113677,"Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-, C12-14-branched and linear alkyl esters",302-210-0,94095-06-4,Eye Dam. 1,Notified C&L,444,H318:441;Not classified:3
113678,Octene,246-920-8,25377-83-7,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,9,H304:5;H410:3;H400:3;H225:5;Not classified:4
113683,R-(-)-1-(1-naphthyl)ethyl isocyanate,255-759-2,42340-98-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H301:39;H334:43;H315:43;H335:43;H317:39;H319:43;H331:5;H302:4
113684,Hexamethylcyclotrisiloxane,208-765-4,541-05-9,Flam. Sol. 1,REACH registration C&L,727,H228:248;Not classified:480;H319:48;H315:47;H335:48
113685,1-(acetyl)thiosemicarbazide,218-956-4,2302-88-7,Acute Tox. 3,REACH registration C&L,44,H301:40;H302:4
113686,1-benzyl-3-carboxylatopyridinium sodium chloride,268-692-9,68133-60-8,Not Classified,REACH registration C&L,14,Not classified:14
113688,1-(triphenylphosphoranylidene)acetone,215-878-2,1439-36-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113690,Orthoperiodic acid,233-937-0,10450-60-9,Ox. Sol. 1;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,227,H318:124;H314:227;H410:13;H271:128;H400:118;H372:105;H272:63;H302:1;Not classified:1
113693,"Sodium 6-hydroxy-5-(4-phenylazophenylazo)naphthalene-2,4-disulphonate",226-502-1,5413-75-2,Not Classified,Notified C&L,56,Not classified:48;H302:3;H319:6;H315:4;H412:2;H317:1;H335:2;H351:1
113695,2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethanol,250-502-0,31173-14-5,Acute Tox. 4,Notified C&L,1,H302:1
113697,"Soaps, stocks, C8-18 and C18-unsatd. alkyl",272-856-5,68918-36-5,Not Classified,Notified C&L,1,Not classified:1
113698,"Distillates (petroleum), catalytic reformed straight-run naphtha overheads;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C",271-008-1,68513-63-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
113702,"(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate",616-536-9,77883-43-3,STOT RE 2;Aquatic Chronic 2,Notified C&L,98,H373:84;H411:92;H302:1;H361:3;H413:1;Not classified:1;H362:1;H336:1;H319:1;H315:1
113706,"5-[(3,4-dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxonicotinonitrile",280-322-8,83249-52-9,Not Classified,REACH registration C&L,128,Not classified:128
113709,"Cyclohexanamine, N,N-dimethyl-, compd. with .alpha.-isotride cyl-.omega.-hydroxypoly(oxy-1,2-ethanediyl) phosphate",605-358-7,164383-18-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,541,H319:536;H411:536;H315:536;Not classified:5
113711,Methylphenylsilane,212-160-0,766-08-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H335:39;H315:39
113722,Chlorobenzoic acid,247-558-3,26264-09-5,,Notified C&L,1,H312:1;H332:1;H314:1;H317:1;H302:1
113725,2-bromo-3-methylbutyryl bromide,247-719-8,26464-05-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H302:1;H317:1;H314:1
113728,Pyridine--borane (1:1),203-773-4,110-51-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 1,Notified C&L,179,H330:178;H301:179;H311:135;H310:44;H225:39;H315:5;H335:4;H319:5;H332:1
113730,"1,8-dihydroxy-4-[[4-(2-hydroxyethyl)phenyl]amino]-5-nitroanthraquinone",239-891-8,15791-78-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H335:38;H315:38;Not classified:3;H412:1
113731,disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-),404-930-1,118556-91-5,Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H318:0;H411:0
113732,"(+)-4'-(2-methylbutoxy)[1,1'-biphenyl]-4-carbonitrile",261-360-4,58600-86-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H315:38;H312:38;H335:38;H332:38;H302:39;H319:38;Not classified:1;H413:1
113736,Heptanedioyl dichloride,205-561-7,142-79-0,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H314:38;H318:38;H335:38
113737,"Dihydrogen [bis(chlorosulphonyl)-29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",250-589-5,31361-57-6,Not Classified,Notified C&L,2,Not classified:2
113738,Cytidylyl-(3'→5')-uridine,219-185-6,2382-64-1,Acute Tox. 4,Notified C&L,38,H302:38
113739,"(S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride",606-861-4,219143-92-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
113741,"2-Hexyldecan-1-ol, ethoxylated",500-116-6,52609-19-5,Aquatic Chronic 3,Notified C&L,106,H412:83;H318:23
113743,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium thiocyanate",282-434-2,84196-24-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H315:2;H410:2;H302:2;H319:2;H400:2
113744,"4-(diisopropylamino)-2,2-diphenylbutyramide",254-572-3,39666-27-8,Not Classified,REACH registration C&L,2,Not classified:2
113746,Pentachloro(methylthio)benzene,217-363-8,1825-19-0,Aquatic Chronic 4,Notified C&L,1,H413:1
113748,Ethyl 2-chloroacrylate,211-693-6,687-46-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
113749,4-tert-butyl-o-cresol,202-651-8,98-27-1,Skin Corr. 1B,Notified C&L,39,H314:39
113750,Tridecan-7-one,207-324-3,462-18-0,,Notified C&L,33,Not classified:32;H319:1;H335:1;H315:1
113752,"2H-1-Benzopyran-2-one, 7-(diethylamino)-3-(methyl-2-benzoxazolyl)-",615-607-1,71838-87-4,Not Classified,Notified C&L,2,Not classified:2
113754,2-Morpholinoethanesulphonic acid,919-085-9,145224-94-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,7,H319:7;H335:5;H315:7
113755,"spinosad (ISO); Reaction mass of Spinosyn A: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione and Spinosyn D: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2.3.4.6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethy-2,3,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione",434-300-1,168316-95-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,69,H410:69;H400:68
113757,1-methyl-N-phenylpiperidin-4-amine,244-882-7,22261-94-5,,Notified C&L,5,H302:4;H319:5;H335:5;H315:5
113759,Methyl 3-Bromo-2-(bromomethyl)propionate,606-968-6,22262-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;H301:1;H331:1;H311:1
113760,"Addition product of dehydrated castor oil, linseed oil and maleic anhydride",927-957-5,,Eye Irrit. 2,REACH registration C&L,72,H319:1;Not classified:71
113761,"Hydrazine, (phenylmethyl)-",611-286-7,555-96-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H312:1;H335:1;H332:1;H302:1;H319:2;H301:1
113763,2-Oxabiciklo(3.3.0)okt-én-3-on,609-011-0,34638-25-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
113766,"3-Methoxy-18-methyl-8,14-seco-1,3,5(10),9(11)-estratetraene-14,17-dione",613-005-3,62298-52-6,Not Classified,REACH registration C&L,3,Not classified:3
113770,"2,4-dichloroaniline",209-057-8,554-00-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,85,H301:84;H331:84;H311:84;H410:83;H373:83;H400:78;H319:3;H315:1;H335:1;H330:1;H371:1;H411:1;H302:2;H310:1;H318:2;H312:1;H332:1
113771,Sodium 4-(4-chloro-o-tolyloxy)butyrate,227-989-3,6062-26-6,Acute Tox. 4,Notified C&L,147,H302:147
113773,"-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one",614-994-4,69655-05-6,Muta. 2,Notified C&L,4,H341:3;H372:1;H319:1;H335:1;H315:1
113776,N-(1-naphthyl)thioacetamide,233-702-2,10319-80-9,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
113779,"(1,1,3,3-tetramethyldisiloxane-1,3-diyl)dipropane-1,3-diyl dimethacrylate",242-419-3,18547-93-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H410:2;H400:2;H319:39;H335:39;H315:39;Not classified:4
113780,"Tris(D-gluconato-O1,O2)iron",254-064-1,38658-53-6,Not Classified,Notified C&L,2,Not classified:2
113781,5-methylthiophene-2-carbaldehyde,237-178-6,13679-70-4,Acute Tox. 4,Notified C&L,1382,H302:1286;Not classified:65;H319:31;H335:30;H315:31
113782,"L-Valine, N-methyl-N-[(phenylmethoxy)carbonyl]-",610-027-5,42417-65-2,Not Classified,Notified C&L,2,Not classified:2
113783,3-methylcyclohex-3-en-1-one,250-855-0,31883-98-4,Skin Sens. 1,Notified C&L,38,H317:38
113784,"6-(isononanoylamino)hexanoic acid, compound with 2,2'-iminodiethanol (1:1)",288-271-3,85702-80-3,Not Classified,Notified C&L,31,Not classified:31
113786,"Fatty acids, tallow, reaction products with diethanolamine",270-450-2,68440-32-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28,H318:28;H315:28
113789,Cobalt hydroxide,235-763-0,12672-51-4,Not Classified,Notified C&L,83,Not classified:83
113790,"(S)-(isopropyl)(β,3,4-trihydroxyphenethyl)ammonium [R-(R*,R*)]-hydrogen tartrate",238-683-4,14638-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
113791,"Diundecyl phthalate, branched and linear",287-401-6,85507-79-5,Not Classified,REACH registration C&L,28,Not classified:28
113793,(6R-trans)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,244-870-1,22252-43-3,Not Classified,REACH registration C&L,54,Not classified:3;H317:50;H334:50;H302:1
113795,"O,O-bis(4-methylpentan-2-yl) hydrogen phosphorodithioate",227-900-8,6028-47-3,Skin Corr. 1C;Eye Dam. 1,Notified C&L,443,H314:441;H318:442;Not classified:1;H315:1
113798,"2,2'-methylenediphenol",219-578-2,2467-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,115,H319:94;H335:93;H315:94;H317:13;H318:13;H411:13;H412:6;Not classified:2
113802,Ammonium oleyl sulphate,241-251-8,17209-70-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
113805,Josamycin,240-871-6,16846-24-5,Not Classified,Notified C&L,3,Not classified:2;H302:1
113807,(-)-Bis[(S)-1-phenylethyl]amine,611-365-6,56210-72-1,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,125,H302:83;H411:83;H315:125;H319:42;H335:42
113810,ziram (ISO);zinc bis dimethyldithiocarbamate,205-288-3,137-30-4,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H318:0;H373:0;H335:0;H317:0;H410:0;H302:0;H400:0
113811,"Extract residues (coal), naphthalene oil alk., distn. overheads;Naphthalene Oil Extract Residue;[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180°C to 220°C (356°F to 428°F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]",292-627-3,90641-04-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
113812,"Bifidobacterium longum, lysate",306-168-4,96507-89-0,Not Classified,Notified C&L,4,Not classified:4
113813,Tripotassium hexachlororhodate,237-569-1,13845-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
113814,"Pyridine-2,4-dicarbonitrile",249-492-0,29181-50-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H335:42;H317:38;H302:42;H319:4
113822,4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate,431-200-1,208538-34-5,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0;H318:0
113829,"3,3-dimethylbutane-1,2,4-triol",239-936-1,15833-80-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113831,LUMILUX ROT CD 361,441-010-9,,Not Classified,Notified C&L,1,Not classified:1
113832,Bis(4-chlorophenyl)ethanedione,222-387-7,3457-46-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
113837,"reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate",410-720-0,141847-13-4,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
113838,Isopropyl 2-methylbutyrate,266-411-4,66576-71-4,Flam. Liq. 3,REACH registration C&L,1700,H226:1699;H411:1
113847,"Neodecanoic acid, ruthenium salt",299-741-2,93894-43-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
113848,"Aloe barbadensis, ext.",305-181-2,94349-62-9,Not Classified,Notified C&L,79,Not classified:79
113849,N2-acetyl-L-asparagine,223-716-7,4033-40-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
113851,"Hexanamide, 6-bromo-",611-582-6,57817-55-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
113856,α-bromo-m-toluonitrile,248-890-1,28188-41-2,Skin Corr. 1;Eye Irrit. 2,REACH registration C&L,50,H314:50;H319:2;H312:6;H332:6;H317:6;H302:8;H318:1
113858,(S)-3-hydroxy-γ-butyrolactone,434-990-4,7331-52-4,Skin Sens. 1,Harmonised C&L,0,H317:0
113862,Ammonium 2-hydroxyethanesulphonate,260-656-0,57267-78-4,Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H319:49;H335:2;H315:47
113863,"Benzene, ethenyl-,homopolymer, brominated",618-171-0,88497-56-7,Eye Irrit. 2,Notified C&L,72,H319:33;Not classified:39
113867,"Benzo[b]naphtho[2,3-d]furan",205-955-9,243-42-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
113871,"Prunus spinosa, ext.",290-213-7,90105-94-5,Not Classified,Notified C&L,89,Not classified:88;H226:1
113873,N-(3-chloro-4-hydroxyphenyl)acetamide,223-570-4,3964-54-3,,Notified C&L,7,H319:6;H335:6;H315:6;H302:1
113876,"4-methylcyclohexanol, mixed isomers",209-664-8,589-91-3,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,2,H302:1;H336:1;H315:1;Not classified:1
113877,"2,4,6-trichloro-1,3,5-triazine;cyanuric chloride",203-614-9,108-77-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2,Harmonised C&L,0,H302:0;H317:0;H314:0;H330:0
113878,N-benzoyl-DL-glutamic acid,229-275-7,6460-81-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113882,"2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-1,3-dimethyl-1H-benzimidazole trichlorozincate",258-493-5,53350-83-7,Eye Irrit. 2,Notified C&L,2,H319:2
113884,"(E)-2,2-dimethylhept-3-ene",243-156-7,19550-75-5,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,1,H304:1;H225:1
113885,2-Bromo-5-fluorobenzoic Acid,609-678-8,394-28-5,,Notified C&L,9,H319:9;H335:7;H315:9
113886,6-phenylnicotinic acid,249-386-4,29051-44-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3,H302:2;H319:3;H335:2;H315:3
113887,potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate,406-500-9,174393-75-0,Skin Sens. 1,Harmonised C&L,0,H317:0
113893,"2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymers with γ-ω-perfluoro-C8-14-alkyl acrylate, acetates, N-oxides",610-389-4,479029-28-2,Not Classified,Notified C&L,37,Not classified:37
113898,Alimemazine,201-577-3,84-96-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H301:2;H318:2;H317:2;H302:2;H411:2
113899,Methyl (Z)-docos-13-enoate,214-305-3,1120-34-9,Not Classified,Notified C&L,28,Not classified:23;H226:5
113901,4-anilino-3-nitrobenzenesulphonamide,235-420-5,12223-84-6,Not Classified,Notified C&L,1,Not classified:1
113904,"1,1'-thiocarbonylbis(imidazole)",228-183-4,6160-65-2,,Notified C&L,11,H302:5;H319:8;H335:7;H315:8;H314:1;H317:1;Not classified:1
113906,4-(aminomethyl)aniline dihydrochloride,611-198-9,54799-03-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
113907,"4,6-dichloro-N-(1,1,3,3-tetramethylbutyl)-1,3,5-triazin-2-amine",276-309-1,72058-41-4,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,89,H318:2;H315:2;H317:86;H410:86;H373:2;H400:86;H319:84;Not classified:3
113915,"1,3-dichlorobutane",214-718-9,1190-22-3,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:43;H319:39;H335:39;H412:1
113916,2-chloro-6-nitropyridine,303-361-5,94166-64-0,,Notified C&L,1,H332:1;H319:1;H315:1
113923,"Phosphoric acid, mono- and bis(2-ethylhexyl) esters",291-933-4,90506-69-7,Skin Corr. 1B,Notified C&L,102,H314:94;Not classified:8;H302:9
113926,Fenuron,202-941-4,101-42-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,235,H410:4;H400:4;H411:168;H361:82;H319:54;H335:54;Not classified:25
113932,"(R)-methyl(α-methylphenethyl)ammonium [R-(R*,R*)]-hydrogen tartrate",298-036-7,93777-08-3,Acute Tox. 3;Carc. 2;Repr. 2,REACH registration C&L,2,H351:2;H301:2;H361:2
113933,divanadyl pyrophosphate,407-130-0,65232-89-5,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H317:0;H318:0;H411:0
113934,Disilver(1+) sulphite,236-714-6,13465-98-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
113942,Benzofuran-2-carboxaldehyde,224-248-6,4265-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
113944,Ethyl (triphenylphosphoranylidene)acetate,214-151-7,1099-45-2,Acute Tox. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,3,H300:1;H317:1;H373:1;H319:2;H411:1;Not classified:1;H301:1;H335:1;H315:1
113947,"1H-Benz[de]isoquinoline-2(3H)-propanaminium, N-[2-hydroxy-3-(2-propen-1-yloxy)propyl]-6-methoxy-N,N-dimethyl-1,3-dioxo-, hydroxide (1:1)",608-131-0,276878-97-8,Not Classified,Notified C&L,11,Not classified:11
113951,Bis(D-glycero-D-ido-heptonato)magnesium,270-642-6,68475-44-5,Not Classified,Notified C&L,8,Not classified:8
113955,N-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitrovinylidenediamine hydrochloride,266-333-0,66357-59-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,76,H334:70;H315:65;H335:70;H317:71;H319:66;Not classified:3;H302:2;H312:1
113960,[No public or meaningful name is available],921-908-1,,Eye Dam. 1,Notified C&L,1,H318:1
113962,"1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea",600-215-5,101463-69-8,Acute Tox. 4,Notified C&L,43,H332:38;H410:4;H411:1;H400:2;H362:2
113968,Scandium(3+) acetate,223-274-5,3804-23-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
113969,(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid,410-430-4,117573-89-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
113971,Ethylene dibenzoate,202-338-6,94-49-5,Aquatic Chronic 2,REACH registration C&L,6,H411:6
113976,4-(Aminomethyl)cyclohexanamine (cis- and trans- mixture),603-740-8,13338-82-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
113981,2-bromochlorobenzene,211-775-1,694-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:51;H335:44;H315:51;H312:4;H332:2;H302:2
113982,"9-Octadecenoic acid (Z)-, di- and triesters with glycerol",295-070-4,91782-95-5,Not Classified,Notified C&L,1,Not classified:1
113985,trans-1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-L-proline,255-490-0,41672-81-5,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H319:2
113987,Sodium trimethylsilanolate,241-939-8,18027-10-6,Skin Corr. 1B,Notified C&L,40,H314:40
113988,"1-[2-(dimethylamino)ethyl]-1,2-dihydro-5H-tetrazole-5-thione",262-868-9,61607-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:43;H335:41;H315:43;Not classified:7;H228:1;H332:1;H302:1;H312:1
113993,Disodium Laureth Sulfosuccinate,609-656-8,39354-45-5,Eye Irrit. 2,Notified C&L,132,H319:70;H318:48;H315:18
113995,4-tert-butylpyrocatechol,202-653-9,98-29-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2604,H318:336;H312:2282;H314:2573;H317:833;H411:2424;H302:2283;H400:272;H311:489;H410:158;Not classified:29;H319:4;H315:4;H335:4;H332:1;H351:1;H361:1
113999,"Methyl 2,6-dichlorophenylacetate",259-221-8,54551-83-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
114000,Trichloro-p-tolylsilane,211-854-0,701-35-9,Skin Corr. 1A,REACH registration C&L,44,H314:44;H318:38
114001,"3-(phenylazo)pentane-2,4-dione",260-089-9,56276-49-4,Acute Tox. 4,Notified C&L,42,H302:38;H319:4;H335:4;H315:4
114003,"2,4-dichloropyridine",247-717-7,26452-80-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,46,H302:43;H317:39;H318:39;H315:45;H335:5;H311:6;H319:6;H301:3;H331:2;H314:1
114005,"Fatty acids, C8-18 and C18-unsatd.",266-929-0,67701-05-7,Not Classified,REACH registration C&L,972,Not classified:85;H314:28;H318:384;H319:503;H315:398
114006,11-aminoundecanoic acid,219-417-6,2432-99-7,Not Classified,REACH registration C&L,85,Not classified:85
114007,Sulfathiazole,200-771-5,72-14-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,144,H319:137;H335:136;H315:137;Not classified:5;H334:1;H302:1
114010,1-[2-(ethylphenylamino)ethyl]pyridinium chloride,238-381-2,14408-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114011,"1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]-",610-979-1,53207-58-2,Aquatic Chronic 3,Notified C&L,84,H412:83;Not classified:1;H402:1
114012,Butyl valerate,209-728-5,591-68-4,Flam. Liq. 3,Notified C&L,1415,H226:1286;Not classified:88;H319:41;H335:40;H315:41
114013,"2,4-dimethyl-1,3-dioxane",212-162-1,766-20-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H302:38;H319:39;H225:2
114016,Sulfogaiacol,215-314-5,1321-14-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,15,H332:8;H302:15;H319:15;H315:15;H335:1
114020,3-(chloromethyl)-1-methylpiperidine,258-108-0,52694-50-5,,Notified C&L,1,H314:1
114021,"4-nitro-2,6-xylenol",219-353-9,2423-71-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
114022,Scandium,231-129-2,7440-20-2,Flam. Sol. 1,Notified C&L,52,H228:45;Not classified:5;H224:2
114028,"Poly(oxy-1,2-ethanediyl), .alpha.-[2-[3,6-bis(diethylamino)xanthylium-9-yl]benzoyl]-.omega.-hydroxy-, hydrogensulfate (consisting of 50 wt % or more of species of the same m. wt.)",600-295-1,102286-62-4,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H412:83;H302:83;H318:83
114033,"Bulnesia sarmienti, ext., dehydrated",305-068-8,94333-89-8,Not Classified,Notified C&L,2,Not classified:1;H304:1;H319:1;H315:1
114034,"9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, sulfated, sodium salt",270-951-6,68511-91-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H319:29;H315:29;Not classified:2
114040,Sodium diethyldithiocarbamate,205-710-6,148-18-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,57,H319:8;H400:22;H315:10;H302:40;H335:5;H318:2;Not classified:1
114042,3-(dimethylamino)-1-propanol hydrochloride,601-495-1,117829-74-0,Not Classified,Notified C&L,84,Not classified:84
114044,Androstanolone,208-307-3,521-18-6,Carc. 2;Repr. 1B,Notified C&L,58,H351:57;H360:56;H312:3;H332:3;H302:4;H334:1;H317:1;H341:1
114046,"Potassium [2S-[2α,5α,6β(S*)]]-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",226-182-3,5321-32-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H317:39;H334:39
114050,TSE-5 HCl,456-210-1,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H317:1;H411:1
114054,"2,2'-bi-1H-imidazole",207-768-8,492-98-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H302:1;H314:1;H360:1
114057,"Amides, coco, N-[3-(dimethylamino)propyl]",268-771-8,68140-01-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,763,H318:582;H400:694;H315:443;H302:229;H314:196;H319:126;H410:68;H317:28;H301:14
114059,p-allylphenol,207-929-2,501-92-8,Skin Mild Irrit. 3;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H316:1;H319:1;H335:1
114072,Silver permanganate,232-040-1,7783-98-4,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,38,H272:38;H312:38;H332:38;H302:38;H319:38
114073,Ethylidynetrimethanol,201-063-9,77-85-0,Not Classified,REACH registration C&L,54,Not classified:47;H319:7;H335:7;H315:7;H302:1
114074,Pyridoxamine phosphate,208-471-6,529-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
114075,"1-phenyl-3-(1,2,3-thiadiazol-5-yl)urea",257-356-7,51707-55-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,134,H315:130;H312:131;H335:130;H332:128;H319:130;H411:1
114076,2-amino-5-chloro-2'-fluorobenzophenone,212-316-8,784-38-3,Not Classified,REACH registration C&L,50,Not classified:6;H319:44;H335:43;H315:44
114077,"3,3-dimethyl-8,9-dinorbornan-2-yl benzoate",259-463-4,55066-54-1,Not Classified,Notified C&L,88,Not classified:88
114081,Ethyl 3-((1-(4-methylamino-3-nitrophenyl)methanoyl)pyridin-2-yl-amino)propionate,454-450-1,,Aquatic Chronic 3,Notified C&L,2,H412:2
114083,Isooctyldinitrophenol,253-410-9,37224-61-6,Acute Tox. 4;Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H361:1;H332:1;H410:1;H302:1;H400:1
114086,"1,3-Benzenedimethanol, 5-(1,1-dimethylethyl)-2-hydroxy-",606-902-6,2203-14-7,Not Classified,Notified C&L,104,Not classified:104
114087,Isobutyl heptanoate,231-940-1,7779-80-8,Not Classified,Notified C&L,1,Not classified:1
114089,"N,N'-dimethylpropane-1,3-diamine",203-859-1,111-33-1,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,51,H314:51;H225:49;H318:3;H312:1;H226:1;H332:1;H302:1;H224:1
114092,N-[5-(methylsulphonyl)-2-[(2-nitrophenyl)thio]phenyl]formamide,298-152-8,93778-18-8,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2;H317:2;H302:2;H319:2
114093,"Oxirane, 2-methyl-, polymer with oxirane, mono[2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl] ether",605-745-0,174955-61-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,114,H302:114;H318:114
114096,"R-2,3-epoxy-1-propanol",404-660-4,57044-25-4,Self-react. C;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Muta. 2;Carc. 1B;Repr. 1B,Harmonised C&L,0,H312:0;H331:0;H360:0;H242:0;H314:0;H350:0;H302:0;H341:0
114097,"2,2-dimethyl-1,3-benzodioxol-4-ol",400-900-7,22961-82-6,Eye Dam. 1,Harmonised C&L,0,H318:0
114102,"3,5-bis(trifluoromethyl)phenylacetic acid",285-295-6,85068-33-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
114105,"1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one",244-240-6,21145-77-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,354,H302:347;H410:346;H400:309;Not classified:5;H411:3
114106,"Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;Gasoil - unspecified;[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 °C to 371 °C (550 °F to 700 °F).]",270-721-5,68477-30-5,Carc. 1B,Harmonised C&L,0,H350:0
114107,"(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl",601-339-2,114977-28-5,Repr. 2,Notified C&L,11,H361:5;H362:2;Not classified:2;H360:4;H372:4;H341:9;H319:7;H351:2;H413:1;H373:1
114110,"Bastnaesite, acid-insol. fraction, cerium rich",272-692-4,68909-12-6,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H317:1;H318:1;H411:1;Not classified:1
114118,"1-(4-amino-3,5-dichlorophenyl)ethan-1-one",253-368-1,37148-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
114120,(2-butoxyethyl)benzene,226-226-1,5331-14-6,Not Classified,Notified C&L,1375,Not classified:1375
114121,"N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-tripropanamine",240-004-1,15875-13-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,230,H312:165;H318:187;H315:132;H314:98;H412:3;H332:1;H302:1
114128,"Fatty acids, C14-18 and C16-18-unsatd., mixed esters with castor oil, castor oil fatty acids, 2-ethylhexanoic acid and 2,2-bis(hydroxymethyl)-1-butanol",295-653-3,92113-48-9,Not Classified,REACH registration C&L,1,Not classified:1
114132,"Methyl 2,6-dihydroxy-p-toluate",240-870-0,16846-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114133,Chamomile ester,430-060-7,,Not Classified;Not Classified,Notified C&L,26,Not classified:26
114136,"2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with eicosyl 2-methyl-2-propenoate, 1-ethenyl-2-pyrrolidinone, hexadecyl 2-methyl-2-propenoate, 2-methylpropyl 2-methyl-2-propenoate and pentadecyl 2-methyl-2-propenoate",613-161-2,63150-06-1,Not Classified,Notified C&L,6,Not classified:6
114137,2-acetoxybenzoyl chloride,226-899-1,5538-51-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H302:45;H314:46;H290:1;H318:1;Not classified:1
114138,"Urs-12-ene-3β,28-diol",208-888-3,545-46-0,Not Classified,Notified C&L,3,Not classified:3
114140,"1-(4-amino-3,5-dichlorophenyl)-2-bromoethan-1-one",253-367-6,37148-47-3,Not Classified,Notified C&L,1,Not classified:1
114142,N-(hydroxymethyl)phthalimide,204-241-4,118-29-6,Not Classified,Notified C&L,38,Not classified:33;H319:5;H335:5;H315:5
114143,MCPA-thioethyl (ISO);,246-831-4,25319-90-8,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H373:0;H400:0
114149,"3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate",226-501-6,5413-60-5,Not Classified,Notified C&L,1763,Not classified:941;H412:822;H226:442
114150,"5-(1,1-dimethylethyl)[1,1'-biphenyl]-2-ol",209-419-5,577-92-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H317:33;H410:33;H400:33
114153,"Phosphoric acid, C12-14-alkyl esters, compds. with triethanolamine",291-895-9,90506-35-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
114158,"Protein hydrolyzates, soya",271-770-5,68607-88-5,Not Classified,REACH registration C&L,227,Not classified:227
114160,"Amines, soya alkyl, ethoxylated",612-399-4,61791-24-0,Acute Tox. 4,Notified C&L,192,H302:133;H318:64;H411:61;Not classified:58;H400:2;H315:4
114161,"Methanone, [5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)phenyl](2-chlorophenyl)-",611-110-9,54196-61-1,Not Classified,REACH registration C&L,1,Not classified:1
114165,"Tetradecyl 4'-(6-tert-butyl-7-chloro-3H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)succinanilate",412-600-3,,Not Classified,Notified C&L,1,Not classified:1
114169,Cobalt dithiocyanate,221-156-8,3017-60-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H312:44;H332:44;H410:44;H302:44;H400:44
114170,Florex,614-980-8,69486-14-2,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,167,H302:167;H411:167
114172,"Proteins, blood, heme-free",293-516-2,91080-24-9,Not Classified,Notified C&L,22,Not classified:22
114173,"Fatty acids, tall-oil, compds. with polyalkylenepolyamines",272-767-1,68911-35-3,Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,26,H314:22;H317:22;H410:22;H319:3;H335:3;H315:3;Not classified:1
114174,"2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol",253-057-0,36483-57-5,Aquatic Chronic 3,Notified C&L,141,H412:83;H319:37;H302:16;H341:16;H350:8;H340:8;Not classified:5
114178,4-(2-aminoethyl)benzenesulphonamide,252-501-0,35303-76-5,Acute Tox. 4,REACH registration C&L,20,H302:13;H318:4;H314:6;H315:3;H312:2;H335:3;H332:2;H319:2
114179,1-Brom-4-(4-trans-pentylcyclohexyl)-benzol,616-745-5,79832-89-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,3,H318:2;H413:2;Not classified:2;H315:2;H335:2;H302:1
114180,"N-(2,2-dimethoxyethyl)prop-2-enamide",610-472-5,49707-23-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H302:39;H317:38
114195,Perfluorohexanesulphonyl fluoride,207-026-3,423-50-7,Skin Corr. 1B,Notified C&L,1,H314:1
114198,N-(2-hydroxyethyl)dodecanamide,205-560-1,142-78-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,502,H319:6;H411:6;H318:496;H315:43;H335:2
114201,"1H-Pyrrole-3-carbonitrile, 4-(2,3-dichlorophenyl)-",616-132-2,74738-17-3,Acute Tox. 4,Notified C&L,127,H332:127
114203,"Thuya orientalis, ext.",294-870-0,91770-83-1,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1388,H304:1369;H226:1388;H317:1388;H302:1383;H411:1388
114206,2-amino-2-methylpropanol,204-709-8,124-68-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0;H315:0
114208,Dibehenoylethylmethylamine,619-968-6,145365-96-4,Skin Irrit. 2,Notified C&L,31,H315:31
114211,3-pyridylacetic acid,207-928-7,501-81-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H302:39;H319:44;H335:43;H315:44
114212,Decamethylcyclopentasiloxane,208-764-9,541-02-6,Not Classified,REACH registration C&L,4566,Not classified:4348;H413:153;H315:53;H319:41;H331:20;H304:5;H335:9;H361:5;H226:1
114213,"1,2-dibromo-[1,1,2,2-2H4]ethane",245-102-8,22581-63-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B,Notified C&L,42,H330:38;H301:42;H315:42;H311:42;H335:42;H350:42;H319:42;H331:4;H411:4
114214,quinolin-8-ol;8-hydroxyquinoline,205-711-1,148-24-3,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H301:0;H318:0;H360:0;H410:0;H317:0;H400:0
114215,"2-bromo-1,4-dimethoxybenzene",246-756-7,25245-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H319:72;H335:71;H315:72
114216,"Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-hexadecanoate monohydrochloride",607-740-9,25507-04-4,Eye Irrit. 2,Notified C&L,9,H319:9
114217,"1,6-diiodohexane",211-073-5,629-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:39;H315:44;H332:1;H302:1;H312:1
114220,"Hydrogen [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]cobaltate(1-)",257-806-2,52277-73-3,Not Classified,Notified C&L,1,Not classified:1
114225,Disilane,216-466-5,1590-87-0,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,185,H220:185;H280:185;H350:40;H340:40;H334:38;H315:38;H312:38;H335:38;H332:64;H319:38
114227,"Cyclohexane-1,2,4-triyltris(ethylene)",220-668-9,2855-27-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;STOT SE 3;Muta. 1B;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,127,H304:2;H340:2;H315:127;H226:2;H317:87;H410:4;H350:2;H336:4;H400:4;H411:84;H319:39;H335:38
114233,"Fatty acids, C9-13-neo-, zinc salts",295-363-7,92044-84-3,Aquatic Chronic 3,REACH registration C&L,5,H412:4;Not classified:1
114234,"2,2-bis[[(mercaptoacetyl)oxy]methyl]-1,3-propanediyl bis(mercaptoacetate)",233-482-8,10193-99-4,Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,42,H312:2;H332:2;H317:2;H302:2;H411:2;H319:39;H335:38;H315:39;Not classified:1
114235,"3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate",617-915-1,86770-31-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
114239,"4,6-dichloro-1,3,5-triazin-2(1H)-one",239-890-2,15791-08-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H335:1;H332:1;H302:1;H319:1
114240,Calcium dodecylbenzenesulphonate,247-557-8,26264-06-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,2087,H413:980;H302:612;H318:1977;H315:1996;H412:193;H411:125;H312:78;Not classified:50;H332:23;H319:21;H310:1
114241,α-methylpyridine-3-methanol,225-280-3,4754-27-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H312:2;H335:2;H332:2;H302:2;H319:2
114245,"4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane",423-230-7,56552-15-9,Eye Dam. 1,Harmonised C&L,0,H318:0
114249,5-methoxy-o-toluidine,256-816-4,50868-72-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H312:39;H335:39;H332:39;H302:40;H319:40
114251,"2,3-epoxypropyl acrylate;glycidyl acrylate",203-440-3,106-90-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0,H301:0;H331:0;H311:0;H314:0;H317:0
114255,"Fatty acids, tallow, zinc salts",270-451-8,68440-34-6,Not Classified,REACH registration C&L,3,Not classified:3
114256,N-acetylimidazole,219-577-7,2466-76-4,,Notified C&L,4,H319:4;H335:4;H315:4
114257,"Oxybis(2,1-ethanediyloxy-2,1-ethanediyl)diacrylate",241-789-3,17831-71-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,152,H302:105;H317:98;H318:67;H315:112;H314:40;H335:33;H319:47;H411:33
114260,"Octahydro-4,7-methano-1H-indene-5,-dimethylamine",278-428-4,76364-76-6,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
114262,Levamisole,238-836-5,14769-73-4,Acute Tox. 4,Notified C&L,195,H302:194;H332:1;H301:1
114266,ethyl (S)-2-hydroxypropionate;ethyl L-lactate;ethyl-(S)-lactate,211-694-1,687-47-8,Flam. Liq. 3;Eye Dam. 1;STOT SE 3,Harmonised C&L,0,H226:0;H318:0;H335:0
114268,"Extract residues (coal), light oil alk., indene naphtha fraction;Light Oil Extract Residues, high boiling;[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155°C to 180°C (311°F to 356°F). Composed primarily of indene, indan and trimethylbenzenes.]",292-626-8,90641-03-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
114270,2-bromo-1-fluoro-4-nitrobenzene,211-855-6,701-45-1,Acute Tox. 4,Notified C&L,40,H302:38;H319:2;H315:2;H335:1
114273,"Disodium 2-[[5-carbamoyl-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridyl]azo]-4-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulphonate",281-619-5,84000-63-5,Not Classified,REACH registration C&L,44,Not classified:37;H318:5;H315:5;H334:3
114276,"Benzene, dibromoethyl Benzene, ethenyl-, ar-bromo derivs.",603-094-7,125904-11-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,7,H411:7;H319:7;H335:7;H315:7
114283,5-methylcytosine,209-058-3,554-01-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H317:38;H319:39;H302:1;H335:1;H315:1
114285,5-fluoro-1H-indole,206-917-4,399-52-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,202,H319:202;H335:201;H315:202
114286,hydrogen bromide,233-113-0,10035-10-6,Press. Gas;Skin Corr. 1A;STOT SE 3,Harmonised C&L,0,Not classified:0;H314:0;H335:0
114287,"Carbamic acid, N-[(1S,3S)-3-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methyl-1-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-dimethylethyl ester",617-890-7,866030-35-5,,Notified C&L,33,Not classified:33
114288,DL-norvaline,212-082-7,760-78-1,Not Classified,Notified C&L,3,Not classified:3
114290,4-hydroxy-6-(methylamino)naphthalene-2-sulphonic acid,228-406-5,6259-53-6,Not Classified,REACH registration C&L,2,Not classified:2
114292,"[2-(29H,31H-phthalocyaninylmethyl)-1H-isoindole-1,3(2H)-dionato(2-)-N29,N30,N31,N32]copper",255-925-4,42739-64-0,Not Classified,REACH registration C&L,17,Not classified:17
114294,Methyl thio-2-furoate,237-177-0,13679-61-3,Acute Tox. 4,Notified C&L,1446,H302:1287;Not classified:159
114296,1-Methyl-3-propylimidazolium Bis(trifluoromethanesulfonyl)imide,619-549-8,216299-72-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,40,H314:39;H301:39;H411:39;H311:39;H319:1;H315:1
114304,Geranyl valerate,233-869-1,10402-47-8,Not Classified,Notified C&L,88,Not classified:88
114308,"4-trans-Propyl-4-trans-vinyl-[1,1-bicylohexyl]",601-409-2,116020-44-1,Skin Irrit. 2;Repr. 1B,Notified C&L,1,H360:1;H315:1
114309,4-hydroxy-1-methyl-3-[(4-nitrophenyl)azo]-2-quinolone,233-310-1,10114-46-2,Not Classified,REACH registration C&L,1,Not classified:1
114310,2-methylbutan-1-ol,205-289-9,137-32-6,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,2013,H318:290;H315:527;H226:727;H335:2007;H332:2001;H319:61;H302:28;H331:10;Not classified:2
114319,4-(dichloromethylsilyl)butyronitrile,214-717-3,1190-16-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,40,H302:39;H314:39;H315:1;Not classified:1;H312:1;H335:1;H319:1
114321,"Fatty acids, coco, triesters with pentaerythritol",294-306-3,91697-45-9,Not Classified,Notified C&L,1,Not classified:1
114333,"4,4'-oxybisbutan-2-ol",212-475-3,821-33-0,Not Classified,Notified C&L,1,Not classified:1
114334,"2-Propenoic acid, 2-methyl-, 2-[(1,1-dimethylethyl)amino]ethyl ester, polymer with methyl 2-methyl-2-propenoate, 1,2-propanediol mono(2-methyl-2-propenoate), 2-propenoic acid and N-(1,1,3,3-tetramethylbutyl)-2-propenamide",615-171-2,70801-07-9,Not Classified,Notified C&L,36,Not classified:36
114335,"2-(4-bromo-3-hydroxy-2-quinolyl)-1H-indene-1,3(2H)-dione",233-701-7,10319-14-9,Skin Sens. 1B,REACH registration C&L,2104,H317:16;Not classified:2088
114337,Aluminum sulfate (Al2(SO4)3) hydrate (1:14),605-512-3,16828-12-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,70,H412:38;H319:70;H335:38;H315:38;H410:32;H400:32
114342,Dimethylbis(octadecyloxy)silane,249-385-9,29043-70-7,Not Classified,REACH registration C&L,2,Not classified:2
114347,"L-Glutamic acid, N-(oxooctyl)-, sodium salt (1:2)",605-493-1,167888-81-5,Eye Irrit. 2,Notified C&L,1,H319:1
114349,DL-arabinose,243-619-3,20235-19-2,Not Classified,Notified C&L,26,Not classified:26
114350,Tetraaluminium trichloride nonahydroxide,234-310-4,11089-92-2,Skin Mild Irrit. 3;Eye Irrit. 2,Notified C&L,4,H320:4;H316:4
114351,Diammonium hexachlorostannate,241-033-2,16960-53-5,,Notified C&L,5,H412:5;H319:5;H335:5;H315:5
114353,"6-(isononanoylamino)hexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",288-270-8,85702-79-0,Not Classified,Notified C&L,41,Not classified:41
114354,"2-isopropyl-4-methyl-1,3-dioxolane",267-550-3,67879-60-1,Flam. Liq. 3,Notified C&L,117,H226:117
114355,"Terpenes and Terpenoids, mixed sour and sweet orange-oil",614-800-8,68917-57-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,96,H304:71;H315:96;H226:71;H317:71;H410:51;H400:51;H411:20
114357,"3,7-bis(diethylamino)phenoxazin-5-ium nitrate",277-539-5,73570-52-2,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,123,H301:97;H318:97;H331:33;H410:72;H400:72;Not classified:26;H411:25
114359,Copper bis(trimethylphosphine)(tetrahydroborate),240-951-0,16903-61-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
114363,"Molybdenum, bis(dibutylcarbamodithioato)di-μ-oxodioxodi-, sulfurized",270-180-5,68412-26-0,Aquatic Chronic 4,REACH registration C&L,525,H413:5;H330:443;Not classified:61;H412:14;H319:2
114373,1-bromo-3-chloro-2-methylpropane,230-224-6,6974-77-2,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,52,H302:52;H319:45;H315:40;H312:39;H335:40;H332:44;H412:6
114376,Flumetasone 21-pivalate,217-901-1,2002-29-1,Carc. 2,Notified C&L,42,H351:38;H362:1;H373:1;H361:3;H413:2;H315:1;H312:1;H335:1;H332:1;H302:1;H319:1
114378,Phloroglucinol,203-611-2,108-73-6,Aquatic Chronic 3,REACH registration C&L,102,H412:9;H317:43;H319:86;H335:86;H315:87;H341:11;H361:11;Not classified:4;H318:1;H301:1
114384,Tiamulin,259-580-0,55297-95-5,Aquatic Chronic 4,Notified C&L,44,H413:38;Not classified:3;H319:3;H335:2;H315:1
114387,Ranitidine,266-332-5,66357-35-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,REACH registration C&L,10,H317:10;H334:10;H319:9;H315:9;H302:1;H335:1
114389,"Polymer, 2-Propennitril mit 1,3 Butadien, carboxyterminierte Polymer mit 2,2´-[(2,2-dimethyl-1,3 propandiyl)bis(oxymethylen))bisoxiran",614-765-9,68909-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,106,H319:103;H335:103;H315:104;Not classified:2;H317:1
114391,4-methylcyclohexanone,209-665-3,589-92-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,205,H302:204;H226:205;H318:159;H314:159;H315:1;H336:1;H319:1
114394,10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine,201-578-9,84-97-9,,Notified C&L,3,H332:2;H302:3
114395,Decyldimethylamine,214-302-7,1120-24-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,278,H302:276;H410:91;H314:238;H400:157;H318:55;H315:38;H312:1;H332:1
114396,Pyridine 1-oxide,211-774-6,694-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:4
114398,"2,4-bis(xylylazo)resorcinol",249-495-7,29190-28-1,Not Classified,Notified C&L,256,Not classified:199;H319:57
114399,Ammonium hexafluorotitanate,241-036-9,16962-40-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,51,H332:45;H302:45;H312:45;H319:5;H335:5;H315:5;Not classified:1
114402,(2S)-2-aminobutanamide hydrochloride,616-393-2,7682-20-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H302:42;H319:42;H335:42;H315:42
114403,Sodium p-[(4-amino-5-methoxy-o-tolyl)azo]benzenesulphonate,222-837-2,3626-35-5,Not Classified,Notified C&L,1,Not classified:1
114404,[No public or meaningful name is available],619-687-9,154186-23-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H317:1
114406,"Benzenamine, reaction products with nitrobenzene, neutralized, sulfonated, sodium salts",309-485-6,100402-49-1,Not Classified,Notified C&L,1,Not classified:1
114408,"(E)-1,4-dibromobut-2-ene",212-472-7,821-06-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Carc. 1B;Aquatic Chronic 2,Notified C&L,129,H330:84;H301:128;H318:86;H311:85;H314:129;H317:85;H350:84;H411:84;H300:1;H331:2;H341:1
114412,1-bromo-2-naphthoic acid,243-984-9,20717-79-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
114415,Isopentyl dihydrogen phosphate,219-575-6,2466-67-3,Not Classified,Notified C&L,7,Not classified:5;H314:2
114418,"Proteinase, Staphylococcus aureus serine",259-611-8,55354-32-0,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H334:1;H319:1;H335:1;H315:1
114421,6-hydroxy-2-oxopyridinium chloride,233-777-1,10357-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
114422,Methyl phenylacetate,202-940-9,101-41-7,Not Classified,REACH registration C&L,1628,Not classified:1625;H319:3;H315:2
114428,"Carrageenanase, κ-",253-447-0,37288-59-8,Resp. Sens. 1,Notified C&L,5,H334:5
114429,N-Succinimidyl Tetradecanoate,615-020-0,69888-86-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
114435,Thulium trihydroxide,215-190-2,1311-33-7,Not Classified,Notified C&L,2,Not classified:2
114436,"Anisyl alcohol (o-,m-,p-)",215-561-9,1331-81-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,137,H302:137;H317:137;H318:137
114439,"[6R-[6α,7β(Z)]]-7-[2-furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",260-086-2,56271-94-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H317:3;H334:3
114440,Methohexital,205-798-6,151-83-7,Acute Tox. 3,Notified C&L,38,H301:38
114445,Rubidium,231-126-6,7440-17-7,Water-react. 1;Skin Corr. 1B,Notified C&L,78,H314:73;H260:77;Not classified:1;H318:1
114448,N-((S)-carbethoxybutyl)-L-alaninyl chloride hydrochloride,617-943-4,869877-95-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
114450,"Myo-Inositol, hexakis(dihydrogen phosphate), dodecasodium salt",241-253-9,17211-15-3,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,3,H302:2;H314:2;H318:2;Not classified:1
114453,"Petrolatum (petroleum), carbon-treated;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C",308-149-6,97862-97-0,Carc. 1B,Harmonised C&L,0,H350:0
114463,N-cyanobenzamide,239-210-4,15150-25-1,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H335:1;H315:1
114464,"2,5-difluorobenzophenone",285-298-2,85068-36-6,,Notified C&L,7,H319:7;H335:6;H315:7
114465,4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidinehydrochloride,618-135-4,882737-42-0,Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,2,H332:1;H302:1;H361:2;H301:1
114466,"Benzene, 1,3-diisocyanatomethyl-, homopolymer",618-500-8,9017-01-0,Resp. Sens. 1,Notified C&L,103,H334:57;H317:43;H319:29;Not classified:5;H315:1
114467,"Phosphonic acid, perfluoro-C6-12-alkyl derivs.",270-204-4,68412-68-0,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
114473,"1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone",617-850-9,86404-63-9,Not Classified,REACH registration C&L,36,Not classified:5;H317:29;H412:1;H301:1;H360:1;H351:1;H373:1;H302:1;H319:1;H335:1;H315:1
114476,"Propanedioic acid, 1,3-diethyl ester, reaction products with 1,6-diisocyanatohexane homopolymer, ethyl acetoacetate, 2-ethyl-1,3-hexanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane homopolymer",600-347-3,102763-23-5,Not Classified,Notified C&L,25,Not classified:25
114479,2-(2-butoxyethoxy)ethyl acetate,204-685-9,124-17-4,Not Classified,REACH registration C&L,376,Not classified:315;H317:34;H319:60;H335:35;H315:36;H334:1;H413:1
114485,"Amides, from tall-oil fatty acids and tetraethylenepentamine",268-945-3,68155-17-9,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,112,H314:87;H410:87;H318:85;H400:84;Not classified:16;H319:8;H315:7;H317:4;H335:1;H411:1
114486,"Pepper (Piper), P. cubeba, ext.",290-148-4,90082-59-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1414,H412:1388;H304:1389;H317:1389;H315:25;H226:14;H411:1
114496,"1,2-Benzenedicarboxylic acid, di-C1-13 alkyl esters, manuf. of, by-products from, distn. lights",284-310-3,84852-02-8,Not Classified,REACH registration C&L,2,Not classified:1;H360:1
114497,3-Acetoxymethyl-4-acetoxyacetophenon,607-317-9,24085-06-1,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H272:1;H318:1;H373:1;H315:1;H317:1;H410:1;H302:1;H400:1
114498,α-hydroxypyridine-2-methanesulphonic acid,222-089-7,3343-41-7,Skin Corr. 1B,Notified C&L,38,H314:38
114502,L-threonine,200-774-1,72-19-5,Not Classified,REACH registration C&L,133,Not classified:132;H319:1;H335:1;H315:1
114503,"Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt",229-390-2,6505-30-2,Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H319:1;Not classified:1
114506,"2,4,6-tribromophenyl methacrylate",253-642-0,37721-71-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H302:38;H319:38;H413:38
114507,"Soaps, stocks, C8-18 and C18-unsatd. alkyl, acidulated",272-859-1,68918-39-8,Not Classified,Notified C&L,1,Not classified:1
114513,"Naphtha (petroleum), hydrotreated light steam-cracked;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",295-438-4,92045-57-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
114525,"N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide",223-277-1,3808-20-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:39;H319:40;Not classified:1;H413:1;H335:1;H315:1
114528,"Trisodium 4-amino-3-[[4-[[4-[(2-amino-4-hydroxyphenyl)azo]phenyl]amino]-3-sulphonatophenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",288-038-6,85631-88-5,,Notified C&L,210,H412:95;Not classified:95;H319:19;H317:1
114530,4-fluoro-N-(propan-2-yl)aniline,619-821-6,70441-63-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Notified C&L,1,H302:1;H317:1;H335:1;H315:1
114531,"N,N-dimethyl-4-(phenylazo)-m-toluidine",200-217-2,54-88-6,Acute Tox. 4;Carc. 2;Aquatic Chronic 4,Notified C&L,39,H351:38;H302:39;H413:38
114533,[No public or meaningful name is available],620-129-1,473584-06-4,Acute Tox. 4,Notified C&L,3,H302:3
114539,"4-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)cyclohexan-1-ol",266-100-3,66068-84-6,Not Classified,REACH registration C&L,361,Not classified:2;H319:280;H315:323;H411:75;H400:35
114544,"Hydrocarbons, C14-C16, n-alkanes, <2% aromatics",921-535-4,,Asp. Tox. 1,REACH registration C&L,1,H304:1
114545,Zinc diricinoleate,235-911-4,13040-19-2,Not Classified,REACH registration C&L,205,Not classified:66;H319:137;H410:2;H400:2
114548,CR-144,615-678-9,71878-19-8,Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,127,H330:70;H319:65;H335:64;Not classified:39;H413:17
114551,2-bromopropiophenone,218-307-5,2114-00-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:41;H335:39;H315:41;H314:4;H331:6;H312:1;H332:1;H302:1
114553,"N-carboxyglycine, compound with glycine (1:1), disodiumsalt",302-746-5,94133-82-1,Not Classified,Notified C&L,1,Not classified:1
114555,"Fatty acids, C12-16, Me esters",287-638-5,85566-27-4,Not Classified,Notified C&L,7,Not classified:7
114557,"Tripotassium 1,1',1''-nitrilotris(ethanesulphonate)",282-374-7,84195-68-6,Not Classified,Notified C&L,83,Not classified:83
114563,"1-(2,4-dichloro-5-fluorophenyl)ethanone",615-113-6,704-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;Not classified:1
114564,"Fatty acids, vegetable-oil, esters with triethylene glycol",305-773-0,95009-44-2,Not Classified,Notified C&L,2,Not classified:2
114566,"1H-Pyrrole-2,5-dione, 3,4-dichloro-1-(4-fluorophenyl)-",609-898-4,41205-21-4,Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,38,H318:38;H331:38;H411:38
114567,Sodium methacrylate,226-896-5,5536-61-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,87,H318:38;H311:38;H332:38;H335:82;H314:38;H302:38;H319:45;H315:45;Not classified:4
114569,o-diethylbenzene,205-170-1,135-01-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,992,H304:920;H315:985;H226:992;H335:985;H319:985;H411:837;H412:83
114571,"Cyclobutane-1,1-dicarboxylic acid",226-651-2,5445-51-2,Skin Corr. 1B,Notified C&L,59,H314:58;H318:1;H290:1;Not classified:1
114574,Zinc nitrate,231-943-8,7779-88-6,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,271,H272:265;H318:188;H315:268;H335:181;H411:203;H302:268;H400:244;H319:100;H410:71;H331:4;Not classified:3
114576,"Octanoic acid, copper salt",243-866-7,20543-04-8,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,3,H302:2;H410:2;H400:2;Not classified:1
114579,"Bulnesia sarmienti, ext., acetate",305-067-2,94333-88-7,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1408,H317:41;H410:41;H400:41;H315:1407;H319:1332;Not classified:1
114581,Ethyl carbazate,223-903-3,4114-31-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H301:41;H319:46;H335:44;H315:46;H300:5;H311:1;H372:1
114582,N-methyldiallylamine,219-354-4,2424-01-3,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,53,H314:47;H318:8;H225:53;H412:6;H312:6;H302:6
114584,"2-ethyl-2-[[(mercaptoacetyl)oxy]methyl]-1,3-propanediyl bis(mercaptoacetate)",233-480-7,10193-96-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:40;H312:40;H335:39;H332:40;H302:41;H319:40
114588,Perphenazine,200-381-5,58-39-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,54,H302:52;H317:49;H330:10;H318:10;H361:14;H315:3;H351:2;H319:3;H301:2;H341:1
114591,"Sodium 3,4-dioxonaphthalene-1-sulphonate",208-308-9,521-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H302:1
114593,"3,4-dichlorotoluene-α-thiol",253-054-4,36480-40-7,,Notified C&L,6,H315:6;H331:4;H335:6;H302:5;H319:6
114598,"[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl] methyl 4-chlorobenzenesulfonate",605-760-2,175712-02-4,Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H410:11;H372:10;H301:10;H400:11;H300:1
114601,"3-hexadecyldihydrofuran-2,5-dione",224-101-6,4200-91-3,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
114602,"3,5-dichloro-2,4-difluorobenzoyl fluoride",401-800-6,101513-70-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H331:0;H314:0;H317:0;H302:0
114603,Ceteth-10 phosphate,610-551-4,50643-20-4,Not Classified,Notified C&L,67,Not classified:36;H318:31;H315:31
114604,"metsulfuron-methyl (ISO);methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate",616-063-8,74223-64-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
114608,4-methyl-1-phenyl-3-pyrazolidone,220-180-6,2654-57-1,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,48,H302:9;H317:7;H410:4;H400:4;H301:38;H411:3;Not classified:1
114609,"Poly(oxy-1,2-ethanediyl), a-phosphono-[?]-(dodecyloxy)-",607-818-2,25852-45-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
114616,N-[3-(dimethylamino)propyl]stearamide phosphate,280-569-1,83721-43-1,,Notified C&L,33,Not classified:33
114617,"Amides, coco, N-(hydroxyethyl)",268-770-2,68140-00-1,Not Classified,Notified C&L,927,Not classified:568;H318:332;H302:52;H315:192;H411:49;H319:27;H413:3;H412:2;H400:2
114620,"1,1,1,2,2,3,3,4,4-nonafluoro-4-iodobutane",207-025-8,423-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:46;H335:45;H315:46;H411:10
114625,"2-[(2R)-2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione",610-200-5,446292-07-5,Not Classified,Notified C&L,3,Not classified:1;H332:1;H302:1;H312:1;H319:1;H335:1;H315:1
114626,"1,2-Dibromohexane",613-031-5,624-20-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114629,"[7S-(7α,7bα,10aα)]-N-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl)acetamide",230-009-7,6901-14-0,Acute Tox. 4,Notified C&L,39,H302:39
114630,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 2,2-dimethylpropane-1,3-diamine",500-646-8,161308-07-2,Not Classified,Notified C&L,1,Not classified:1
114632,"Fatty acids, C16-18",266-928-5,67701-03-5,Not Classified,REACH registration C&L,801,Not classified:304;H319:497;H315:497;H335:2
114635,(S)-(+)-1-aminopropan-2-ol,220-533-4,2799-17-9,Skin Corr. 1B,Notified C&L,48,H314:48;H318:2;H227:1;H312:1
114636,1-(1H-indol-3-yl)butan-1-one,245-103-3,22582-67-8,Acute Tox. 4,Notified C&L,38,H302:38
114637,sec-butyl 3-methylbutanethioate,219-416-0,2432-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1377,H319:1366;H335:1287;H315:1287;Not classified:11
114638,"2-(3,4-dihydroxyphenyl)-3-(β-D-glucopyranosyloxy)-5,7-dihydroxy-1-benzopyrylium chloride",230-384-7,7084-24-4,Not Classified,Notified C&L,2,Not classified:2
114642,"Thuya occidentalis, ext.",290-370-1,90131-58-1,Flam. Liq. 4;Acute Tox. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1677,H227:8;H304:1646;H301:1297;H315:10;H317:1661;H411:1463;H226:1631;H302:368;H412:15;H319:1
114648,Dichloroacetonitrile,221-159-4,3018-12-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,47,H302:47;H226:47;H314:47;H341:4;H318:1
114649,1-(benzyloxy)-2-bromobenzene,608-640-8,31575-75-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
114650,"Erica arborea, ext.",289-826-2,90028-36-7,Not Classified,Notified C&L,88,Not classified:88
114652,"Acetic acid, 2-[[2-chloro-4-fluoro-5-[(tetrahydro-3-oxo-1H,3H-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene)amino]phenyl]thio]-, methyl ester",601-473-1,117337-19-6,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
114654,Decyloxirane,220-667-3,2855-19-8,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,148,H410:89;H400:89;H315:148;H319:43;H335:38;H317:13
114655,2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate,402-120-2,133514-97-3,Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H410:0;H317:0;H373:0;H400:0
114660,"N,N'-dithiodi-o-phenylenedibenzamide",205-201-9,135-57-9,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,74,H317:71;H413:18;H410:54;H400:54;H319:1;H412:1
114661,"Phenol, 4-amino-, reaction products with aniline, 4-methyl-1,3-benzenediamine, p-phenylenediamine, sodium sulfide (Na2S) and sulfur",274-987-3,70892-38-5,Not Classified,REACH registration C&L,39,Not classified:39
114663,"Benzene, (tetrapropenyl) derivs.",270-954-2,68512-02-7,Not Classified,Notified C&L,228,Not classified:216;H304:8;H413:11;H312:1
114664,"2,4-dichloro-3-ethylphenol",401-060-4,121518-45-4,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H410:0;H400:0
114665,2-ethylhexanoyl chloride,212-081-1,760-67-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,139,H330:137;H318:92;H314:139;H317:49;H302:139;H290:134;H312:2;H332:2
114668,"2,6-bis[(3-methoxypropyl)amino]-4-methylnicotinonitrile",257-286-7,51560-72-6,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,116,H412:83;H330:83;H318:83;H315:116;H335:116;H312:33;H332:33;H302:33;H319:33
114670,"reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt",440-510-4,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
114674,"Poly(oxy-1,2-ethanediyl), α-(2-furanylmethyl)-ω-hydroxy-",608-660-7,31692-86-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
114675,"2,3,4,5-tetrahydro-1H-1,5-methano-3-benzazepin-3-ium chloride",607-193-6,230615-52-8,Carc. 2,REACH registration C&L,4,H351:2;Not classified:2
114676,Barium dioleate,209-726-4,591-65-1,Acute Tox. 4,Notified C&L,94,H302:92;H332:7;Not classified:2
114684,Aluminium trioctanoate,227-902-9,6028-57-5,Not Classified,Notified C&L,8,Not classified:8
114688,"N-(4-chlorophenyl)benzene-1,2-diamine",272-391-8,68817-71-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,40,H319:40;H335:40;H315:40
114689,"2,2,3,3-Tetramethylbutanedinitrile",608-859-9,3333-52-6,Acute Tox. 1;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1,Notified C&L,607,H300:585;H330:545;H315:442;H319:442;H310:545;H412:104;H370:79;H372:79;H371:40;H331:39;H311:39;H373:40;Not classified:22
114692,2-methoxybutan-1-ol,239-486-6,15467-25-1,Flam. Liq. 3,Notified C&L,1,H226:1
114693,"Extract residues (coal), tar oil alk., carbonated, limed;Crude Phenols;[The product obtained by treatment of coal tar oil alkaline extract with CO",292-629-4,90641-06-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
114699,"17-Hydroxy-3-(1-pyrrolidinyl)pregna-3,5-dien-20-one",607-261-5,23712-54-1,Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H400:1;H361:1
114705,Bis(acetato-O)dioxouranium,208-767-5,541-09-3,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,41,H300:40;H330:40;H373:40;H411:40;H332:1;H302:1;H315:1
114711,1-chloroheptane,211-070-9,629-06-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H226:71;H319:39;H335:38;H315:39;Not classified:2
114715,"2-PROPENENITRILE, POLYMER WITH 1,3-BUTADIENE, CARBOXY-TERMINATED, POLYMERS WITH BISPHENOL A AND EPICHLOROHYDRIN",680-511-9,68610-41-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,123,H317:78;H319:77;H411:103;H315:77;Not classified:11
114716,Palladium dicyanide,217-999-6,2035-66-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1,Notified C&L,42,H300:42;H330:42;H400:42;H310:42;H410:4
114718,"Antimony tris[O,O-dipropyl] tris(dithiophosphate)",240-001-5,15874-48-3,Not Classified,Notified C&L,14,Not classified:8;H315:6;H332:4;H302:4;H319:6;H411:4;H412:3
114720,"2,2-Bis(hydroxymethyl)butanoic acid",600-143-4,10097-02-6,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,40,H412:40;H318:40
114723,"Disodium 4-amino-5-hydroxy-3,6-bis[[4-[(4-hydroxyphenyl)azo]phenyl]azo]naphthalene-2,7-disulphonate",305-247-0,94386-24-0,Not Classified,Notified C&L,1,Not classified:1
114727,"9,10-Anthracenedione, 1,4-diamino-, N,N'-mixed Et and Me and 2-methoxyethyl derivs.",273-490-9,68987-39-3,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H412:2;H319:2
114730,4-methoxy-3-nitro-N-phenylbenzamide,202-572-9,97-32-5,Eye Irrit. 2,Notified C&L,39,H319:38;Not classified:1
114733,"Ethyl 2,3-epoxy-3-phenylbutyrate",201-061-8,77-83-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1859,H317:1458;H411:1458;H412:336;H226:43;H319:45;H335:43;H315:44;Not classified:21
114735,"Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;Gasoil - unspecified;[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 °C (550 °F).]",270-722-0,68477-31-6,Carc. 1B,Harmonised C&L,0,H350:0
114736,Anisyl butyrate,230-163-5,6963-56-0,Not Classified,Notified C&L,88,Not classified:88
114737,3-isopropoxypropiononitrile,203-771-3,110-47-4,Skin Irrit. 2,Notified C&L,38,H315:38
114738,copper phosphite,917-696-5,,Not Classified,Notified C&L,1,Not classified:1
114740,"(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate",256-032-2,42978-66-5,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H335:0;H317:0;H319:0;H411:0
114741,p-tolyl isovalerate,259-465-5,55066-56-3,Not Classified,Notified C&L,89,Not classified:54;H302:35
114742,"Tris(2,2,2-trifluoroethyl) phosphite",609-327-9,370-69-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
114745,"2,4,6-Trimethylbenzophenone",619-126-8,954-16-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H302:14;H410:14;H319:14;H400:14
114746,"(9R,10S,13S)-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]",611-207-6,5488-51-7,Aquatic Chronic 1,REACH registration C&L,1,H410:1
114750,Potassium O-pentyl dithiocarbonate,220-329-5,2720-73-2,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,20,H315:16;H312:9;H335:8;H228:9;H302:17;H319:11;H411:6;Not classified:2;H314:2;H250:1;H311:1;H317:1;H332:1
114751,Aniba Rosaeodora (Rosewood) Wood Oil,616-963-0,8015-77-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,55,H412:54;H317:54;H315:54;Not classified:1;H319:1
114752,Ethyl dimethylcarbamate,211-695-7,687-48-9,Acute Tox. 4;Carc. 2,Notified C&L,1,H351:1;H302:1
114753,2-bromo-1-(2-furyl)-2-nitroethylene,406-110-9,35950-52-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H314:0;H317:0;H410:0;H302:0;H400:0
114754,Sodium 2-chloro-5-nitrobenzenesulphonate,213-418-5,946-30-5,Eye Irrit. 2,Notified C&L,40,H319:39;Not classified:1
114756,(3-(trifluoromethyl)phenyl)boronic acid,604-284-2,1423-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:99;H335:98;H315:99;H332:1;H302:1;H312:1
114758,"1,4-dichloronaphthalene",217-365-9,1825-31-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,39,H302:39;H318:39;H411:39
114760,heptane;n-heptane,205-563-8,142-82-5,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H315:0;H410:0;H225:0;H336:0;H400:0
114761,"1,3,3,5,5-hexamethyltrisiloxane",214-716-8,1189-93-1,Flam. Liq. 2,Notified C&L,44,H225:44
114762,(2-hydroxypropyl)trimethylammonium chloride,219-183-5,2382-43-6,Not Classified,REACH registration C&L,38,Not classified:38
114763,"Glycerol, propoxylated, esters with acrylic acid",500-114-5,52408-84-1,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,3309,H317:2963;H319:3289;H315:146;H335:56;Not classified:6;H412:2
114764,3-pyridylamine,207-322-2,462-08-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,57,H301:48;H315:50;H311:46;H410:10;H319:50;H400:10;H331:41;H335:45;H373:39;H300:9;H312:4;H412:1;H330:1;H310:1
114765,"Bis(alkyl)methylammonium tetrakis(pentafluorophenyl)borate where alkyl is C14, C16 or C18 forming a complex reaction mixture",431-960-2,,Not Classified,Notified C&L,56,Not classified:55;H226:1;H314:1;H410:1;H302:1;H336:1;H400:1
114768,"ammonium salt of DNOC;ammonium 4,6-dinitro-o-tolyl oxide",221-037-0,2980-64-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H330:0;H410:0;H373:0;H400:0;H310:0
114771,6-methylcyclohex-3-ene-1-methanol,226-063-6,5259-31-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114772,Trimethylindium,222-200-9,3385-78-2,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,181,H314:181;H318:109;H250:181;H260:88;H261:38
114774,"1,4-Oxathiane-2,6-dione",608-761-6,3261-87-8,,Notified C&L,6,H319:4;H335:4;H315:4;H302:2
114777,Methanesulphonyl chloride,204-706-1,124-63-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT SE 3,REACH registration C&L,242,H330:242;H301:161;H318:170;H311:199;H335:142;H314:242;H317:25;H290:110;H412:39;H312:38;H302:37;H300:43;H400:24;H310:4;H371:1
114781,Quinoa extract,607-039-8,223749-71-1,Skin Sens. 1,Notified C&L,1,H317:1
114783,2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate,419-040-9,89604-92-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
114788,Aluminium sulphate,605-511-8,16828-11-8,Eye Dam. 1,Notified C&L,66,H318:65;H319:1;H335:1;H315:1
114793,Sodium 3-Morpholinopropanesulfonate,615-252-2,71119-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H335:45;H315:45;Not classified:2
114795,"Fatty acids, coco, 2-ethylhexyl esters",295-366-3,92044-87-6,Not Classified,REACH registration C&L,299,Not classified:299
114796,Indium oxide,235-765-1,12672-71-8,Not Classified,Notified C&L,2,Not classified:2
114798,"Sodium hydrogen 4-amino-5-hydroxynaphthalene-2,7-disulphonate",226-736-4,5460-09-3,Not Classified,REACH registration C&L,115,Not classified:113;H319:1;H315:1;H317:1
114799,Diethyl 2-methylglutarate,242-417-2,18545-83-0,Not Classified,Notified C&L,1,Not classified:1
114802,Kromasil C-18,615-738-4,72245-35-3,Eye Irrit. 2,Notified C&L,42,H319:42
114804,"Phosphoric acid, C3-9-alkyl esters",271-123-7,68515-98-0,Not Classified,Notified C&L,5,Not classified:3;H314:2
114805,4-allyl-2-methoxyphenyl phenylacetate,233-868-6,10402-33-2,Not Classified,Notified C&L,88,Not classified:88
114810,"2,6-Difluor-4-(trans-4-ethylcyclohexyl)-benzonitril",606-664-3,208844-07-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
114816,Isobutyl dihydrogen phosphate,219-576-1,2466-73-1,Skin Corr. 1B,Notified C&L,2,H314:2
114820,"Acid chlorides, C12-18 and C18-unsatd.",306-166-3,96507-87-8,Skin Corr. 1B,Notified C&L,1,H314:1
114823,"2,6-dichlorothiophenol",416-720-7,24966-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4;H312:1;H332:1;H302:1
114826,α-ethyl-p-fluorobenzyl alcohol,211-856-1,701-47-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
114827,Perhydroazonine,227-115-0,5661-71-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
114829,1-furfuryl-1H-pyrrole,215-876-1,1438-94-4,Acute Tox. 4,Notified C&L,1591,H302:1591;H332:38;H312:38
114832,"N,N-dimethyldecylamine N-oxide",220-020-5,2605-79-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,619,H411:84;H302:103;H318:564;H400:579;H315:535;H319:55;H335:39;H412:16;H410:3
114833,"Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, molybdatetungstatephosphate",235-424-7,12224-98-5,Not Classified,REACH registration C&L,172,Not classified:111;H410:61;H318:43;H400:58
114836,Bis(2-bromoethyl) ether,226-504-2,5414-19-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H318:46;H335:45;H315:46;H330:4;H301:4;H311:4;H351:4;Not classified:1;H360:1
114839,"1,10-phenanthroline monohydrochloride monohydrate",223-325-1,3829-86-5,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,52,H410:50;H301:48;H400:49;H332:1;H302:1;H312:1;Not classified:1
114843,"1,3-Benzenedicarboxylic acid, polymer with 1,4-benzenedicarboxylic acid and 1,2-ethanediol",607-459-1,24938-04-3,Not Classified,Notified C&L,5,Not classified:5
114845,"Dihydrogen [29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",249-494-1,29188-28-1,Not Classified,Notified C&L,1,Not classified:1
114847,Sodium (3β)-androst-5-en-17-one 3-sulphate,214-152-2,1099-87-2,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16,H332:16;H312:16;H360:16;H351:16
114849,Ethyl (Z)-docos-13-enoate,253-712-0,37910-77-3,Not Classified,Notified C&L,1,Not classified:1
114850,"(Z,Z,Z)-icosatri-8,11,14-enoic acid",217-233-0,1783-84-2,Not Classified,Notified C&L,1,Not classified:1
114863,"Extracts (petroleum) heavy naphtha solvent, clay-treated;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",308-261-5,97926-43-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
114864,hexane (containing < 5 % n-hexane (203-777-6));2-methylpentane,203-523-4,107-83-5,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H304:0;H315:0;H225:0;H336:0;H411:0
114866,"1,3,5-tris(6-isocyanatohexyl)biuret",223-718-8,4035-89-6,Not Classified,Notified C&L,203,Not classified:187;H317:16;H334:16
114875,"Glycerides, C10-20 and C10-20-unsatd., oxidized",295-734-3,92128-40-0,Not Classified,REACH registration C&L,10,Not classified:10
114878,"1,2,3,4,5,6,7,8-octahydro-8,8-dimethylnaphthalene-2-carbonitrile",277-081-6,72928-51-9,Not Classified,Notified C&L,89,Not classified:88;H319:1;H335:1;H315:1
114880,"lead acetate, basic",215-630-3,1335-32-6,Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0,H360:0;H410:0;H351:0;H373:0;H400:0
114881,Anisyl acetate,215-562-4,1331-83-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,234,H319:224;H315:224;H317:10
114884,Potassium 3-sulphopropyl methacrylate,250-466-6,31098-21-2,Skin Sens. 1A,REACH registration C&L,166,H317:1;Not classified:71;H319:94;H335:93;H315:94
114885,Lithium docosanoate,224-801-1,4499-91-6,Not Classified,REACH registration C&L,9,Not classified:9
114888,"Ethyl 3,4-dihydro-6-methyl-2H-pyran-5-carboxylate",233-543-9,10226-28-5,Flam. Liq. 3,Notified C&L,157,H226:157
114889,"Molybdenum, bis(2-ethylhexyl)carbamodithioate bis(2-ethylhexyl)carbamothioate oxo thio complexes",273-245-6,68954-53-0,Aquatic Chronic 2,Notified C&L,447,H411:446;H315:4;Not classified:1
114891,"N,N,N',N'-tetrabutylhexane-1,6-diamine",248-219-2,27090-63-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,38,H302:38;H317:38;H226:38;H314:38
114894,8-bromo-1H-adenine,230-225-1,6974-78-3,Acute Tox. 4,Notified C&L,38,H302:38
114895,"Chromate(2-), [4-hydroxy-3-[(2-hydroxy-5-nitro-3-sulfophenyl)azo]-6-[(sulfomethyl)amino]-2-naphthalenesulfonato(5-)]-, sodium",287-404-2,85507-82-0,,Notified C&L,87,H412:84;Not classified:3
114897,Ruthenium,231-127-1,7440-18-8,Not Classified,REACH registration C&L,462,Not classified:99;H228:276;H413:83;H314:3;H372:1;H315:1;H251:1
114901,"Cyclopentane-1,1-diacetic anhydride",227-116-6,5662-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
114902,Diisoundecyl phthalate,306-165-8,96507-86-7,Not Classified,Notified C&L,4,Not classified:4
114905,Furfuryl methacrylate,222-383-5,3454-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
114907,Sodium oxide,235-641-7,12401-86-4,Not Classified,Notified C&L,61,Not classified:41;H314:20;H318:20;H290:20;H335:20
114909,"2,5-dimethylpyridine",209-666-9,589-93-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H312:38;H226:40;H335:38;H332:38;H302:40;H319:39
114911,"Hexahydro-1,3,5-trimethyl-1,3,5-triazine",203-612-8,108-74-7,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,73,H412:70;H318:32;H314:70;H317:70;H302:71;H226:60;H373:62;H335:20;H315:2;H312:1;H332:1;H319:2;Not classified:1
114912,4-Bromo-1-chloro-2-fluorobenzene,612-035-4,60811-18-9,,Notified C&L,7,H319:6;H335:6;H315:7
114916,7-(β-D-galactopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one,228-185-5,6160-78-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
114917,"Guanidine, cyano-, reaction products with ammonium chloride and formaldehyde",284-029-6,84777-03-7,Acute Tox. 4,Notified C&L,22,H302:17;Not classified:5
114918,"2,2-Dichloro-1-[5-(2-furyl)-2,2-dimethyl-1,3-oxazolidin-3-yl]ethanone",601-807-6,121776-33-8,Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 2,Notified C&L,157,H302:157;H317:119;H411:119
114920,"Tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",235-422-6,12224-02-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1;H315:1
114921,"Methyl N-[3-(acetylamino)-4-[(2,4-dinitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-β-alaninate",274-828-8,70729-65-6,Not Classified,REACH registration C&L,30,Not classified:30
114924,Methyl (Z)-hexadec-9-enoate,214-303-2,1120-25-8,Not Classified,Notified C&L,6,Not classified:4;H319:2;H335:2;H315:2
114925,diquat dibromide,201-579-4,85-00-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H315:0;H335:0;H317:0;H410:0;H302:0;H372:0;H319:0;H400:0
114937,"Cuprate(4-), [μ-[[3,3'-[azobis[(2-hydroxy-4,1-phenylene)azo]]bis[4-hydroxy-6-[(3-sulfophenyl)amino]-2-naphthalenesulfonato]](8-)]]di-, ammonium sodium",276-982-1,72905-97-6,Not Classified,REACH registration C&L,11,Not classified:11
114938,Tricalcium dinitride,234-592-9,12013-82-0,Water-react. 2;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Notified C&L,213,H314:213;H261:171;H331:171;H400:171;H260:38;H228:4
114942,Pyrophosphoric acid,219-574-0,2466-09-3,Skin Corr. 1B,Notified C&L,114,H314:81;H302:38;Not classified:33
114946,"Oleic acid, copper salt",233-866-5,10402-16-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,72,H411:9;H302:11;H400:4;Not classified:61;H332:7;H312:7;H410:2
114952,"Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11β,16β)-",205-797-0,151-73-5,Acute Tox. 4,Notified C&L,95,H302:49;H330:45;H372:37;H360:49;H410:36;H317:10;H373:14;H341:1;H362:1;H361:3;H413:1;H332:1;H411:1
114955,"bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;thiocyclam-oxalate",250-859-2,31895-22-4,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H312:0;H400:0
114958,N-3-bromopropylphthalimide,226-738-5,5460-29-7,,Notified C&L,3,Not classified:1;H319:2;H335:1;H315:2;H302:1
114960,Sodium 4-nitrotoluene-2-sulphonate,226-062-0,5258-64-0,Not Classified,Notified C&L,1,Not classified:1
114965,"2-chloro-4,6-dinitrophenol",213-419-0,946-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114968,"Trisodium bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-5-nitrobenzene-1-sulphonato(3-)]chromate(3-)",282-437-9,84204-63-7,,Notified C&L,1,H319:1
114969,"4,9-diazoniadodecamethylenediammonium tetrachloride",206-189-8,306-67-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H315:45;H335:3;H302:1
114974,Potassium hydrogen 9(or 10)-(sulphonatooxy)octadecanoate,270-640-5,68473-93-8,Eye Dam. 1,Notified C&L,21,H318:21
114975,Ethoxydimethylphenylsilane,217-366-4,1825-58-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
114976,"2,3,3a,4,5,8,9,11a-octahydro-10-(hydroxymethyl)-6-methyl-3-methylene-2-oxocyclodeca[b]furan-4-yl 3,4-dihydroxy-2-methylenebutyrate",246-221-8,24394-09-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H335:2;H315:2;H302:1
114977,"2,4-difluorobenzophenone",285-297-7,85068-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
114983,"Pittosporum viridiflorum, ext.",297-192-3,93348-49-3,Not Classified,Notified C&L,52,Not classified:52
114984,"9-Octadecenoic acid (Z)-, isodecyl esters, sulfated, sodium salts",295-072-5,91782-96-6,Not Classified,Notified C&L,6,Not classified:6
114985,"2,5-cyclohexadien-1-one, 4-[[4-(phenylamino)phenyl]imino]-, reaction products with sodium sulfide (Na2(Sx)), thiosulfonated",215-485-6,1327-60-2,Not Classified,Notified C&L,37,Not classified:37
114995,ethyl N,434-630-6,60372-77-2,Eye Dam. 1;Aquatic Acute 1,Harmonised C&L,0,H318:0;H400:0
115001,Pent-4-en-1-ol,212-473-2,821-09-0,Flam. Liq. 3,Notified C&L,46,H226:46
115003,"Bis(cyano-C)bis(1,10-phenanthroline-N1,N10)iron",238-833-9,14768-11-7,Acute Tox. 3,Notified C&L,38,H301:38
115004,"5-((6-(ethyl(phenyl)amino)-1,3,5-triazin-2-yl)amino)-3-((E)-(5-((propanoyl)amino)- phenyl)diazenyl)-4-hydroxy polycarbocyclyl, polysulfonate, polyhalogeno, sodium salt",415-950-5,,Skin Sens. 1B,REACH registration C&L,2,H317:1;Not classified:1
115005,Decane,204-686-4,124-18-5,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,1812,H304:1732;H226:1600;H332:85;H319:74;H335:73;H315:114;H225:22;H302:30;Not classified:11;H331:8;H311:8;H400:8;H411:4
115011,"Fatty acids, vegetable-oil, Me esters, chlorinated",305-774-6,95009-45-3,Not Classified,Notified C&L,1,Not classified:1
115013,"3,3,5-trimethylcyclohexyl acrylate",289-200-9,86178-38-3,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,464,H315:464;H335:463;H317:20;H411:463;H319:464;H400:6
115014,"4,6-dimethoxypyrimidin-2-amine",252-969-6,36315-01-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,230,H319:50;H335:48;H315:50;H332:156;H302:170;H312:156;Not classified:11;H410:1
115017,L-valine,200-773-6,72-18-4,Not Classified,REACH registration C&L,423,Not classified:423
115019,"7,6-benzo-1,3-diazaspiro(4,5)decane-2,4-dione",257-658-9,52094-70-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
115020,"Mannanase, endo-1,4-β-",253-446-5,37288-54-3,Resp. Sens. 1,REACH registration C&L,204,H334:203;Not classified:1
115021,"2-hydroxyethanesulphonic acid, compound with 4,4'-[hexane-1,6-diylbis(oxy)]bis[3-bromobenzenecarboxamidine] (2:1)",299-116-4,93856-83-8,Not Classified,Notified C&L,3,Not classified:3
115024,sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate,618-852-2,92484-48-5,Eye Dam. 1,Notified C&L,79,H318:79
115026,Tetrahydrofuran--borane,237-881-8,14044-65-6,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,150,H318:112;H315:150;H225:150;H302:112;H260:137;H319:38;H335:25;H261:4;H351:1;H336:1
115030,"4,5-dihydro-1-(4-nitrophenyl)-5-oxo-1H-pyrazole-3-carboxylic acid",263-399-2,62084-02-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
115031,Triethoxysilane,213-650-7,998-30-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,107,H330:99;H318:33;H315:31;H226:99;H302:31;H314:68;H252:22;H260:22;Not classified:8;H335:2;H301:1;H311:1
115032,"sodium (5s,8s)-8-methoxy-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-ide",929-513-6,1400584-86-2,Not Classified,REACH registration C&L,2,Not classified:2
115039,Cinnamyl benzoate,226-180-2,5320-75-2,Not Classified,Notified C&L,233,Not classified:233
115040,"Ethanamine, 2-(1-bicyclo[2.2.1]hept-5-en-2-yl-1-phenylethoxy)-N,N-diethyl-",611-926-5,59985-93-2,Acute Tox. 4,Notified C&L,38,H302:38
115041,"5-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione",208-309-4,521-31-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:52;H335:50;H315:52;H302:7;H371:1;Not classified:1
115043,"Phosphoric acid, C16-18-alkyl esters, compds. with triethanolamine",291-898-5,90506-37-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:1;H315:1;H319:1
115045,1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium hydrogen sulphate,281-853-8,84041-73-6,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
115049,Disodium 5-[(4-hydroxyphenyl)azo]-8-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]naphthalene-2-sulphonate,286-587-6,85283-58-5,,Notified C&L,33,Not classified:33
115050,Potassium decanoate,235-910-9,13040-18-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,61,H319:56;H315:56;Not classified:5
115052,"Hydrocarbons, C11-C14, n-alkanes, isoalkanes, cyclics, aromatics (2-25%)",925-653-7,,Asp. Tox. 1;Aquatic Chronic 3,REACH registration C&L,4,H412:4;H304:4
115054,Allyl butyrate,218-129-8,2051-78-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1562,H301:1562;H318:1;H315:1562;H226:1562;H311:1562;H319:1561;H335:38;H312:1;H302:1
115055,O-benzoyl-N-(1-methyl-2-oxo-2-phenylethylidene)hydroxylamine,241-321-8,17292-57-8,Not Classified,Notified C&L,1,Not classified:1
115059,"1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl-, 1-oxide, trans-",600-785-5,106900-12-3,Acute Tox. 3;Repr. 2,Notified C&L,3,H301:3;H361:2;H412:1;H319:1
115062,1-(1-chlorocyclopropyl)ethanone,613-147-6,63141-09-3,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,34,H412:34;H302:34;H317:34;H226:34
115063,"2-Propenoic acid, polymer with 2-aminoethanol, (chloromethyl)oxirane, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 4,4'-(1-methylethylidene)bis[phenol] and oxirane",606-328-6,194944-42-8,Eye Irrit. 2,Notified C&L,83,H319:83
115068,"Methyl 3'-amino-[1,1'-biphenyl]-3-carboxylate hydrochloride",605-522-8,168619-25-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115075,cis-4-isopropylcyclohexanecarboxylic acid,230-385-2,7084-93-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115079,"Soaps, stocks, C16-18 and C18-unsatd. alkyl",272-858-6,68918-38-7,Not Classified,Notified C&L,1,Not classified:1
115081,2-methoxybenzaldehyde,205-171-7,135-02-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1454,H319:1452;H335:1447;H315:1452;Not classified:2;H303:1
115082,"Bis[4,4'-dimethoxy-α,α'-stilbenedithiolato(2-)]nickel",254-212-5,38951-97-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H301:1;H331:1;H311:1;H372:1;H350:1;H317:1;H334:1
115085,"Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (1:1) (salt)",259-581-6,55297-96-6,Acute Tox. 4,Notified C&L,57,H302:50;H319:8;H335:8;H315:5;H410:4;H400:3;H412:1;Not classified:1;H332:2;H312:2;H411:1
115086,"Methanone, [3-[2-(3-chlorophenyl)ethyl]-2-pyridinyl](1-methyl-4-piperidinyl)-, hydrochloride (1:1)",601-629-9,119770-60-4,,Notified C&L,1,H302:1;H410:1;H318:1;H400:1
115088,2-methylbicyclo[2.2.1]heptane-2-carboxylic acid,251-070-6,32508-22-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115094,Promazine,200-382-0,58-40-2,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,157,H302:157;H317:157;H411:157
115097,"1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid",604-773-0,151096-09-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,25,H412:24;H302:25;H319:24
115098,"Bastnaesite, calcined conc.",272-694-5,68909-13-7,Skin Corr. 1B,Notified C&L,42,H314:38;Not classified:3;H317:1;H318:1;H411:1
115099,"O,O'-dioctadecylpentaerythritol bis(phosphite)",223-276-6,3806-34-6,Aquatic Chronic 4,REACH registration C&L,159,H413:9;Not classified:101;H340:38;H360:38;H319:11
115102,Iproniazid,200-218-8,54-92-2,Acute Tox. 4,Notified C&L,1,H302:1
115104,3-aminoquinuclidine dihydrochloride,229-424-6,6530-09-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H302:5;H319:4;H335:4;H315:4;H332:1;H312:1;Not classified:1
115107,"Exo-2-methoxy-1,7,7-trimethylbicyclo[2.2.1]heptane",226-228-2,5331-32-8,,Notified C&L,1442,H226:1404;H319:38;H335:38;H315:38
115111,"Naphtha (petroleum), hydrotreated heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-150-3,64742-48-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
115113,sodium;2-chloroprop-2-enoate;hydrate,608-818-5,32997-86-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;STOT SE 1,REACH registration C&L,2,H301:1;H331:1;H311:1;H317:1;H370:1;H319:1;H315:1
115115,1-amidino-2-thiourea,218-308-0,2114-02-5,Acute Tox. 4;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,48,H402:2;H412:2;H302:9;H373:2;H319:40;H335:40;H315:40;H361:5;H317:1;H271:1;H332:1;H312:1
115117,"α,α,4-trimethylcyclohex-3-ene-1-methanethiol",275-223-1,71159-90-5,Not Classified,Notified C&L,1485,Not classified:1481;H302:3;H319:1;H315:1
115121,m-(1-cyanoethyl)benzoic acid,226-897-0,5537-71-3,Eye Irrit. 2,REACH registration C&L,43,H319:3;H302:41;H317:39;H318:39;H315:1
115126,"Fatty acids, animal",309-567-1,100403-25-6,Not Classified,Notified C&L,5,Not classified:5
115130,Benzen dienyl- polymer s ethenylbenzenem a ethenylethylbenzenem,622-577-3,69011-19-4,,Notified C&L,35,Not classified:33;H319:2;H228:2
115131,4-fluorotoluene,206-520-6,352-32-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,78,H315:41;H312:39;H332:72;H225:78;H302:39;H319:41;H335:6
115132,"Trisiloxane, 3-ethyl-1,1,1,3,5,5,5-heptamethyl-",469-070-1,17861-60-8,Flam. Liq. 3,REACH registration C&L,17,H226:17
115133,1H-imidazole-4-propylamine dihydrochloride,255-103-5,40836-55-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115140,Trimethyl(2-propionylthioethyl)ammonium chloride,217-482-5,1866-73-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
115142,"(3R,5R)-3,5-dihydroxy-7-((1R,2S,6S,8R,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-heptanoic acid monosodium salt",617-202-5,81131-70-6,Carc. 2;Repr. 2;Lact.,Notified C&L,8,H351:4;H362:5;H360:3;H361:6;H372:1;H411:1;H315:1
115145,"Thyme, Thymus capitatus, ext.",290-371-7,90131-59-2,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1622,H412:1430;H304:1617;H315:1620;H317:1620;H302:1619;H319:1609;H311:320;H312:11;H411:4;H314:1;H226:1;H318:1
115146,1-[(2R)-1-ethylpyrrolidin-2-yl]methanamine,607-159-0,22795-97-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:41;H315:38;H226:40;H335:39;H302:39;H314:3;H312:1
115150,"2,6-Pyridinedicarboxylicacid, 2,6-diethyl ester",605-063-3,15658-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12,H319:12;H335:12;H315:12
115151,"4,6-dichloropyrimidin-5-ylamine",226-503-7,5413-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
115153,Tetrabenazine,200-383-6,58-46-8,Acute Tox. 4,Notified C&L,43,H302:42;H361:1
115155,"Pyrene-1,3,6,8-tetrasulphonic acid",229-423-0,6528-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
115156,"Disodium 4,4'-[1,3-phenylenebis[azo(4,6-diamino-3,1-phenylene)azo]]bis(benzenesulphonate)",228-375-8,6252-62-6,Not Classified,Notified C&L,58,Not classified:48;H319:10;H315:10
115157,2-benzothiazol-2-ylphenol,222-299-9,3411-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
115159,"Thyme, Thymus hyemalis, ext.",294-872-1,91770-85-3,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H304:2;H226:2;H314:2;H317:2;H302:2;H411:2
115160,8-isopropyl-6-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde,267-308-7,67845-30-1,Skin Sens. 1,Notified C&L,275,H317:274;Not classified:1
115162,Sodium 7-hydroxynaphthalene-2-sulphonate,205-200-3,135-55-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,38,H318:38;H315:38
115163,Diethylmethylsilane,212-080-6,760-32-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38;H225:38
115164,"Glycerides, corn-oil mono- and di-",287-489-6,85536-08-9,Not Classified,Notified C&L,22,Not classified:22
115165,"(1S)-(-)-1-Phenyl-1,2-ethandiyl-bis[4-(trans-4-pentylcyclohexyl)benzoat]",605-415-6,165660-09-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
115166,Hexyl salicylate,228-408-6,6259-76-3,Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,1897,H317:1865;H410:1864;H400:1728;H315:572;H319:292;H411:33;Not classified:1;H335:1;H361:1
115170,"Trisodium 7-[[4-chloro-6-[ethyl[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxy-2-sulphonatophenyl)azo]naphthalene-2-sulphonate",280-489-7,83567-04-8,Not Classified,REACH registration C&L,23,Not classified:19;H319:4
115172,Hexaphenyldistannathiane,201-060-2,77-80-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H331:38;H311:38;H410:38;H400:38
115173,4-aminobenzanilide,212-313-1,782-45-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,127,H317:127;H319:127;H315:127
115175,1-Amino-1-cyclopropanecarboxylic acid hydrochloride,614-722-4,68781-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
115177,2-methoxyethyl acetate;methylglycol acetate,203-772-9,110-49-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1B,Harmonised C&L,0,H332:0;H302:0;H312:0;H360:0
115185,"O,O-didodecyl hydrogen dithiophosphate",227-901-3,6028-51-9,,Notified C&L,1,Not classified:1
115187,Circulin,232-717-1,9008-54-2,Not Classified,Notified C&L,1,Not classified:1
115188,"2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione",610-201-0,446292-08-6,,REACH registration C&L,6,H411:4;H332:1;H302:1;H312:1;H319:1;H335:1;H315:1
115191,Acrylic anhydride,218-128-2,2051-76-5,,Notified C&L,2,H332:2;H302:2;H312:2;H314:2
115193,1-Butyl-3-methylimidazolium Iodide,619-502-1,65039-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
115195,Heptane-1-nitrile,211-071-4,629-08-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:39;H312:43;H226:43;H335:38;H332:43;H302:43;H319:39
115197,4-hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonic acid,246-758-8,25251-42-7,Not Classified,REACH registration C&L,5,Not classified:5
115199,"Fatty acids, coco, iso-Bu esters",294-304-2,91697-43-7,Not Classified,REACH registration C&L,3,Not classified:3
115201,Tetrakis(hydroxymethyl)phosphonium chloride,204-707-7,124-64-1,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Carc. 1B;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,220,H301:131;H318:211;H400:21;H314:110;H317:22;H350:4;H411:119;H290:21;H361:11;H302:89;H330:89;H315:110;H312:72;H334:38;H311:39;H360:11;H410:1
115204,1-(1H-indol-3-yl)propan-1-one,245-104-9,22582-68-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
115211,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-, N,N'-bis(p-anisyl and Ph) derivs.",290-823-3,90268-23-8,Not Classified,REACH registration C&L,41,Not classified:41
115215,"3-aminomethyl-3,5,5-trimethylcyclohexylamine",220-666-8,2855-13-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H312:0;H314:0;H317:0;H302:0
115220,Dihexadecylamine,240-779-6,16724-63-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
115221,Pentadecane-1-sulphonic acid,250-501-5,31169-63-8,Not Classified,Notified C&L,5,Not classified:5
115226,Methyl α-D-glucoside,202-571-3,97-30-3,Not Classified,REACH registration C&L,460,Not classified:460
115232,"2-Propenenitrile, polymer with 1,1-dichloroethene",921-913-9,9010-76-8,,Notified C&L,4,H351:4;H319:4;H335:4;H315:4
115234,γ-ethoxy-4-methylbenzenebutyronitrile,281-222-7,83898-14-0,Acute Tox. 4,Notified C&L,38,H302:38
115236,Reaction products of tetrahydrofurfuryl alcohol with ethylene oxide,608-659-1,31692-85-0,Eye Irrit. 2;Repr. 1B,REACH registration C&L,5,H319:3;H360:2;Not classified:2
115238,Phenyl dihydrogen phosphate,211-857-7,701-64-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,61,H319:40;H315:40;H314:16;Not classified:5
115243,"Tris(2,2,6,6-tetramethylheptane-3,5-dionato-O,O')gadolinium",238-834-4,14768-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
115250,"Extract residues (coal), naphthalene oil alk., distn. residues;Methylnaphthalene Oil Extract Residue;[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220°C to 300°C (428°F to 572°F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]",292-628-9,90641-05-7,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
115251,"Xylosidase, α-",258-495-6,53362-86-0,Resp. Sens. 1,Notified C&L,1,H334:1
115252,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with glycerol, propoxylated",500-115-0,52409-10-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,21,H334:20;H315:20;H335:20;H332:20;H317:20;H351:20;H373:20;H319:20;Not classified:1
115253,Tin zinc oxide (SnZnO3),405-290-6,12036-37-2,Not Classified,REACH registration C&L,1,Not classified:1
115257,"2-tert-Butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine",619-312-9,98015-45-3,Skin Corr. 1B,Notified C&L,40,H314:40;H226:2;H318:1
115260,"Octasodium 2,2'-[1,4-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(1-hydroxy-3,6-disulphonatonaphthalene-2,8-diyl)azo]]bisnaphthalene-1,5-disulphonate",275-108-6,71002-20-5,Not Classified,REACH registration C&L,65,Not classified:44;H412:10;H290:10;H319:11;H317:1;H334:1;H315:1
115262,Hexamethyldisilathiane,222-201-4,3385-94-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H226:43;H301:38;H331:38;H311:38;H319:5;H335:5;H315:5;H332:1;H302:1;H312:1;H225:1
115263,"reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate",410-065-0,,Skin Sens. 1,Harmonised C&L,0,H317:0
115267,Norethisterone enantate,223-326-7,3836-23-5,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 4,Notified C&L,41,H351:40;H360:40;H362:24;H413:24;H312:17;H332:17;H302:17;H315:1;H335:1;H319:1
115272,"Benzo[1,2-b:4,5-b']difuran-2,6-dione, 3-(4-butoxyphenyl)-7-phenyl-",605-194-6,159968-00-0,Not Classified,Notified C&L,2,Not classified:2
115274,"3-[[4-[[4-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-6(or 7)-sulpho-1-naphthyl]azo]-1-naphthyl]azo]naphthalene-1,5-disulphonic acid",301-263-7,93982-74-2,Not Classified,Notified C&L,2,Not classified:2
115278,"Gases (petroleum), reformer effluent low-pressure flash drum off;Refinery gas;[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]",271-005-5,68513-19-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H220:0;H340:0;H350:0
115281,"Phosphoric acid, mono- and di-C8-16-alkyl esters",291-935-5,90506-70-0,Skin Irrit. 2,Notified C&L,2,H317:1;H315:1;Not classified:1
115282,5-fluoro-1H-indole-2-carboxylic acid,206-919-5,399-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
115285,7-chloroquinoline-8-carboxylic acid,617-994-2,87293-44-5,Acute Tox. 5;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H303:1;H319:1;H335:1;H315:1
115291,Arginine,200-811-1,74-79-3,Not Classified,REACH registration C&L,1707,Not classified:1470;H319:237;H315:36;H335:2;H372:1;H351:1
115294,Trisodium 6-[(4-amino-2-hydroxyphenyl)azo]-3-[[4-[[4-[[7-[(4-amino-2-hydroxyphenyl)azo]-1-hydroxy-3-sulphonato-2-naphthyl]azo]phenyl]amino]-3-sulphonatophenyl]azo]-4-hydroxynaphthalene-2-sulphonate,279-047-6,79057-88-8,Not Classified,Notified C&L,1,Not classified:1
115295,1-bromo-3-methylbutane,203-522-9,107-82-4,Flam. Liq. 3;Aquatic Chronic 2,REACH registration C&L,52,H226:9;H411:10;H302:41;H315:49;H335:47;H225:44;H319:9;Not classified:2;H412:3
115296,S-(2-carboxyethyl)-L-cysteine,223-717-2,4033-46-9,,Notified C&L,4,Not classified:3;H332:1;H302:1;H312:1
115298,"Phosphoric acid, iron salt",233-867-0,10402-24-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13,H319:13;H315:13
115299,"difenacoum (ISO);3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin",259-978-4,56073-07-5,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H300:0;H330:0;H360:0;H410:0;H372:0;H400:0;H310:0
115301,"Cypress, Cupressus sempervirens, ext.",283-626-9,84696-07-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1639,H304:1637;H315:17;H226:1637;H317:1636;H411:61;H410:1390;H400:1354;Not classified:1;H319:2
115305,1-(3-methyl-2-thienyl)ethan-1-one,237-179-1,13679-72-6,Not Classified,Notified C&L,93,Not classified:88;H302:5
115310,5-bromo-6-methylpyridin-2-amine,255-927-5,42753-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H312:4;H332:4;H302:4
115313,Chlorosulphonyl isocyanate,214-715-2,1189-71-5,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,85,H302:85;H314:85;H334:45;H330:24;H332:14;H312:14;H318:1;H290:1;Not classified:1;H317:3
115315,"5-(1,1-dimethylheptyl)resorcinol",260-193-4,56469-10-4,,Notified C&L,5,H319:4;H335:3;H315:4;H332:1;H302:1;H312:1
115316,(Z)-non-6-enyl acetate,278-397-7,76238-22-7,Not Classified,Notified C&L,90,Not classified:89;H302:1;H317:1;H319:1;H315:1
115321,4-Chloro-3-nitropyridine,603-447-5,13091-23-1,Acute Tox. 3;Eye Dam. 1,Notified C&L,45,H301:41;H318:40;H302:4;H319:5;H335:5;H315:4;H331:1;H311:1;H314:1
115324,2-hydroxyethylammonium chloride,217-900-6,2002-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,213,H319:185;H335:205;H315:185;H412:21;H318:21;H312:21;H332:21;H314:21;H302:21;H290:22;Not classified:7
115330,"tert-butyl 2-[(2S,3S)-2-(benzyloxy)pentan-3-yl]hydrazinecarboxylate",606-022-2,184177-88-6,Not Classified,Notified C&L,1,Not classified:1
115332,"Paraffin waxes and Hydrocarbon waxes, oxidized, alkali metal salts",614-807-6,68918-93-4,Not Classified,Notified C&L,5,Not classified:5
115333,3-Aminopiperidine,611-081-2,54012-73-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H318:1;H302:1;H335:1
115337,"Urea, N-[(1R)-3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propyn-1-yl]-N-hydroxy-",604-947-6,154355-76-7,Acute Tox. 4,Notified C&L,38,H302:38
115345,3-(methylthio)aniline,217-232-5,1783-81-9,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,47,H301:2;H318:2;H331:2;H311:6;H317:2;H410:2;H351:2;H372:2;H341:2;H400:2;H319:45;H335:40;H315:45;H332:6;H302:7;H312:2
115346,4-methyl-2-oxo-2H-1-benzopyran-7-yl β-D-glucopyranosiduronic acid,228-186-0,6160-80-1,Not Classified,Notified C&L,2,Not classified:2
115351,"1-(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane",222-384-0,3454-29-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,170,H412:104;H317:130;H319:114;H315:120;H318:39;H334:39;H335:39;H302:16;H312:16;H411:10;Not classified:1
115355,Hydrogen [1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),257-804-1,52277-71-1,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,9,H317:7;H319:8;Not classified:1;H335:1;H315:1
115357,Ethyl 2-bromodecanoate,230-226-7,6974-85-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H302:39;H319:39;H413:39
115362,"5-amino-3-morpholin-4-yl-1,2,3-oxadiazolidin-3-ium chloride",605-254-1,16142-27-1,Flam. Sol. 1;Self-react. B;Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,2,H241:1;H317:1;H228:1;H302:2;H411:1
115363,[(phenylmethoxy)methoxy]methanol,252-570-7,35445-70-6,Not Classified,Notified C&L,3,Not classified:3
115365,Tin(2+) neodecanoate,256-370-0,49556-16-3,Skin Corr. 1;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,4,H314:3;H317:3;H318:3;H413:1
115367,"reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate",428-400-4,,Eye Dam. 1,Harmonised C&L,0,H318:0
115368,Benzo[b]fluorene,205-952-2,243-17-4,Not Classified,Notified C&L,3,Not classified:3
115369,"[1,4'-bipiperidine]-4'-carboxamide dihydrochloride",280-605-6,83732-56-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H319:1;H335:1;H315:1
115377,"4-hydroxy-5-[(2-hydroxy-1-naphthyl)azo]-3-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt",300-406-0,93940-13-7,Not Classified,Notified C&L,2039,Not classified:2039
115379,o-aminobenzenesulphonamide,221-988-1,3306-62-5,Eye Irrit. 2,Notified C&L,39,H319:39
115385,"Hydrogen 3,6-bis(diethylamino)-9-(2,4-disulphonatophenyl)xanthylium, sodium salt",222-529-8,3520-42-1,Not Classified,REACH registration C&L,1766,Not classified:1686;H319:75;H335:40;H315:66;H412:2;H317:1
115387,Oxyphenbutazone,204-936-2,129-20-4,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39,H302:39;H400:39;H410:1
115389,4-[[5-(anilino)carbonyl-2-methoxyphenyl]azo]-3-hydroxy-N-phenylnaphthalene-2-carboxamide,229-099-0,6410-29-3,Not Classified,Notified C&L,34,Not classified:34
115391,Dilithium azelate,254-184-4,38900-29-7,Acute Tox. 4,REACH registration C&L,226,H302:121;Not classified:58;H319:47;H315:47
115395,"Fatty acids, tallow, hydrogenated, calcium salts",266-106-6,66071-81-6,Not Classified,Notified C&L,9,Not classified:9
115396,"Phosphoric acid, mono- and di-C10-16-alkyl esters",291-936-0,90506-71-1,Eye Dam. 1,Notified C&L,8,H314:8;H318:8
115397,"(S)-3,7-dimethyloct-7-enyl phenylacetate",234-003-5,10486-14-3,Not Classified,Notified C&L,88,Not classified:88
115399,"4-hydroxy-5-[[(2-hydroxyphenyl)methylene]amino]naphthalene-2,7-disulphonic acid",250-975-3,32266-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2
